Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LDLR,Low-density lipoprotein receptor,40356,-0.210036826603314,0.00462714617283922,-0.219106033102079,-0.200967620104549,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFGE8,Lactadherin,40332,-0.157232884920014,0.00375306549602071,-0.164588893292215,-0.149876876547814,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PON3,Serum paraoxonase/lactonase 3,40422,0.0913109625702305,0.00246746934795561,0.0864747226482375,0.0961472024922235,1.11274404392059e-287
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOM,Apolipoprotein M,40372,0.0877459555450725,0.00241727715872873,0.0830080923139642,0.0924838187761809,2.88170209284958e-277
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,40411,0.0933115042711732,0.00287575922337973,0.0876750161933489,0.0989479923489975,1.01535206513693e-223
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGRP,Agouti-related protein,40516,-0.153397563290741,0.00485951564977472,-0.162922213964299,-0.143872912617182,3.06767110895911e-212
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASGR1,Asialoglycoprotein receptor 1,40228,-0.0800023960019801,0.00267320136346045,-0.0852418706743626,-0.0747629213295976,1.85352586621692e-191
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,-0.086098716052634,0.00292101731968072,-0.0918239099992082,-0.0803735221060598,6.2448504813038e-186
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCG,Pro-glucagon,39980,-0.335803895770182,0.0113952038676841,-0.358138495350843,-0.313469296189521,9.00224847654138e-186
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GDF15,Growth/differentiation factor 15,40536,-0.115306118028188,0.00393955122544232,-0.123027638430055,-0.107584597626321,1.61648322691871e-183
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRAP1,Proline-rich acidic protein 1,37998,-0.112073702902527,0.00387957678885668,-0.119677673408686,-0.104469732396368,3.99925322972105e-178
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,40332,0.08255392731756,0.00287078022274572,0.0769271980809784,0.0881806565541417,2.53827085647096e-177
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD4,T-cell surface glycoprotein CD4,40309,-0.080121132183657,0.00278748178782531,-0.0855845964877946,-0.0746576678795194,3.71849508468045e-177
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,40313,-0.144659640129617,0.00504061392238329,-0.154539243417489,-0.134780036841746,1.24771199548747e-176
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPR37,Prosaposin receptor GPR37,40042,-0.172628793287751,0.00614995779547176,-0.184682710566876,-0.160574876008627,3.56753690166651e-169
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPL,Lipoprotein lipase,40359,0.115898501452009,0.0042045842115286,0.107657516397413,0.124139486506605,1.98681670417796e-163
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLTP,Phospholipid transfer protein,40461,0.0854874208762406,0.00313941172648119,0.0793341738923375,0.0916406678601437,1.20292425841092e-159
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,-0.168293881207375,0.00618787362636504,-0.180422113515051,-0.1561656488997,3.07803155381199e-159
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS8,Prostasin,40293,-0.100627682938352,0.00370396599849481,-0.107887456295402,-0.0933679095813027,6.7255811096627e-159
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOS3,"Nitric oxide synthase, endothelial",39961,-0.135932625431203,0.00501266749670749,-0.14575745372475,-0.126107797137657,2.90714219306196e-158
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,40063,-0.104310161488554,0.00388632411547547,-0.111927356754886,-0.096692966222222,3.55685842764573e-155
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADIPOQ,Adiponectin,38013,0.164019079034593,0.00612791321113082,0.152008369140777,0.17602978892841,7.72315948518589e-154
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,-0.092464908587753,0.00350351759609426,-0.0993318030760978,-0.0855980140994083,2.66028006169468e-150
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF1,Macrophage colony-stimulating factor 1,40422,-0.0640416987557173,0.002491079766705,-0.0689242150984591,-0.0591591824129755,7.46155467907699e-143
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPY,Pro-neuropeptide Y,40489,-0.155075003478357,0.00612681349770581,-0.16708355793386,-0.143066449022853,1.25877540242841e-138
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PYY,Peptide YY,37562,-0.221818502730709,0.00875202869351873,-0.238972478970006,-0.204664526491413,2.14175132877352e-138
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40489,-0.0764285353981875,0.003031828703882,-0.0823709196577962,-0.0704861511385788,1.51128964462146e-137
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN1,CCN family member 1,40280,-0.179885201125826,0.00716687902605211,-0.193932284016889,-0.165838118234764,2.30509693717311e-136
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFF3,Trefoil factor 3,40309,-0.123568097299395,0.00492453457977586,-0.133220185075755,-0.113916009523034,2.71204567827036e-136
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL13,C-X-C motif chemokine 13,40471,-0.143531606934988,0.00583179696866695,-0.154961928993575,-0.1321012848764,2.55936872864808e-131
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KITLG,Kit ligand,40359,0.0822174435358424,0.0033550047149504,0.0756416342945396,0.0887932527771451,3.27962942148927e-130
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,-0.0880227229330021,0.00359194179379537,-0.095062928848841,-0.0809825170171632,3.35987130943747e-130
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,-0.103180339367078,0.00422651005188967,-0.111464299068782,-0.0948963796653744,3.17268001395171e-129
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS4,Galectin-4,40357,-0.118162726417542,0.00487534727073072,-0.127718407068174,-0.108607045766909,1.84809759115792e-127
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOF,Apolipoprotein F,37987,0.0542959745432244,0.00223957598609344,0.0499064056104813,0.0586855434759676,3.87103584852778e-127
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RTN4R,Reticulon-4 receptor,40489,-0.0751790618775906,0.00311851489074842,-0.0812913510634575,-0.0690667726917237,3.64437782417916e-126
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,-0.0854835370800949,0.0035886750743049,-0.0925173402257325,-0.0784497339344573,8.0844204672927e-123
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,-0.0755951753145148,0.00318134012527291,-0.0818306019600497,-0.0693597486689799,1.1040608840992e-122
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,-0.121363132872767,0.00512129641698464,-0.131400873850057,-0.111325391895477,5.40437139533906e-122
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,-0.0631765582386264,0.0026674034748899,-0.0684046690494107,-0.0579484474278422,6.67930453602936e-122
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGF,Placenta growth factor,40516,-0.0572314813111343,0.00242111886875548,-0.061976874293895,-0.0524860883283735,1.82352636446306e-121
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,-0.0670089942843607,0.00283604111938401,-0.0725676348783533,-0.061450353690368,2.48319327685118e-121
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,-0.0950097110171803,0.00403524885333406,-0.102918798769715,-0.0871006232646455,1.77307026388969e-120
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS9,Galectin-9,40350,-0.0698366535645491,0.00296694914034407,-0.0756518738796234,-0.0640214332494747,1.88785716547369e-120
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,-0.0711756554545483,0.00305875169452056,-0.0771708087758086,-0.065180502133288,8.26703574747243e-118
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL23,C-C motif chemokine 23,40422,-0.0877311622258281,0.00378185725746882,-0.095143602450467,-0.0803187220011892,4.09618492443931e-117
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTRK3,NT-3 growth factor receptor,40471,0.0465779545024487,0.00201324327602864,0.0426319976814326,0.0505239113234649,1.63115943285887e-116
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOA1,Apolipoprotein A-I,38013,0.0590922619799652,0.00256262176022599,0.0540695233299222,0.0641150006300081,1.94468187877292e-115
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MENT,Protein MENT,37671,0.0463285786372446,0.00201387164273226,0.0423813902174894,0.0502757670569998,7.41988368478438e-115
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD27,CD27 antigen,40411,-0.0847222609192099,0.0037593258948788,-0.0920905396731724,-0.0773539821652475,9.66714196511856e-111
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,-0.0755505639721513,0.00335374220163982,-0.0821238986873653,-0.0689772292569372,1.20835927938899e-110
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HGF,Hepatocyte growth factor,40516,-0.0711233083643558,0.00316194582156946,-0.0773207221746319,-0.0649258945540796,2.41517330831045e-110
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RARRES2,Retinoic acid receptor responder protein 2,40424,-0.0958146374157716,0.0042645458795215,-0.104173147339634,-0.0874561274919094,4.33721882683073e-110
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MXRA8,Matrix remodeling-associated protein 8,37671,0.0627941288327606,0.00283509215059975,0.057237348217585,0.0683509094479361,9.24916247758314e-107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOC1,Apolipoprotein C-I,37981,0.0740622404789803,0.00337123497979411,0.0674546199185839,0.0806698610393768,3.89755838651038e-105
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,40305,-0.110575224482767,0.005060971285255,-0.120494728201867,-0.100655720763667,2.75557130484002e-104
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGSF9,Protein turtle homolog A,37990,-0.161087096326034,0.00738178976709935,-0.175555404269549,-0.146618788382519,8.69348956491222e-104
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,-0.110147296757546,0.00507516324826349,-0.120094616724143,-0.10019997679095,6.10162016965608e-103
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40471,-0.0696220296392828,0.0032124597507552,-0.075918450750763,-0.0633256085278026,1.10819558887873e-102
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGA11,Integrin alpha-11,40341,0.0680134238278738,0.00314837693482165,0.0618426050356233,0.0741842426201242,4.95422346143087e-102
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,40264,-0.0532866104902263,0.00247468244170219,-0.0581369880759626,-0.04843623290449,2.18857798923962e-101
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTH,Parathyroid hormone,37572,-0.157880259092593,0.00733247880571754,-0.172251917551799,-0.143508600633387,4.37932584574266e-101
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,-0.122268553615058,0.00570654137982738,-0.13345337471952,-0.111083732510597,2.16116921917867e-100
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARB2,Lysosome membrane protein 2,40011,-0.0611428901952148,0.00285567870925883,-0.0667400204653621,-0.0555457599250675,2.93860669232466e-100
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMBP,Protein AMBP,40470,-0.0394425534322948,0.001849343704465,-0.0430672670930462,-0.0358178397715434,1.51063303572017e-99
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD5,T-cell surface glycoprotein CD5,40470,-0.0657838970349293,0.00308853047332512,-0.0718374167626465,-0.059730377307212,2.72766517144757e-99
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGAV,Integrin alpha-V,40489,0.0322353252478846,0.00151507819348632,0.0292657719886514,0.0352048785071178,4.38624829776726e-99
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37815,-0.0613608737096802,0.00288476691930658,-0.0670150168715211,-0.0557067305478393,9.1363552257578e-99
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,-0.0537110826030325,0.00252901136416196,-0.05866794487679,-0.0487542203292751,1.00123318218458e-98
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRIP2,Cysteine-rich protein 2,40228,-0.0708809815543573,0.00333814206408146,-0.077423739999957,-0.0643382231087577,1.11729901612351e-98
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OCLN,Occludin,37959,-0.0861169622959523,0.00405643770365597,-0.094067580195118,-0.0781663443967866,2.04285741753974e-98
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,40391,-0.0454271868703514,0.00214545982054629,-0.0496322881186221,-0.0412220856220806,3.74202207895967e-98
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASET2,Ribonuclease T2,40465,-0.0516726055292315,0.00244671610546569,-0.0564681690959443,-0.0468770419625188,1.13426334847659e-97
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,-0.0759668624626801,0.003598934069986,-0.0830207732398526,-0.0689129516855075,2.48958078726304e-97
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFNA4,Ephrin-A4,40203,-0.0572835152360024,0.00272370620431403,-0.0626219793964579,-0.0519450510755469,7.2268093864645e-97
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39535,-0.0739518792567319,0.00351818781506518,-0.0808475273742597,-0.0670562311392042,1.04638439106913e-96
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,-0.0721450452020262,0.00345499960533465,-0.0789168444284821,-0.0653732459755703,1.46677340206017e-95
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL15,C-C motif chemokine 15,40536,-0.0860687859496888,0.00412528432404633,-0.0941543432248196,-0.077983228674558,2.09276810601042e-95
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,-0.104984135831769,0.00504299993907068,-0.114868415712348,-0.095099855951191,5.82564631771351e-95
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,-0.0720660260336564,0.00346863071234872,-0.0788645422298599,-0.0652675098374529,1.30079996310754e-94
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSO,Cathepsin O,40516,-0.0577322542927811,0.00278386350863932,-0.0631886267697142,-0.0522758818158481,2.68658263031615e-94
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST3,Cystatin-C,40372,-0.0538579604778209,0.00260397819488368,-0.0589617577397929,-0.0487541632158489,8.41320712879279e-94
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,-0.139729141471886,0.00674818843375427,-0.152955590802044,-0.126502692141727,8.60062682196239e-94
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLUL1,Clusterin-like protein 1,40338,0.0871588445303773,0.00421667718539826,0.0788941572469967,0.0954235318137579,1.09855886138286e-93
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,-0.056874862333221,0.00275691232574911,-0.0622784104916892,-0.0514713141747527,2.44861016658812e-93
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGSF8,Immunoglobulin superfamily member 8,40359,-0.0562137268061072,0.00276820132143581,-0.0616394013961214,-0.050788052216093,1.56428372013915e-90
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMPRSS15,Enteropeptidase,40305,-0.172431278788091,0.00852229421226536,-0.189134975444131,-0.155727582132051,6.8319242262325e-90
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGFR,Epidermal growth factor receptor,40536,0.0306284278898719,0.00151931476874488,0.0276505709431319,0.0336062848366118,2.81584520496451e-89
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFA,Protransforming growth factor alpha,40341,-0.0894133060987419,0.00443589871474226,-0.0981076675796367,-0.0807189446178471,3.05712457043974e-89
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCAM,Cell surface glycoprotein MUC18,40403,0.0634958647359658,0.0031580643912877,0.0573060585290419,0.0696856709428897,8.22840163414683e-89
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NECTIN2,Nectin-2,40330,-0.053888655668745,0.00268078003662058,-0.0591429845405214,-0.0486343267969687,9.01925129270925e-89
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,40332,-0.0639437785433469,0.00319014120133473,-0.0701964552979629,-0.0576911017887308,2.79618615627738e-88
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CES1,Liver carboxylesterase 1,40352,-0.141313045523301,0.00705378668102702,-0.155138467418114,-0.127487623628488,3.42701941507175e-88
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300E,CMRF35-like molecule 2,40436,-0.0741671851155702,0.0037025366415241,-0.0814241569329574,-0.0669102132981829,3.53133689593718e-88
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,40359,0.0496646844354079,0.00249308646241051,0.0447782349690832,0.0545511339017325,3.09391840560737e-87
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMP1,Metalloproteinase inhibitor 1,40167,-0.0518310064282711,0.00260778379975687,-0.0569422626757946,-0.0467197501807476,7.71737582214424e-87
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL16,C-C motif chemokine 16,40536,-0.0974596852110999,0.00490780363270209,-0.107078980331196,-0.0878403900910038,1.02390153636393e-86
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AREG,Amphiregulin,40305,-0.0910340994794875,0.0045934981567519,-0.100037355866721,-0.0820308430922538,2.30609910685675e-86
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIGR,Polymeric immunoglobulin receptor,40154,-0.0641926874948796,0.00326089248913409,-0.0705840367735825,-0.0578013382161768,3.04727501616485e-85
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOD,Apolipoprotein D,37345,0.0819933049749239,0.00416048492042086,0.073838754530899,0.0901478554189487,3.31137052054477e-85
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT18,"Keratin, type I cytoskeletal 18",40305,-0.140256343751367,0.00713693286312362,-0.154244732163089,-0.126267955339644,5.672506956118e-85
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL27,C-C motif chemokine 27,40359,-0.108075856004171,0.00551455135885007,-0.118884376667517,-0.0972673353408249,1.58472784499585e-84
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBP5,Retinol-binding protein 5,40305,-0.100294131065539,0.005126997874919,-0.11034304690038,-0.0902452152306976,3.20501212497072e-84
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPY30,Protein dpy-30 homolog,40414,-0.107636231645382,0.00550690647324726,-0.118429768332947,-0.0968426949578177,4.31057192779604e-84
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE6,Ribonuclease K6,37917,-0.053941615546532,0.00276035302987159,-0.0593519074850804,-0.0485313236079837,7.03714199365224e-84
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL18R1,Interleukin-18 receptor 1,40516,-0.0580199766673593,0.00301812832754441,-0.0639355081893464,-0.0521044451453723,1.91887353665438e-81
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,-0.13501354360991,0.00702511142647068,-0.148782762005793,-0.121244325214027,3.13384304105302e-81
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,-0.0786282296110561,0.00409733080946152,-0.0866589979976007,-0.0705974612245115,3.62010849252276e-81
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGRN,Agrin,40422,-0.0590013819819525,0.00307891849049357,-0.0650360622233199,-0.0529667017405851,6.09680630754678e-81
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FURIN,Furin,40411,-0.0597121262643445,0.00312048828392165,-0.065828283300831,-0.0535959692278581,1.02331108454447e-80
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MVK,Mevalonate kinase,40044,-0.135400602649506,0.00708878261230995,-0.149294616569634,-0.121506588729379,2.0616639943013e-80
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSD,Cathepsin D,39243,-0.0705912269141443,0.00369871210210362,-0.0778407026342674,-0.0633417511940212,3.0727324634171e-80
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UMOD,Uromodulin,40502,0.0956550475273978,0.00503292185660508,0.0857905206884519,0.105519574366344,1.14223049652748e-79
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,-0.0606102840869983,0.00321746961333295,-0.0669165245291309,-0.0543040436448657,2.58570227132732e-78
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACE2,Angiotensin-converting enzyme 2,40042,-0.0853656867280677,0.00453923252345594,-0.0942625824740413,-0.0764687909820941,4.90181429822758e-78
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSC2,Desmocollin-2,40177,-0.0586662341241668,0.00312946739355409,-0.0647999902155329,-0.0525324780328008,1.44987093816309e-77
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NHLRC3,NHL repeat-containing protein 3,37370,-0.0558599037591153,0.00299102328216008,-0.0617223093921491,-0.0499974981260815,7.96912406012488e-77
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL10,C-X-C motif chemokine 10,40422,-0.116846170058633,0.00626725348312022,-0.129129986885549,-0.104562353231718,9.22727638611742e-77
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40453,-0.0725698898586978,0.00389254578225965,-0.0801992795919267,-0.0649405001254689,9.29952148871067e-77
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CKAP4,Cytoskeleton-associated protein 4,40457,-0.0451780096593599,0.00242684856967578,-0.0499346328559244,-0.0404213864627954,1.53361339841095e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,40341,-0.0650923545034786,0.00349809658217621,-0.071948623804544,-0.0582360852024132,1.79822921001704e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300LG,CMRF35-like molecule 9,40332,0.0650550218629473,0.0034961431436398,0.0582025813014133,0.0719074624244814,1.80937801882026e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL18BP,Interleukin-18-binding protein,40403,-0.0526675537214806,0.00283821967960956,-0.0582304642935154,-0.0471046431494459,4.55862935814436e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,0.0423318032437027,0.00228398430826791,0.0378551939994976,0.0468084124879078,6.91422798998754e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF23,Fibroblast growth factor 23,40469,-0.10602758944301,0.00572510632612224,-0.11724879784221,-0.0948063810438107,8.8383720996066e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37671,-0.0647503915343549,0.00351796968317829,-0.0716456121133843,-0.0578551709553254,1.0133624428475e-74
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL6A3,Collagen alpha-3(VI) chain,40536,-0.0586200173110682,0.00319056185232675,-0.0648735185416286,-0.0523665160805077,1.25392340434757e-74
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTSL2,ADAMTS-like protein 2,37998,-0.0530271201998883,0.00288474724854261,-0.0586812248070318,-0.0473730155927448,1.47580251715773e-74
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HLA_E,,40341,-0.0491056809665728,0.00267398629632891,-0.0543466941073774,-0.0438646678257681,1.49912446312151e-74
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL10RB,Interleukin-10 receptor subunit beta,40422,-0.0482819073065218,0.00264593276267793,-0.0534679355213705,-0.043095879091673,1.21014384375546e-73
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHI3L1,Chitinase-3-like protein 1,40054,-0.126089386069181,0.00691821439627682,-0.139649086285884,-0.112529685852478,1.86392034394166e-73
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHA1,Ephrin type-A receptor 1,40400,-0.057757814587442,0.0031711218623365,-0.0639732134376215,-0.0515424157372625,2.22656566415795e-73
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALCA,Calcitonin,40192,-0.0924399879481612,0.00510217820630452,-0.102440257232518,-0.0824397186638044,1.26146209891749e-72
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GZMA,Granzyme A,40516,-0.0591789546084944,0.00326830889650877,-0.0655848400456516,-0.0527730691713372,1.47930820739202e-72
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL7,Angiopoietin-related protein 7,40489,-0.0618832253617771,0.00343585152420842,-0.0686174943492256,-0.0551489563743286,8.13661813463543e-72
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GUSB,Beta-glucuronidase,40419,-0.0977687603308027,0.00542823799434481,-0.108408106799718,-0.0871294138618868,8.17806490397295e-72
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL9,C-X-C motif chemokine 9,40422,-0.112876082537499,0.00629752387099921,-0.125219229324658,-0.100532935750341,3.8191925218153e-71
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,40332,-0.072028805557076,0.00402819094977133,-0.0799240598186278,-0.0641335512955242,8.17200621172857e-71
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,40141,-0.245068100232306,0.0137468765005707,-0.272011978173424,-0.218124222291187,2.14924098427698e-70
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACY1,Aminoacylase-1,40359,-0.0982985250950716,0.00552607367427586,-0.109129629496652,-0.0874674206934909,4.16819278353604e-70
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,-0.0573598841540469,0.00322758599272303,-0.0636859526997841,-0.0510338156083098,5.5222257206647e-70
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPT2,Angiopoietin-2,40489,-0.0639025849115868,0.00359915111012991,-0.0709569210874415,-0.0568482487357322,7.35871993995409e-70
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFR2,Fibroblast growth factor receptor 2,40411,-0.0351897024817524,0.00198509406648846,-0.0390804868520697,-0.031298918111435,1.20715451526116e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFRA1,GDNF family receptor alpha-1,40453,-0.0456929576835489,0.00258538267479177,-0.0507603077261407,-0.040625607640957,3.04699347625749e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RETN,Resistin,40283,-0.0680789093532644,0.00385571493215329,-0.0756361106202848,-0.0605217080862439,4.1570852449396e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRPB1,Signal-regulatory protein beta-1,40335,-0.0738471644392024,0.00418322143979156,-0.0820462784611939,-0.065648050417211,4.39162016110533e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OXT,Oxytocin-neurophysin 1,40471,-0.216641903312794,0.0122749683742738,-0.240700841326371,-0.192582965299217,4.6561671732106e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4D,C-type lectin domain family 4 member D,40341,-0.100229556451424,0.00568372084773147,-0.111369649312978,-0.0890894635898705,6.07079125245616e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA3F,Semaphorin-3F,40359,-0.0422622529296203,0.00240373654018501,-0.046973576548383,-0.0375509293108577,1.50767822974258e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,-0.0626812467991215,0.00357513577700689,-0.069688512922055,-0.055673980676188,3.53761454246143e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHISA5,Protein shisa-5,37998,-0.0407508500599626,0.00232510663672245,-0.0453080590679386,-0.0361936410519866,5.06155492370749e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB6A,Ras-related protein Rab-6A,40341,0.0776791065018022,0.00443602678670258,0.0689844939998652,0.0863737190037393,5.14060855422426e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B2M,Beta-2-microglobulin,38013,-0.052027955420312,0.00297206379991279,-0.0578532004681411,-0.046202710372483,7.21986795727417e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCS1,Neuronal calcium sensor 1,40489,-0.0463931700782557,0.00265318938810602,-0.0515934212789435,-0.0411929188775679,7.82292086312687e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39865,-0.0614997635223857,0.00351690750165653,-0.0683929022256325,-0.0546066248191389,8.13719074169855e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOMO1,Nodal modulator 1,40332,-0.0381825088417979,0.0021985630537356,-0.0424916924271197,-0.0338733252564762,6.08829660868027e-67
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,40405,-0.0824390199545978,0.00474778849716135,-0.091744685409034,-0.0731333545001615,6.40719157211054e-67
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE4,Ribonuclease 4,37575,-0.0444194752071228,0.00256597021972687,-0.0494487768377874,-0.0393901735764581,2.12016856372152e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT19,"Keratin, type I cytoskeletal 19",40310,-0.10920023988259,0.00631810947761293,-0.121583734458711,-0.0968167453064685,2.5281753573543e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39980,-0.0575481430583744,0.00335034489166418,-0.0641148190460362,-0.0509814670707126,1.59646415873903e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,-0.0437942517783214,0.00255049705446935,-0.0487932260050813,-0.0387952775515614,1.69846764524224e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BPIFB1,BPI fold-containing family B member 1,40261,0.0983649941868459,0.00573104760203184,0.0871321408868635,0.109597847486828,1.94933495675274e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD72,B-cell differentiation antigen CD72,37671,-0.0679253392095554,0.0039689312673693,-0.0757044444935992,-0.0601462339255115,5.81095036019428e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL12A_IL12B,Interleukin-12,40305,-0.124414332020091,0.00729079440844591,-0.138704289060645,-0.110124374979537,1.02994480639019e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,40234,-0.046947662540613,0.00275325708227147,-0.0523440464218651,-0.0415512786593609,1.28681310191898e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,40312,-0.0322328372609858,0.00189139702869194,-0.035939975437222,-0.0285256990847496,1.50897868086174e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSTB,Cystatin-B,40097,-0.0663008248191317,0.00389090077475191,-0.0739269903376455,-0.058674659300618,1.58468344607838e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,-0.0419143434162516,0.00246157675103152,-0.0467390338482734,-0.0370896529842298,1.91770235316342e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LSP1,Lymphocyte-specific protein 1,40341,-0.0631427038238337,0.00370973606774351,-0.070413786516611,-0.0558716211310564,2.14172465231492e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MUC13,Mucin-13,39961,-0.0792196834328445,0.00466499242539214,-0.0883630685866131,-0.0700762982790759,4.25337095829768e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UPB1,Beta-ureidopropionase,37990,-0.14401054670063,0.00853043425591441,-0.160730197842222,-0.127290895559037,2.70877206270322e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD302,CD302 antigen,40305,-0.0472206947300115,0.00279958346600089,-0.0527078783233733,-0.0417335111366498,2.80066298703362e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD274,Programmed cell death 1 ligand 1,40228,-0.0543398366869149,0.00322925584626882,-0.0606691781456018,-0.048010495228228,5.44710397238556e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,40359,-0.0552008022902419,0.0032858635903906,-0.0616410949274074,-0.0487605096530763,8.55827000698848e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIT,Mast/stem cell growth factor receptor Kit,40372,0.0464213681005071,0.00276524615378941,0.0410014856390798,0.0518412505619343,1.04384195276265e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XCL1,Lymphotactin,40489,-0.0876481663547853,0.00524213107578401,-0.0979227432633219,-0.0773735894462486,3.15484397464611e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL3,C-C motif chemokine 3,40341,-0.0953220259152949,0.00571695865762516,-0.10652726488424,-0.0841167869463495,6.84893429658745e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC6A,C-type lectin domain family 6 member A,39980,-0.0726369592105915,0.00436705617014139,-0.0811963893040686,-0.0640775291171144,1.37204337808651e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4A,C-type lectin domain family 4 member A,40341,0.053065082528868,0.00319754491607798,0.0467978944933552,0.0593322705643808,2.46235229313664e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUCB2,Nucleobindin-2,40447,-0.0570555431911688,0.00345025350678014,-0.0638180400644578,-0.0502930463178797,6.40356593616572e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL7,C-C motif chemokine 7,40341,-0.0934298280856109,0.00565113205286258,-0.104506046909222,-0.0823536092620003,6.85256929620503e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTA1,Glutathione S-transferase A1,40333,-0.127196176922278,0.00769502895353277,-0.142278433671202,-0.112113920173354,7.23393682323219e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,-0.0750280990620922,0.00455054073470195,-0.083947158902108,-0.0661090392220764,1.80269904940301e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,-0.128673733155367,0.00782848549937747,-0.144017564734147,-0.113329901576587,3.35607656117056e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGSF3,Immunoglobulin superfamily member 3,40305,-0.052763255610421,0.00321286034692943,-0.0590604618904027,-0.0464660493304393,4.13745810608849e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGLN1,Egl nine homolog 1,40341,-0.0809310842935471,0.00493012770735592,-0.0905941345999647,-0.0712680339871295,4.61520286001146e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,40192,-0.111703700425756,0.00680970235663735,-0.125050717044765,-0.0983566838067466,5.66569486395457e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFASC,Neurofascin,40516,-0.0415449748598716,0.00253342276317928,-0.046510483475703,-0.0365794662440402,5.99070741262392e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLA,Alpha-galactosidase A,37642,-0.0556005678113019,0.00339133067665674,-0.0622475759375491,-0.0489535596850547,8.11111928456669e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDCP1,CUB domain-containing protein 1,40228,-0.0739312406501613,0.00451355946223079,-0.0827778171961336,-0.0650846641041889,8.3050945509528e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL4R,Interleukin-4 receptor subunit alpha,40341,-0.0552900549564467,0.00337590505979487,-0.0619068288736447,-0.0486732810392487,8.50452897895832e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,40009,-0.0787244375885873,0.00482496881772496,-0.0881813764713282,-0.0692674987058464,2.35987297351473e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNF,Tumor necrosis factor,40014,-0.0603134516597889,0.00370764027008572,-0.0675804265891569,-0.0530464767304209,5.16246026194425e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,-0.138444663413747,0.00854397877533936,-0.155190861813412,-0.121698465014082,1.427077589991e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,-0.0504996864470296,0.00312473351312668,-0.0566241641327579,-0.0443752087613013,2.75705229181804e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,-0.0570778078303775,0.00353290930847308,-0.0640023100749847,-0.0501533055857702,2.96600558711131e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,-0.0632572308977568,0.00391879168985512,-0.0709380626098728,-0.0555763991856408,3.75044686976784e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXADR,Coxsackievirus and adenovirus receptor,40341,-0.0796373835789638,0.0049362149792906,-0.0893123649383734,-0.0699624022195542,4.30810866152218e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSZ,Cathepsin Z,40345,-0.0467100658376476,0.00289601468400573,-0.0523862546182988,-0.0410338770569964,4.60535959880907e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300C,CMRF35-like molecule 6,40471,-0.051142766412755,0.00317283953468563,-0.0573615319007389,-0.0449240009247712,5.36961182142371e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100P,Protein S100-P,40042,-0.0805018259404715,0.00499578830507024,-0.0902935710184092,-0.0707100808625338,5.98172741827136e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,-0.0501563574175453,0.00311435523173232,-0.0562604936717407,-0.04405222116335,6.75366902659681e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,-0.0864139144476833,0.00539383601133303,-0.0969858330298961,-0.0758419958654706,3.09109163672405e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,-0.0608333074048959,0.00380533631797984,-0.0682917665881364,-0.0533748482216554,4.46725513899344e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37920,-0.124529597126112,0.00779000311309783,-0.139798003227784,-0.109261191024441,5.36131430671702e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLL1,Delta-like protein 1,40411,-0.0434961295100965,0.00272663482004823,-0.048840333757391,-0.0381519252628019,7.55052743430835e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40502,-0.0562312152504975,0.00352507065012864,-0.0631403537247496,-0.0493220767762453,7.56886774750968e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA6,Carbonic anhydrase 6,40295,0.0945621546701743,0.00593707066749908,0.0829254961618761,0.106198813178472,1.12588327790965e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37628,-0.0451711393956796,0.00283723518367051,-0.0507321203556738,-0.0396101584356854,1.52831083876441e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL12B,Interleukin-12 subunit beta,40516,-0.0803496825484076,0.00505144592171768,-0.0902505165549743,-0.070448848541841,1.54846230216816e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC1,Sialoadhesin,40422,-0.0641140307191133,0.00403636224811924,-0.072025300725427,-0.0562027607127995,2.20602258648582e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PON1,Serum paraoxonase/arylesterase 1,37987,0.0386494646705527,0.00243233467208864,0.0338820887132589,0.0434168406278464,2.40556051369025e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G15,Phospholipase A2 group XV,40411,-0.0379358259418471,0.00239474228819969,-0.0426295208267185,-0.0332421310569758,4.31938814061824e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMOT,Angiomotin,37671,-0.0618757869225162,0.00391533274596486,-0.0695498391046073,-0.054201734740425,9.53059428308632e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FETUB,Fetuin-B,40372,-0.0496908531928651,0.00315211093797115,-0.0558689906312885,-0.0435127157544416,1.4412505055587e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,-0.0387366970641505,0.00246896311436217,-0.0435758647683003,-0.0338975293600006,4.60440680948423e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SULT2A1,Bile salt sulfotransferase,40341,-0.0775433797689574,0.00495281751102316,-0.0872509020905628,-0.067835857447352,7.71512917536416e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAL,Galanin peptides,40422,0.0911049171119671,0.00582033256179385,0.0796970652908512,0.102512768933083,8.11200270661392e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL21,C-C motif chemokine 21,40422,-0.0618663730066128,0.00396202801615381,-0.0696319479182742,-0.0541007980949513,1.46080383139915e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,-0.0394789715188607,0.00252734061980571,-0.0444325591336799,-0.0345253839040415,1.58355425957928e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL11,C-X-C motif chemokine 11,40471,-0.115311809727192,0.00739593533984298,-0.129807842993284,-0.1008157764611,2.09618862585001e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL16,Pro-interleukin-16,40516,-0.058523238866957,0.00375622318356832,-0.0658854363067509,-0.0511610414271631,2.47341815849619e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,-0.0665468952884634,0.00426821003638622,-0.0749125869597804,-0.0581812036171464,2.54130244510717e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,-0.0868927450674078,0.00558660370412762,-0.0978424883274979,-0.0759430018073177,3.76876948447611e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,40305,-0.127028525180231,0.00816977865210439,-0.143041291338355,-0.111015759022106,4.0813707883103e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELOA,Elongin-A,40305,-0.0736845216230031,0.00474989282070607,-0.082994311551587,-0.0643747316944192,7.06342881724083e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ULBP2,UL16-binding protein 2,40228,-0.0537074111882979,0.00347039536487242,-0.0605093861034478,-0.046905436273148,1.25087620695473e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPB6,Heat shock protein beta-6,40489,-0.052548784214326,0.00339621713047108,-0.0592053697900493,-0.0458921986386027,1.29336462596447e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,-0.0487773925729235,0.00315579198968743,-0.0549627448727109,-0.0425920402731361,1.67101327273405e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40536,-0.0707032806837646,0.00457459145147075,-0.0796694799286473,-0.061737081438882,1.67559319112254e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEL1L,Protein sel-1 homolog 1,37628,-0.0469225998674451,0.00304238641164402,-0.0528856772342673,-0.0409595225006228,3.3438245020705e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHA2,Ephrin type-A receptor 2,39759,-0.0442747944563627,0.00287338997630628,-0.049906638809923,-0.0386429501028023,3.59388039191064e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,-0.0758822543323859,0.0049277124943875,-0.0855405708213854,-0.0662239378433864,4.09853663265577e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD160,CD160 antigen,40516,-0.0655481526239873,0.00425721191909101,-0.0738922879854057,-0.0572040172625689,4.10829057457661e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MDK,Midkine,40352,-0.0725093701508629,0.00471855907442295,-0.0817577459367319,-0.0632609943649939,6.55594246129123e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37959,-0.053703851605356,0.00351716168949649,-0.0605974885167691,-0.0468102146939429,3.35088816090478e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VEGFA,Vascular endothelial growth factor A,40456,-0.0832361495226337,0.00546699474020179,-0.0939514592134292,-0.0725208398318381,5.56464481001723e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCLY,Selenocysteine lyase,40434,-0.0673359884532896,0.00443445818480588,-0.0760275264955091,-0.0586444504110701,1.02484472635339e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,-0.0829491728546987,0.0054650074992493,-0.0936605875532273,-0.0722377581561701,1.15714279680106e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PXN,Paxillin,39961,-0.0730891250708487,0.00481644783537543,-0.0825293628281846,-0.0636488873135129,1.21781277335838e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THBS2,Thrombospondin-2,40332,-0.0506014053185657,0.00333629154452954,-0.0571405367458436,-0.0440622738912878,1.34522239360144e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,40357,-0.0395654182947117,0.00261758562286837,-0.0446958861155337,-0.0344349504738897,2.91739007656515e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGR3,Anterior gradient protein 3,39963,-0.0836452834020586,0.00554936513003919,-0.0945220390569354,-0.0727685277471818,5.60184764223783e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD48,CD48 antigen,40396,-0.0412484093057776,0.00273745215646413,-0.0466138155324473,-0.0358830030791079,5.88223704022991e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPPC,C-type natriuretic peptide,40341,-0.0603263828197664,0.00401043074446715,-0.0681868270789221,-0.0524659385606108,8.66616817323139e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INHBC,Inhibin beta C chain,40332,-0.0596060403913458,0.00396444351615313,-0.0673763496830059,-0.0518357310996856,9.65292802402021e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP12,Macrophage metalloelastase,40346,-0.0723879773096656,0.00482063968594876,-0.0818364310941252,-0.062939523525206,1.27788845471991e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGR2,Anterior gradient protein 2 homolog,39839,-0.141540176880336,0.00943160174505614,-0.160026116300646,-0.123054237460026,1.50484072187794e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD80,T-lymphocyte activation antigen CD80,37990,-0.0478443248975304,0.0031899941598179,-0.0540967134507735,-0.0415919363442873,1.91522458153005e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F9,Coagulation factor IX,40372,-0.0250633646672746,0.0016774127248287,-0.0283510936079388,-0.0217756357266103,3.85888709677855e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL18,Interleukin-18,40292,-0.0659355816464887,0.00441749234494774,-0.0745938666425863,-0.0572772966503911,4.88383916543822e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,-0.0762792113056803,0.00511239141467988,-0.0862994984784529,-0.0662589241329078,5.41167789526312e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,40451,-0.0594852504601598,0.00399241007897782,-0.0673103742149563,-0.0516601267053632,7.16199023113608e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,-0.0804845330468416,0.00542043753202641,-0.0911085906096134,-0.0698604754840699,1.75723242777549e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,-0.0479072161911915,0.00323171228267802,-0.0542413722652404,-0.0415730601171426,2.19165575431267e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN5,CCN family member 5,40332,-0.0541541846756119,0.00365730520191311,-0.0613225028713616,-0.0469858664798622,2.8080154501713e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF21,Fibroblast growth factor 21,40453,-0.160846224505452,0.010902053467642,-0.18221424930203,-0.139478199708873,6.10179936175808e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA14,Carbonic anhydrase 14,40489,0.0474349753842207,0.00321692947957961,0.0411297936042447,0.0537401571641967,6.88113545514516e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNCG,Gamma-synuclein,40228,-0.091871323995547,0.00623037128906439,-0.104082851722113,-0.0796597962689808,6.93408076402256e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,40359,-0.0425913624296966,0.0028907841814078,-0.0482572994252559,-0.0369254254341373,8.23916325291343e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,-0.0632326798718031,0.00429942073684142,-0.0716595445160123,-0.0548058152275939,1.20209177907253e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSIP1,PC4 and SFRS1-interacting protein,40341,-0.0848457077686796,0.00576992369117873,-0.0961547582033899,-0.0735366573339692,1.25287160047763e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSM,Oncostatin-M,40268,-0.0992198637509938,0.00675501096066307,-0.112459685233893,-0.0859800422680942,1.59832524789499e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STC1,Stanniocalcin-1,40471,-0.0563502420606843,0.00385445192629012,-0.0639049678362129,-0.0487955162851556,4.303187923719e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KYNU,Kynureninase,40516,-0.0607122376475687,0.00415316485751196,-0.0688524407682921,-0.0525720345268452,4.37094828692011e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL6,Interleukin-6,40305,-0.0993686863533775,0.00680712753128052,-0.112710656314687,-0.0860267163920677,5.94271642780976e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300A,CMRF35-like molecule 8,37671,-0.040601007329664,0.00278105717110721,-0.0460518793850342,-0.0351501352742939,6.70867466577204e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,40291,-0.039487774816101,0.00270790680558609,-0.0447952721550497,-0.0341802774771522,7.42395709376656e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REN,Renin,40359,-0.0970165254565289,0.00665470783713201,-0.110059752817308,-0.0839732980957502,7.81581759892396e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE1,Ribonuclease pancreatic,37987,-0.0331422620941603,0.00227245959523628,-0.0375962829008234,-0.0286882412874972,8.1448344921691e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD83,CD83 antigen,40341,-0.0456272233139382,0.00313150809078048,-0.0517649791718679,-0.0394894674560085,8.81399688688263e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSS,Cathepsin S,37057,-0.0333549587733195,0.00228946508811893,-0.0378423103460326,-0.0288676072006064,1.08097774031447e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,-0.0706116239163522,0.00485710372362393,-0.0801315472146552,-0.0610917006180493,1.40210552952719e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MME,Neprilysin,40305,-0.109961743495296,0.00757892391055306,-0.12481643435998,-0.0951070526306124,2.14178246323624e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COLEC12,Collectin-12,40357,-0.0346160972735891,0.00238653176712475,-0.0392936995371536,-0.0299384950100246,2.26724017986918e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,-0.0436045773385916,0.00301275453486933,-0.0495095762269355,-0.0376995784502477,3.5701627392795e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,40044,0.0517607865924684,0.00358755632882495,0.0447291761879715,0.0587923969969653,6.92677219855036e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,-0.0477071491723992,0.0033074181460386,-0.0541896887386349,-0.0412246096061636,7.15272871620632e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,-0.0509903613494389,0.00354129160088728,-0.057931292887178,-0.0440494298116998,1.04935962061277e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTA3,Glutathione S-transferase A3,39980,-0.10151303149138,0.00706239619785263,-0.115355328039171,-0.0876707349435887,1.50464497448057e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,40373,-0.036037718176284,0.00251003221664526,-0.0409573813209087,-0.0311180550316593,1.86545460681567e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,-0.0370664786138906,0.00259721228563146,-0.0421570146937282,-0.0319759425340529,6.29412859091127e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSR1,Macrophage scavenger receptor types I and II,40471,-0.0594275402585783,0.00416598014254626,-0.067592861337969,-0.0512622191791877,6.91037537515985e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40470,-0.0810442814132784,0.005695240630694,-0.0922069530494387,-0.0698816097771182,1.13002557746737e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFBR2,TGF-beta receptor type-2,40411,-0.0418439637846372,0.00294321690705143,-0.047612668922458,-0.0360752586468164,1.36257752480993e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINF1,Pigment epithelium-derived factor,37790,-0.0346180530215521,0.00243633436044381,-0.039393268368022,-0.0298428376750822,1.72769520093592e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSL,Cathepsin L1,40359,-0.0321011074983627,0.00226137051080096,-0.0365333936995326,-0.0276688212971928,1.8530690707081e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HJV,Hemojuvelin,37959,-0.0611149825695746,0.00432589595602407,-0.0695937386433818,-0.0526362264957674,5.35964001953901e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPB1,Carboxypeptidase B,40536,-0.0740968391139563,0.00525918282311104,-0.084404837447254,-0.0637888407806587,8.19244207855036e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HYOU1,Hypoxia up-regulated protein 1,40536,-0.0284639032259021,0.00202072211765676,-0.0324245185765094,-0.0245032878752949,8.54762033604697e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,40422,-0.0339403749471832,0.00241218461628995,-0.0386682567951115,-0.0292124930992549,1.06786156425757e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCD1,Programmed cell death protein 1,40455,-0.0574081372857572,0.00408284153687761,-0.0654105066980373,-0.0494057678734771,1.21881998590347e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,-0.0534562409714952,0.00380567339094559,-0.0609153608177485,-0.0459971211252418,1.51340162750432e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,-0.0640171114465472,0.00456200389356988,-0.0729586390779441,-0.0550755838151502,1.83393837554908e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LBR,Delta(14)-sterol reductase LBR,40471,-0.0855036752732668,0.00610797860993667,-0.0974753133487427,-0.0735320371977909,2.89468918894604e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BST2,Bone marrow stromal antigen 2,40471,-0.0698001110656766,0.00499118114888201,-0.0795828261174853,-0.0600173960138678,3.51608689418003e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSME2,Proteasome activator complex subunit 2,40152,-0.0481403266051649,0.00344883258462966,-0.054900038471039,-0.0413806147392907,5.12149121838974e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPY,Pancreatic prohormone,40337,-0.130910374534047,0.00939353762223888,-0.149321708273635,-0.112499040794459,6.91871681440506e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH2,Cadherin-2,40359,-0.0458232886201926,0.00328817310517906,-0.0522681079063436,-0.0393784693340417,6.95403557938684e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,40306,-0.0467423485371192,0.0033583700868721,-0.0533247539073885,-0.0401599431668498,8.89084719960464e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPL,N-acetylneuraminate lyase,37990,-0.0561370085799102,0.00404242437850859,-0.064060160361787,-0.0482138567980333,1.51099196132105e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPO,Erythropoietin,40341,-0.101160057204541,0.00729867141497031,-0.115465453177882,-0.0868546612311987,1.97884579989245e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39961,-0.0345063667103527,0.00249227195464159,-0.0393912197414502,-0.0296215136792552,2.45739280690705e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,-0.101959827675705,0.00737260518346018,-0.116410133835287,-0.087509521516123,3.01431456765286e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BMPER,BMP-binding endothelial regulator protein,37671,-0.0291810520872545,0.00211354604740269,-0.0333236023401638,-0.0250385018343452,4.62127513381779e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,0.0255085598624707,0.00185693172070371,0.0218689736898914,0.02914814603505,1.07115326607025e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,40341,-0.0692677933879693,0.00504265408026716,-0.0791513953852929,-0.0593841913906457,1.07806324120964e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSME1,Proteasome activator complex subunit 1,40216,-0.048153697511317,0.00351223718539034,-0.0550376823946821,-0.0412697126279519,1.54583872283713e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRC1,Macrophage mannose receptor 1,37987,-0.036499720150198,0.00266094418700628,-0.0417151707567303,-0.0312842695436657,1.54954371771738e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFNA1,Ephrin-A1,40303,-0.0348915176354364,0.0025476408408735,-0.0398848936835485,-0.0298981415873244,1.88114364411275e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL2,Angiopoietin-related protein 2,40377,-0.0508930228635303,0.00371831692210016,-0.0581809240308466,-0.043605121696214,2.10649619273223e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,40443,-0.0393883136276587,0.00287799657013919,-0.0450291869051315,-0.0337474403501859,2.133251698676e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4M,C-type lectin domain family 4 member M,37969,0.0622768421031718,0.00454879191221191,0.0533612099552364,0.0711924742511071,2.20733208934376e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,40379,0.0404903882408493,0.00296159796727237,0.0346856562249955,0.0462951202567032,2.59355322627943e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELE,E-selectin,40536,-0.0637756166845124,0.00466686649053372,-0.0729226750059584,-0.0546285583630663,2.80591044418398e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS2,Trypsin-2,40403,-0.0640485999988765,0.00469025205339122,-0.0732414940235233,-0.0548557059742297,3.22546989955847e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP1,"Fatty acid-binding protein, liver",40357,-0.118507048334437,0.00868660476959369,-0.135532793682841,-0.101481302986034,3.86279754359362e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAYN,Layilin,40192,-0.0436142165731303,0.00320329441607414,-0.0498926736286356,-0.037335759517625,5.60564395127473e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39980,-0.102128280443258,0.00750674476312309,-0.116841500178979,-0.0874150607075366,6.51382733157082e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPP4,Dipeptidyl peptidase 4,40068,0.0379922816050831,0.00279274012675213,0.032518510956649,0.0434660522535173,6.57538838083313e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40536,0.0439206534224543,0.0032307885433902,0.0375883078774095,0.0502529989674991,7.36229575662595e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH2D1A,SH2 domain-containing protein 1A,40341,-0.0692912085833759,0.00510588598798539,-0.0792987451198272,-0.0592836720469245,1.01843702280069e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FSTL3,Follistatin-related protein 3,40293,-0.0396127934892017,0.00292140052389272,-0.0453387385160314,-0.033886848462372,1.1883805659883e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SRP14,Signal recognition particle 14 kDa protein,40305,-0.074859376238854,0.00553466643590586,-0.0857073224532295,-0.0640114300244785,1.87670754239486e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXNB2,Plexin-B2,40472,-0.029428138217782,0.0021766955792374,-0.0336944615530873,-0.0251618148824767,2.02065898398858e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,-0.103894912928006,0.00769237631645023,-0.118971970508249,-0.0888178553477639,2.45981297407349e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IMMT,MICOS complex subunit MIC60,37900,-0.056247069999004,0.00417280138684328,-0.0644257607172168,-0.0480683792807912,3.82190287934009e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL17,C-X-C motif chemokine 17,40516,-0.051960186025712,0.00386017481939763,-0.0595261286717313,-0.0443942433796926,4.45528370411409e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,-0.0391561580804962,0.00291010824718178,-0.0448599702449725,-0.0334523459160199,4.79029908782995e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,40208,-0.0506919605358846,0.00377149552008232,-0.0580840917552459,-0.0432998293165232,5.8610831111648e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELN,Elastin,37990,-0.0441227600436035,0.00329674538070385,-0.0505843809897831,-0.037661139097424,1.36315041902182e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUOM,Fucose mutarotase,37671,-0.0783665441864946,0.00586731999073323,-0.0898664913683318,-0.0668665970046575,1.98566268312786e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,0.0481490988290099,0.00361220410606039,0.0410691787811315,0.0552290188768883,2.56524016486585e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM3B,Protein FAM3B,40305,-0.0448380641693895,0.00337038842848985,-0.0514440254892296,-0.0382321028495494,3.62519412293218e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,-0.0848280070166719,0.00637558849398874,-0.0973241604648898,-0.072331853568454,3.93405781212401e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB8,Serpin B8,40516,-0.0676607854455657,0.00508856184716667,-0.0776343666660124,-0.0576872042251191,3.94545177774848e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRELD2,Protein disulfide isomerase CRELD2,40396,-0.063991404267303,0.00483471155484905,-0.0734674389148071,-0.0545153696197989,8.83462206022998e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,-0.071018786549888,0.00536825868658312,-0.0815405735755909,-0.0604969995241851,9.62650001647987e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,-0.039521791804155,0.00299137519977498,-0.0453848871957139,-0.033658696412596,1.3193976646966e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPM,Carboxypeptidase M,40415,-0.0421252767834655,0.00319114777340994,-0.0483799264193489,-0.035870627147582,1.40193173851527e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37942,-0.0361796183248328,0.00274039645090866,-0.0415507953686138,-0.0308084412810519,1.49607400402512e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPP1,Tripeptidyl-peptidase 1,40255,-0.0551578249759838,0.00418138777369505,-0.0633533450124261,-0.0469623049395415,1.59353978864624e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD59,CD59 glycoprotein,39665,-0.0277923329515983,0.00210789067566059,-0.0319237986758931,-0.0236608672273036,1.76473515828902e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HAO1,Hydroxyacid oxidase 1,40489,-0.15995101863811,0.0121573516441972,-0.183779427860736,-0.136122609415483,2.48858925454907e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFPI,Tissue factor pathway inhibitor,40309,0.0382660738768043,0.00290956302443746,0.0325633303489068,0.0439688174047017,2.66758781220883e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,-0.0537692255307467,0.00409071786169697,-0.0617870325396728,-0.0457514185218207,2.94774509867571e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPA2,Carboxypeptidase A2,40398,-0.0785352529755227,0.005975674289218,-0.09024757458239,-0.0668229313686554,3.00618873169198e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BPIFA2,BPI fold-containing family A member 2,37150,0.137020244212343,0.0104252726481732,0.116586709821923,0.157453778602762,3.36028886381387e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,40341,-0.0800283438310345,0.00609399140157399,-0.0919725669781195,-0.0680841206839495,3.4386974323139e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOLR2,Folate receptor beta,40471,-0.0360789873261867,0.00274837401054767,-0.0414658003868601,-0.0306921742655133,3.65420589044679e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,-0.0622880144523662,0.0047476549687055,-0.0715934181910289,-0.0529826107137034,4.03452774209661e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFF2,Trefoil factor 2,40396,-0.0697658281392105,0.00532818623456512,-0.0802090731589581,-0.0593225831194628,5.68149592179028e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIAE,Sialate O-acetylesterase,40374,-0.0570350566781124,0.00436724844736095,-0.0655948636349398,-0.0484752497212849,8.84943575849872e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PALM2,Paralemmin-2,37942,-0.04524586651942,0.00347239345941427,-0.0520517576998719,-0.038439975338968,1.40884333010622e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCG2,Secretogranin-2,40392,-0.039158559882497,0.00300690764809727,-0.0450520988727677,-0.0332650208922263,1.42702570662658e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,-0.126538396736668,0.00972468315017717,-0.145598775711015,-0.10747801776232,1.64634187248022e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,-0.0536633016439206,0.00412658340067521,-0.061751405109244,-0.0455751981785972,1.81960113214966e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL7R,Interleukin-7 receptor subunit alpha,40332,0.0639653916538866,0.00492026459368639,0.0543216730502612,0.0736091102575119,1.91224682079257e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD209,CD209 antigen,40382,0.0471603922411036,0.00363164981269222,0.0400423586082268,0.0542784258739803,2.302066990998e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,-0.0320335687172363,0.00246764807975003,-0.0368701589535464,-0.0271969784809263,2.43796778565401e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRD1,Natural killer cells antigen CD94,40516,-0.0551791218794085,0.00425638159867713,-0.0635216298128157,-0.0468366139460013,3.05058159013796e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THY1,Thy-1 membrane glycoprotein,40471,-0.0338589489122665,0.00261429286790807,-0.0389829629333663,-0.0287349348911666,3.58326455461591e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40500,0.141600041668735,0.0109565489711576,0.120125205685266,0.163074877652204,5.11496464064762e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFI,Complement factor I,38013,-0.0243330050145843,0.00188965493217866,-0.0280367286816544,-0.0206292813475141,1.00935002170433e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFF1,Trefoil factor 1,40261,-0.0930014391998425,0.0072584727874832,-0.10722804586331,-0.0787748325363755,2.13351590400984e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGBL1,Integrin beta-like protein 1,37998,-0.0420524872701268,0.00328132674484042,-0.0484838876900141,-0.0356210868502396,2.20785301036305e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL14,C-C motif chemokine 14,40309,-0.0466343818064731,0.00364819003930537,-0.0537848342835116,-0.0394839293294346,3.12015677672938e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOLR1,Folate receptor alpha,40299,-0.0338084272685934,0.00264888776698903,-0.0390002472918919,-0.0286166072452949,4.00604026900009e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALDH1A1,Retinal dehydrogenase 1,40332,-0.062865170959491,0.00492709722690582,-0.0725222815242264,-0.0532080603947556,4.22122163053246e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN1,Contactin-1,40536,0.0327984085735399,0.00258251350438894,0.0277366821049376,0.0378601350421423,8.85875868953777e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POF1B,Protein POF1B,37598,-0.0554893420826417,0.00436691233711128,-0.0640484902633798,-0.0469301939019035,8.92169257466556e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F11R,Junctional adhesion molecule A,40332,-0.0669195674443135,0.00527111999347608,-0.0772509626315267,-0.0565881722571004,9.44741550928993e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,-0.0682115038156832,0.00537010264100365,-0.0787369049920504,-0.0576861026393161,9.45447132089925e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,-0.0499522006935169,0.00393612882598802,-0.0576670131924534,-0.0422373881945804,1.00227470589012e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PENK,Proenkephalin-A,37671,-0.036803364513685,0.00290391608620644,-0.0424950400426496,-0.0311116889847203,1.35025407609718e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTNB,Dystrobrevin beta,37878,-0.0495256319887893,0.00392107138046026,-0.0572109318944914,-0.0418403320830872,2.30376613839202e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40536,-0.0368600281945046,0.00292655844065095,-0.0425960827381804,-0.0311239736508287,3.33386319376753e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,-0.048777585815612,0.00387391146772854,-0.0563704522923599,-0.041184719338864,3.51254049149956e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GOLM2,Protein GOLM2,40471,-0.0263514621708121,0.00209292159796612,-0.0304535885028257,-0.0222493358387985,3.5222198896228e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM20A,Pseudokinase FAM20A,37990,-0.0333980955751253,0.00265423978992916,-0.0386004055633864,-0.0281957855868641,4.17401189684385e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM3C,Protein FAM3C,40330,-0.0348802654941381,0.00277323131926087,-0.0403157988798894,-0.0294447321083868,4.17445746172864e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,-0.0679100122698809,0.00539750105535935,-0.0784891143383852,-0.0573309102013766,4.24881541589632e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSG2,Desmoglein-2,40332,0.0316010434419608,0.00251351214299516,0.0266745596416903,0.0365275272422313,4.44502179071408e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LMNB2,Lamin-B2,37942,-0.0323421798222721,0.002572454010351,-0.0373841896825601,-0.0273001699619841,4.76311242143603e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,-0.122908261863226,0.00978061981678286,-0.142078276704121,-0.103738247022332,4.79236315262067e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADA2,Adenosine deaminase 2,40258,-0.0492752959872317,0.00392123885076736,-0.0569609241347357,-0.0415896678397277,4.81320762016055e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EZR,Ezrin,40471,-0.027693964027114,0.00220695733332737,-0.0320196004004357,-0.0233683276537924,5.98073137303128e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLAMF8,SLAM family member 8,39980,-0.062837994158037,0.00501095110018101,-0.0726594583143918,-0.0530165300016823,6.72007456486324e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC39A5,Zinc transporter ZIP5,40341,-0.0625187616600552,0.00498969611597264,-0.0722985660473616,-0.0527389572727488,7.59855065382439e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IDUA,Alpha-L-iduronidase,40489,-0.0528421420623806,0.00421817638467478,-0.0611097677763431,-0.044574516348418,7.79440842774848e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMG3,Proteasome assembly chaperone 3,40341,-0.0595357333543192,0.00478054066010928,-0.0689055930481334,-0.0501658736605051,1.95239452720405e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40490,-0.0372560277819341,0.00299443881833667,-0.043125127865874,-0.0313869276979942,2.25861556365959e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,-0.0505563501917856,0.00406308940002036,-0.0585200054158255,-0.0425926949677457,2.41876086426628e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHB4,Ephrin type-B receptor 4,40536,-0.0286278934935966,0.00230413572482806,-0.0331439995142596,-0.0241117874729336,2.79123652290105e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,-0.0578635285862838,0.00466165182037857,-0.0670003661542258,-0.0487266910183418,3.5442117827334e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTBS,Di-N-acetylchitobiase,37819,-0.0317068434994937,0.0025557613427016,-0.0367161357311888,-0.0266975512677986,3.78379937656522e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGL1,Fibrinogen-like protein 1,37987,-0.0733785901137376,0.0059163766907716,-0.0849746884276499,-0.0617824917998252,3.92456314869719e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL6,C-X-C motif chemokine 6,40516,-0.0898854592230159,0.00725090768777294,-0.104097238291051,-0.0756736801549809,3.95473675537898e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAXX,Protein PAXX,37671,-0.0528370607913854,0.00426582694882071,-0.061198081611074,-0.0444760399716968,4.8604277530656e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,-0.120013651405626,0.00970417172468069,-0.139033827986001,-0.100993474825252,6.08801795620201e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADM,Pro-adrenomedullin,40489,-0.030925965498651,0.00251423337435352,-0.0358538629123838,-0.0259980680849181,1.29161659539326e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWC2,Brorin,40167,-0.044446951354124,0.00362664714787889,-0.0515551797639666,-0.0373387229442814,2.24867782450008e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEPH,Hephaestin,37990,-0.0287971852952359,0.00235535934971764,-0.0334136896206825,-0.0241806809697893,3.40950907769427e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLT4,Vascular endothelial growth factor receptor 3,40411,-0.0379102175268195,0.00310427361063205,-0.0439945938036583,-0.0318258412499807,3.79713942501643e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,-0.0486563882462852,0.00398763401972045,-0.0564721509249373,-0.0408406255676331,4.312927499613e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG1B,Lithostathine-1-beta,40536,-0.0637920352489212,0.00522956805156788,-0.0740419886299943,-0.0535420818678482,4.48665020501854e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,-0.0659507683428528,0.00543683283373037,-0.0766069606969643,-0.0552945759887413,1.0261962098257e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F7,Coagulation factor VII,40376,-0.0339335845816305,0.00279966499481047,-0.039420927971459,-0.028446241191802,1.15596240048852e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAST,Gastrin,37942,-0.14846098929074,0.0122451956331565,-0.172461572731727,-0.124460405849753,1.17897900980203e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GDF2,Growth/differentiation factor 2,40359,0.0403897309163426,0.00333931859094548,0.0338446664780894,0.0469347953545957,1.57131219077876e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN5,Contactin-5,40367,0.0418187294095064,0.0034583885698847,0.0350402878125324,0.0485971710064804,1.63351050653974e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDC1,Syndecan-1,40359,-0.0452358225280945,0.00374156486791296,-0.0525692896692039,-0.0379023553869851,1.67143002144723e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCAM1,Neural cell adhesion molecule 1,40403,0.0311828574918935,0.00258800180795989,0.0261103739482921,0.0362553410354948,2.73823021239106e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1RL,Complement C1r subcomponent-like protein,37993,-0.0219887170290672,0.00182605087297477,-0.0255677767400977,-0.0184096573180367,3.17115892161529e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,-0.0321822951032984,0.00267458746331246,-0.0374244865313908,-0.026940103675206,3.32503505531836e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,-0.0634471420546027,0.00527750523052638,-0.0737910523064344,-0.053103231802771,4.0568818877202e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGXT,Serine--pyruvate aminotransferase,40359,-0.0862821581239823,0.00718062451468916,-0.100356182172773,-0.0722081340751916,4.0750653119041e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBP1,Guanylate-binding protein 1,37931,-0.0727101774287954,0.00605738658225362,-0.0845826551300125,-0.0608376997275783,5.01506205551059e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37628,0.0716790567057843,0.00597498876841984,0.0599680787196814,0.0833900346918872,5.50367036319679e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,-0.0642225190188171,0.00536920050110427,-0.0747461520009814,-0.0536988860366527,7.85989333445458e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIP,Gastric inhibitory polypeptide,37628,-0.058069197800341,0.00485813898100511,-0.067591150203111,-0.048547245397571,9.25161494805019e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HNMT,Histamine N-methyltransferase,40147,-0.0516080814810743,0.00432706493399334,-0.0600891287517013,-0.0431270342104474,1.18732981453588e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PI3,Elafin,40074,-0.0596535600876291,0.0050027791542456,-0.0694590072299505,-0.0498481129453078,1.22832611016717e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH3,Cadherin-3,40471,-0.0394641737331678,0.00331055386294991,-0.0459528593045496,-0.032975488161786,1.26832099835308e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB1,Integrin beta-1,40333,0.0243958469613436,0.00205045617110859,0.0203769528659708,0.0284147410567164,1.6706771416421e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,-0.0442198688764508,0.00371762675625543,-0.0515064173187115,-0.0369333204341902,1.83333945907133e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA7A,Semaphorin-7A,40490,-0.0298710934864846,0.00251658649632723,-0.0348036030192859,-0.0249385839536832,2.32382060141523e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,40305,-0.0343346924432534,0.00289657012930321,-0.0400119698966877,-0.0286574149898191,2.82262541635895e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL19,Interleukin-19,39924,-0.0753469771638548,0.00635795319851532,-0.0878085654329448,-0.0628853888947648,2.93828595478366e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37910,-0.045683167635635,0.00386291994875265,-0.0532544907351902,-0.0381118445360798,4.12726594715352e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FMNL1,Formin-like protein 1,39961,-0.0659806614029553,0.00559528454648058,-0.0769474191140572,-0.0550139036918534,5.86407214671873e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL22,C-C motif chemokine 22,40204,-0.0566949605263767,0.00481039899839443,-0.0661233425632298,-0.0472665784895236,6.28309695403653e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MLN,Promotilin,40341,-0.0974924892261416,0.00827655039114506,-0.113714527992786,-0.0812704504594973,6.76870704266716e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEP1A,Meprin A subunit alpha,37901,-0.0758848229438662,0.00644304879067426,-0.0885131985735878,-0.0632564473141447,7.28575572189478e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39980,-0.0395879557959813,0.00336999256173215,-0.0461931412169764,-0.0329827703749863,9.94542371252343e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,-0.0370243367851684,0.00315466775257835,-0.0432074855802219,-0.0308411879901148,1.11934160395828e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUS,RNA-binding protein FUS,39960,-0.0432899793770887,0.00369126617125157,-0.0505248610727417,-0.0360550976814356,1.25057398599838e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VCAM1,Vascular cell adhesion protein 1,40372,-0.0296939689876295,0.00253282723328327,-0.0346583103648647,-0.0247296276103943,1.30069184708911e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAMDC4,Apical endosomal glycoprotein,37900,-0.0600205288584687,0.00513274008000115,-0.0700806994152709,-0.0499603583016664,1.94946197664549e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNXB,Tenascin-X,40332,0.0278162266561743,0.00238126776576435,0.0231489418352761,0.0324835114770724,2.1358589987661e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,40408,0.0263404291244153,0.00226394832877565,0.0219030904000151,0.0307777678488156,3.66679519326404e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OGN,Mimecan,40332,-0.0441885202360843,0.00380636359178649,-0.0516489928759858,-0.0367280475961828,4.94323793448239e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GM2A,Ganglioside GM2 activator,37714,-0.0419926974359551,0.00362320504240606,-0.049094179319071,-0.0348912155528392,6.53076799180377e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37900,-0.0555243787652847,0.00480418746023612,-0.0649405861873475,-0.0461081713432219,9.45211709226999e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPIND1,Heparin cofactor 2,37981,-0.0297553526570044,0.00257638605840752,-0.0348050693314832,-0.0247056359825257,1.03726390941434e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,-0.0298362973221509,0.0025875631718183,-0.0349079211389148,-0.024764673505387,1.22476651092776e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EBI3_IL27,Interleukin-27,40453,-0.0335252720276752,0.00291446494048437,-0.0392376233110246,-0.0278129207443258,1.67810786410299e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHBG,Sex hormone-binding globulin,37987,0.0584419989117005,0.00508235074040583,0.0484805914605051,0.068403406362896,1.84811083119968e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG4,Regenerating islet-derived protein 4,40379,-0.0521623611932123,0.00455257151151482,-0.0610854013557814,-0.0432393210306433,2.82468098223033e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEG1,Protein HEG homolog 1,37671,-0.0285112050091783,0.00248883632070364,-0.0333893241977575,-0.0236330858205992,3.0601810480517e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC7A,C-type lectin domain family 7 member A,40516,-0.0626895893783118,0.0054770112060435,-0.073424531342157,-0.0519546474144665,3.22675557293552e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMP4,Metalloproteinase inhibitor 4,40332,0.0432994579310933,0.00379612588369738,0.0358590511990465,0.0507398646631402,5.09465426059881e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS3,Galectin-3,40374,-0.0315016720646714,0.00276702373184815,-0.0369250385790938,-0.026078305550249,6.50694084753727e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OMD,Osteomodulin,40422,0.0471177248200572,0.00414610968877358,0.038991349830061,0.0552440998100534,8.19474786744456e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTSS1,Protein MTSS 1,37901,-0.118435528746821,0.0104215894225522,-0.138861844015023,-0.0980092134786184,8.59578648383378e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINT2,Kunitz-type protease inhibitor 2,40422,-0.0445349418036678,0.00392225112978777,-0.0522225540180518,-0.0368473295892838,9.16839797520617e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DKK4,Dickkopf-related protein 4,40203,-0.048323602641486,0.00425680139503576,-0.0566669333757561,-0.0399802719072159,9.44956160917356e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL20,C-C motif chemokine 20,40516,-0.0939229672499611,0.00828865922086121,-0.110168739322849,-0.0776771951770731,1.18727644388252e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDT,D-dopachrome decarboxylase,37998,-0.0436029472611437,0.0038473571442835,-0.0511437672639393,-0.036062127258348,1.22154014488614e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPA1,Carboxypeptidase A1,40536,-0.0605612069607904,0.00535284412121939,-0.0710527814383804,-0.0500696324832003,1.44963040928029e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM1,Intercellular adhesion molecule 1,40291,-0.0300080174712971,0.00267146084869496,-0.0352440807347392,-0.0247719542078549,3.62712733028118e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,-0.0316587190299228,0.00281826354083131,-0.0371825155699521,-0.0261349224898934,3.76798564480488e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,-0.0304554648568641,0.00271183277056607,-0.0357706570871736,-0.0251402726265546,3.90959624220471e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAPG,Macrophage-capping protein,40185,-0.0608069902382586,0.00542055953920996,-0.0714312869351101,-0.0501826935414071,4.29792755441334e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,-0.0805296647364746,0.00718079623745795,-0.0946040253618922,-0.066455304111057,4.6488695596633e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OGFR,Opioid growth factor receptor,40305,-0.0346025016685627,0.00308713409986219,-0.0406532845042926,-0.0285517188328328,4.75728827124758e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN4,CCN family member 4,40489,-0.0428007277702411,0.00382392707936847,-0.0502956248458033,-0.0353058306946789,5.65847869227894e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSAP,Prosaposin,37901,-0.0299483712473646,0.00267655198606357,-0.0351944131400492,-0.02470232935468,6.18372620340762e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP5,Fatty acid-binding protein 5,40432,-0.0720037865755729,0.00645395851663715,-0.0846535452681817,-0.0593540278829641,8.50086075414492e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,-0.041471118382201,0.00371803228640823,-0.0487584616635611,-0.0341837751008408,9.13205622016545e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCAM2,Neural cell adhesion molecule 2,40332,0.0281430059844048,0.00252427975765069,0.0231954176594095,0.0330905943094002,9.26767463157291e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,-0.0394686891231518,0.00354086067750925,-0.0464087760510699,-0.0325286021952337,9.50711805079887e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,40305,-0.0404082692170829,0.00363304190592774,-0.0475290313527013,-0.0332875070814645,1.24532095700892e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBKS,Ribokinase,39991,-0.0516394133193631,0.00464611843192531,-0.0607458054459366,-0.0425330211927895,1.36643061168157e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP1,Interstitial collagenase,39757,-0.0963042569192464,0.0087116697617279,-0.113379129652233,-0.0792293841862598,2.66431001953347e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,-0.0728294686404792,0.0065877875871323,-0.0857415323112585,-0.0599174049696999,2.75371762471412e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCN1,Ficolin-1,37967,-0.058836738375105,0.00532239312367014,-0.0692686288974985,-0.0484048478527115,2.75412251759578e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NECTIN4,Nectin-4,40411,-0.031565351446641,0.00285822124115583,-0.0371674650793064,-0.0259632378139756,2.97611177865983e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL5,Fc receptor-like protein 5,40332,-0.0576559498543715,0.00523350665057607,-0.0679136228895006,-0.0473982768192424,4.01415132986155e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,-0.0248139069354857,0.00226158621246672,-0.0292466159119204,-0.0203811979590509,6.58251432649678e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRLB,Fc receptor-like B,39980,-0.0627214738878875,0.00572077634209145,-0.0739341955183867,-0.0515087522573882,7.21825077100625e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37959,-0.0537098418445506,0.00489851772026662,-0.0633109365762731,-0.044108747112828,7.41786817825061e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENO3,Beta-enolase,37628,-0.0583096480586021,0.0053378189515956,-0.0687717732037295,-0.0478475229134747,1.16464512772665e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37671,-0.0391080643226094,0.00358757542057331,-0.0461397121469331,-0.0320764164982858,1.49364784933503e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTDH,Protein LYRIC,37598,-0.0937772327669833,0.00860284910218923,-0.110638817007274,-0.0769156485266924,1.50004134538426e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,-0.0485608566958031,0.00445830217808512,-0.0572991289648499,-0.0398225844267562,1.63348456204037e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL3,Angiopoietin-related protein 3,40355,0.0369959956551526,0.00339994636111886,0.0303321007873597,0.0436598905229456,1.76795443952252e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,-0.0751210054940499,0.00690490518678204,-0.0886546196601427,-0.0615873913279571,1.8096905182587e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFAP5,Microfibrillar-associated protein 5,40536,-0.0417575600763198,0.00383866582221983,-0.0492813450878707,-0.0342337750647689,1.82613860050147e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,-0.0685663399427485,0.00630519124566371,-0.0809245147842493,-0.0562081651012476,1.91321321025172e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40536,-0.0618393094116901,0.00570891433376974,-0.0730287815058788,-0.0506498373175014,3.01302866964291e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEPTIN8,Septin-8,37921,-0.0324916899642757,0.003000423631019,-0.0383725202810729,-0.0266108596474785,3.2463324406892e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KHK,Ketohexokinase,37628,-0.0655031613973989,0.00605905098392025,-0.0773789013258826,-0.0536274214689152,3.97679769180574e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,40044,-0.0358834283977954,0.00332729682721365,-0.0424049301791341,-0.0293619266164566,5.07150666263218e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCD5,Programmed cell death protein 5,40471,-0.058683811508593,0.00544610375899822,-0.0693581748762295,-0.0480094481409565,5.56742237792023e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMN,Protein amnionless,40044,-0.0478698415690189,0.00444232782330654,-0.0565768041026998,-0.0391628790353381,5.57145095118066e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSN,Gelsolin,37928,0.0193610220276875,0.0017969112562153,0.0158390759655055,0.0228829680898694,5.8422400365777e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP3,"Fatty acid-binding protein, heart",37990,-0.0481699611236918,0.00447300852134775,-0.0569370578255334,-0.0394028644218502,6.1971679180321e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH17,Protocadherin-17,40359,-0.035099571574792,0.00326196628976959,-0.0414930255027404,-0.0287061176468436,6.56325568776665e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCAR,Immunoglobulin alpha Fc receptor,40341,-0.0472695468921351,0.00439664475196057,-0.0558869706059778,-0.0386521231782924,7.23079044697739e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGLC2,Immunoglobulin lambda constant 2,37978,-0.0246219828749253,0.00229020289831112,-0.0291107805556151,-0.0201331851942355,7.525112507936e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTN,Pleiotrophin,40042,-0.0504264331473324,0.00470063817061152,-0.0596396839617309,-0.0412131823329338,9.36780693028194e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP8,Neutrophil collagenase,40442,-0.0733694058140495,0.00684313939756555,-0.086781959033278,-0.0599568525948211,9.93489149470674e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,-0.0850617192198059,0.00793674207044997,-0.100617733677888,-0.069505704761724,1.08573439728028e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,-0.0279161252497078,0.00260664281441825,-0.0330251451659676,-0.0228071053334481,1.13113395840257e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOP2B,DNA topoisomerase 2-beta,37598,-0.079626838420359,0.00743314920223673,-0.094195810856743,-0.0650578659839751,1.14692707599599e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,-0.0981623835324644,0.00917997460207897,-0.116155133752539,-0.0801696333123896,1.40918924112997e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCAN,Neurocan core protein,40471,0.0372172486985948,0.00348467921328014,0.0303872774405657,0.0440472199566238,1.54681601744377e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MET,Hepatocyte growth factor receptor,40375,0.0200824956517247,0.00188199848466683,0.0163937786217777,0.0237712126816717,1.71274642288438e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGR,Tyrosine-protein kinase Fgr,39961,-0.0550827663519259,0.00516709155068231,-0.0652102657912633,-0.0449552669125886,1.92714982858666e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,-0.0274204858072209,0.00257267905742772,-0.0324629367597793,-0.0223780348546626,1.95946459525597e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLO1,Lactoylglutathione lyase,40042,-0.0590026057829407,0.00554368256430541,-0.0698682236089793,-0.0481369879569021,2.3099573666e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,-0.0302175699656356,0.00283943670968466,-0.0357828659166175,-0.0246522740146536,2.32524035403607e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LY9,T-lymphocyte surface antigen Ly-9,40182,-0.0285730677482163,0.00268701076583516,-0.0338396088492532,-0.0233065266471794,2.5496611998226e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SORD,Sorbitol dehydrogenase,40417,-0.066323302626199,0.00624152555761914,-0.0785566927191325,-0.0540899125332655,2.75735516751936e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACAN,Aggrecan core protein,40224,0.0282152907910452,0.00265776884273066,0.0230060638592931,0.0334245177227973,3.07373980792402e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MARCO,Macrophage receptor MARCO,40359,-0.0263698102415663,0.00248594032482286,-0.0312422532782191,-0.0214973672049135,3.3613410300412e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YTHDF3,YTH domain-containing family protein 3,40044,-0.0836364204664807,0.00790069918222835,-0.0991217908636482,-0.0681510500693131,4.24580786568669e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTYMK,Thymidylate kinase,37990,-0.0689124991431644,0.0065089960343333,-0.0816701313704577,-0.0561548669158711,4.31779378593176e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37990,-0.0649434801745992,0.00613445665338102,-0.076967015215226,-0.0529199451339724,4.34523711890233e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39980,-0.107661340724823,0.0101741064067675,-0.127602589282088,-0.087720092167559,4.43601337111886e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFH,Complement factor H,37301,-0.0231113780612639,0.00218539512877516,-0.0273947525136632,-0.0188280036088646,4.95855797031692e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK11,Kallikrein-11,40260,-0.0293437500483488,0.00277886528352144,-0.0347903260040509,-0.0238971740926468,5.59614074780902e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCOF1,Treacle protein,37990,-0.0300296379037957,0.00284473316152809,-0.0356053149003908,-0.0244539609072006,5.99628846041887e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NADK,NAD kinase,40359,-0.0527970416403824,0.00500923696729488,-0.0626151460962803,-0.0429789371844844,6.88145297435669e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THOP1,Thimet oligopeptidase,40288,-0.0295196455865293,0.00280103865700561,-0.0350096813542603,-0.0240296098187983,6.96910759214601e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST7,Cystatin-F,40376,-0.0905837588901467,0.00861001121680047,-0.107459380875076,-0.0737081369052177,8.42384961452656e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD7,T-cell antigen CD7,37567,-0.0425468515687679,0.00404317771601826,-0.0504714798921637,-0.0346222232453721,8.56421703007125e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLF4,Krueppel-like factor 4,37541,-0.0387218572170139,0.0036913584587833,-0.0459569197962291,-0.0314867946377986,1.21535245105311e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAP,Prolyl endopeptidase FAP,40536,0.0265423459183287,0.00253321409125392,0.021577246299471,0.0315074455371864,1.32191329667883e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCF2,Neutrophil cytosol factor 2,40324,-0.0813804019051422,0.00776840169926694,-0.0966064692357054,-0.066154334574579,1.35212263929709e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC3B,Tetranectin,37681,0.0208406665497978,0.00199089665439277,0.016938509107188,0.0247428239924076,1.52510321155322e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,-0.0727639567199809,0.00696370521201302,-0.0864128189355264,-0.0591150945044354,1.85007163383393e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELPLG,P-selectin glycoprotein ligand 1,40341,-0.0269667344145685,0.00258247311185913,-0.0320283817138124,-0.0219050871153246,1.92270046386871e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RASSF2,Ras association domain-containing protein 2,39980,-0.0537484312598282,0.00515108768030338,-0.0638445631132229,-0.0436522994064336,2.09592288669464e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NELL1,Protein kinase C-binding protein NELL1,40411,0.0412143649116618,0.00397379914852537,0.0334257185805521,0.0490030112427716,4.0156199636313e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APLP1,Amyloid-like protein 1,40359,0.0503979082287331,0.00486862534142222,0.0408554025595456,0.0599404138979207,4.94355056726996e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNDP1,Beta-Ala-His dipeptidase,40403,0.0443190491301079,0.00428395462063865,0.0359224980736561,0.0527156001865596,5.26980963237146e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPO,Myeloperoxidase,40332,-0.0452336685254661,0.0043731123156125,-0.0538049686640666,-0.0366623683868657,5.37188568923807e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERMAP,Erythroid membrane-associated protein,37598,-0.0436541239290644,0.00422606026797389,-0.0519372020542932,-0.0353710458038356,6.43798989130904e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37901,-0.0538342917596123,0.00521646158408882,-0.0640585564644264,-0.0436100270547983,7.07970798059265e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,-0.0399687803723802,0.00387626745164929,-0.0475662645776129,-0.0323712961671476,7.5096190628569e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37598,-0.0817704615462573,0.0079303407341161,-0.0973139293851248,-0.0662269937073897,7.80643747615243e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TREML2,Trem-like transcript 2 protein,40332,-0.0322965850982815,0.0031341707317192,-0.0384395597324511,-0.0261536104641119,8.03651899427705e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADH1B,All-trans-retinol dehydrogenase,37671,-0.0718099623060687,0.00696766657606494,-0.085466588795156,-0.0581533358169814,8.20322969073682e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS3BP,Galectin-3-binding protein,38013,-0.0287646767771859,0.00279341081413852,-0.0342397619728974,-0.0232895915814744,8.93784523554261e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DKK1,Dickkopf-related protein 1,40471,-0.0573218778307433,0.00557058687332147,-0.0682402281024534,-0.0464035275590333,9.32657294102297e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CREG1,Protein CREG1,40145,-0.0345466795359876,0.00336395674255437,-0.0411400347513941,-0.027953324320581,1.15559124445839e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABL1,Tyrosine-protein kinase ABL1,40305,-0.0651517333796825,0.00635062216120316,-0.0775989528156407,-0.0527045139437243,1.28574874916738e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH1,Cadherin-1,39806,-0.038494846960641,0.00375666127033973,-0.0458579030505069,-0.0311317908707752,1.46319573093347e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD2AP,CD2-associated protein,40359,-0.061178145366604,0.00597943724915546,-0.0728978423749486,-0.0494584483582593,1.70777835541036e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGFL7,Epidermal growth factor-like protein 7,39980,-0.038674507462169,0.00378222619142874,-0.0460876707973693,-0.0312613441269687,1.82562594977817e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLIN1,Perilipin-1,39961,-0.0338681039310933,0.00331342215342411,-0.0403624113518046,-0.0273737965103821,1.89935758594582e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C9,Complement component C9,37987,0.0469162952650565,0.00459352428411232,0.0379129876681964,0.0559196028619167,2.11366629103743e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,40350,-0.047130556022272,0.0046213805226982,-0.0561884618467605,-0.0380726501977836,2.3961204066993e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL5A1,Collagen alpha-1(V) chain,37671,-0.0382741932715962,0.00375420027924684,-0.04563242581892,-0.0309159607242724,2.56704342348488e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRP,Gastrin-releasing peptide,37628,-0.0521697360387175,0.00512061666141711,-0.0622061446950951,-0.04213332738234,2.75503033211031e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,-0.0488934951635928,0.00480068622492323,-0.0583028401644423,-0.0394841501627432,2.84286076214581e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,-0.0314867055927853,0.00310628717514552,-0.0375750284560705,-0.0253983827295001,4.64548890870036e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LY96,Lymphocyte antigen 96,40228,-0.0327851389842412,0.00324562019672636,-0.0391465545698248,-0.0264237233986575,6.44231158956629e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YAP1,Transcriptional coactivator YAP1,37942,-0.0253554399326644,0.00251054917375414,-0.0302761163132225,-0.0204347635521063,6.74791357353064e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38484,0.0295613265390902,0.00293228916710741,0.0238140397715597,0.0353086133066207,8.05469938982685e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COCH,Cochlin,37990,-0.0441876585369273,0.00438660299406331,-0.0527854004052914,-0.0355899166685632,8.79123947615357e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37714,-0.0525525994209959,0.00522607381560843,-0.0627957040995884,-0.0423094947424034,1.05272918006258e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FEN1,Flap endonuclease 1,39980,-0.0583767484733789,0.00580896049327355,-0.0697623110401951,-0.0469911859065628,1.09163125912833e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RSPO3,R-spondin-3,40489,-0.0268575732829025,0.00267337075324055,-0.032097379959254,-0.021617766606551,1.12034568967121e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,-0.0258908523772668,0.00257650621371598,-0.0309408045561501,-0.0208409001983835,1.12688024799862e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA7,Thyroxine-binding globulin,38013,-0.0177309128256675,0.00176508666868956,-0.0211904826962991,-0.014271342955036,1.16513609829563e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPR,Nucleoprotein TPR,37562,-0.0442751721868393,0.00441728431848345,-0.0529330494510668,-0.0356172949226117,1.46581884441116e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37900,-0.0638800325743083,0.00638834442320438,-0.0764011876437889,-0.0513588775048277,1.85029277092674e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,-0.025439463643101,0.00254831921987277,-0.0304341693140517,-0.0204447579721504,2.12006791444247e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,0.0227372123161695,0.00227775888061006,0.0182728049101738,0.0272016197221653,2.13435265458783e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WDR46,WD repeat-containing protein 46,37900,-0.0334359739783054,0.00335141067437068,-0.0400047389000719,-0.0268672090565388,2.3242808162639e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300LF,CMRF35-like molecule 1,40489,-0.0566533479880671,0.00568056632305944,-0.0677872579812636,-0.0455194379948706,2.33589195143854e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALB2,Calretinin,39961,-0.0293624575076141,0.00294580124292656,-0.0351362279437502,-0.0235886870714781,2.48425696961421e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL32,Interleukin-32,40341,0.0397726158767551,0.00399124252486829,0.0319497805280133,0.047595451225497,2.53969389416497e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNCA,Alpha-synuclein,37671,-0.106936442066867,0.0107385120103972,-0.127983925607246,-0.085888958526489,2.8042881028374e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,L1CAM,Neural cell adhesion molecule L1,40411,0.0263644053077468,0.00264839866232244,0.0211735439295949,0.0315552666858988,2.80821693145533e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS7_LGALS7B,Galectin-7,40270,-0.0373994584361853,0.00375737066570328,-0.0447639049409638,-0.0300350119314069,2.8466771976295e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,40332,0.0400972387930004,0.00403118754753458,0.0321961111998326,0.0479983663861682,3.0469366282913e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP20,Centrosomal protein 20,39980,-0.0685598503460088,0.0068943142059562,-0.0820727061896829,-0.0550469945023346,3.13032919746335e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,-0.0314316665270895,0.00316260855393166,-0.0376303792927955,-0.0252329537613834,3.3027182320853e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP9,Matrix metalloproteinase-9,40312,-0.0568362706216605,0.0057212793202394,-0.0680499780893297,-0.0456225631539913,3.45462014890983e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PZP,Pregnancy zone protein,38013,-0.0611122159790281,0.0061526731673815,-0.0731714553870958,-0.0490529765709603,3.60229896931055e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BECN1,Beclin-1,37628,-0.0569118737329653,0.00573728989743805,-0.0681569619319439,-0.0456667855339867,4.12089075525759e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,-0.065426680580744,0.0066031175019752,-0.0783687908846154,-0.0524845702768726,4.60763703952627e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GUCA2A,Guanylin,40276,-0.0309919942445818,0.00313286786399026,-0.0371324152580027,-0.0248515732311609,5.23087105764373e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,-0.0346147001042881,0.00349932239700279,-0.0414733720024136,-0.0277560282061627,5.26417371665133e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,-0.0281263475832826,0.00284473965606739,-0.0337020373091747,-0.0225506578573905,5.66913974928475e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALCAM,CD166 antigen,40536,-0.0179463534441371,0.00181744037395856,-0.0215085365770959,-0.0143841703111783,6.23893693015283e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL19,C-C motif chemokine 19,40471,-0.120876391775384,0.0122477022500647,-0.14488188818551,-0.0968708953652567,6.57350323904999e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL25,C-C motif chemokine 25,40516,-0.0450852188074517,0.0045709708540911,-0.0540443216814702,-0.0361261159334331,6.9684519854474e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMSB10,Thymosin beta-10,40332,-0.0699172457479019,0.00709566949325404,-0.0838247579546798,-0.056009733541124,7.69680665359331e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASGR2,Asialoglycoprotein receptor 2,37987,-0.0240310655220735,0.00244124126644621,-0.028815898404308,-0.0192462326398389,8.69562948436605e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP7,Matrilysin,40015,-0.0443509874456317,0.0045197636464909,-0.0532097241927539,-0.0354922506985096,1.15527691537625e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,40305,-0.0781354748610426,0.00797673894837145,-0.0937698831998506,-0.0625010665222345,1.36550042556074e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,-0.048969157246506,0.0050006142124593,-0.0587703611029262,-0.0391679533900857,1.44650050603899e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40536,-0.0618811417411566,0.00632159985225376,-0.074271477451574,-0.0494908060307392,1.4536160171141e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCAN,Brevican core protein,40228,0.0306948807408099,0.00313562691423452,0.0245490519889102,0.0368407094927095,1.45441642221752e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,-0.019826638197148,0.00202747963080168,-0.0238004982735192,-0.0158527781207767,1.64765587860673e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT8,"Keratin, type II cytoskeletal 8",37541,-0.0567700241356611,0.0058238807947117,-0.0681848304932961,-0.0453552177780262,2.24610025191994e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,-0.0409707356632986,0.00420774475665001,-0.0492179153863326,-0.0327235559402646,2.42373961701834e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37959,-0.056608889673408,0.00581364472719059,-0.0680036333387016,-0.0452141460081145,2.47676713370014e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLAMF6,SLAM family member 6,39980,-0.0346478879905059,0.00356320001714368,-0.0416317600241075,-0.0276640159569043,2.76296889125798e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,-0.0386880620101875,0.00397993104498436,-0.0464887268583568,-0.0308873971620181,2.91736171422212e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL11,Eotaxin,40516,-0.0341390143660386,0.00351947136641661,-0.0410371782442151,-0.027240850487862,3.46720164738684e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERP44,Endoplasmic reticulum resident protein 44,40280,-0.0232109546857609,0.00239382396177158,-0.0279028496508332,-0.0185190597206886,3.60747127611027e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HYAL1,Hyaluronidase-1,40214,-0.0208978759672535,0.00215550878960482,-0.0251226731948789,-0.016673078739628,3.64782801709396e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,-0.0450411437689649,0.00464622058115156,-0.054147736108022,-0.0359345514299079,3.78899266022806e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NBN,Nibrin,40044,-0.046031526578769,0.00475493242879865,-0.0553511941392144,-0.0367118590183237,4.19916500946097e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,40303,-0.0437856885948879,0.00452873665139507,-0.0526620124316222,-0.0349093647581536,4.72518120637543e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHRDL2,Chordin-like protein 2,40359,-0.0512511165275704,0.00533277770723813,-0.0617033608337571,-0.0407988722213836,8.26830304658064e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD63,CD63 antigen,40203,-0.0468062855264033,0.00487088150562957,-0.0563532132774372,-0.0372593577753693,8.37414990324944e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZBP1,Z-DNA-binding protein 1,37598,-0.0363948998550822,0.00379495072189667,-0.0438330032699997,-0.0289567964401647,1.03391245223349e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNG,Interferon gamma,40044,-0.10149335823842,0.0106204217908189,-0.122309384948425,-0.0806773315284149,1.39656425053503e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRTN3,Myeloblastin,39897,-0.042050540514389,0.00440223369584709,-0.0506789185582493,-0.0334221624705287,1.45788810045163e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EREG,Proepiregulin,40192,-0.071577028147533,0.00749608612295013,-0.0862693569485153,-0.0568846993465508,1.50390914831887e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AP3S2,AP-3 complex subunit sigma-2,37942,-0.0418630547412591,0.00439047433148199,-0.0504683844309638,-0.0332577250515544,1.75207181665725e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,-0.0790544821476207,0.00829963031549434,-0.0953217575659897,-0.0627872067292518,1.88978292766623e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37942,-0.0270556312746407,0.0028418744494968,-0.0326257051956544,-0.021485557353627,2.01518642867954e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAB2,Stabilin-2,37998,-0.0250159288581046,0.00263060480785582,-0.030171914281502,-0.0198599434347072,2.23224691780956e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,-0.0404771412068166,0.00426136435666319,-0.0488294153458764,-0.0321248670677567,2.48849391173055e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGA5,Integrin alpha-5,40332,-0.022095831904046,0.00232799945885418,-0.0266587108434002,-0.0175329529646918,2.59774700028239e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTN1,Dynactin subunit 1,40489,-0.058246907585321,0.00614497136940111,-0.0702910514693471,-0.0462027637012948,2.92415187126917e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL1,Angiopoietin-related protein 1,40136,-0.0262342181443251,0.00277056002790186,-0.0316645157990127,-0.0208039204896374,3.22155898918582e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A12,Protein S100-A12,40139,-0.0677549346269205,0.00717123588470717,-0.0818105569609465,-0.0536993122928944,3.92478389969556e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INSL5,Insulin-like peptide INSL5,37901,-0.0837080507091335,0.00886460864158417,-0.101082683646638,-0.0663334177716285,4.21269889827981e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TALDO1,Transaldolase,37966,-0.039604882432957,0.00420206062694428,-0.0478409212617677,-0.0313688436041462,4.98493438747684e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PQBP1,Polyglutamine-binding protein 1,39980,-0.0486764354154884,0.00517311448295641,-0.0588157398020829,-0.0385371310288938,5.66876463107524e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BMP10,Bone morphogenetic protein 10,37671,0.025523024879901,0.00271210586252157,0.0202072973893587,0.0308387523704433,5.727511537121e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHAD,Chondroadherin,37671,0.0478074686205744,0.00508019147792494,0.0378502933238415,0.0577646439173073,5.73906460813338e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QA,Complement C1q subcomponent subunit A,40442,-0.0199588981044662,0.00212568964660361,-0.0241252498118092,-0.0157925463971231,6.83120372848754e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,-0.0426709405917498,0.00454791702516603,-0.0515848579610752,-0.0337570232224243,7.293750887359e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,0.0393591735096111,0.00419705772308873,0.0311329403723571,0.047585406646865,7.62133169353497e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS1,Galectin-1,40359,-0.0295067719490496,0.00314935834991035,-0.0356795143148739,-0.0233340295832253,8.2731468564531e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD248,Endosialin,37998,0.0353601923390771,0.00377501239874587,0.0279611680375352,0.042759216640619,8.63150094237992e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPAN1,Tetraspanin-1,40042,-0.0267838239305215,0.00286167474519421,-0.0323927064311021,-0.0211749414299408,9.08232171023269e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INHBB,Inhibin beta B chain,37671,-0.0455693544692175,0.00486885938305404,-0.0551123188600034,-0.0360263900784315,9.30053072958122e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NGRN,Neugrin,37942,-0.0193563044919914,0.00207664790607562,-0.0234265343878996,-0.0152860745960831,1.32975602731782e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,-0.054822180302293,0.00589757783511381,-0.0663814328591161,-0.0432629277454699,1.64866797777538e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCDC80,Coiled-coil domain-containing protein 80,40359,-0.0305861361011328,0.00329074039048264,-0.0370359872664787,-0.0241362849357868,1.66517536895279e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37628,-0.0632704929387092,0.00680894224273338,-0.0766160197344666,-0.0499249661429518,1.74450420138677e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FSTL1,Follistatin-related protein 1,37628,-0.0196541215910758,0.0021203692881425,-0.0238100453958351,-0.0154981977863165,2.16317007148404e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL3A1,Collagen alpha-1(III) chain,37998,-0.0201476162965594,0.00217905846189799,-0.0244185708818795,-0.0158766617112394,2.67340433139775e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL10,Interleukin-10,40044,-0.0742938093405633,0.00804492989449675,-0.090061871933777,-0.0585257467473497,2.9127607636424e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,-0.0433890227707653,0.00469886013442176,-0.052598788634232,-0.0341792569072987,2.93947505588794e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLB1,Beta-galactosidase,40228,-0.0351360162446339,0.00381392032009583,-0.0426113000720217,-0.027660732417246,3.57709945232068e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAT,Linker for activation of T-cells family member 1,40516,-0.0650069813940837,0.00706397448179974,-0.0788523713784112,-0.0511615914097562,3.9149325406038e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39980,-0.0427289073656255,0.00464732305485073,-0.0518376605531329,-0.0336201541781181,4.24414224781317e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD207,C-type lectin domain family 4 member K,40029,-0.0330670314534692,0.00359686904487172,-0.0401168947814178,-0.0260171681255206,4.28293329054569e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BSG,Basigin,40502,-0.0173427745717606,0.00188988291963205,-0.0210469450942394,-0.0136386040492818,4.97798997548826e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40471,-0.0574677542305956,0.00626547073394967,-0.0697480768691369,-0.0451874315920543,5.19042990608229e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFRP4,Secreted frizzled-related protein 4,37671,-0.0361655854373344,0.00395067338274232,-0.0439089052675094,-0.0284222656071595,6.26533648722934e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARSA,Arylsulfatase A,40332,-0.0381147255376775,0.00416868439043583,-0.0462853469429317,-0.0299441041324232,6.78919346412578e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLAT,Tissue-type plasminogen activator,40490,-0.0418460274782897,0.00458898130640958,-0.0508404308388525,-0.032851624117727,8.47874724792605e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA2,Annexin A2,37441,-0.0614576507368661,0.00674351469291273,-0.074674939534975,-0.0482403619387571,9.12517737129606e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL4,C-C motif chemokine 4,40376,-0.0576291926562987,0.00633118389473839,-0.0700383130899859,-0.0452200722226114,9.85975186880019e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,-0.0437219366603678,0.00481737293103152,-0.0531639876051896,-0.0342798857155461,1.28234663080901e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLAMF7,SLAM family member 7,40341,-0.0489649067216448,0.00539910663342992,-0.0595471557231674,-0.0383826577201221,1.3380561759638e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC27,Cell division cycle protein 27 homolog,39980,-0.0517244188338751,0.00570487101072203,-0.0629059660148903,-0.0405428716528599,1.37069057759997e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,-0.0487256647997727,0.00537557738315589,-0.0592617964707582,-0.0381895331287872,1.40100018882038e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINH1,Serpin H1,37714,-0.109974387261235,0.0121408430453791,-0.133770439630178,-0.0861783348922925,1.50927432948256e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUMB,Protein numb homolog,37598,-0.0710676777928098,0.00785258291182359,-0.0864587402999841,-0.0556766152856356,1.62497491444132e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37598,-0.0267375290059965,0.00296005252615268,-0.0325392319572558,-0.0209358260547373,1.9042378003362e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,-0.0921439229571969,0.0102190081873642,-0.112173179004431,-0.072114666909963,2.19388330325073e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,40225,-0.0492346639111873,0.00546229732405489,-0.0599407666663349,-0.0385285611560397,2.21990011854258e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG1A,Lithostathine-1-alpha,40274,-0.0412198311919432,0.00457352194231622,-0.0501839341988829,-0.0322557281850034,2.23603361278282e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,-0.026559178563538,0.00294638685764874,-0.0323340968045295,-0.0207842603225464,2.25450385363749e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNAP29,Synaptosomal-associated protein 29,40411,-0.0767777813666388,0.00852382846305839,-0.0934844851542332,-0.0600710775790444,2.34365201390782e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTRB1,Chymotrypsinogen B,40332,-0.0447851914556778,0.00498018355652432,-0.0545463512264654,-0.0350240316848901,2.6802360294247e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40471,-0.0688965641374787,0.00767268076102023,-0.0839350184290784,-0.053858109845879,3.01794049148407e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASAH1,Acid ceramidase,37882,-0.039025618607903,0.00434894587062737,-0.0475495525143326,-0.0305016847014733,3.24658614102414e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPPK1,Epiplakin,37628,-0.0620643374126577,0.00693078672924037,-0.0756486794019688,-0.0484799954233466,3.85223268746872e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37900,-0.0671824072286997,0.00750506507615938,-0.0818923347779721,-0.0524724796794273,3.9573643987979e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,-0.0512004177179542,0.00572846060703695,-0.0624282005077466,-0.0399726349281617,4.39494257754569e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39980,-0.029385817287048,0.00329034092884731,-0.0358348855075887,-0.0229367490665073,4.69018399960677e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FSHB,Follitropin subunit beta,37628,0.0588345570476871,0.00658647365944532,0.0459250686751743,0.0717440454202,4.70580565837475e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,40357,-0.0421114971255515,0.00471634789203095,-0.0513555389939321,-0.0328674552571708,4.76771977754605e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,-0.0535221015091796,0.00599509734194061,-0.0652724922993832,-0.041771710718976,4.81899278113426e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN2,CCN family member 2,40358,-0.0481435031761758,0.00539524856521931,-0.0587181903640057,-0.037568815988346,5.01030672282187e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PVR,Poliovirus receptor,40471,-0.0306657998912925,0.00343755705874446,-0.0374034117264316,-0.0239281880561533,5.12063034967373e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL5,C-C motif chemokine 5,40403,-0.0835075780163936,0.00939055014243983,-0.101913056295576,-0.0651020997372115,6.59094587858753e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CIT,Citron Rho-interacting kinase,37572,-0.0378488487492867,0.00425928847839372,-0.0461970541669384,-0.029500643331635,7.13971586228123e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,-0.0303239368428018,0.00341445130903678,-0.0370162614085139,-0.0236316122770897,7.47322051841338e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POSTN,Periostin,37998,0.0316828863413013,0.00356923275698798,0.0246871901376049,0.0386785825449978,7.74475568338255e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD46,Membrane cofactor protein,40250,-0.0237914545208693,0.00268651618956342,-0.0290570262524137,-0.018525882789325,9.17131103556125e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAG1,Dystroglycan,40422,-0.0391770639062564,0.00443025865517081,-0.0478603708703912,-0.0304937569421216,1.02701240501026e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPON2,Spondin-2,40267,-0.0285926838303997,0.00323499879554524,-0.0349332814696684,-0.022252086191131,1.07021936804177e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL6,Fc receptor-like protein 6,40341,-0.0558429589368932,0.00631877620862566,-0.0682277603057995,-0.0434581575679869,1.07855713493651e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39961,-0.0403196702334271,0.00457184379290127,-0.0492804840675136,-0.0313588563993406,1.2744622787099e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHB6,Ephrin type-B receptor 6,40192,-0.0256941582426971,0.00291984823645847,-0.0314170607861557,-0.0199712556992385,1.51041396537094e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMOX1,Heme oxygenase 1,40184,0.0386422796795382,0.00439259673838495,0.0300327900723037,0.0472517692867727,1.54692600664759e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YOD1,Ubiquitin thioesterase OTU1,37562,-0.0525942796217371,0.00598027934269962,-0.0643156271334284,-0.0408729321100459,1.6127765037196e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RTBDN,Retbindin,40305,-0.0240865747207801,0.00273975489637941,-0.0294564943176837,-0.0187166551238764,1.62487399054475e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPOCK1,Testican-1,40228,0.0206608547315439,0.00235413990630819,0.0160467405151798,0.0252749689479079,1.85835808857376e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,40333,-0.0797018317733491,0.00908666579675295,-0.0975116967349849,-0.0618919668117133,1.9427864490765e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,-0.0575086883260409,0.00655855543485053,-0.0703634569783479,-0.0446539196737338,1.99569967008104e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASAH2,Neutral ceramidase,40228,-0.0430402445362825,0.00491222824237029,-0.0526682118913283,-0.0334122771812367,2.11306176575602e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXLNA,Alpha-taxilin,40228,-0.0728946649391843,0.00832975550983704,-0.0892209857384649,-0.0565683441399037,2.32314995350704e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17C,Interleukin-17C,40044,-0.0572683297141944,0.00656429391852483,-0.0701343457945031,-0.0444023136338857,2.94739223385577e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,-0.0569941805852684,0.00654185255016069,-0.0698162115835833,-0.0441721495869534,3.27096751273051e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRN,Progranulin,40262,-0.0197765477137187,0.0022722387041394,-0.0242301355738319,-0.0153229598536054,3.52942517129824e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,-0.047125894043789,0.00541840144583429,-0.0577459608776242,-0.0365058272099538,3.73056846804834e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,-0.0170587702552669,0.00196404942230289,-0.0209083071229806,-0.0132092333875532,4.1287179453438e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CES2,Cocaine esterase,40305,-0.0434996325461547,0.00500941643539001,-0.0533180887595191,-0.0336811763327902,4.20376267341189e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTA,Lymphotoxin-alpha,40341,-0.0326221194111272,0.0037662100778178,-0.0400038911636501,-0.0252403476586043,5.08471368251183e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,-0.0719428650749391,0.00830688385846499,-0.0882243574375305,-0.0556613727123478,5.14043640441083e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNAPIN,SNARE-associated protein Snapin,37959,-0.0467499255615531,0.00540573078541079,-0.0573451579009583,-0.036154693222148,5.81545187623936e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFC1,Cryptic protein,39980,-0.037456608135679,0.00433203702533103,-0.0459474007053278,-0.0289658155660302,5.82664202802999e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,0.0278161747611192,0.00321758674055423,0.0215097047496329,0.0341226447726055,5.88343576919113e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM2,Intercellular adhesion molecule 2,40536,-0.0252489339508912,0.00292296439363638,-0.0309779441624185,-0.0195199237393639,6.24350438648003e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM4,Intercellular adhesion molecule 4,40341,0.0426525145380005,0.00493777666623637,0.0329744722721772,0.0523305568038237,6.25712612157193e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,40434,-0.058409344058462,0.00676659182790047,-0.071671864041147,-0.0451468240757771,6.58823285024966e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAEP,Glycodelin,40228,-0.106219795814051,0.0123088163827821,-0.130345075924303,-0.0820945157037978,6.73788500252575e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBS,Cystathionine beta-synthase,37628,-0.0412753471025812,0.00478619316773012,-0.0506562857113322,-0.0318944084938302,7.20848798285531e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EEF1D,Elongation factor 1-delta,37990,-0.0743152413235837,0.00862254967762618,-0.091215438691731,-0.0574150439554364,7.51532794286021e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,-0.0279259701842767,0.00324568847281387,-0.0342875195909918,-0.0215644207775615,8.40236042295262e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP53I3,Quinone oxidoreductase PIG3,37419,-0.0435924937494761,0.00506638749063267,-0.0535226132311161,-0.033662374267836,8.55824254675488e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ROBO1,Roundabout homolog 1,40379,-0.019413791768908,0.00225747653111418,-0.0238384457698918,-0.0149891377679242,8.72097616892805e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT5,ADP-sugar pyrophosphatase,40332,-0.0419030323972907,0.00488110693281676,-0.0514700019856116,-0.0323360628089699,9.93717885086813e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAT2,Linker for activation of T-cells family member 2,40305,-0.0981116888707816,0.0114384023342546,-0.120530957445921,-0.0756924202956426,1.05909561206497e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMP3,Metalloproteinase inhibitor 3,40422,-0.105839736510673,0.0123511528832368,-0.130047996161817,-0.0816314768595289,1.13595052079079e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARF1,Scavenger receptor class F member 1,40536,-0.0339918294906619,0.00396861768608353,-0.0417703201553857,-0.0262133388259382,1.17582651972721e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,-0.018360812977588,0.00214523394547159,-0.0225654715107123,-0.0141561544444637,1.24261099421527e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPARCL1,SPARC-like protein 1,40346,0.0221646808263503,0.0025899135931228,0.0170884501838296,0.0272409114688709,1.25122170025718e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C3,Complement C3,37360,-0.0381404305776981,0.0044573771346084,-0.0468768897615305,-0.0294039713938656,1.29165548150466e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,-0.0356565821628497,0.0041720037382573,-0.043833709489834,-0.0274794548358653,1.3838518755797e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGMN,Legumain,40422,-0.0284071600956427,0.00332514370063459,-0.0349244417488865,-0.0218898784423989,1.42271470010616e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,-0.052214851071448,0.00611065547683052,-0.0641917358060358,-0.0402379663368602,1.42698001795035e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFPI2,Tissue factor pathway inhibitor 2,40357,-0.0318147887757905,0.00372649223082,-0.0391187135481977,-0.0245108640033833,1.49451572567045e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40516,-0.0446234470399369,0.00523250509042359,-0.0548791570171672,-0.0343677370627067,1.61826502744251e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VAMP5,Vesicle-associated membrane protein 5,40042,-0.0447312996440411,0.0052528945311217,-0.0550269729250396,-0.0344356263630425,1.80753993051735e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GZMH,Granzyme H,40042,-0.0595394347036487,0.00699725012247032,-0.0732540449436905,-0.0458248244636068,1.91254892609687e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,-0.0494979588350792,0.00581887676021992,-0.0609029572851103,-0.0380929603850482,1.98009543259921e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,-0.0345133955168963,0.00406442819630849,-0.0424796747816609,-0.0265471162521317,2.2557417860628e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL8,Interleukin-8,40209,-0.0538315708498761,0.00634932069598516,-0.066276239414007,-0.0413869022857452,2.48488101893819e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,-0.0462962415181453,0.0054720006834608,-0.0570213628577285,-0.0355711201785622,2.89003074886828e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RALY,RNA-binding protein Raly,37900,-0.038516011000923,0.0045536229962847,-0.047441112073641,-0.029590909928205,2.99016554959003e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,40359,0.0204169688585665,0.00241572168093852,0.015682154363927,0.0251517833532061,3.11665390839657e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSLN,Mesothelin,40271,-0.0428791278161217,0.00507659654469106,-0.0528292570437162,-0.0329289985885272,3.26147148517796e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL2,Fc receptor-like protein 2,40442,-0.0384920781838055,0.00455953490375969,-0.0474287665951745,-0.0295553897724365,3.38096807263767e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELENOP,Selenoprotein P,38013,0.0180045399709389,0.00213576705408198,0.0138184365449383,0.0221906433969396,3.80220401390784e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,-0.0381213600637736,0.00452385934487643,-0.0469881243797314,-0.0292545957478158,3.85304321782219e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINT1,Kunitz-type protease inhibitor 1,40278,-0.0201381124793955,0.00239721035850169,-0.0248366447820588,-0.0154395801767322,4.81328696889321e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHCHD6,MICOS complex subunit MIC25,37900,-0.0229807828229889,0.00273511698587854,-0.0283416121153108,-0.0176199535306669,4.82150845147919e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APP,Amyloid-beta precursor protein,40309,-0.0526017066240303,0.00626886099509798,-0.0648886741744224,-0.0403147390736383,5.22453785634538e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM3D,Protein FAM3D,37901,-0.0652054069897312,0.00777397998279033,-0.0804424077560003,-0.0499684062234622,5.4499824103225e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NSFL1C,NSFL1 cofactor p47,40471,-0.0522737487995905,0.00623511308635424,-0.0644945704488449,-0.0400529271503362,5.54758690706571e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,40042,-0.0297035439335951,0.00354431308701088,-0.0366503975841364,-0.0227566902830538,5.709706777942e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAFA5,Chemokine-like protein TAFA-5,40305,-0.0281638188573614,0.00336213587422993,-0.034753605170852,-0.0215740325438707,5.89110904674771e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,-0.0491882113919037,0.00588036352302719,-0.060713723897037,-0.0376626988867704,6.60711042882764e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39980,-0.0448793599237191,0.00536822812119695,-0.0554010870412651,-0.034357632806173,6.78812751298851e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,-0.0488424424051465,0.00587680683707124,-0.0603609838058062,-0.0373239010044869,1.03859359571032e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,-0.0512313179057668,0.00616863132174986,-0.0633218352963966,-0.0391408005151371,1.07597164303594e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,-0.0762667540071039,0.00919165422177102,-0.094282396281775,-0.0582511117324327,1.14874302058388e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6AP2,Renin receptor,39980,-0.0324186657608052,0.00391163779313978,-0.0400854758353592,-0.0247518556862512,1.24766896186652e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4G,C-type lectin domain family 4 member G,40341,-0.0255033321673751,0.00307947579280871,-0.0315391047212802,-0.0194675596134701,1.30996678695806e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,-0.0278751696555217,0.00336824293811882,-0.0344769258142346,-0.0212734134968088,1.39761874562506e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,-0.0278346774338838,0.00336464429050352,-0.0344293802432706,-0.0212399746244969,1.43512701117247e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,-0.0313771729758888,0.00379432004496048,-0.0388140402640114,-0.0239403056877663,1.46958627808473e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CGA,Glycoprotein hormones alpha chain,40332,0.069270877523632,0.0083911985832134,0.0528241283005337,0.0857176267467302,1.63487919364469e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,-0.0343849447805389,0.00416544414087862,-0.042549215296661,-0.0262206742644168,1.66436812666447e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPE,Carboxypeptidase E,40360,0.0295202830574456,0.00358137589585953,0.0225007863015609,0.0365397798133303,1.8134961816594e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF19,Fibroblast growth factor 19,40422,-0.0590575189476045,0.00717675891548676,-0.0731239664219586,-0.0449910714732505,2.03225179900499e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,-0.0769458706584133,0.00935352137496184,-0.0952787725533385,-0.0586129687634881,2.07556271040595e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39961,-0.0470485978552282,0.00572309856167644,-0.058265871036114,-0.0358313246743424,2.17971327254538e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VEGFC,Vascular endothelial growth factor C,40411,-0.0428433581655816,0.00522408735391081,-0.0530825693792468,-0.0326041469519164,2.56134279426198e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDNF,Cerebral dopamine neurotrophic factor,40305,-0.0248562776230993,0.00303341503332454,-0.0308017710884154,-0.0189107841577832,2.7146623519781e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGAM,Integrin alpha-M,40332,0.0242669821965731,0.00296713056529755,0.0184514062885899,0.0300825581045563,3.08692988906562e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IDS,Iduronate 2-sulfatase,40516,0.00662311232925092,0.000810010178165013,0.00503549238004749,0.00821073227845434,3.13638224815992e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STK11,Serine/threonine-protein kinase STK11,40042,-0.0558330522136357,0.00683267371405673,-0.0692250926931868,-0.0424410117340845,3.27837350745919e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TDRKH,Tudor and KH domain-containing protein,39961,-0.0649184892448735,0.00795770291568181,-0.0805155869596099,-0.0493213915301372,3.66701917449808e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNM3,Dynamin-3,37959,-0.0421108447518915,0.00517299062683196,-0.0522499063804822,-0.0319717831233009,4.27828855081505e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDHR5,Cadherin-related family member 5,40359,-0.0296601079251396,0.00364592524452849,-0.0368061214044155,-0.0225140944458638,4.41613420778917e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,-0.10708122898218,0.0131640480715117,-0.132882763202343,-0.0812796947620169,4.50174778701691e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADA,Adenosine deaminase,40516,-0.0258921213921689,0.00318407348133361,-0.0321329054155828,-0.0196513373687551,4.53736343123115e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,-0.0464488770263789,0.0057206243591243,-0.0576613007702625,-0.0352364532824953,5.01984051816146e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37990,-0.0228418693673381,0.00281561906051868,-0.0283604827259547,-0.0173232560087215,5.3808632877478e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,40422,-0.0291022041709759,0.00358873341974287,-0.036136121673672,-0.0220682866682799,5.45683174663124e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GHR,Growth hormone receptor,37671,-0.0220820027154393,0.00272328113251445,-0.0274196337351677,-0.016744371695711,5.56898344252042e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37950,-0.015191719955901,0.00187434173032176,-0.0188654297473317,-0.0115180101644704,5.7212323191572e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA10,Annexin A10,39961,-0.0626955415854667,0.00773848641119063,-0.0778629749514003,-0.047528108219533,5.81648939315638e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL17,C-C motif chemokine 17,40333,-0.0686985184722445,0.00847979127203152,-0.0853189093654263,-0.0520781275790628,5.82316693159497e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL15,Interleukin-15,40341,-0.0248555221250176,0.00306876746026349,-0.030870306347134,-0.0188407379029011,5.91553938358927e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPL,Periplakin,37598,-0.0251971615760139,0.00311291214028994,-0.0312984693709822,-0.0190958537810456,6.25788781520233e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDHR2,Cadherin-related family member 2,40305,-0.0581715745822701,0.00719265580220757,-0.0722691799545969,-0.0440739692099433,6.5201715742692e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,-0.0586022373361681,0.0072559879987793,-0.0728239738137755,-0.0443805008585607,7.23155864139388e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,-0.0222311393357436,0.00275379204268347,-0.0276285717394032,-0.016833706932084,7.34763873826983e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THBD,Thrombomodulin,40359,-0.020983881064256,0.00260077188391945,-0.0260813939567381,-0.0158863681717739,7.63162528310582e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HGFAC,Hepatocyte growth factor activator,37849,0.0221074997859452,0.00274166875874758,0.0167338290188,0.0274811705530905,8.0386271403296e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,40291,-0.0326159564946441,0.00404583634251339,-0.0405457957259703,-0.0246861172633178,8.06356975260543e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOS1,"Nitric oxide synthase, brain",39961,-0.0376581102670834,0.00467544326753109,-0.0468219790714444,-0.0284942414627225,8.56044427281665e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARF6,ADP-ribosylation factor 6,37901,-0.0796838667038134,0.00991426111550034,-0.0991158184901941,-0.0602519149174328,9.94609315320789e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37835,-0.044535425318259,0.00554278786300532,-0.0553992895297494,-0.0336715611067686,1.01503112032859e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPL14,60S ribosomal protein L14,37628,-0.0313075953599866,0.00389912664545043,-0.0389498835850694,-0.0236653071349038,1.06229728486436e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39961,-0.0287932759231412,0.00358702385568983,-0.0358238426802933,-0.0217627091659891,1.06941686653323e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SRPK2,SRSF protein kinase 2,40341,-0.0619965768376326,0.00772953510034751,-0.0771464656343137,-0.0468466880409515,1.12389644348902e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARSB,Arylsulfatase B,40305,-0.0411710862991741,0.0051420334907682,-0.0512494719410798,-0.0310927006572685,1.25874286412652e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JUN,Transcription factor AP-1,40044,-0.0388060478009555,0.00485101045595735,-0.0483140282946319,-0.029298067307279,1.33563943094809e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLAMF1,Signaling lymphocytic activation molecule,40044,-0.0444990290880466,0.00556820205551841,-0.0554127051168627,-0.0335853530592306,1.42426054209307e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37990,-0.0189234716092717,0.00237005649722821,-0.023568782343839,-0.0142781608747044,1.52536509918508e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,40044,-0.0516958721940516,0.00650794643881332,-0.0644514472141257,-0.0389402971739775,2.09896288825807e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD6,T-cell differentiation antigen CD6,40502,-0.0394917791695365,0.00497213178426252,-0.0492371574666911,-0.029746400872382,2.10981799404432e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAP18,Chromatin complexes subunit BAP18,37942,-0.0485378002311389,0.00611232219922496,-0.0605179517416198,-0.036557648720658,2.1638933347006e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,-0.020776030835365,0.00262041970176467,-0.0259120534508238,-0.0156400082199063,2.39060102986413e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFB,Platelet-derived growth factor subunit B,40422,-0.0635128147979444,0.00802462072418075,-0.0792410714173387,-0.0477845581785501,2.63930992784187e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BGN,Biglycan,39956,0.0901707790139477,0.0114018440203594,0.0678231647340433,0.112518393293852,2.78115651389646e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,-0.077362448837338,0.00978426406549346,-0.0965396064057052,-0.0581852912689709,2.8141673201411e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CES3,Carboxylesterase 3,40305,-0.0507313910539777,0.00642396043959023,-0.0633223535155745,-0.0381404285923808,3.03790535826426e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,QDPR,Dihydropteridine reductase,40290,-0.0323487488805206,0.00410014255513166,-0.0403850282885787,-0.0243124694724626,3.22686649544413e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNL1,Interferon lambda-1,39961,-0.033529932797639,0.00424994094188549,-0.0418598170437346,-0.0252000485515435,3.23526562747559e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCXR,L-xylulose reductase,40411,-0.0385271812370128,0.00489040791311997,-0.0481123807467279,-0.0289419817272976,3.53663661385776e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSV,Cathepsin L2,40444,0.0312566793535363,0.00397464989937469,0.0234663655507619,0.0390469931563107,3.95651310320134e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS22,Brain-specific serine protease 4,37598,-0.0262375678280666,0.00333610665301375,-0.0327763368679736,-0.0196987987881597,3.98657595521623e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39961,-0.0357498733645447,0.00455813254729476,-0.0446838131572425,-0.026815933571847,4.68060619131831e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HPSE,Heparanase,37848,-0.0687092308580488,0.00875978357296114,-0.0858784066610527,-0.051540055055045,4.70399336610162e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37987,-0.044681965405502,0.00570464785744108,-0.0558630752060866,-0.0335008556049175,5.1351568194123e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD244,Natural killer cell receptor 2B4,40516,-0.0195136680708252,0.00249316272285205,-0.0244002670076152,-0.0146270691340352,5.31158486384132e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIMAP7,GTPase IMAP family member 7,37671,0.0240079197037591,0.0030676803352516,0.017995266246666,0.0300205731608523,5.4143363761255e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSB,Cathepsin B,40353,0.0396317128548126,0.00506568009553793,0.0297029798675583,0.049560445842067,5.45561326926579e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFA,Platelet-derived growth factor subunit A,40536,-0.052672143169638,0.00673738886392637,-0.0658774253429337,-0.0394668609963423,5.70277512026884e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA12,Carbonic anhydrase 12,40305,-0.023649611061596,0.00302789801972492,-0.0295842911802569,-0.0177149309429352,6.04769720143547e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPK9,Mitogen-activated protein kinase 9,40341,-0.0313315961946952,0.00401403518488239,-0.0391991051570647,-0.0234640872323257,6.29351700877716e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17RB,Interleukin-17 receptor B,40126,0.0390236124901426,0.00500259547149077,0.0292185253660207,0.0488286996142645,6.54398449504016e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP85,Centrosomal protein of 85 kDa,39980,-0.0460680966054896,0.00590607943805479,-0.0576440123040769,-0.0344921809069022,6.57665359842498e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,-0.0398043104267539,0.00510423556539577,-0.0498086121349296,-0.0298000087185782,6.66367431561633e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C19orf12,Protein C19orf12,39961,-0.0453593593609035,0.00581705348670738,-0.0567607841948499,-0.033957934526957,6.70622263511355e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGA4,Pepsin A-4,37987,-0.0501588528352845,0.00643416704070735,-0.0627698202350709,-0.0375478854354981,6.87117024167613e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLVRB,Flavin reductase,40332,-0.0484325653387105,0.00621467334409946,-0.0606133250931454,-0.0362518055842755,6.93275475588498e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,-0.0636157390470024,0.00817741420309899,-0.0796434708850764,-0.0475880072089283,7.72836276693195e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOBR,Apolipoprotein B receptor,37628,0.0310861464827046,0.00399982462620259,0.0232464902153475,0.0389258027500617,8.30450019201648e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,-0.0270806433065174,0.00348650101413831,-0.0339141852942285,-0.0202471013188063,8.50721843763247e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX15,Sorting nexin-15,37671,-0.0396613155023921,0.0051204544328111,-0.0496974061907018,-0.0296252248140823,1.01990382203908e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYH9,Myosin-9,37998,-0.0818643412944549,0.0105790816543474,-0.102599341336976,-0.0611293412519339,1.0784447132166e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,-0.0163288295740221,0.00211101389210123,-0.0204664168025405,-0.0121912423455037,1.10629288606959e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,0.0151583268984438,0.00196090769499664,0.0113149478162504,0.0190017059806372,1.13851464419119e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTGR1,Prostaglandin reductase 1,37990,-0.057884110895483,0.0074880819639501,-0.0725607515448252,-0.0432074702461409,1.14956895306763e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,-0.0504058114002323,0.00652228856907597,-0.0631894969956212,-0.0376221258048434,1.15552745327744e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPXM1,Probable carboxypeptidase X1,40411,-0.0495871359908353,0.00643524623483281,-0.0622002186111076,-0.036974053370563,1.37909384249856e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNLR1,Interferon lambda receptor 1,40341,-0.0269667225143873,0.00350006232542891,-0.033826844672228,-0.0201066003565466,1.3893010017541e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSE,Cathepsin E,37671,-0.0375471887265956,0.00487313073349825,-0.0470985249642522,-0.027995852488939,1.40208951230746e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLIN3,Perilipin-3,40359,-0.0306195151605562,0.00397758799855328,-0.0384155876377206,-0.0228234426833917,1.46292306386115e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,0.0461404977747463,0.00600045064809841,0.0343796145044734,0.0579013810450192,1.56291618319973e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JAM3,Junctional adhesion molecule C,37671,-0.0367528160443406,0.00478449544201865,-0.0461304271106972,-0.0273752049779841,1.68081805503299e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,-0.0697533143351092,0.00909794304555999,-0.0875852827044068,-0.0519213459658116,1.86340677317296e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,-0.0605861157999554,0.00790402631826655,-0.0760780073837579,-0.045094224216153,1.90711137011609e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL2L15,Bcl-2-like protein 15,37598,-0.0408656256783781,0.00533119104639777,-0.0513147601293177,-0.0304164912274384,1.90781147522008e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALPP,"Alkaline phosphatase, placental type",40305,-0.07373309543102,0.0096592963885503,-0.0926653163525786,-0.0548008745094614,2.41660151782917e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AP3B1,AP-3 complex subunit beta-1,37901,-0.0549396451018868,0.00720697907687061,-0.0690653240925531,-0.0408139661112204,2.64181739813643e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAG4,BAG family molecular chaperone regulator 4,37598,-0.0349506000883276,0.00458535748833815,-0.0439379007654704,-0.0259632994111848,2.66414152169756e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39961,-0.0275266185409896,0.00361590793073409,-0.0346137980852284,-0.0204394389967508,2.83971514344196e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RFC4,Replication factor C subunit 4,37900,-0.0147191439029992,0.00193683350615085,-0.0185153375750549,-0.0109229502309435,3.16686593044149e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,0.0295597510532752,0.00389072466373416,0.0219339307123562,0.0371855713941941,3.18619453644905e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,A1BG,Alpha-1B-glycoprotein,38013,-0.0125643186370653,0.00165471971815498,-0.015807569284649,-0.00932106798948151,3.32929341922412e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASPN,Asporin,37990,0.0195327851654151,0.00257319854742975,0.0144893160124528,0.0245762543183774,3.38542256533924e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,-0.0847178957183796,0.0111629867987957,-0.106597349844019,-0.06283844159274,3.39767654193639e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDA,Cytidine deaminase,37970,-0.032712923143873,0.00432353275740937,-0.0411870473483954,-0.0242387989393507,4.08948041428014e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39980,-0.0366284215946175,0.00484291074770408,-0.0461205266601175,-0.0271363165291175,4.14907765851122e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLRX,Glutaredoxin-1,40260,-0.040109466425589,0.00530766687302981,-0.0505124934967274,-0.0297064393544506,4.35387535805621e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AZU1,Azurocidin,39809,-0.05500639771071,0.00728327598603653,-0.0692816186433416,-0.0407311767780784,4.51234575493885e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,-0.0486669814186182,0.00644344112293615,-0.0612961260195731,-0.0360378368176634,4.53628335901817e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRTAC1,Cartilage acidic protein 1,40536,0.020729075571149,0.00274795345574645,0.015343086797886,0.0261150643444121,4.82075892465916e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COMP,Cartilage oligomeric matrix protein,40198,0.0239251951089462,0.00317564994056157,0.0177009212254455,0.0301494689924468,5.18969087217183e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MILR1,Allergin-1,40044,-0.0351424813128434,0.00467206488580824,-0.0442997284890276,-0.0259852341366593,5.69543893753131e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPK1,Thiamin pyrophosphokinase 1,37990,-0.0192116778779104,0.00255471017734508,-0.0242189098255068,-0.0142044459303141,5.81745769089339e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17A,Interleukin-17A,40028,-0.0300286240550362,0.00399494461420713,-0.0378587154988821,-0.0221985326111902,5.92483822636237e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,0.018333714296641,0.00244349965439393,0.0135444549740289,0.0231229736192531,6.62278651760545e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC16A1,Monocarboxylate transporter 1,39961,-0.0422167279806376,0.00563091146777424,-0.0532533144574751,-0.0311801415038001,6.86554700258423e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,0.0185139218090374,0.00247633069856118,0.0136603136398575,0.0233675299782173,8.04039135086053e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,-0.0334980250420822,0.00448012213403523,-0.0422790644247912,-0.0247169856593732,8.06985132825865e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37901,-0.0587392984456849,0.00785940023880621,-0.0741437229137451,-0.0433348739776248,8.27434500400955e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,-0.054813856870847,0.00734943969810612,-0.069218758679135,-0.040408955062559,9.23200062376168e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A11,Protein S100-A11,40207,-0.0313970691764906,0.00421371830303995,-0.0396559570504489,-0.0231381813025323,9.73231269224284e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK10,Kallikrein-10,40354,-0.0274003062781489,0.00367747530555099,-0.0346081578770288,-0.0201924546792689,9.75044591576151e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBLIF,Cobalamin binding intrinsic factor,40330,-0.0508700377310882,0.00684631688840908,-0.06428881883237,-0.0374512566298064,1.13880614131999e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLNK,B-cell linker protein,37598,-0.0268562538109498,0.00361588629730298,-0.0339433909536636,-0.019769116668236,1.17670131971556e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEFTY2,Left-right determination factor 2,40453,-0.0360338163876706,0.0048604770694002,-0.0455603514436949,-0.0265072813316462,1.29025368631525e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YES1,Tyrosine-protein kinase Yes,40305,-0.0787143887883519,0.0106239395684161,-0.0995373103424473,-0.0578914672342564,1.33509602521146e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIMAP8,GTPase IMAP family member 8,37482,-0.0362402424061035,0.00489249409655913,-0.0458295308353594,-0.0266509539768476,1.36809025914871e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANG,Angiogenin,40309,-0.0239490920340265,0.00323422490541533,-0.0302881728486405,-0.0176100112194125,1.37847822214732e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAA80,N-alpha-acetyltransferase 80,37572,-0.0830675469006832,0.0112246506302976,-0.105067862136066,-0.0610672316652999,1.43973329125483e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,-0.0504383200351333,0.00681646406671923,-0.063798589605903,-0.0370780504643636,1.44819348457568e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MERTK,Tyrosine-protein kinase Mer,40516,-0.0181147389499469,0.00245145788740066,-0.0229195964092522,-0.0133098814906416,1.54772139861983e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,-0.0205571050585795,0.00278273298474588,-0.0260112617086814,-0.0151029484084775,1.57177581617287e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BACH1,Transcription regulator protein BACH1,40341,-0.0500658022208064,0.00678927140755895,-0.0633727741796219,-0.0367588302619909,1.73416265770657e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39961,-0.0544199185614574,0.00738267527077527,-0.0688899620921769,-0.0399498750307379,1.77495445370238e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STIP1,Stress-induced-phosphoprotein 1,40307,-0.0451361644663938,0.00612692944923489,-0.0571449461868942,-0.0331273827458935,1.83304112891937e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,-0.0399563610470532,0.00542796025990158,-0.0505951631564603,-0.0293175589376461,1.91381099573626e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SWAP70,Switch-associated protein 70,37901,-0.0244599267668997,0.00332255785503086,-0.0309721401627602,-0.0179477133710392,1.92017855363948e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGAL,Integrin alpha-L,37598,-0.0302399214043024,0.00411373052582601,-0.0383028332349214,-0.0221770095736834,2.08397010911161e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,-0.0265241413418529,0.0036135609207699,-0.0336067207465619,-0.0194415619371439,2.23672706191754e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL8,C-C motif chemokine 8,40470,-0.0414440142100249,0.00564840513464102,-0.0525148882739213,-0.0303731401461285,2.28396285101992e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGBP1,Immunoglobulin-binding protein 1,37959,-0.0423062660206372,0.00577862998621524,-0.0536323807936191,-0.0309801512476553,2.59738643372219e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS8,Galectin-8,40471,-0.0412943365390706,0.00565221213571672,-0.0523726723250754,-0.0302160007530658,2.88446717745802e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NT5E,5'-nucleotidase,40411,-0.0395561628945013,0.00541698060748492,-0.0501734448851718,-0.0289388809038309,2.96338593426172e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC14A,C-type lectin domain family 14 member A,40332,-0.0215230735141985,0.00294757588799295,-0.0273003222546647,-0.0157458247737323,2.97056358580074e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP43,Centrosomal protein 43,39934,-0.047208732012857,0.00646557500085819,-0.059881259014539,-0.034536205011175,2.9830403539087e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEFL,Neurofilament light polypeptide,39903,-0.0291653192208644,0.00400207239127236,-0.0370093811077582,-0.0213212573339706,3.30898650993539e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHGA,Chromogranin-A,37998,-0.062103652949789,0.00852155040327625,-0.0788058917402105,-0.0454014141593676,3.32407603406633e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCN2,Transcobalamin-2,40497,-0.0204173131652584,0.00280263022058345,-0.0259104683976019,-0.0149241579329148,3.36484608231801e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PEPD,Xaa-Pro dipeptidase,37987,0.0177874708830931,0.00244292835341697,0.0129993313103958,0.0225756104557903,3.49101178963907e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,-0.0309757174001979,0.0042567322737785,-0.0393189126568038,-0.0226325221435921,3.57637984468673e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,-0.0446481585848086,0.00613815066413979,-0.0566789338865226,-0.0326173832830946,3.68637140018469e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,-0.0311471933589987,0.00428475847938825,-0.0395453199785996,-0.0227490667393977,3.78181388458709e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNMBP,Dynamin-binding protein,40228,-0.0418735786558776,0.00576375157982089,-0.0531705317523265,-0.0305766255594287,3.90521265499199e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VNN2,Vascular non-inflammatory molecule 2,40305,-0.0305476583261492,0.00421119061595869,-0.0388015919334282,-0.0222937247188701,4.2359046461602e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,-0.017390075614022,0.00239782276783669,-0.0220898082389819,-0.0126903429890621,4.28326021409771e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NID1,Nidogen-1,40355,-0.0269342795174078,0.00371427808994065,-0.0342142645736915,-0.0196542944611241,4.30993010501483e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,0.0284752474593491,0.00393061398407301,0.020771244050566,0.0361792508681322,4.54079034847039e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,-0.0796548449752047,0.0109959235212324,-0.10120685507682,-0.0581028348735893,4.59231563993572e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB44,Ras-related protein Rab-44,37900,-0.0272420939636322,0.00376337900243021,-0.0346183168083954,-0.019865871118869,4.7747122621362e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRK1,NKG2-D type II integral membrane protein,37942,-0.031496106583746,0.00435450436830759,-0.0400309351456289,-0.0229612780218632,4.97930373826108e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,-0.0246298586703784,0.00340544196298545,-0.0313045249178299,-0.0179551924229269,5.00191171251048e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AP2B1,AP-2 complex subunit beta,37572,-0.0334265269362825,0.00462470784734861,-0.0424909543170858,-0.0243620995554792,5.17980115452632e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUSD4,Sushi domain-containing protein 4,37900,-0.0304591517225503,0.00421520212750215,-0.0387209478924545,-0.0221973555526461,5.2413508781571e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MANSC1,MANSC domain-containing protein 1,40411,-0.0185466890103561,0.00256894392142485,-0.0235818190963488,-0.0135115589243634,5.44997428325615e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A4,Protein S100-A4,40411,-0.0389978680841669,0.00540335916174632,-0.0495884520411897,-0.0284072841271441,5.54015278561191e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BID,BH3-interacting domain death agonist,40341,-0.0451835154317022,0.00626344660372081,-0.057459870774995,-0.0329071600884095,5.68494566124422e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLGN,Calmegin,37572,-0.0302947955348406,0.00420527330534375,-0.0385371312133143,-0.0220524598563668,6.16621182687183e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,-0.0502761004350228,0.00698123675063769,-0.0639593244662727,-0.0365928764037729,6.27546960372654e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL16,C-X-C motif chemokine 16,40517,-0.016019412204381,0.00222788775732083,-0.0203860722087298,-0.0116527522000322,6.7445336643237e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTSS2,Protein MTSS 2,37900,-0.0665775683776126,0.00926959414476458,-0.0847459729013511,-0.048409163853874,7.21204643701743e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37959,-0.0513421021524212,0.0071508568549175,-0.0653577815880595,-0.0373264227167829,7.34340885304531e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,-0.0511341438782019,0.0071280008088219,-0.0651050254634928,-0.037163262292911,7.62258739239091e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,-0.0250111775945589,0.00349323907341002,-0.0318579261784426,-0.0181644290106753,8.49994162010427e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,-0.0211505191607399,0.00295651513682345,-0.0269452888289138,-0.0153557494925659,8.80506710945242e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PROK1,Prokineticin-1,40341,-0.0459872525885824,0.00645027509424019,-0.0586297917732932,-0.0333447134038716,1.0506881772235e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39961,-0.0443963521940445,0.00622730242526723,-0.0566018649475682,-0.0321908394405207,1.05325986645306e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,40411,-0.0181503860760984,0.00254698172370915,-0.0231424702545683,-0.0131583018976285,1.07565519118073e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGB3A2,Secretoglobin family 3A member 2,40396,0.0566474850704293,0.00795184509478175,0.0410618686846571,0.0722331014562015,1.09467858873822e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,-0.024028119651598,0.00337464814205607,-0.0306424300100279,-0.0174138092931681,1.12400576108006e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,-0.0515951119182362,0.00725679867743712,-0.065818437326013,-0.0373717865104595,1.21962944382483e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPAN8,Tetraspanin-8,37901,-0.0697399238940812,0.00982505845683963,-0.0889970384694869,-0.0504828093186755,1.3275954217768e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,-0.0478283825727443,0.00674237599095564,-0.0610434395150174,-0.0346133256304713,1.36083443584172e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37562,-0.0247472972575104,0.00348898011273476,-0.0315856982784705,-0.0179088962365502,1.37981033007982e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,0.017197549330425,0.00242575824972345,0.0124430631609671,0.021952035499883,1.40143163314799e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NIT2,Omega-amidase NIT2,37936,-0.0504725102505312,0.00712084285609352,-0.0644293622484745,-0.0365156582525879,1.42832654036753e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,-0.0537639697696079,0.00758540057996776,-0.0686313549063447,-0.0388965846328711,1.43184870981917e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPBP,Platelet basic protein,37934,-0.0561534672275119,0.00792730791661789,-0.071690990744083,-0.0406159437109409,1.47479276160909e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTGES2,Prostaglandin E synthase 2,37484,-0.0365495850091964,0.00516516646820546,-0.0466733112868791,-0.0264258587315137,1.5577406217827e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSNK2A1,Casein kinase II subunit alpha,37959,0.0302206715718153,0.00427579542162289,0.0218401125454344,0.0386012305981962,1.65076365566521e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,40341,-0.0364789843068778,0.00516314882401976,-0.0465987560019566,-0.0263592126117991,1.66972568376285e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,0.019194189845254,0.00271852146643218,0.0138658877710469,0.0245224919194611,1.72657767640336e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC5A,C-type lectin domain family 5 member A,40314,-0.0186490874147438,0.00264784927288324,-0.0238388719895949,-0.0134593028398926,1.95720160620572e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,40044,-0.0395575590985172,0.00562266196097492,-0.050577976542028,-0.0285371416550063,2.06988923226665e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,-0.0635397823257358,0.00904304758667777,-0.0812641555956242,-0.0458154090558473,2.20755470123746e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASC3,Protein CASC3,37572,-0.0271978627371964,0.00387445455487385,-0.0347917936647491,-0.0196039318096436,2.33128458603394e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRLF1,Cytokine receptor-like factor 1,40422,-0.0172992943907197,0.00246514483378787,-0.0221309782649439,-0.0124676105164955,2.34857395830333e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,40400,-0.0468820583794845,0.00668130300454978,-0.0599774122684021,-0.033786704490567,2.35967452250442e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39980,-0.0421970307440629,0.0060188828718523,-0.0539940411728934,-0.0304000203152324,2.46768155609732e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNR,Tenascin-R,40228,0.027860067478258,0.00397573203521605,0.0200676326892346,0.0356525022672815,2.52376043035433e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,-0.0365405862063849,0.00522113191789975,-0.0467740047654684,-0.0263071676473014,2.68901356591321e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37598,0.0213156100485355,0.00304546904289901,0.0153464907244535,0.0272847293726176,2.70065233752263e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,-0.0296180136224993,0.0042327934374329,-0.0379142887598678,-0.0213217384851308,2.73638018716852e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGFLAM,Pikachurin,37901,-0.0203569803597604,0.00290975136773883,-0.0260600930405285,-0.0146538676789923,2.75590668848316e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RILP,Rab-interacting lysosomal protein,40434,-0.0394163779015817,0.00563706398384166,-0.0504650233099114,-0.028367732493252,2.81003937457609e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FYB1,FYN-binding protein 1,40311,-0.0597768359878249,0.00855162327825629,-0.0765380176132072,-0.0430156543624425,2.85606820541078e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC1B,C-type lectin domain family 1 member B,40471,-0.062972580204993,0.00900948298427666,-0.0806311668541752,-0.0453139935558107,2.86566725851909e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA2,Carbonic anhydrase 2,40291,-0.0462581199179094,0.006620586250231,-0.0592344689683622,-0.0332817708674566,2.91987354528998e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH9,Protocadherin-9,37901,-0.0223227755493193,0.00319487305965288,-0.0285847267462389,-0.0160608243523996,2.9391395019827e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,-0.0706469952447612,0.0101218736416916,-0.0904858675824767,-0.0508081229070458,3.09772001627986e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD5L,CD5 antigen-like,37934,-0.030767245492087,0.00441046634826685,-0.03941175953469,-0.022122731449484,3.1795633659782e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH3GLB2,Endophilin-B2,37942,-0.0440537234097134,0.00631839583498472,-0.0564377792462834,-0.0316696675731433,3.26316951642067e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,-0.0616341974459848,0.00885619811748258,-0.0789923457562507,-0.044276049135719,3.55073650163434e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,P4HB,Protein disulfide-isomerase,40266,-0.0251629183709223,0.00361720822629275,-0.0322526464944561,-0.0180731902473885,3.62643114808276e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELP,P-selectin,40403,-0.0376200439895994,0.00540927048585684,-0.0482222141418788,-0.02701787383732,3.66939910128649e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINE2,Glia-derived nexin,37990,-0.0420970484770298,0.00605240065408259,-0.0539597537590316,-0.0302343431950279,3.67624402861724e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCK2,Cytoplasmic protein NCK2,40422,-0.0679984604647996,0.00978677116607383,-0.0871805319503043,-0.0488163889792949,3.8482113423728e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39978,-0.0319900724964934,0.00460476806007668,-0.0410154178942437,-0.0229647270987431,3.87516064364197e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,-0.030621727747093,0.00440984638767814,-0.0392650266669422,-0.0219784288272439,3.96477119054009e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGMB,RGM domain family member B,40471,-0.016881142731394,0.00243126636404837,-0.0216464248049288,-0.0121158606578592,3.97605267818289e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RSPO1,R-spondin-1,40228,-0.0230273488479739,0.00331766662856611,-0.0295299754399635,-0.0165247222559843,4.04996855054524e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDIA3,Protein disulfide-isomerase A3,37671,-0.0167754928300651,0.00241659552562775,-0.0215120200602955,-0.0120389655998347,4.05238021080275e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMOX2,Heme oxygenase 2,39961,-0.0296387388120725,0.00427128015486144,-0.0380104479156009,-0.021267029708544,4.10299509463595e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLA2,Src-like-adapter 2,37959,-0.0675223633367178,0.00972972823150639,-0.0865926306704703,-0.0484520960029653,4.10562690096793e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NID2,Nidogen-2,40332,-0.0479476307117181,0.00691077139737465,-0.0614927426505724,-0.0344025187728638,4.12758486759009e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,-0.0224278081151963,0.00323317496475143,-0.0287648310461091,-0.0160907851842835,4.16678112670152e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYN,Tyrosine-protein kinase Lyn,40305,-0.0543764885066176,0.00785958779935299,-0.0697812805933495,-0.0389716964198858,4.73946911697129e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNPEP,Aspartyl aminopeptidase,37942,-0.0386448062535382,0.00561500927531507,-0.0496502244331557,-0.0276393880739207,6.1446761288065e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGA2,Integrin alpha-2,37671,0.022032914714755,0.0032013120444712,0.0157583431075914,0.0283074863219185,6.1478679761171e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MIA,Melanoma-derived growth regulatory protein,40411,-0.0238427749070342,0.00346488913749863,-0.0306339576165315,-0.0170515921975369,6.15357402635632e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAX1BP1,Tax1-binding protein 1,37942,-0.0416386912726978,0.00605070368899372,-0.0534980705031255,-0.0297793120422702,6.17847434755944e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OTUD7B,OTU domain-containing protein 7B,37959,-0.041007266315222,0.0059634431972483,-0.0526956149818287,-0.0293189176486154,6.40638161349555e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37687,-0.0417654187072827,0.00607398617095157,-0.0536704316023478,-0.0298604058122177,6.42673724030499e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBPL,FK506-binding protein-like,37901,-0.03824858224484,0.00556738867373656,-0.0491606640453636,-0.0273365004443163,6.69736167041133e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37628,-0.0326168721822461,0.00475205456280927,-0.0419308991253523,-0.02330284523914,7.00821423543894e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RLN2,Prorelaxin H2,37643,-0.0914824500000327,0.0133449495510403,-0.117638551120072,-0.0653263488799937,7.43743313085052e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH3BP1,SH3 domain-binding protein 1,37901,-0.0302509275893986,0.00441593716504248,-0.0389061644328818,-0.0215956907459153,7.68473051169248e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRG2,Bone marrow proteoglycan,37998,-0.0337353864534352,0.00492647592420844,-0.0433912792648837,-0.0240794936419866,7.82418191648037e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37901,-0.0497008901486596,0.00727000539135685,-0.063950100715719,-0.0354516795816002,8.46924353369969e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GOLGA3,Golgin subfamily A member 3,37959,-0.0505412522446959,0.00739516221449339,-0.065035770185103,-0.0360467343042889,8.59009119194852e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37572,-0.0523373468860728,0.0076617728453956,-0.0673544216630482,-0.0373202721090975,8.80608948990878e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,40228,-0.014493971539833,0.00212268828000639,-0.0186544405686456,-0.0103335025110205,8.91737347375957e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERBIN,Erbin,40305,-0.0654457623764973,0.00959265124346195,-0.0842473588136828,-0.0466441659393119,9.2714470290973e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SARG,Specifically androgen-regulated gene protein,37931,-0.0697872858060909,0.0102390816628904,-0.089855885865356,-0.0497186857468257,9.77426904824554e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFC,Platelet-derived growth factor C,39980,-0.0189845329546466,0.00278689371821149,-0.0244468446423412,-0.0135222212669521,9.97340992563075e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX8,Syntaxin-8,40341,-0.0311290434975887,0.00457123649904607,-0.040088667035719,-0.0221694199594584,1.01262474289129e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IMPACT,Protein IMPACT,37942,-0.0365569726622345,0.00536843900586472,-0.0470791131137294,-0.0260348322107396,1.02006605663549e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRSF1,G-rich sequence factor 1,37402,-0.0508379134135122,0.00746829382335413,-0.0654757693072863,-0.0362000575197381,1.03926531617844e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39961,-0.0335688518744768,0.00493733474706276,-0.0432460279787199,-0.0238916757702338,1.0920658144557e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APCS,Serum amyloid P-component,37882,-0.0230272350193209,0.00339220989989944,-0.0296759664231238,-0.016378503615518,1.18252025876173e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BOLA1,BolA-like protein 1,37541,-0.0351798657498711,0.00518769923804427,-0.0453477562564379,-0.0250119752433044,1.24126185948121e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AAMDC,Mth938 domain-containing protein,37628,-0.034304245902641,0.00506000525142578,-0.0442218561954356,-0.0243866356098465,1.25739490239526e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD58,Lymphocyte function-associated antigen 3,40335,0.0112501561378673,0.00166118062784521,0.0079942421072907,0.0145060701684439,1.31119185942788e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R9B,Neurabin-2,40516,-0.0595005939431611,0.00878627242977309,-0.0767216879055163,-0.0422794999808058,1.3142189359454e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,-0.0228412113965576,0.00337370964097975,-0.0294536822928779,-0.0162287405002373,1.33758322801143e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LONP1,"Lon protease homolog, mitochondrial",37628,-0.0553213553372688,0.00817716335984904,-0.0713485955225729,-0.0392941151519647,1.38606916838166e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESYT2,Extended synaptotagmin-2,37942,-0.0520214338102515,0.00769663340267035,-0.0671068352794854,-0.0369360323410176,1.44670668708025e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,-0.0365526679971491,0.00541254008934132,-0.0471612465722581,-0.0259440894220401,1.49631938397005e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLOD4,Glyoxalase domain-containing protein 4,40328,-0.0229931295743653,0.0034075834316082,-0.0296719931003174,-0.0163142660484132,1.55471527490704e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,-0.0609754544388746,0.00903870849632261,-0.0786913230916669,-0.0432595857860823,1.58125812583737e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL18,C-C motif chemokine 18,40172,-0.04444579326585,0.00659009926252906,-0.057362387820407,-0.031529198711293,1.59096599726782e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLSCR3,Phospholipid scramblase 3,37919,-0.038079558143196,0.00565047309640529,-0.0491544854121504,-0.0270046308742417,1.65761778137791e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUSD2,Sushi domain-containing protein 2,40332,0.0180796377011347,0.00268395571101414,0.012819084507547,0.0233401908947225,1.68176759313739e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,-0.0224625701888843,0.00333502564632501,-0.0289992204556813,-0.0159259199220873,1.69157268228283e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40489,-0.0340269087802256,0.00505878848059105,-0.043942134202184,-0.0241116833582671,1.79919434655419e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,-0.0359690248962528,0.0053631153053291,-0.0464807308946978,-0.0254573188978078,2.05676866890989e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA4D,Semaphorin-4D,40471,-0.0187261982086235,0.00279306513264863,-0.0242006058686148,-0.0132517905486322,2.08801373389671e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,-0.0224976290470325,0.00335620801339659,-0.0290757967532899,-0.0159194613407752,2.12097625311461e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37928,-0.0258318179783527,0.00385427590706974,-0.0333861987562094,-0.018277437200496,2.13586511100887e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,40228,-0.0370372112906823,0.00554238122022769,-0.0479002784823286,-0.026174144099036,2.42692551994347e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,-0.0335152730320573,0.00501798316941541,-0.0433505200441115,-0.0236800260200031,2.49977994264141e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LIF,Leukemia inhibitory factor,39961,-0.0329648503279465,0.00493681219148196,-0.0426410022232511,-0.0232886984326418,2.51557014213345e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYDGF,Myeloid-derived growth factor,37990,-0.0631771494353771,0.00946237765098801,-0.0817234096313136,-0.0446308892394406,2.53965983476566e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,-0.0179621005403457,0.00269338147923994,-0.0232411282396559,-0.0126830728410354,2.67918315707027e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GET3,ATPase GET3,37990,-0.0352855988291896,0.00529766641436476,-0.0456690250013445,-0.0249021726570346,2.83255781132491e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,-0.0701701787373411,0.0105389382288227,-0.0908264976658335,-0.0495138598088486,2.88149003203855e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS27,Serine protease 27,40314,-0.0251912469866099,0.00379208473392003,-0.0326237330650931,-0.0177587609081266,3.17117863613762e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ING1,Inhibitor of growth protein 1,39925,-0.0277638985902597,0.00417933356568137,-0.0359553923789951,-0.0195724048015242,3.17314186246421e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JAM2,Junctional adhesion molecule B,40471,-0.0162462567331411,0.00244563678739457,-0.0210397048364345,-0.0114528086298478,3.17356136936479e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,-0.0483241252050828,0.00727412112535898,-0.0625814026107864,-0.0340668477993792,3.18550111774925e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,-0.0428478895660768,0.00645308847474569,-0.0554959429765783,-0.0301998361555752,3.25885459677676e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBP7,Retinoid-binding protein 7,37901,-0.0366792009067074,0.00552565821839952,-0.0475094910147705,-0.0258489107986443,3.30209480560423e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSC,Dipeptidyl peptidase 1,40349,-0.0265154315851437,0.00399506228347165,-0.0343457536607481,-0.0186851095095393,3.30371322498702e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLIT2,Slit homolog 2 protein,39961,-0.0325819574271859,0.00491572544629246,-0.0422167793019191,-0.0229471355524526,3.51233115469465e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,-0.0367069580010045,0.00553746222816952,-0.0475603839682167,-0.0258535320337922,3.51464116220175e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN4,Contactin-4,40332,0.015102004473141,0.00227856484297169,0.0106360173809165,0.0195679915653655,3.5155940821766e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAT2,Signal transducer and activator of transcription 2,37598,-0.0479871053880083,0.00724422940716357,-0.0621857950260489,-0.0337884157499677,3.62763710044106e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP1,Caspase-1,39961,-0.0417640563497979,0.00630611434615719,-0.054124040468266,-0.0294040722313298,3.64077075926754e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE3,Eosinophil cationic protein,40288,-0.0674150087007688,0.0101839654438798,-0.0873755809707731,-0.0474544364307644,3.71441567679232e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,-0.0297686107979943,0.00449927099115001,-0.0385871819406483,-0.0209500396553402,3.82194449167569e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATXN3,Ataxin-3,37942,-0.0389141067793347,0.00588268208320985,-0.0504441636624261,-0.0273840498962434,3.85488608895653e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37990,-0.0394744362822405,0.00597728576015539,-0.0511899163721451,-0.0277589561923359,4.14939964585227e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,-0.0277516174386936,0.00420726580645289,-0.0359978584193412,-0.0195053764580459,4.38181327588641e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USO1,General vesicular transport factor p115,40305,-0.0559682423433515,0.00848853576202051,-0.0726057724369117,-0.0393307122497913,4.43471802823426e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37608,-0.035129111253762,0.00533792264540641,-0.0455914396387586,-0.0246667828687654,4.84854338030842e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37901,-0.0291124443598042,0.00442551770221486,-0.0377864590561453,-0.0204384296634631,4.93415465266115e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL1A1,Collagen alpha-1(I) chain,40536,0.0160370975420158,0.00243886518799226,0.011256921773551,0.0208172733104806,4.99368009117973e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,-0.0400028732568593,0.00608442689733494,-0.0519283499756358,-0.0280773965380829,5.0561645470048e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,-0.0442687891870429,0.0067344154668955,-0.057468243502158,-0.0310693348719277,5.07007940545982e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATG4A,Cysteine protease ATG4A,39980,-0.0367219334187799,0.00558822633565318,-0.0476748570366601,-0.0257690098008997,5.14644729692004e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,-0.0159327823806332,0.00242695457453553,-0.0206896133467228,-0.0111759514145435,5.39559289740329e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRP1,Neuropilin-1,40424,0.0173387358040699,0.00264320701345775,0.0121580500576927,0.0225194215504471,5.55598870181069e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL22,Interleukin-22,37900,-0.0404426779977509,0.00616629769817496,-0.0525286214861738,-0.028356734509328,5.6276650357448e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,0.0204188754730218,0.00311486292579683,0.01431374413846,0.0265240068075836,5.75406509712804e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37901,-0.0397797948934647,0.00607117322479571,-0.0516792944140643,-0.0278802953728651,5.87436191881287e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,-0.0422215254782453,0.00644788809944905,-0.0548593861531654,-0.0295836648033251,6.00886688610578e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OLFM4,Olfactomedin-4,37177,-0.076398302026517,0.0116685587375599,-0.0992686771521344,-0.0535279269008996,6.08106432564891e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PKD2,Polycystin-2,37562,-0.036724635510404,0.00561396623742107,-0.0477280093357493,-0.0257212616850587,6.3100481180527e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DFFA,DNA fragmentation factor subunit alpha,40516,-0.0415548189342114,0.00635876122264718,-0.0540179909305999,-0.029091646937823,6.55020814953717e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37901,-0.0244417350549655,0.0037416442009033,-0.031775357688736,-0.017108112421195,6.70742869058796e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PF4,Platelet factor 4,37934,-0.0600010402557297,0.00919157493445137,-0.0780165271272544,-0.041985553384205,6.9117425295484e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL13,C-C motif chemokine 13,40483,-0.0425770119456974,0.00652751644281106,-0.055370944173607,-0.0297830797177877,7.11210634787591e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEPR,Leptin receptor,40359,0.0187542127484022,0.00287550318688364,0.0131182265021103,0.0243901989946941,7.14380398398405e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37671,-0.0336073620731979,0.00515351724527306,-0.0437082558739331,-0.0235064682724627,7.22605478829993e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,-0.0324574416810335,0.00497866841536403,-0.042215631775147,-0.02269925158692,7.32095831790734e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD22,B-cell receptor CD22,40516,-0.0250161512984103,0.00383887095744024,-0.0325403383749931,-0.0174919642218274,7.40891268081957e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,-0.022479974716641,0.00345139695115298,-0.0292447127409008,-0.0157152366923812,7.61881806227594e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,-0.0248508120571878,0.00382245156110061,-0.032342817116945,-0.0173588069974306,8.2502725566577e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPT1,Angiopoietin-1,40263,-0.0517259006822421,0.00796417433496174,-0.0673356823787671,-0.0361161189857171,8.56119230794818e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ROBO2,Roundabout homolog 2,40471,0.0141510140414546,0.0021813742235301,0.0098755205633356,0.0184265075195736,9.00085400707937e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATG16L1,Autophagy-related protein 16-1,37901,-0.0517723359852961,0.00799277380955957,-0.0674381726520329,-0.0361064993185593,9.65674613340948e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,-0.0195167641298918,0.00301933409693017,-0.0254346589598749,-0.0135988692999086,1.05023882300052e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,-0.0242341739234259,0.00375006632455991,-0.0315843039195633,-0.0168840439272885,1.06639734779637e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,40305,0.0381133703401945,0.00590341490186736,0.0265426771325345,0.0496840635478546,1.10516966493097e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,-0.0315556665290611,0.00488845464562673,-0.0411370376344895,-0.0219742954236327,1.11239313984977e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX4,Syntaxin-4,40305,-0.0360749586136494,0.00559728781996504,-0.0470456427407809,-0.0251042744865179,1.18876061955612e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFX1,Transcriptional repressor NF-X1,37562,-0.0410391714479799,0.00639492398485338,-0.0535732224582925,-0.0285051204376672,1.43334057139831e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAB2,Disabled homolog 2,40489,-0.0661938307022934,0.0103168895187668,-0.0864149341590763,-0.0459727272455105,1.43761344323442e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LY6D,Lymphocyte antigen 6D,40268,-0.0224939475508533,0.00350670014035012,-0.0293670798259395,-0.015620815275767,1.45238177993088e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,-0.0378536974921038,0.00590662224834395,-0.0494306770988579,-0.0262767178853496,1.50872473154863e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,-0.0570964486187745,0.00891623949909667,-0.074572278037004,-0.039620619200545,1.56008845449609e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMIGO2,Amphoterin-induced protein 2,40305,-0.0135262988946491,0.00211469311908083,-0.0176710974080476,-0.00938150038125072,1.63602103535936e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,-0.0396433534695216,0.00619752160890451,-0.0517904958229744,-0.0274962111160688,1.64060594256736e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH7,Protocadherin-7,37901,-0.0210825568146707,0.00329665698145038,-0.0275440044983135,-0.014621109131028,1.65712814523359e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,-0.0211671823016072,0.00331496774422335,-0.027664519080285,-0.0146698455229294,1.76642978222342e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,-0.0567926183844966,0.00892364974755797,-0.0742829718897102,-0.0393022648792829,2.01557858496315e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37628,-0.0335894771650598,0.00528869665547632,-0.0439553226097933,-0.0232236317203262,2.20685193470743e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,40311,-0.0521683358830205,0.00821696853353268,-0.0682735942087446,-0.0360630775572965,2.22822099169884e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFD,Complement factor D,38013,-0.0114343491482068,0.0018015756385404,-0.014965437399746,-0.00790326089666759,2.26745634375997e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD14,Monocyte differentiation antigen CD14,40048,-0.024719550734626,0.00390089273792233,-0.0323653005009538,-0.0170738009682983,2.40874990732523e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA5,Plasma serine protease inhibitor,37835,-0.019742449535235,0.00311603259554926,-0.0258498734225115,-0.0136350256479584,2.43730143750063e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40471,-0.0136687430193759,0.00215830528614287,-0.0178990213802159,-0.00943846465853583,2.46702199282637e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TADA3,Transcriptional adapter 3,37900,-0.0232585629778776,0.00367244799417983,-0.0304565610464701,-0.0160605649092852,2.47674230330852e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA3,Carbonic anhydrase 3,40500,-0.0362844410690182,0.00573020908561379,-0.0475156508768212,-0.0250532312612151,2.48224480070234e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOST,Sclerostin,40330,-0.0229068064934023,0.00362314543277881,-0.0300081715416488,-0.0158054414451558,2.64489669497157e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP10,Caspase-10,39961,-0.0424962225756217,0.00672166844034339,-0.0556706927186947,-0.0293217524325486,2.64793125743143e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAT5B,Signal transducer and activator of transcription 5B,40305,-0.0815338514122564,0.0128986918823352,-0.106815287501633,-0.0562524153228795,2.66659465949463e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PADI2,Protein-arginine deiminase type-2,40044,-0.0331588124201132,0.00525201361121493,-0.0434527590980945,-0.022864865742132,2.8009748677344e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA3G,Semaphorin-3G,37671,-0.0258422005070215,0.00409294581863789,-0.0338643743115517,-0.0178200267024912,2.809036279889e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH15,Cadherin-15,40435,-0.0261775281781353,0.00414861819571243,-0.0343088198417317,-0.0180462365145389,2.86494204720647e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPPB,Natriuretic peptides B,40042,-0.0760426115841671,0.0120521348981988,-0.0996647959846368,-0.0524204271836975,2.87545319909681e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,-0.041028292425838,0.00650727918456643,-0.0537825596275882,-0.0282740252240878,2.97204437384363e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,0.0262194945413037,0.00416289740319321,0.018060215631045,0.0343787734515624,3.08656737496927e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,-0.020498710564214,0.00325553508881216,-0.0268795593382859,-0.0141178617901422,3.1234999692948e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39961,-0.0398348605684079,0.00632721492681267,-0.0522362018249608,-0.0274335193118551,3.14051371487838e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPI,Glucose-6-phosphate isomerase,37987,-0.0278750220808175,0.00442861125592101,-0.0365551001424227,-0.0191949440192123,3.18308902648869e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,-0.0444127379075805,0.00705710815914518,-0.058244669899505,-0.0305808059156559,3.20562601177485e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37959,-0.029329983874361,0.00467358371867141,-0.0384902079629569,-0.020169759785765,3.58711322868662e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHMP6,Charged multivesicular body protein 6,37990,-0.0329381313242761,0.0052529600184945,-0.0432339329605253,-0.0226423296880268,3.71075201049075e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37562,-0.0227409820019826,0.00362701549116581,-0.0298499323646676,-0.0156320316392976,3.72642959851644e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,40332,-0.0175687056785375,0.0028043878277726,-0.0230653058209718,-0.0120721055361032,3.83114840419147e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,0.021815379894875,0.00348344762169106,0.0149878225563605,0.0286429372333894,3.90417376507226e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37671,0.0148181206760225,0.00236767624230584,0.0101774752411031,0.0194587661109419,4.00683896668807e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F2R,Proteinase-activated receptor 1,40396,-0.0336976679204824,0.00538871237988216,-0.0442595441850514,-0.0231357916559133,4.1189234917311e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACYP1,Acylphosphatase-1,37622,-0.0391242674645234,0.00625567375929843,-0.0513853880327483,-0.0268631468962985,4.11899777691176e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EHBP1,EH domain-binding protein 1,37990,-0.0439198405065715,0.00703423066165436,-0.057706932603414,-0.0301327484097289,4.40018445160657e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLB1,"Phospholipase B1, membrane-associated",37942,0.0357403482450251,0.00573588948400908,0.0244980048563673,0.0469826916336829,4.77238357578286e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAX,Apoptosis regulator BAX,39934,-0.0521113556569252,0.00836936430396838,-0.0685153096927032,-0.0357074016211472,4.89456362442949e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOXO1,Forkhead box protein O1,40341,-0.0492630360010972,0.0079145421426311,-0.0647755386006542,-0.0337505334015403,4.95628257613414e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAP3,Cytosol aminopeptidase,40044,-0.0285784908965204,0.00459408400183702,-0.037582895540121,-0.0195740862529198,5.07520064303105e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSCAM,Down syndrome cell adhesion molecule,37959,-0.0206990334248941,0.00332774879599625,-0.0272214210650468,-0.0141766457847415,5.11391344497642e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,-0.0316412617791451,0.00509040257333728,-0.0416184508228862,-0.0216640727354041,5.23461047325342e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPARC,SPARC,40411,-0.0411542505725502,0.00662981230994259,-0.0541486827000377,-0.0281598184450628,5.51809821191694e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,-0.0316999032654917,0.00510744577909362,-0.0417104969925152,-0.0216893095384682,5.57206606794258e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,40422,-0.0119719344696206,0.00193277608413305,-0.0157601755945214,-0.00818369334471979,6.00296822568926e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMG4,Proteasome assembly chaperone 4,37598,-0.0330301833658612,0.00533223611158266,-0.0434813661445632,-0.0225790005871592,6.02394258281482e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOD3,Extracellular superoxide dismutase,37987,0.0346856463380384,0.00559998461618747,0.023709676490311,0.0456616161857659,6.0399087440892e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,-0.0518734628579379,0.00838370402638113,-0.0683055227496449,-0.0354414029662309,6.26609241955764e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DXO,Decapping and exoribonuclease protein,37942,-0.0267332843930261,0.00432519705316303,-0.0352106706172256,-0.0182558981688265,6.56042233101472e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PARK7,Parkinson disease protein 7,40332,-0.0309795310463931,0.00501309583176215,-0.0408051988766469,-0.0211538632161393,6.57822897277407e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCR,Breakpoint cluster region protein,40341,-0.0526095276171644,0.00851616976538166,-0.0693012203573125,-0.0359178348770164,6.66667382610867e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRISP2,Cysteine-rich secretory protein 2,40489,0.0354684287546417,0.00574407826867859,0.0242100353480317,0.0467268221612517,6.78508391650805e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPME1,Protein phosphatase methylesterase 1,40305,-0.0354372475549615,0.00574749643097173,-0.0467023405596661,-0.0241721545502569,7.1879314323491e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,METAP2,Methionine aminopeptidase 2,40453,-0.0339713030515789,0.0055107713669241,-0.0447724149307502,-0.0231701911724077,7.23892707340527e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DBI,Acyl-CoA-binding protein,40270,-0.045549944083398,0.00739183212627405,-0.0600379350508951,-0.0310619531159009,7.34795153415394e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC1A,C-type lectin domain family 1 member A,40042,-0.0191014103618143,0.00310391503926171,-0.0251850838387673,-0.0130177368848614,7.74134555050711e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,-0.0448904172790093,0.00729955483409007,-0.0591975447538258,-0.0305832898041928,7.94768075706143e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOXO3,Forkhead box protein O3,39980,-0.0559281740516279,0.00910386063910154,-0.073771740904267,-0.0380846071989889,8.27711305019008e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHSG,Alpha-2-HS-glycoprotein,37987,-0.0157240820976042,0.00255939735814111,-0.0207405009195608,-0.0107076632756477,8.28985551107254e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCN2,Ficolin-2,40291,-0.0236659265006459,0.00385310681535177,-0.0312180158587354,-0.0161138371425565,8.34154711984379e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPHOSPH8,M-phase phosphoprotein 8,40042,-0.0430404875044182,0.00700840424745973,-0.0567769598294393,-0.0293040151793971,8.38512917572292e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,-0.0529195471518201,0.00861900647771103,-0.0698127998481337,-0.0360262944555065,8.4963905236351e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WNT9A,Protein Wnt-9a,40044,-0.0164852120528785,0.00268546231981684,-0.0217487181997195,-0.0112217059060375,8.52212375006397e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FDX1,"Adrenodoxin, mitochondrial",37562,-0.0364609936261426,0.005938970910687,-0.0481013766110892,-0.0248206106411961,8.52903288434438e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA9,Serpin A9,40228,-0.0415104617118022,0.00676268768994078,-0.0547653295840862,-0.0282555938395183,8.54795434243521e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37653,-0.0316610691751163,0.00515800638383089,-0.0417707616874248,-0.0215513766628078,8.58322229367971e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G10,Group 10 secretory phospholipase A2,40228,-0.0343876231129548,0.00560330603887821,-0.045370102949156,-0.0234051432767535,8.60915915140706e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,-0.0489524866535921,0.0079827946334135,-0.0645987641350826,-0.0333062091721017,8.86951421082441e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C8B,Complement component C8 beta chain,38013,0.0177138503801569,0.00288985725622297,0.0120497301579599,0.023377970602354,9.05069718694306e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WASHC3,WASH complex subunit 3,37942,-0.0433359798659242,0.00707680192783509,-0.057206511644481,-0.0294654480873675,9.39845990742432e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37959,-0.0394380208212978,0.00644920409266072,-0.0520784608429128,-0.0267975807996828,9.91099095360249e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,0.0281104324733916,0.00460310530215542,0.0190883460811669,0.0371325188656162,1.04478953579325e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSNAX,Translin-associated protein X,37562,-0.022716958273151,0.00372103761361068,-0.0300101919958279,-0.015423724550474,1.05699047102754e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBLN4,Cerebellin-4,40489,0.017996832393223,0.00295142043004527,0.0122120483503342,0.0237816164361117,1.10082241798715e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PREB,Prolactin regulatory element-binding protein,40044,-0.0169176326517733,0.00277577723222275,-0.0223581560269299,-0.0114771092766167,1.12197580290477e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM3,Intercellular adhesion molecule 3,40536,-0.0144424518421766,0.00237013621343038,-0.0190879188205001,-0.00979698486385303,1.12978231288078e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEXIM1,Protein HEXIM1,40341,-0.0465510408090788,0.00764314372470524,-0.061531602509501,-0.0315704791086565,1.15106363944525e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAMBP,STAM-binding protein,40192,-0.0367930777121364,0.00604997835788099,-0.0486510352935831,-0.0249351201306896,1.21798744679996e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,-0.0377308709070557,0.0062050450340967,-0.0498927591738852,-0.0255689826402261,1.22918217474267e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,-0.0384383550269931,0.00632197530391254,-0.0508294266226617,-0.0260472834313245,1.23430807347442e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,-0.0127546269679763,0.00209802554910814,-0.0168667570442283,-0.00864249689172436,1.23434320246459e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAG3,Lymphocyte activation gene 3 protein,40305,-0.0234548301345587,0.00385861817360188,-0.0310177217548184,-0.0158919385142991,1.24046660941521e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,-0.0210709572463861,0.00347562867860955,-0.0278831894564608,-0.0142587250363114,1.37064771110223e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,0.0217006472838367,0.00358945888662265,0.0146653078660563,0.0287359867016171,1.52124997046493e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,-0.0285742007915219,0.00472989599172525,-0.0378447969353034,-0.0193036046477404,1.56418477199304e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GYS1,"Glycogen [starch] synthase, muscle",40042,-0.0526994713801479,0.0087276124496186,-0.0698055917814004,-0.0355933509788955,1.59333892469967e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,-0.0306487276787739,0.00507980502439009,-0.0406051455265785,-0.0206923098309694,1.64087555416604e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP2,Microtubule-associated protein 2,37942,-0.0261087683431559,0.00432810013099087,-0.034591844599898,-0.0176256920864138,1.65783931479594e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLSTN3,Calsyntenin-3,37942,-0.017400692052701,0.00288807021102075,-0.0230613096663017,-0.0117400744391003,1.73487430297374e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNGR1,Interferon gamma receptor 1,40422,-0.0115613648311519,0.00192189806635862,-0.0153282850412148,-0.00779444462108899,1.83135734404012e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VEGFB,Vascular endothelial growth factor B,37598,-0.0162120717838431,0.00269505245787796,-0.0214943746012839,-0.0109297689664023,1.84102548724037e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFB,Complement factor B,37770,-0.0186856773675824,0.00310799396022251,-0.0247773455296185,-0.0125940092055463,1.87885720984413e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PON2,Serum paraoxonase/arylesterase 2,40042,-0.0193466042421266,0.00322412542238373,-0.0256658900699988,-0.0130273184142545,2.00974097126033e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPTLC1,Serine palmitoyltransferase 1,37942,-0.0203603854277559,0.00339292879028411,-0.0270105258567127,-0.013710244998799,2.01343980355113e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37572,-0.0343801698830729,0.00573112698675332,-0.0456131787771094,-0.0231471609890364,2.03951524722793e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,-0.0515288932855906,0.0085904666493959,-0.0683662079184066,-0.0346915786527747,2.04393811445335e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALB1,Calbindin,40305,-0.0238589040064687,0.00397889030589733,-0.0316575290060275,-0.01606027900691,2.06155767545762e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,-0.015451389480269,0.00257722058463311,-0.0205027418261499,-0.0104000371343881,2.073642390557e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STC2,Stanniocalcin-2,40309,-0.0152531621734958,0.00254495248442203,-0.0202412690429629,-0.0102650553040286,2.09826558463033e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYAR,Cell growth-regulating nucleolar protein,39980,-0.0296019315002546,0.0049410679307256,-0.0392864246444768,-0.0199174383560325,2.13163412466766e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEP1B,Meprin A subunit beta,40359,0.0664403144746064,0.0111041571446624,0.0446761664710681,0.0882044624781448,2.23251916363323e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPP7,Dipeptidyl peptidase 2,40251,-0.032563170381048,0.00544245071849324,-0.0432303737892948,-0.0218959669728013,2.23546524417347e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DHPS,Deoxyhypusine synthase,37900,-0.0232575752907528,0.00388924761996903,-0.0308805006258921,-0.0156346499556135,2.28841585884997e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,-0.0164786218395227,0.00275888722411233,-0.0218860407987828,-0.0110712028802625,2.38045826094209e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DGKA,Diacylglycerol kinase alpha,37598,-0.030530289782853,0.00512430514191065,-0.0405739278609979,-0.0204866517047081,2.61973728183381e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF3,Granulocyte colony-stimulating factor,40044,-0.0271912582044408,0.00457204050940563,-0.0361524576028759,-0.0182300588060058,2.78442394190769e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,-0.021819396603724,0.00366935243748327,-0.0290113273811912,-0.0146274658262567,2.79797363975705e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDLIM7,PDZ and LIM domain protein 7,40422,-0.0696001215120496,0.0117124575341752,-0.0925565382790329,-0.0466437047450662,2.8671818369982e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA5,Annexin A5,39896,-0.017025395556653,0.00286935743829986,-0.0226493361357207,-0.0114014549775852,3.02844933450065e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,-0.0465503944618711,0.00785273367376155,-0.0619417524624437,-0.0311590364612985,3.14440009118693e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,-0.032522157051995,0.00548985374664729,-0.0432822703954237,-0.0217620437085664,3.20645189613946e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL2,C-C motif chemokine 2,40203,-0.029323744110521,0.00495422516592398,-0.039034025435732,-0.01961346278531,3.30757738018334e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39980,0.0209007637558813,0.00353118827104618,0.0139796347446308,0.0278218927671318,3.30920784957971e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,-0.0406471989112077,0.00686739341457627,-0.0541072900037772,-0.0271871078186382,3.32023721544997e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD164,Sialomucin core protein 24,40332,-0.0147081899652794,0.00248658976076868,-0.019581905896386,-0.00983447403417276,3.38682326294598e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,-0.0302253983199527,0.00511233768731888,-0.0402455801870977,-0.0202052164528077,3.4452139829293e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LBP,Lipopolysaccharide-binding protein,40403,-0.0323385190522571,0.00547172815290983,-0.0430631062319603,-0.0216139318725538,3.4884541024664e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA9,Carbonic anhydrase 9,40489,-0.0249094503093548,0.00421959972021003,-0.0331798657609664,-0.0166390348577431,3.63549774699935e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACTA2,"Actin, aortic smooth muscle",40042,-0.0241932727974739,0.00410170914972629,-0.0322326227309374,-0.0161539228640104,3.74776187414111e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37790,-0.0312160919590981,0.00529336642111379,-0.0415910901444811,-0.0208410937737151,3.78648389308123e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBP4,Guanylate-binding protein 4,39961,-0.027266992390865,0.00462416093365257,-0.036330347820824,-0.0182036369609059,3.78696369062281e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,-0.039649407099114,0.00673489049837974,-0.0528497924759383,-0.0264490217222897,4.02409916861937e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL5,C-X-C motif chemokine 5,40309,-0.0631486639002424,0.0107558215052411,-0.0842300740505149,-0.0420672537499699,4.41520984775014e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATXN2L,Ataxin-2-like protein,37959,-0.0267529450710248,0.00455801415310342,-0.0356866528111076,-0.0178192373309421,4.47554425749792e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCRIB,Protein scribble homolog,37628,-0.0514985286100953,0.00878296031796991,-0.0687131308333164,-0.0342839263868743,4.64183333058555e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,-0.0302048342111959,0.00515223125529391,-0.0403032074715719,-0.0201064609508198,4.65073279539455e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,38013,-0.0141630476872408,0.00241909172708589,-0.0189044674723291,-0.00942162790215242,4.8893781334261e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,0.013293587388536,0.0022711355788845,0.0088421616539224,0.0177450131231497,4.91430207267696e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,-0.0367614418346024,0.0062844671338236,-0.0490789974168966,-0.0244438862523081,5.02750999016965e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNIP1,TNFAIP3-interacting protein 1,37942,-0.0488733444272609,0.00836479165602336,-0.0652683360730666,-0.0324783527814551,5.25322652057943e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INSR,Insulin receptor,37598,-0.0093221856273609,0.00159550195528376,-0.0124493694597171,-0.00619500179500474,5.25488590257041e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAT,Catalase,37786,-0.0301341693744417,0.00515856899961605,-0.0402449646136891,-0.0200233741351942,5.29156538046234e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37998,0.0274474356945813,0.00470156516995536,0.0182323679614688,0.0366625034276938,5.40618610174556e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNRD2,Protein ZNRD2,37901,-0.0375284224248154,0.00643136321957587,-0.0501338943351842,-0.0249229505144467,5.49564055247469e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37900,-0.062872031989216,0.0107758339371924,-0.0839926665061131,-0.0417513974723188,5.51807400566794e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEDD9,Enhancer of filamentation 1,37598,-0.0182150843882852,0.00312359711168876,-0.0243373347271951,-0.0120928340493752,5.62408704601648e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COMMD1,COMM domain-containing protein 1,37628,-0.0337967889790645,0.0058072767353694,-0.0451790513803885,-0.0224145265777405,6.03135551102848e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDN1,Endothelin-1,37628,-0.0159917656385318,0.00274842388663565,-0.0213786764563377,-0.0106048548207259,6.07501445956534e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VAMP8,Vesicle-associated membrane protein 8,37598,-0.0486431291398203,0.00836612770791313,-0.06504073944733,-0.0322455188323105,6.23047310762318e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TJAP1,Tight junction-associated protein 1,40411,-0.0449086462466844,0.0077267608427568,-0.0600530974984878,-0.0297641949948811,6.28737054254701e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUB1,NEDD8 ultimate buster 1,40341,-0.0453859081210254,0.00781440039428392,-0.0607021328938218,-0.0300696833482289,6.44378610410402e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C2,Complement C2,40372,-0.013073638395161,0.0022524342968461,-0.0174884096169794,-0.0086588671733427,6.58938342094872e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GMPR2,GMP reductase 2,37671,-0.0372184162651223,0.00641277681990016,-0.0497874588321266,-0.024649373698118,6.63192008272625e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD36,Platelet glycoprotein 4,37598,-0.0242856564085495,0.00418605994917022,-0.0324903339089231,-0.0160809789081759,6.72160364515197e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA1,Alpha-1-antitrypsin,37779,-0.00446510048833611,0.000769659570206018,-0.00597363324593991,-0.00295656773073232,6.72585472838783e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK4,Kallikrein-4,40489,-0.0330728817519464,0.00570315829452748,-0.0442510720092203,-0.0218946914946725,6.7947730947113e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,-0.0228732317222775,0.00394453191778589,-0.0306045142811378,-0.0151419491634171,6.80907769954939e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,-0.0399359467342356,0.00689073849368911,-0.0534417941818663,-0.026430099286605,6.9360682009633e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,-0.0226519970842618,0.00391495096263262,-0.0303253009710217,-0.0149786931975018,7.370564840335e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCRG1,Scrapie-responsive protein 1,37990,-0.0149767037040557,0.0025902386158952,-0.0200535713912103,-0.00989983601690115,7.5456073066939e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AXIN1,Axin-1,40341,-0.0507965317253379,0.00879275392056819,-0.0680303294096515,-0.0335627340410243,7.74256705600107e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBXN1,UBX domain-containing protein 1,37671,-0.0377252754604138,0.00653501986560087,-0.0505339143969915,-0.0249166365238361,7.97223781675725e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA12,Serpin A12,39903,-0.0619290806217089,0.0107375075431549,-0.0829745954062926,-0.0408835658371253,8.19715790659076e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL1,Growth-regulated alpha protein,40329,-0.0525295037909833,0.00911275847139853,-0.0703905103949244,-0.0346684971870422,8.34745611452992e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOA2,Apolipoprotein A-II,37987,0.0259254754763824,0.00450220156658668,0.0171011604058726,0.0347497905468923,8.67592719730622e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,-0.02041878194806,0.00354858858082217,-0.0273740155664714,-0.0134635483296485,8.90194931500552e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,-0.0281270792471292,0.00488958789578069,-0.0377106715228593,-0.018543486971399,8.98775022077316e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOXJ3,Forkhead box protein J3,37598,-0.0237062603670303,0.00412187655418801,-0.0317851384132387,-0.0156273823208218,9.05164437114939e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,-0.0336090152591335,0.00584433945356157,-0.0450639205881141,-0.0221541099301528,9.08600326858427e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37900,-0.0218438267744185,0.00381331385397336,-0.0293179219282063,-0.0143697316206308,1.03610929345716e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCBP2,Poly(rC)-binding protein 2,37959,-0.0387967339215313,0.00677707826544192,-0.0520798073217975,-0.0255136605212651,1.05820804187843e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TLR3,Toll-like receptor 3,40516,-0.0325865471276828,0.00570823813350515,-0.0437746938693529,-0.0213984003860127,1.15861503377261e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX7,Syntaxin-7,37598,-0.0271116271668867,0.00475219912374898,-0.0364259374494347,-0.0177973168843387,1.18803207709132e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,-0.0216330597951115,0.00379395263408893,-0.0290692069579258,-0.0141969126322972,1.20903037536397e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39980,-0.0317536885874086,0.005574500434732,-0.0426797094394833,-0.0208276677353338,1.24698208745901e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LARP1,La-related protein 1,37900,-0.0341209282021919,0.00599197515193428,-0.0458651994999831,-0.0223766569044007,1.26368882070397e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCT5,T-complex protein 1 subunit epsilon,39980,-0.0242902199149961,0.00426884394592782,-0.0326571540490147,-0.0159232857809776,1.29243309095285e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39980,-0.0287712501652274,0.00505693127853275,-0.0386828354711516,-0.0188596648593032,1.29733912371346e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,-0.0487903265393645,0.00858995349059051,-0.0656266353809219,-0.031954017697807,1.37541449035818e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CETN2,Centrin-2,39961,-0.0356855593799697,0.00629405856474996,-0.0480219141668797,-0.0233492045930598,1.4557765551746e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37671,-0.0360621080415814,0.00636090842596739,-0.0485294885564775,-0.0235947275266853,1.46353605974416e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD99,CD99 antigen,40332,0.0103146180411929,0.0018211631356564,0.00674513829530636,0.0138840977870795,1.50663051585712e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,-0.0331577921471323,0.00585397299066091,-0.0446315792088277,-0.021684005085437,1.50843698145434e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,40042,-0.0294911487793842,0.00520731430761178,-0.0396974848223033,-0.0192848127364651,1.51013352800507e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRR3,Small proline-rich protein 3,37942,-0.0380962402967161,0.00672689155887891,-0.0512809477521188,-0.0249115328413135,1.51541693916263e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37562,-0.0335176718983759,0.00592038194296213,-0.0451216205065817,-0.0219137232901701,1.5328986540598e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN3,Contactin-3,40332,-0.0185346297382459,0.00327454468456686,-0.0249527373199969,-0.0121165221564948,1.53795203033609e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,-0.0467082310582102,0.00825129820262925,-0.0628807755353635,-0.0305356865810569,1.53826234654799e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AK1,Adenylate kinase isoenzyme 1,40359,-0.0338146805614795,0.00599673589391979,-0.0455682829135623,-0.0220610782093967,1.7410162118564e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,-0.027088012364538,0.00480774126242329,-0.0365111852388877,-0.0176648394901884,1.78874833955363e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LMNB1,Lamin-B1,37874,-0.0303546397191723,0.00539031881812308,-0.0409196646026936,-0.0197896148356511,1.82418182918831e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FST,Follistatin,40396,-0.0274502957816837,0.00487628782358798,-0.0370078199159162,-0.0178927716474513,1.83944931288213e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37628,-0.0545166326641646,0.00969827134138963,-0.0735252444932883,-0.035508020835041,1.93403341184925e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,-0.0251084014769587,0.00446789213129809,-0.033865470054303,-0.0163513328996145,1.95120937438336e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHRDL1,Chordin-like protein 1,40396,-0.0160822455715394,0.00286451176834077,-0.0216966886374873,-0.0104678025055915,2.00642685518582e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1R1,Interleukin-1 receptor type 1,40303,-0.0117553260216891,0.00209399539488524,-0.0158595569956642,-0.00765109504771405,2.01218588628174e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,-0.00973247611802808,0.00173422479456144,-0.0131315567153685,-0.00633339552068765,2.03436323010711e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MB,Myoglobin,40536,-0.0258852910618874,0.00461411266178844,-0.0349289518789927,-0.0168416302447821,2.05629322840426e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSPN,Persephin,40341,-0.0522418663500416,0.00931380506733105,-0.0704969242820105,-0.0339868084180728,2.06796751061208e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,-0.0345442679641323,0.00615962214843705,-0.0466171273750689,-0.0224714085531957,2.07951249007999e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,40341,-0.0555927158526845,0.00991806552029935,-0.0750321242724712,-0.0361533074328978,2.11475461354937e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACRBP,Acrosin-binding protein,37900,-0.0200371104432562,0.00357469473782573,-0.0270435121293947,-0.0130307087571178,2.12026076349875e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AIF1,Allograft inflammatory factor 1,39980,-0.0277035341292773,0.00495470681443281,-0.0374147594855656,-0.017992308772989,2.29097846020223e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TLR1,Toll-like receptor 1,37598,-0.01383251641177,0.00247656391443917,-0.0186865816840708,-0.00897845113946926,2.37835771149618e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,-0.0407711915571077,0.00731550899923523,-0.0551095891956087,-0.0264327939186066,2.54932161755092e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSC22D1,TSC22 domain family protein 1,37959,-0.0354123138458541,0.00635648756618476,-0.0478710294755762,-0.022953598216132,2.58047878177096e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSNL1,Visinin-like protein 1,37942,-0.0197058448006962,0.00353785396765642,-0.0266400385773028,-0.0127716510240897,2.59612057649627e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",40293,-0.0302247712829514,0.00543152048948372,-0.0408705514423395,-0.0195789911235633,2.66862882191833e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,-0.0307177058592031,0.0055223388738942,-0.0415414900520357,-0.0198939216663705,2.71075343250632e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,-0.0245273010320948,0.00441908850144824,-0.0331887144949333,-0.0158658875692562,2.89691213552885e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHACTR2,Phosphatase and actin regulator 2,37959,-0.059657409286229,0.0107646735829141,-0.0807561695087405,-0.0385586490637174,3.04703045700593e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PI16,Peptidase inhibitor 16,37987,0.0128748274022775,0.00233355570801509,0.00830105821456788,0.017448596589987,3.50654485924928e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAGED1,Melanoma-associated antigen D1,39980,-0.0251813804389411,0.00456713590424857,-0.0341329668112683,-0.0162297940666139,3.57165926688038e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40489,-0.0195546068222352,0.00355209516285157,-0.0265167133414243,-0.0125925003030461,3.7464087386334e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37900,-0.0172779601742156,0.00313926877602316,-0.023430926975221,-0.0111249933732102,3.78460340820572e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP3R1,Calcineurin subunit B type 1,40228,-0.0212731987787337,0.00386952833186826,-0.0288574743091955,-0.0136889232482719,3.90924800264111e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,-0.0196649041435893,0.00357841712735933,-0.0266786017132136,-0.0126512065739651,3.96844886833611e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,-0.0123162338668761,0.00224506150556239,-0.0167165544177784,-0.0079159133159738,4.17616975641102e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLK1,Protein delta homolog 1,40536,-0.0272700124505253,0.00497401643464681,-0.037019084662433,-0.0175209402386175,4.25687908794182e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,-0.0155618725981862,0.00284015309995913,-0.0211285726741061,-0.00999517252226627,4.33812363569133e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,-0.0271987935801941,0.00498169345049186,-0.0369629127431581,-0.01743467441723,4.85388595655009e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN3,CCN family member 3,40522,-0.017305541125646,0.00317161800504454,-0.0235219124155333,-0.0110891698357587,4.93138770327308e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPR15L,Protein GPR15L,37901,-0.031088448549183,0.0057036832452691,-0.0422676677099104,-0.0199092293884555,5.10873233313361e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,0.0137268160428547,0.00252193480346219,0.00878382382806883,0.0186698082576406,5.33139345874421e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YWHAQ,14-3-3 protein theta,37671,-0.0379823518663431,0.00697818998519953,-0.0516596042373342,-0.024305099495352,5.3322377685253e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,-0.0767257366620765,0.0140979180533354,-0.104357656046614,-0.0490938172775392,5.33626144868583e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC12A,C-type lectin domain family 12 member A,37598,-0.0105224559882405,0.00193544041163767,-0.0143159191950503,-0.00672899278143066,5.52380009606468e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBCA,Tubulin-specific chaperone A,37671,-0.0447780866292548,0.00824200563515757,-0.0609324176741636,-0.028623755584346,5.64236729493323e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,-0.0396611676800745,0.00730500793371095,-0.053978983230148,-0.0253433521300011,5.74215717148311e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,0.0105099672068544,0.00193614793383659,0.00671511725653467,0.0143048171571741,5.79048754738158e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F11,Coagulation factor XI,37810,0.0155389070591729,0.00286533388051649,0.00992285265336058,0.0211549614649852,5.96032023039205e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YJU2,Splicing factor YJU2,37900,-0.0163764129662578,0.00302171840313795,-0.0222989810364082,-0.0104538448961074,6.0772530872642e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,-0.0525205837664474,0.00969987929681358,-0.0715323471882021,-0.0335088203446928,6.23315678559345e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM13A,Protein FAM13A,37901,-0.0344345461073922,0.00636451221552067,-0.0469089900498127,-0.0219601021649717,6.39614757998722e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAX,Protein max,39961,-0.0528606850726561,0.00978591486713733,-0.0720410782122452,-0.0336802919330669,6.69812630851648e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,-0.0751418807048065,0.0139306215648139,-0.102445898971842,-0.0478378624377711,7.0069152480706e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CETN3,Centrin-3,37901,-0.0391254173255132,0.00725443477310043,-0.0533441094807901,-0.0249067251702364,7.03412266911913e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37942,-0.0270498742934643,0.00501794399782101,-0.0368850445291935,-0.0172147040577352,7.1393020595514e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,40044,-0.0304036572354157,0.00564137377999825,-0.0414607498442122,-0.0193465646266191,7.17180339010145e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFHR2,Complement factor H-related protein 2,37911,-0.0291642369652978,0.0054129143921683,-0.0397735491739477,-0.0185549247566479,7.24860285375618e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40490,-0.0229013804437402,0.00425416684174568,-0.0312395474535617,-0.0145632134339186,7.41683800581198e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTPP1,dCTP pyrophosphatase 1,40359,-0.0160153379756246,0.00297689788065653,-0.0218500578217114,-0.0101806181295378,7.55920120478856e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPAG1,Sperm-associated antigen 1,37959,-0.0292240090378015,0.00544191351293138,-0.039890159523147,-0.018557858552456,7.99643497838154e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SYTL4,Synaptotagmin-like protein 4,37990,-0.0370400115766515,0.00690560053142893,-0.0505749886182522,-0.0235050345350508,8.28456608318385e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMPD3,AMP deaminase 3,37942,-0.0366712746428631,0.00685546413090991,-0.0501079843394465,-0.0232345649462797,8.97845560444679e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNLY,Granulysin,40332,-0.0254562852256214,0.00476073460655554,-0.0347873250544703,-0.0161252453967725,9.05943260341996e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,-0.0257909378602412,0.00483743937464148,-0.0352723190345385,-0.0163095566859439,9.87530772097789e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,-0.0301055332247301,0.0056594168601449,-0.0411979902706141,-0.0190130761788461,1.05441672121918e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R2,Protein phosphatase inhibitor 2,40359,-0.0394393470175713,0.0074325886810108,-0.0540072208323525,-0.0248714732027902,1.13389158647922e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNAP23,Synaptosomal-associated protein 23,40359,-0.0432202188774332,0.00814911612699934,-0.0591924864863519,-0.0272479512685145,1.15016371182434e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDIA4,Protein disulfide-isomerase A4,37998,-0.0302498624965361,0.00570460272558247,-0.0414308838386777,-0.0190688411543944,1.15888364132197e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,-0.0447688879410116,0.00844723805047868,-0.0613254745199499,-0.0282123013620734,1.17744507549458e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB5,Integrin beta-5,40411,0.0184023413097128,0.00347435004432606,0.0115926152228337,0.0252120673965918,1.19525461027623e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEPACAM2,HEPACAM family member 2,37942,0.0203815319099922,0.00384841403080085,0.0128386404096226,0.0279244234103619,1.20169254820265e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MIF,Macrophage migration inhibitory factor,40307,-0.0341708965015908,0.00645431262451814,-0.0468213492456463,-0.0215204437575352,1.2108355745591e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,-0.0470040086126133,0.00891301033831771,-0.064473508875716,-0.0295345083495106,1.35496525514751e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL1,Fc receptor-like protein 1,40359,-0.0222701287348689,0.00422473796944572,-0.0305506151549825,-0.0139896423147553,1.37183453752061e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37990,-0.0233307827321485,0.00443333495662288,-0.0320201192471294,-0.0146414462171677,1.44216022813852e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39925,-0.0215865773977249,0.0041050472170291,-0.0296324699431019,-0.0135406848523479,1.4713159725029e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CENPF,Centromere protein F,37714,-0.0271525595771439,0.00516783608389233,-0.0372815183015729,-0.0170236008527149,1.51017363255115e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RCOR1,REST corepressor 1,40042,-0.0220480357288521,0.00420692590000853,-0.0302936104928688,-0.0138024609648353,1.61887166890182e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37671,-0.0180966459524624,0.00345473559931301,-0.0248679277271159,-0.0113253641778089,1.64627717825084e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,-0.0132716840615206,0.00253716397004819,-0.018244525442815,-0.00829884268022612,1.70825403137247e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39836,-0.0591598463456302,0.0113174697388495,-0.0813420870337752,-0.0369776056574852,1.74249790718591e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HPCAL1,Hippocalcin-like protein 1,40516,-0.0359170835224794,0.00687297529298878,-0.0493881150967374,-0.0224460519482214,1.75532807449547e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,-0.0142957187971737,0.00273788859590411,-0.0196619804451457,-0.00892945714920162,1.80166902705203e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GHRL,Appetite-regulating hormone,40359,-0.0385641082096164,0.00739580533361549,-0.0530598866635028,-0.0240683297557301,1.86801750506026e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,40283,-0.0157758751723739,0.00302558993314688,-0.0217060314413418,-0.00984571890340606,1.86987218127569e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CILP,Cartilage intermediate layer protein 1,37998,-0.0264493870705817,0.00508413445851091,-0.0364142906092631,-0.0164844835319003,1.99667813084197e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37942,-0.0350537142397246,0.00673874325730776,-0.0482616510240478,-0.0218457774554013,2.00238839300094e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ST13,Hsc70-interacting protein,37671,-0.0280194943983155,0.0053901447941584,-0.038584178194866,-0.017454810601765,2.04136919110158e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AZI2,5-azacytidine-induced protein 2,37959,-0.0270291719386087,0.00520296227369626,-0.0372269779950533,-0.016831365882164,2.0774536994667e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DOK2,Docking protein 2,40359,-0.0587577572702492,0.0113120166759522,-0.0809293099551156,-0.0365862045853828,2.08051819882465e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37598,-0.0439938666417294,0.00847750985172485,-0.0606097859511101,-0.0273779473323487,2.14022786329213e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGF1R,Insulin-like growth factor 1 receptor,40305,-0.0106619066179397,0.00206070705776953,-0.014700892451168,-0.00662292078471144,2.32044263350868e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37671,-0.0386295018511752,0.00746558386473404,-0.0532620462260539,-0.0239969574762965,2.32061467024945e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,-0.0144430665781699,0.00279432120581145,-0.0199199361415603,-0.00896619701477944,2.38586774830856e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCD6,Programmed cell death protein 6,40359,0.0338372411711726,0.00655111923784988,0.0209970474649868,0.0466774348773583,2.43200356451889e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMPRSS5,Transmembrane protease serine 5,40159,0.0182953583009951,0.00354398581826529,0.0113491460971951,0.025241570504795,2.46820668554947e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHMP1A,Charged multivesicular body protein 1a,40228,-0.0383448306271195,0.00743944147972186,-0.0529261359273744,-0.0237635253268647,2.57705930004598e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP10,Stromelysin-2,40341,-0.0289699295478522,0.00562818607180571,-0.0400011742485914,-0.017938684847113,2.67421871649101e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSF,Cathepsin F,40411,-0.0192955054352683,0.00375126582306672,-0.0266479864484791,-0.0119430244220576,2.72522745581695e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,-0.0537395388792329,0.010448798034703,-0.0742191830272508,-0.033259894731215,2.73439128105888e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37557,-0.0410037559125587,0.00799628747837957,-0.0566764793701827,-0.0253310324549348,2.97250536178121e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,-0.036351707972416,0.00709207492226982,-0.0502521748200648,-0.0224512411247672,2.99956726841197e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,-0.0125176697628777,0.00244955909983472,-0.0173188055985537,-0.00771653392720164,3.26368951930156e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LIPF,Gastric triacylglycerol lipase,37628,0.0287885790645725,0.00564264304833495,0.017728998689836,0.039848159439309,3.40816050510313e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37628,-0.0235634280272931,0.00461861752734084,-0.0326159183808811,-0.014510937673705,3.41052215805836e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL2,Apoptosis regulator Bcl-2,37901,-0.0260051149871761,0.00511560902380166,-0.0360317086738273,-0.0159785213005248,3.75552267556788e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADD1,Alpha-adducin,37671,-0.0337381671904316,0.00664054207872057,-0.0467536296647239,-0.0207227047161393,3.81306585024703e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMPD1,Sphingomyelin phosphodiesterase,40380,-0.022600548027238,0.00444952591947205,-0.0313216188294032,-0.0138794772250728,3.83075358346523e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,-0.0199099625666905,0.00392010760787231,-0.0275933734781203,-0.0122265516552608,3.84747906340787e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEZ6L2,Seizure 6-like protein 2,40305,0.0113170943798776,0.00222891852780965,0.00694841406537074,0.0156857746943846,3.8698651336454e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,-0.0189120575790807,0.00372942830409686,-0.0262217370551106,-0.0116023781030509,4.00924600543674e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,-0.0277332382311203,0.00547329334599752,-0.0384608931892755,-0.0170055832729652,4.08638994714821e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH17,Cadherin-17,40359,-0.0321696889750875,0.00635638450462207,-0.0446282026041467,-0.0197111753460282,4.21705815335033e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AFM,Afamin,38013,-0.00891265606391336,0.00176243757049213,-0.0123670337020779,-0.00545827842574879,4.31451029776457e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40536,-0.0139982332855327,0.00277089095376325,-0.0194291795549087,-0.00856728701615675,4.4225409467153e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPE,Ribulose-phosphate 3-epimerase,37714,-0.0334025705773769,0.00661262794789148,-0.0463633213552442,-0.0204418197995096,4.44574344685091e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNAS,Neuroendocrine secretory protein 55,37959,-0.0430729559152948,0.00852915414397742,-0.0597900980374905,-0.0263558137930991,4.47370085326764e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,-0.0432720245920851,0.00858155552838532,-0.0600918734277203,-0.0264521757564499,4.65577002709542e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37900,-0.0240954387437868,0.00478704691311337,-0.033478050693489,-0.0147128267940846,4.87917089440971e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIF1C,Kinesin-like protein KIF1C,37562,-0.0178661799883877,0.00354989015505377,-0.0248239646922931,-0.0109083952844824,4.89564600761371e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,-0.0290776000586347,0.00578642173036486,-0.0404189866501498,-0.0177362134671196,5.08648430836588e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,-0.0398254482196848,0.00794095798741214,-0.0553897258750126,-0.024261170564357,5.36522264601638e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OGA,Protein O-GlcNAcase,37901,-0.0332673930424437,0.00663532869654614,-0.0462726372876741,-0.0202621487972133,5.40795047443807e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPTX1,Neuronal pentraxin-1,40332,0.0185441687947119,0.00370014264495383,0.0112918892106024,0.0257964483788214,5.45190974166579e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MBL2,Mannose-binding protein C,37810,0.0505857856593061,0.0101036991550279,0.0307825353154514,0.0703890360031607,5.60887056490688e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,-0.0485004519889808,0.00969640463611575,-0.0675054050757677,-0.029495498902194,5.74840138796135e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IKBKG,NF-kappa-B essential modulator,40341,-0.0430317369445991,0.00860567052878333,-0.0598988511810144,-0.0261646227081838,5.78232396552651e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTSL4,ADAMTS-like protein 4,37628,-0.011076990695909,0.0022194762601917,-0.0154271641658847,-0.00672681722593322,6.08933963756727e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL2A1,Collagen alpha-1(II) chain,37628,-0.038713624619396,0.00777010425890474,-0.0539430289668492,-0.0234842202719427,6.36030753645717e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NIT1,Deaminated glutathione amidase,37628,-0.0232808652870975,0.00468167631693436,-0.0324569508682888,-0.0141047797059061,6.6836432558282e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,-0.0265847581320353,0.00535003855866409,-0.0370708337070169,-0.0160986825570537,6.79703101309026e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HS1BP3,HCLS1-binding protein 3,37628,-0.0419247649440359,0.00843885094923988,-0.0584649128045461,-0.0253846170835258,6.84723501393903e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VASN,Vasorin,40116,0.012799594485568,0.00258041002714527,0.00774199083236332,0.0178571981387728,7.11238643809396e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,-0.040370550453211,0.00814760643824547,-0.0563398590721721,-0.0244012418342499,7.32460917630701e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DMD,Dystrophin,37628,-0.0243000783826382,0.00491108427021426,-0.0339258035522581,-0.0146743532130182,7.59031522135244e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RWDD1,RWD domain-containing protein 1,40471,-0.0298342039099149,0.00603252753187441,-0.0416579578723887,-0.0180104499474411,7.66958006866173e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,-0.0126043697889629,0.00255290267460575,-0.0176080590311901,-0.00760068054673561,8.01661854623677e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,-0.029381886800921,0.00595183785513968,-0.0410474889969947,-0.0177162846048472,8.03181939731596e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BOC,Brother of CDO,40042,0.0109442202235075,0.00221762185852766,0.00659768138079326,0.0152907590662217,8.09302698267942e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBP2,Guanylate-binding protein 2,40044,-0.0274805879878924,0.00557356871041557,-0.038404782660307,-0.0165563933154779,8.28548317878199e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,-0.0186054736149695,0.00378046605318433,-0.0260151870792107,-0.0111957601507282,8.69047620671639e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GMPR,GMP reductase 1,40516,-0.0235174494568128,0.00478290560022534,-0.0328919444332545,-0.0141429544803712,8.87577094956692e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL2RG,Cytokine receptor common subunit gamma,37900,-0.0179632179062282,0.00365377597600128,-0.0251246188191907,-0.0108018169932657,8.92161316960119e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,-0.0370638850554052,0.00753951769037758,-0.0518413397285453,-0.0222864303822652,8.92554742633086e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AXL,Tyrosine-protein kinase receptor UFO,40403,-0.0127155847651236,0.00258717351237452,-0.0177864448493777,-0.00764472468086958,8.97300757554895e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,-0.0214079609699808,0.00435622232921148,-0.0299461567352353,-0.0128697652047263,8.99912079169442e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UROD,Uroporphyrinogen decarboxylase,37671,-0.0327045357461445,0.00665670429055545,-0.0457516761556331,-0.0196573953366558,9.07570523841244e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37562,-0.0314060169690572,0.00640675245108431,-0.0439632517731825,-0.018848782164932,9.59925229372096e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTA4H,Leukotriene A-4 hydrolase,40489,-0.0266190514740671,0.00543320667096354,-0.0372681365491556,-0.0159699663989786,9.7104123651586e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GZMB,Granzyme B,40341,-0.0288527707860271,0.00589804269357938,-0.0404129344654427,-0.0172926071066115,1.00833101583453e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A14,Protein S100-A14,37959,-0.0248849341019031,0.00508740946880467,-0.0348562566607603,-0.014913611543046,1.01236323726328e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEC31A,Protein transport protein Sec31A,37628,-0.0353107017303955,0.0072201262656428,-0.0494621492110554,-0.0211592542497356,1.01719031780631e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37880,-0.0404294364840438,0.00827708597477949,-0.0566525249946116,-0.024206347973476,1.04886015316123e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1B,Interleukin-1 beta,39946,-0.0257168901188348,0.00528348252654442,-0.0360725158708619,-0.0153612643668078,1.14182187551198e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REEP4,Receptor expression-enhancing protein 4,37959,-0.0285735615244969,0.00587108936584075,-0.0400808966815447,-0.017066226367449,1.14686849586408e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37900,-0.0225517600171581,0.00464016669120964,-0.031646486731929,-0.0134570333023872,1.18639633277019e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXN,Thioredoxin,37819,-0.0205087142470665,0.0042215593185225,-0.0287829705113706,-0.0122344579827624,1.19867394149934e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATOX1,Copper transport protein ATOX1,40411,-0.0326268700535356,0.00672041875665387,-0.0457988908165772,-0.019454849290494,1.21595833041733e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,-0.0362910519318469,0.00748417414919428,-0.0509600332642677,-0.0216220705994261,1.25442935846886e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEPTIN9,Septin-9,40305,-0.0127900013100017,0.00264070053508954,-0.0179657743587772,-0.00761422826122618,1.28833124268436e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC39A14,Zinc transporter ZIP14,39961,-0.0151646958605383,0.00313585053308595,-0.0213109629053868,-0.00901842881568987,1.33808434146605e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,-0.0446622093387913,0.00923830327499464,-0.0627692837577808,-0.0265551349198018,1.34973924272546e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEO1,RNA polymerase-associated protein LEO1,37959,-0.014168423566593,0.002931203203682,-0.0199135818458097,-0.00842326528737629,1.35524047047612e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHA4,Ephrin type-A receptor 4,37671,-0.0128981787054303,0.00267010545928084,-0.0181315854056208,-0.00766477200523988,1.37657430565516e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37598,-0.0415254404413401,0.00860722401113414,-0.058395599503163,-0.0246552813795172,1.41939436906394e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBC1D17,TBC1 domain family member 17,39961,-0.020814505846285,0.00431556552740534,-0.0292730142799994,-0.0123559974125705,1.42669483676421e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARA5,Scavenger receptor class A member 5,40471,-0.0132387032132039,0.00274623788296404,-0.0186213294638134,-0.00785607696259441,1.44390507484947e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37990,-0.0147112402087481,0.00305523204444156,-0.0206994950158535,-0.00872298540164263,1.48719273638705e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSNK1D,Casein kinase I isoform delta,37598,-0.0289758148809224,0.00601893391591086,-0.0407729253561077,-0.0171787044057371,1.49502461779819e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENAH,Protein enabled homolog,40044,-0.0213144493644215,0.00442829636933868,-0.0299939102483253,-0.0126349884805177,1.49895094383023e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AOC3,Membrane primary amine oxidase,40403,0.0137480052136025,0.00285845203839861,0.00814543921834125,0.0193505712088638,1.52615351154775e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37598,-0.0175082223094854,0.00364277931958453,-0.0246480697758711,-0.0103683748430997,1.5546420394646e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KAZN,Kazrin,37901,-0.0471233175287754,0.0098094377181699,-0.0663498154563884,-0.0278968196011624,1.57302725443477e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,-0.025507880555885,0.00531171558117353,-0.0359188430949852,-0.0150969180167849,1.58368212078571e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTN6,Dynactin subunit 6,39961,-0.0318133141981644,0.00663408488284265,-0.044816120568536,-0.0188105078277928,1.63830889556251e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS53,Serine protease 53,37942,0.0166543056823553,0.00347318241839835,0.0098468681422945,0.0234617432224161,1.64318883413347e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLYR1,Putative oxidoreductase GLYR1,37900,-0.0274742100236118,0.00573033839322706,-0.0387056732743368,-0.0162427467728868,1.64812844036484e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMEM106A,Transmembrane protein 106A,37900,-0.0317159029360302,0.00661533869296773,-0.0446819667742469,-0.0187498390978134,1.64993673515998e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMBS,Porphobilinogen deaminase,40489,-0.0204348996009983,0.00426275518073758,-0.028789899755244,-0.0120798994467527,1.65099224582855e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37598,-0.0418047888909126,0.00872115108226277,-0.0588982450121477,-0.0247113327696776,1.65695332292016e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MINK1,Misshapen-like kinase 1,37942,-0.0418966830080224,0.00874503781197573,-0.0590369571194948,-0.02475640889655,1.67794511573177e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,-0.0305190400605842,0.00637386392170052,-0.0430118133471172,-0.0180262667740511,1.70162568986938e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD2,T-cell surface antigen CD2,37562,-0.0172872341263493,0.00361063891495092,-0.0243640863996531,-0.0102103818530455,1.70411160437309e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,-0.0222029458462532,0.00464211578130791,-0.0313014927776167,-0.0131043989148897,1.74300510859519e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,-0.0137768870994389,0.00288306933509828,-0.0194277029962315,-0.00812607120264625,1.78419275044216e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MATN2,Matrilin-2,40379,-0.013313838779683,0.00278637583676193,-0.0187751354197364,-0.00785254213962958,1.7845590220052e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STK24,Serine/threonine-protein kinase 24,39961,-0.0276446017348687,0.00578817596517268,-0.0389894266266071,-0.0162997768431302,1.80409104239067e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGN,Secretagogin,40044,-0.0196300855993209,0.00411163044560675,-0.0276888812727102,-0.0115712899259317,1.81986931154293e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALPI,Intestinal-type alkaline phosphatase,37598,-0.0547158274412062,0.0114804649541425,-0.0772175387513254,-0.0322141161310869,1.89936913360196e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,0.0107800631845288,0.00226233019148957,0.00634589600920925,0.0152142303598484,1.90500054798826e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,-0.0171355237191197,0.00360833219874209,-0.0242078548286542,-0.0100631926095852,2.06658068442346e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMA4,Laminin subunit alpha-4,40422,-0.0145985288332602,0.0030776584186075,-0.0206307393337309,-0.00856631833278947,2.11990256900497e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBM17,Splicing factor 45,37959,-0.0341567145535558,0.00720907710076034,-0.0482865056710461,-0.0200269234360655,2.18020220848038e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFIC,Nuclear factor 1 C-type,37959,-0.0195393634843243,0.00412711665648004,-0.0276285121310252,-0.0114502148376234,2.21950519508954e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37746,-0.024906745417862,0.00527228574345459,-0.035240425475033,-0.014573065360691,2.33514768348518e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGB1A1,Uteroglobin,40384,-0.0251441390911065,0.00532736024349551,-0.0355857651683577,-0.0147025130138553,2.38069847548434e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,-0.0156563906845929,0.00332148075312008,-0.0221664929607083,-0.00914628840847757,2.45821345769532e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELOB,Elongin-B,37562,-0.017813341150636,0.00378846214802835,-0.0252387269607715,-0.0103879553405004,2.60253551772992e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,-0.0185130557999109,0.00393756189739647,-0.0262306771188079,-0.0107954344810138,2.60271030876505e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",40359,-0.0318984463771375,0.00679463116673121,-0.0452159234639306,-0.0185809692903443,2.69285554990248e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,-0.0373139685234748,0.0079479279853814,-0.0528919073748224,-0.0217360296721273,2.69542888376344e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1R2,Interleukin-1 receptor type 2,40330,-0.00860357249777477,0.00183290705846799,-0.012196070332372,-0.00501107466317751,2.70219160501337e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSMB,Beta-microseminoprotein,40236,-0.0305072618251193,0.00650217274663316,-0.0432515204085202,-0.0177630032417183,2.73008027321599e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,40341,-0.049037881302203,0.0104601094604094,-0.0695396958446055,-0.0285360667598005,2.78064505378498e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGCC,Regulator of cell cycle RGCC,37959,-0.0331472314080847,0.00707350807942709,-0.0470113072437618,-0.0192831555724076,2.81165887767235e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDGF,Hepatoma-derived growth factor,40471,-0.0419021781662036,0.00895094067162105,-0.0594460218825809,-0.0243583344498263,2.8737529478569e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37572,-0.0191155828701622,0.00408320588291929,-0.027118666400684,-0.0111124993396404,2.87616197605571e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,-0.0183295253616762,0.00392043926392116,-0.0260135863189617,-0.0106454644043908,2.95874567528627e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPSAB1,Tryptase alpha/beta-1,40498,-0.0230935237193234,0.00494396344108675,-0.0327836920638535,-0.0134033553747934,3.02087674971066e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C7orf50,Uncharacterized protein C7orf50,37942,-0.00969083584868779,0.00207458708929175,-0.0137570265436996,-0.00562464515367595,3.02318871877258e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNN,Tenascin-N,37998,-0.0193060188897174,0.00413652989052208,-0.0274136174751407,-0.0111984203042941,3.08255764256807e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,40403,0.0118943575110923,0.00255530802759864,0.00688595377699892,0.0169027612451856,3.26962186256816e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37572,-0.0303613506400236,0.00652255902851851,-0.0431455663359199,-0.0175771349441273,3.27436944583506e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRY2,Protein sprouty homolog 2,40044,-0.0400771736346086,0.00861227133650384,-0.0569572254541561,-0.0231971218150611,3.29038524107388e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SYAP1,Synapse-associated protein 1,37671,-0.0248648421784586,0.00534468702043583,-0.0353404287385129,-0.0143892556184044,3.31511070883532e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDHB,Succinate dehydrogenase,37901,-0.0312937300283588,0.00672909146936371,-0.0444827493083116,-0.0181047107484059,3.34262003044228e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTF1,Cardiotrophin-1,40042,-0.0368733289507305,0.00793411226629622,-0.0524241889926711,-0.02132246890879,3.38827804167898e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,-0.0221125343573918,0.00476247138439256,-0.0314469782708013,-0.0127780904439824,3.46501865531169e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RANBP1,Ran-specific GTPase-activating protein,37628,-0.0232850710116021,0.00501716674577078,-0.0331187178333128,-0.0134514241898914,3.49935372305432e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA1,Carbonic anhydrase 1,40003,-0.0272188669297772,0.00587469672289269,-0.0387332725066469,-0.0157044613529076,3.6291098178478e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCTN3,Tectonic-3,37990,-0.0127395799234553,0.00275346787793772,-0.0181363769642132,-0.00734278288269737,3.7491088436974e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37671,-0.0137188933983132,0.00297057657976579,-0.0195412234946542,-0.00789656330197226,3.9062152709784e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,40451,-0.0129427930699835,0.00280274412682575,-0.018436171558562,-0.00744941458140507,3.90659942507094e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17D,Interleukin-17D,40044,-0.0148159680435225,0.00320876863984875,-0.021105154577626,-0.00852678150941895,3.91798259845717e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,-0.0290016161302777,0.00628441796772429,-0.0413190753470173,-0.016684156913538,3.97075651359653e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP53,Cellular tumor antigen p53,39980,-0.0186572306685968,0.00404656251334776,-0.0265884931947584,-0.0107259681424352,4.04637716792006e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NACC1,Nucleus accumbens-associated protein 1,37900,-0.0238590909587007,0.00518946026678307,-0.0340304330815956,-0.0136877488358059,4.31267990414536e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OPLAH,5-oxoprolinase,37628,-0.0295556236941434,0.00642888963828263,-0.0421562473851773,-0.0169550000031094,4.31951574501437e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DGCR6,Protein DGCR6,37541,-0.0197993570006423,0.00430771327259365,-0.0282424750149259,-0.0113562389863588,4.34170550936031e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBA,Lysosomal acid glucosylceramidase,37572,-0.0230069078064971,0.00500745239299537,-0.0328215144967681,-0.0131923011162262,4.37758688665396e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,-0.0407881953174697,0.00888880311264096,-0.058210249418246,-0.0233661412166934,4.49416319365486e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM5,Tripartite motif-containing protein 5,40341,-0.0365392426423413,0.00797077902145907,-0.0521619695244011,-0.0209165157602816,4.59311782844675e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,-0.0178687909695435,0.00390158540699267,-0.0255158983672491,-0.0102216835718379,4.68733731201393e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37990,-0.0257513939138171,0.00562747036652294,-0.0367812358322021,-0.0147215519954322,4.78126506370079e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GASK1A,Golgi-associated kinase 1A,37562,-0.0186787815939378,0.00408831761553395,-0.0266918841203843,-0.0106656790674912,4.94955901558099e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37958,-0.00635093835597162,0.00139435866867502,-0.00908388134657465,-0.00361799536536858,5.29098951216313e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABHD14B,Protein ABHD14B,40171,-0.0249188878580105,0.00548243479920256,-0.0356644600644475,-0.0141733156515735,5.52862705230091e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,-0.0130681030268347,0.00287994417839744,-0.0187127936164937,-0.00742341243717573,5.73958194883986e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTN2,Dynactin subunit 2,40305,-0.0399885575920524,0.00882086642595298,-0.0572774557869203,-0.0226996593971846,5.84652019426692e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,-0.0150730150405794,0.0033251221902687,-0.0215902545335061,-0.00855577554765279,5.86454353018956e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37921,-0.0165239314377987,0.00365007692133356,-0.0236780822036125,-0.00936978067198494,6.03371298880098e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYO9B,Unconventional myosin-IXb,40044,-0.0280624969292627,0.00620425797047291,-0.0402228425513896,-0.0159021513071358,6.13891190648206e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYBB1,Beta-crystallin B1,37990,-0.0276434940184288,0.00611586048987671,-0.0396305805785872,-0.0156564074582705,6.23732279688715e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,-0.0103128289629378,0.00228277353194542,-0.0147870650855508,-0.00583859284032478,6.29732876734211e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,-0.0390192568999547,0.00864381202074473,-0.0559611284606144,-0.022077385339295,6.4043872655485e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39961,-0.0272362098359497,0.00604774601511754,-0.0390897920255801,-0.0153826276463193,6.73211599609898e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SF3B4,Splicing factor 3B subunit 4,40305,-0.0309900132646608,0.00688176479539584,-0.0444782722636367,-0.017501754265685,6.74129841511439e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39980,-0.0171711813674322,0.00381985611594291,-0.0246580993546803,-0.00968426338018405,6.9993193321173e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,-0.0207327841372522,0.00461334016761191,-0.0297749308657715,-0.0116906374087328,7.0463424935517e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD226,CD226 antigen,37598,-0.017717490351064,0.00395604102878937,-0.0254713307674912,-0.00996364993463684,7.57704845677698e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNST,Consortin,40359,-0.0452499718922609,0.0101106871590844,-0.0650669187240662,-0.0254330250604555,7.67764231179347e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,40359,-0.0284486309355964,0.00636949583172004,-0.0409328427657676,-0.0159644191054251,8.00997591476483e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICA1,Islet cell autoantigen 1,40044,-0.0331136310825217,0.00741519273150797,-0.0476474088362773,-0.0185798533287661,8.03878897078304e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,-0.0460290355485964,0.0103137496948636,-0.0662439849505291,-0.0258140861466636,8.14190514622713e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,-0.0312609776607136,0.0070117424089189,-0.0450039927821947,-0.0175179625392326,8.32474068312116e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP3,Stromelysin-1,40332,-0.0201845156608681,0.00453253596924845,-0.029068286160595,-0.0113007451611411,8.51572317464074e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPD52L2,Tumor protein D54,37671,-0.0453887661944969,0.0102099370986903,-0.06540024290793,-0.0253772894810638,8.83822002251404e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INSL4,Early placenta insulin-like peptide,37900,-0.0227502771936515,0.00512194355582844,-0.0327892865630752,-0.0127112678242277,8.99517175776422e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIL1,Nucleotide exchange factor SIL1,37628,-0.013434136415998,0.00302529538187852,-0.0193637153644798,-0.00750455746751606,9.0437069400736e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SORT1,Sortilin,40330,-0.0150988657639707,0.00340640371038155,-0.0217754170363186,-0.00842231449162289,9.37733779616578e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRKL,Crk-like protein,40374,-0.0442502560009252,0.00999358523841677,-0.063837683068222,-0.0246628289336283,9.58035482835209e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37572,-0.03012953846022,0.00680705170601976,-0.0434713598040188,-0.0167877171164213,9.66707907146171e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RRAS,Ras-related protein R-Ras,37572,-0.0544962592229924,0.0123421346823013,-0.0786868432003029,-0.0303056752456819,1.0159925710598e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LCP1,Plastin-2,37998,-0.019637042657733,0.00444869478267678,-0.0283564844317795,-0.0109176008836865,1.02209398182851e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CMIP,C-Maf-inducing protein,37900,-0.0341758956185258,0.00775093804876769,-0.0493677341941105,-0.0189840570429412,1.04529578431167e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,0.0250843232978433,0.00569246019938134,0.0139271013070559,0.0362415452886307,1.05699662551315e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,-0.018647367578876,0.00423192667769951,-0.026941943867167,-0.0103527912905849,1.05813355413086e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK13,Kallikrein-13,40032,-0.017926168288478,0.00407172629952889,-0.0259067518355546,-0.00994558474140132,1.07674884953016e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,40305,0.00851643677654032,0.00193712627772023,0.00471966927220867,0.012313204280872,1.10762656039162e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAFB2,Scaffold attachment factor B2,37959,-0.0115142543929499,0.00262048771388473,-0.0166504103121639,-0.0063780984737358,1.12165310770955e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPEP1,Dipeptidase 1,40192,0.0208900504156506,0.00476195510827284,0.0115566184034359,0.0302234824278654,1.15743829239629e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,-0.0147858385169215,0.00337113315715123,-0.021393259504938,-0.00817841752890511,1.16346985115694e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD276,CD276 antigen,40357,-0.0148165750048241,0.00338163059836818,-0.0214445709776257,-0.00818857903202249,1.18625820765456e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGH,Gamma-glutamyl hydrolase,40077,-0.0140843893230029,0.00321797881472788,-0.0203916277998696,-0.00777715084613627,1.21226309067287e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLTA,Clathrin light chain A,40042,-0.0194625160658552,0.00445108987282316,-0.0281866522165886,-0.0107383799151219,1.23611712664851e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX6,Syntaxin-6,39980,-0.0282384270930403,0.00647257919078977,-0.0409246823069882,-0.0155521718790923,1.29249469770563e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDIA5,Protein disulfide-isomerase A5,37482,-0.0253643796558656,0.00581364694931781,-0.0367591276765285,-0.0139696316352026,1.29334781569748e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FXN,"Frataxin, mitochondrial",40489,-0.0302114759285949,0.0069313363696057,-0.043796895213022,-0.0166260566441677,1.31663584367072e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,-0.0368806703501679,0.00847319226226228,-0.0534881271842019,-0.0202732135161338,1.35500768178919e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF2,Fibroblast growth factor 2,40341,-0.0268899112722209,0.00620232567669332,-0.0390464695985398,-0.0147333529459021,1.46353215059526e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ISM1,Isthmin-1,40341,-0.0158113171647743,0.00365257388164801,-0.0229703619728044,-0.00865227235674423,1.50830792414367e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLPS,Colipase,40311,-0.0278129248003623,0.00643106303237837,-0.0404178083438239,-0.0152080412569006,1.5361751392766e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPO,Lactoperoxidase,39831,-0.0240090627936943,0.00555514022661652,-0.0348971376378627,-0.0131209879495259,1.5562478339005e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1RL2,Interleukin-1 receptor-like 2,40044,-0.0163489027891687,0.00378994278235555,-0.0237771906425856,-0.00892061493575186,1.61488712173178e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL28,C-C motif chemokine 28,40278,-0.024100445341486,0.00559108211773093,-0.0350589662922386,-0.0131419243907334,1.63858812192005e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,-0.0312431640642115,0.0072572282766798,-0.0454673314865039,-0.0170189966419191,1.67903382196683e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,-0.0197119488156923,0.00458148627187832,-0.0286916619085738,-0.0107322357228108,1.69872454751097e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBCC,Tubulin-specific chaperone C,40228,-0.0327089659407774,0.00760927751060622,-0.0476231498615656,-0.0177947820199892,1.72939501089022e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL4,Angiopoietin-related protein 4,40396,-0.0183976964538255,0.00428409588083236,-0.026794524380257,-0.0100008685273941,1.76188306053126e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BMP6,Bone morphogenetic protein 6,40024,-0.0170162857627006,0.0039739062516636,-0.0248051420159613,-0.00922742950943998,1.86326101028978e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOA4,Apolipoprotein A-IV,38013,0.0149215923961022,0.00348511810762831,0.00809076090515073,0.0217524238870537,1.86899824513715e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEMIP2,Cell surface hyaluronidase,37598,-0.0136521028972403,0.00319086519032525,-0.0199061986702778,-0.00739800712420277,1.89491726061944e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,-0.0184125040336288,0.00430719296805826,-0.026854602251023,-0.00997040581623458,1.92604210759489e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37562,-0.0232369065406189,0.0054414934043022,-0.0339022336130512,-0.0125715794681866,1.96569116948023e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNGR2,Interferon gamma receptor 2,40228,-0.0206401411235612,0.00483711973772938,-0.0301208958095108,-0.0111593864376117,1.99246719713843e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGT,Angiotensinogen,37987,-0.00978562716649211,0.00229483231592827,-0.0142834985057115,-0.00528775582727271,2.01979240057088e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37998,0.0132508005725144,0.00311682743831499,0.00714181879341702,0.0193597823516118,2.13886094718827e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MITD1,MIT domain-containing protein 1,40228,-0.0384320723256708,0.00904931199886724,-0.0561687238434506,-0.020695420807891,2.17931201364031e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRAP,BRCA1-associated protein,37778,-0.0440026611366997,0.0103604260889758,-0.0643090962710922,-0.0236962260023072,2.17940653862749e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F3,Tissue factor,40393,0.011150585290648,0.00263299539197748,0.00598991432237217,0.0163112562589239,2.29891732016729e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,40044,-0.0126394902119794,0.00298573477268973,-0.0184915303664513,-0.00678745005750756,2.31612572470946e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CIAPIN1,Anamorsin,40411,-0.0253020966480682,0.00598021427462829,-0.0370233166263396,-0.0135808766697967,2.33986265593616e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD101,Immunoglobulin superfamily member 2,37901,-0.0170256846930234,0.00402466195896792,-0.0249140221326005,-0.00913734725344632,2.34884486943945e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TWF2,Twinfilin-2,37998,-0.0330820710529547,0.00782038353257087,-0.0484100227767936,-0.0177541193291158,2.34980475873065e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERI1,3'-5' exoribonuclease 1,37714,-0.0134569664804049,0.00318124444002416,-0.0196922055828522,-0.00722172737795752,2.35160898049793e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,-0.0345776405506055,0.00818461299151268,-0.0506194820139704,-0.0185357990872407,2.40821877631279e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DRAXIN,Draxin,40228,-0.0171515244822842,0.0040620600281221,-0.0251131621374035,-0.00918988682716491,2.43100185617074e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CMC1,COX assembly mitochondrial protein homolog,37990,-0.0358166632162643,0.00849225430008656,-0.0524614816444339,-0.0191718447880946,2.48556821964716e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD33,Myeloid cell surface antigen CD33,40411,-0.0313730340470007,0.00744688490236323,-0.0459689284556327,-0.0167771396383688,2.53489149195808e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARG1,Arginase-1,40227,-0.0208496483761617,0.004952758967363,-0.0305570559521932,-0.0111422408001302,2.57122080686475e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MKI67,Proliferation marker protein Ki-67,37598,-0.0150322521244263,0.00357246362575807,-0.0220342808309122,-0.00803022341794053,2.59567993723886e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL33,Interleukin-33,40044,-0.0152434311168275,0.00362564424894325,-0.0223496938447563,-0.0081371683888987,2.63308664190571e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB27B,Ras-related protein Rab-27B,37990,-0.0324943990179532,0.00773834077811678,-0.0476615469430621,-0.0173272510928443,2.6964059305413e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TK1,"Thymidine kinase, cytosolic",37714,-0.0177892105378275,0.0042372798569037,-0.0260942790573588,-0.00948414201829626,2.70726058350534e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37598,-0.0227982284500742,0.005431872381784,-0.0334446983183709,-0.0121517585817776,2.72106104867935e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRCAM,Neuronal cell adhesion molecule,40359,-0.01101781150561,0.00262667397671582,-0.016166092499973,-0.00586953051124697,2.74850895514871e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTSL5,ADAMTS-like protein 5,37990,-0.0153632967836456,0.0036638192953865,-0.0225443826026031,-0.00818221096468801,2.76739770035666e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLT1,Vascular endothelial growth factor receptor 1,40272,-0.00911313812727856,0.00217403686256794,-0.0133742503779117,-0.00485202587664539,2.78248035637193e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGCT,Gamma-glutamylcyclotransferase,37978,-0.0191260912893802,0.00456333569158129,-0.0280702292448795,-0.0101819533338808,2.79181955115973e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,40419,-0.0124822015450341,0.0029871706622201,-0.0183370560429855,-0.00662734704708273,2.94865002196857e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IST1,IST1 homolog,37812,-0.0395827730099472,0.00947374715709995,-0.0581513174378631,-0.0210142285820313,2.95753364314079e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WIF1,Wnt inhibitory factor 1,40489,0.0134140995850396,0.0032107523323868,0.00712102501356146,0.0197071741565177,2.95811816445606e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP6,Gastrotropin,40017,-0.021918750176475,0.00525003009937245,-0.032208809171245,-0.011628691181705,2.99638457050119e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAG6,Large proline-rich protein BAG6,40042,-0.0140470895833735,0.00337073299354783,-0.0206537262507273,-0.00744045291601979,3.09796797831133e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HLA_DRA,,40288,-0.0140812888207559,0.00337941798925717,-0.0207049480796999,-0.00745762956181182,3.10572730103416e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,-0.0128349827983526,0.0030896696253914,-0.0188907352641197,-0.00677923033258544,3.28172542440886e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40497,0.0247722379231952,0.00596329715328176,0.0130841755027629,0.0364603003436274,3.28235650795776e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDC,Nuclear migration protein nudC,40516,-0.024608510299688,0.00592721715304929,-0.0362258559196646,-0.0129911646797114,3.31599393265082e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,-0.0287731651329946,0.00693003770203315,-0.0423560390289795,-0.0151902912370096,3.31674637175348e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,-0.0236128098388063,0.0056886427064604,-0.0347625495434686,-0.0124630701341439,3.32954306308911e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHGB,Secretogranin-1,40406,-0.0156646352502041,0.00377928801902796,-0.0230720397674989,-0.0082572307329093,3.4177062543444e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OTUD6B,Deubiquitinase OTUD6B,37901,-0.0230068196180954,0.00556620453149958,-0.0339165804998345,-0.0120970587363562,3.59751551825702e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37901,-0.0442909742378548,0.0107164000457247,-0.0652951183274751,-0.0232868301482345,3.60214894148981e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX9,Sorting nexin-9,40359,-0.0266255019288828,0.00644330574311405,-0.0392543811853864,-0.0139966226723793,3.61030985569222e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6V1F,V-type proton ATPase subunit F,39925,-0.0255837702736249,0.00619468382891423,-0.0377253505782967,-0.013442189968953,3.64738182165223e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDF1,Endothelial differentiation-related factor 1,37959,-0.0271754018257182,0.0065807145480994,-0.040073602339993,-0.0142772013114434,3.65657151957772e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40453,-0.0256162836751944,0.00620429464016536,-0.0377767011699185,-0.0134558661804703,3.66512977654819e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPI,Mannose-6-phosphate isomerase,40305,-0.033159866355173,0.00805026885457298,-0.048938393310136,-0.01738133940021,3.82284047550801e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37879,-0.0162255988648644,0.00394121912884669,-0.0239503883574039,-0.00850080937232492,3.86301607335176e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TTR,Transthyretin,37871,-0.00994138103384142,0.0024167866256732,-0.0146782828201609,-0.00520447924752194,3.92079296716662e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1S,Complement C1s subcomponent,38013,-0.00806635122375701,0.00196258408422097,-0.0119130160288301,-0.00421968641868391,3.97872328940804e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LACTB2,Endoribonuclease LACTB2,40359,-0.025378435847496,0.00619276741351987,-0.037516259977995,-0.0132406117169971,4.18663133949696e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHCY,Adenosylhomocysteinase,40359,-0.0260437775547159,0.0063613879754082,-0.0385120979865159,-0.0135754571229158,4.26015262099607e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA3,Annexin A3,40442,-0.0268164400524375,0.00655515951900787,-0.0396645527096929,-0.013968327395182,4.31825713019541e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APRT,Adenine phosphoribosyltransferase,40216,-0.0185572449078928,0.00454322509841126,-0.0274619661007789,-0.00965252371500676,4.43715192698791e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKAP12,A-kinase anchor protein 12,37671,0.00844057685131495,0.00206638626004609,0.00439045978162461,0.0124906939210053,4.43931785436846e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,-0.010835793664658,0.00265604853183581,-0.0160416487870562,-0.00562993854225982,4.53219356367252e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UNC79,Protein unc-79 homolog,37482,-0.0218028557920149,0.00535085991065215,-0.0322905412168931,-0.0113151703671367,4.63576286053985e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB6,Serpin B6,40433,-0.0227190569415665,0.005595253964816,-0.0336857547126059,-0.0117523591705271,4.92188798095363e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37998,0.00812269817153939,0.00200162356994785,0.00419951597444159,0.0120458803686372,4.97608432380973e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC11A,C-type lectin domain family 11 member A,40296,-0.0182234376185386,0.00449518485059492,-0.0270339999257046,-0.00941287531137254,5.05918074771467e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,-0.0155472660129435,0.00383709582189547,-0.0230679738238587,-0.00802655820202842,5.11104107922575e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,-0.0216749087453285,0.00535195034860302,-0.0321647314285904,-0.0111850860620666,5.15317308286394e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NME3,Nucleoside diphosphate kinase 3,40379,0.00911076875554327,0.00225093034789103,0.00469894527367685,0.0135225922374097,5.19995218728741e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,-0.0188532693874951,0.00466436023350891,-0.0279954154451726,-0.00971112332981769,5.33001191417123e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,-0.0261449316676745,0.00647938918212376,-0.0388445344646371,-0.0134453288707119,5.48890997815765e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MUC16,Mucin-16,40305,-0.0708451375419803,0.0175913051482946,-0.105324095632638,-0.036366179451323,5.6688249754014e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP8,Caspase-8,40434,-0.023333833340205,0.00579802267100949,-0.0346979577753836,-0.0119697089050264,5.73725354786813e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,-0.0232631245552421,0.0057822909381787,-0.0345964147940724,-0.0119298343164119,5.77402142877201e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BDNF,Brain-derived neurotrophic factor,37998,-0.0314101912372768,0.0078078086548111,-0.0467134962007065,-0.016106886273847,5.77930672864663e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TEK,Angiopoietin-1 receptor,40411,-0.00811932626484525,0.00201891512805123,-0.0120763999158257,-0.00416225261386483,5.80631665854364e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,0.0076574187983899,0.00191001251428604,0.00391379427038926,0.0114010433263905,6.12898048153703e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XRCC4,DNA repair protein XRCC4,39961,-0.0139970915582723,0.0034939776108239,-0.0208452876754872,-0.00714889544105746,6.20274912706987e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C5,Complement C5,38013,-0.0057927824253112,0.00144777243765715,-0.00863041640311921,-0.00295514844750319,6.33651607871647e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PKN3,Serine/threonine-protein kinase N3,37714,-0.0291460384860451,0.00730257713881624,-0.0434590896781249,-0.0148329872939653,6.60938980148828e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,-0.0131253671578556,0.00328930069368077,-0.0195723965174699,-0.00667833779824128,6.62855550895783e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,-0.0410209521380744,0.0102904514659681,-0.0611902370113718,-0.020851667264777,6.74626888391131e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA1,Annexin A1,37608,-0.0156564668952473,0.00392980111463724,-0.0233588770799363,-0.00795405671055831,6.81198605078649e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,-0.0250954541439302,0.00630635182689269,-0.0374559037246399,-0.0127350045632205,6.94656120976699e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGER,Advanced glycosylation end product-specific receptor,40311,-0.0151501684912001,0.00380935400169827,-0.0226165023345287,-0.00768383464787146,7.00715464436089e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRUNE2,Protein prune homolog 2,37714,-0.0111278086378078,0.00280007531295714,-0.0166159562512038,-0.00563966102441176,7.10168272815411e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,-0.0388901244604214,0.00979162585838424,-0.0580817111428545,-0.0196985377779883,7.16538933257057e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFRAL,GDNF family receptor alpha-like,37477,0.0233031187138359,0.00587645277569503,0.0117852712734737,0.0348209661541982,7.36315377876013e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH2B3,SH2B adapter protein 3,39980,-0.0363062514458547,0.00917186445775017,-0.054283105783045,-0.0183293971086643,7.57777149372592e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,-0.0319532846337981,0.00807489979404805,-0.0477800882301322,-0.0161264810374639,7.62493338504538e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CR1,Complement receptor type 1,37959,-0.0135776716795403,0.00343441487558492,-0.0203091248356867,-0.00684621852339386,7.74359173658688e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITM2A,Integral membrane protein 2A,40341,-0.0218791412161648,0.00554408763437149,-0.0327455529795329,-0.0110127294527966,7.9679157035686e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37628,-0.0308012745280449,0.00781193083902406,-0.0461126589725321,-0.0154898900835578,8.09353785505813e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX16,Syntaxin-16,39980,-0.0218870373387043,0.00555380373365562,-0.0327724926566693,-0.0110015820207392,8.15287983495649e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VNN1,Pantetheinase,37987,-0.0269896164460248,0.00685197411022608,-0.040419485702068,-0.0135597471899817,8.22478595026708e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DENR,Density-regulated protein,37598,-0.0214086601040619,0.0054404159548115,-0.0320718753754924,-0.0107454448326314,8.35849406811338e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,40305,-0.0206843629358481,0.00526385687890402,-0.0310015224185,-0.0103672034531962,8.54813305341517e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37990,-0.0262508620384464,0.00668699123175841,-0.0393573648526929,-0.0131443592241999,8.69200799865344e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,-0.0143302267640139,0.00366187263494293,-0.021507497128502,-0.00715295639952576,9.14656872361936e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PADI4,Protein-arginine deiminase type-4,39934,-0.0254999763317946,0.00651877783594249,-0.0382767808902419,-0.0127231717733473,9.20124950051355e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGA,Fibrinogen alpha chain,37698,-0.0114126294764331,0.0029209879890522,-0.0171377659349754,-0.00568749301789076,9.38698716194024e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",40411,-0.0224765208536646,0.0057540932829238,-0.0337545436881952,-0.0111984980191339,9.41532963918489e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TREH,Trehalase,37998,-0.0274213306637913,0.00702908801502822,-0.0411983431732466,-0.013644318154336,9.62105325759817e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,0.0119560696173299,0.00307978678675589,0.00591968751528837,0.0179924517193715,0.000103973884190746
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DBNL,Drebrin-like protein,40422,-0.0335944347466733,0.0086565154320191,-0.0505612049934308,-0.0166276644999159,0.000104520346354576
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPP,Lipoma-preferred partner,37562,-0.0245705965233789,0.0063311468330963,-0.0369796443162476,-0.0121615487305101,0.000104576875272666
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,-0.0244720754075798,0.00631103709938001,-0.0368417081223647,-0.012102442692795,0.000105964242752299
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIT1,ARF GTPase-activating protein GIT1,37598,-0.035728574613101,0.00922736672987062,-0.0538142134036475,-0.0176429358225546,0.000108458329490691
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDK2,Protein sidekick-2,37671,-0.0139546653041634,0.00361596537121311,-0.021041957431741,-0.00686737317658566,0.000114308437866525
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,-0.0289027736043774,0.00750306938975629,-0.0436087896082998,-0.0141967576004551,0.000117556232167587
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL26,C-C motif chemokine 26,40341,-0.0320600128002342,0.00832497756448183,-0.0483769688266186,-0.0157430567738498,0.000118067580215787
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,-0.0269774268872697,0.00701134053588062,-0.0407196543375957,-0.0132351994369437,0.000119805508223762
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TTF2,Transcription termination factor 2,37572,-0.017712460232169,0.00460748462040503,-0.0267431300881629,-0.00868179037617518,0.000121477697261461
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,-0.0346660241014959,0.00902373812307586,-0.0523525508227246,-0.0169794973802672,0.000122686069849255
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYL4,Myosin light chain 4,37628,-0.0190962765596465,0.00497496767507081,-0.0288472132027853,-0.00934533991650771,0.00012438066931369
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,-0.0310124984509038,0.00808925713066137,-0.0468674424270001,-0.0151575544748076,0.000126771193780454
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,-0.0359629242136429,0.00941131759770005,-0.054409106705135,-0.0175167417221508,0.000133286946519292
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CIRBP,Cold-inducible RNA-binding protein,37901,-0.0343654565652489,0.00900894505102272,-0.0520229888652534,-0.0167079242652443,0.000137017692682863
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,-0.0333211343771927,0.00877182229104914,-0.050513906067649,-0.0161283626867364,0.000146120550092432
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,-0.00996674081098494,0.00262409263127741,-0.0151099623682887,-0.00482351925368122,0.00014631001046915
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PKLR,Pyruvate kinase PKLR,40374,-0.0237221774052884,0.00625087320819052,-0.0359738888933418,-0.011470465917235,0.000148179453863176
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFHR4,Complement factor H-related protein 4,37973,0.0263411712988511,0.00695099973691996,0.012717211814488,0.0399651307832143,0.000151574362449686
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THTPA,Thiamine-triphosphatase,37884,-0.0316122550731953,0.00836469412747502,-0.0480070555630464,-0.0152174545833443,0.000157982616805926
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,-0.0176264730476788,0.00468903074561867,-0.0268169733090914,-0.00843597278626621,0.000171144874039015
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPART,Spartin,37671,-0.0274271182212939,0.00730289676638841,-0.0417407958834152,-0.0131134405591726,0.000173634519624992
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLG,Plasminogen,37705,-0.00798225421071433,0.00212578373740755,-0.0121487903360331,-0.00381571808539553,0.000174103601797113
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAS2,Growth arrest-specific protein 2,37714,-0.0190224538377623,0.00506667583000291,-0.028953138464568,-0.00909176921095662,0.000174482014225741
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MICALL2,MICAL-like protein 2,37572,-0.0243156980761071,0.00647997160242381,-0.0370164424168578,-0.0116149537353564,0.00017587704898655
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAMR1,Inactive serine protease PAMR1,40332,-0.00981072497054625,0.00261739937843322,-0.0149408277522754,-0.00468062218881715,0.000178688131235883
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,-0.0098955271411964,0.00264216803015796,-0.015074176480306,-0.00471687780208681,0.000181000114315871
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBCB,Tubulin-folding cofactor B,40228,-0.0354487208984187,0.00947244707788693,-0.0540147171710771,-0.0168827246257603,0.000182991656859753
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,-0.0114193804351386,0.0030523362206407,-0.0174019594275944,-0.00543680144268284,0.000183807588278284
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37714,-0.0243132874930841,0.00649911462422186,-0.037051552156559,-0.0115750228296093,0.000184050678923887
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD40LG,CD40 ligand,40516,-0.0268340746623344,0.00717624006945973,-0.0408995051984755,-0.0127686441261933,0.000185178209305261
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEXN,Nexilin,37987,-0.0241088782377265,0.00646631067874925,-0.036782847168075,-0.011434909307378,0.000193498516583619
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFAP,Glial fibrillary acidic protein,39959,0.0164130353764333,0.00440760796881783,0.00777412375755038,0.0250519469953163,0.000196944052448369
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,-0.0167575503260013,0.00450029333524006,-0.0255781252630718,-0.00793697538893081,0.000197051695922088
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPK13,Mitogen-activated protein kinase 13,37482,-0.0145683262964197,0.00391344819464544,-0.0222386847579248,-0.00689796783491465,0.000197987122551261
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL6R,Interleukin-6 receptor subunit alpha,40273,-0.0117493273294722,0.00316302815170249,-0.0179488625068091,-0.00554979215213534,0.00020423979516724
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNPY4,Protein canopy homolog 4,40305,-0.0260013085016629,0.00701137155409895,-0.0397435967476968,-0.012259020255629,0.00020924446871169
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39980,-0.0173229713605594,0.0046746294415435,-0.0264852450659846,-0.00816069765513411,0.000211504528241216
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,-0.0140280520422003,0.00378824671646748,-0.0214530156064765,-0.006603088477924,0.000213900126102042
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C7,Complement component C7,37678,-0.011054708282435,0.00298781409988559,-0.0169108239182107,-0.0051985926466592,0.000216531634005673
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37572,-0.0216249933490268,0.00584915453864984,-0.0330893362447805,-0.0101606504532731,0.000218952651868387
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,-0.0326022074290795,0.00882393918592037,-0.0498971282334834,-0.0153072866246755,0.00022084610556125
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD177,CD177 antigen,40316,-0.0442675822707842,0.0119929382805554,-0.0677737413006728,-0.0207614232408955,0.000224001150224689
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLG4,Disks large homolog 4,37942,-0.0244449284406796,0.0066228009164445,-0.0374256182369108,-0.0114642386444483,0.000224231187663232
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,-0.0190250683123511,0.00517245927653597,-0.0291630884943616,-0.00888704813034061,0.000235850091407075
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL36G,Interleukin-36 gamma,37551,-0.0239799966227959,0.00652957070805488,-0.0367779552105835,-0.0111820380350083,0.000241123717450332
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,-0.0276623644451991,0.00753298695875977,-0.0424270188843682,-0.0128977100060299,0.000241308969409141
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SBSN,Suprabasin,37977,0.0116367430605774,0.00317445575941796,0.00541480977211825,0.0178586763490366,0.000247564320758986
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LUZP2,Leucine zipper protein 2,37900,-0.0154566767733763,0.00422533985143463,-0.0237383428821882,-0.00717501066456446,0.000255071668462659
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RCC1,Regulator of chromosome condensation,37900,-0.0176731638932344,0.00483395230423042,-0.027147710409526,-0.00819861737694274,0.000257109286589583
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37539,-0.0142194498076068,0.0038933034519877,-0.0218503245735027,-0.00658857504171095,0.0002609324226138
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,-0.02237184102455,0.00612805089107222,-0.0343828207710515,-0.0103608612780484,0.00026236998397883
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37901,-0.00897896533847224,0.00246408178436808,-0.0138085656358337,-0.0041493650411108,0.000269507112305724
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB1,Leukocyte elastase inhibitor,40287,-0.0303633901651052,0.00833509286349646,-0.0467001721775583,-0.0140266081526521,0.000270509885869429
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP2,"Fatty acid-binding protein, intestinal",40359,0.0264344683665551,0.0072568648970688,0.0122110131683002,0.0406579235648099,0.000270667037730958
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPING1,Plasma protease C1 inhibitor,37981,0.00641256803384744,0.00176187400878789,0.00295929497662317,0.0098658410910717,0.000274048130657293
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRH,Corticoliberin,39947,0.0296907128342904,0.00817172578568246,0.0136741302943528,0.045707295374228,0.00028067272165936
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,40044,-0.0225183689270778,0.00619826690017002,-0.0346669720514111,-0.0103697658027446,0.000281032825342283
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFRP1,Secreted frizzled-related protein 1,40178,-0.0148284080941164,0.00408433420813422,-0.0228337031420595,-0.00682311304617332,0.000283708068777339
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,-0.0339541553051441,0.00935846419229529,-0.0522967451220428,-0.0156115654882453,0.000286483235599607
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL3,C-X-C motif chemokine 3,40350,-0.0316307984512083,0.00873166593856639,-0.0487448636907984,-0.0145167332116181,0.000292634238474432
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F10,Coagulation factor X,37987,-0.0088634732467214,0.00245562289318517,-0.0136764941173643,-0.00405045237607847,0.000307942264522365
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTD,Biotinidase,38013,-0.00704974281525492,0.00195410393420344,-0.0108797865262937,-0.00321969910421618,0.000310081855228694
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,0.0126406636055915,0.00350502975029775,0.0057708052950079,0.0195105219161751,0.000311422840821233
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37628,-0.0316733060375809,0.00880522826558598,-0.0489315534381295,-0.0144150586370324,0.000322959954152339
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JCHAIN,Immunoglobulin J chain,40044,-0.0207797652975406,0.00578927962630659,-0.0321267533651015,-0.00943277722997967,0.000332517331951559
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NXPH3,Neurexophilin-3,37598,0.0102934445020376,0.00286783716302828,0.00467248366250213,0.015914405341573,0.000332810818751727
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,-0.0272295545788844,0.00758676959688277,-0.0420996229887746,-0.0123594861689942,0.00033284042478242
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAPK2,Death-associated protein kinase 2,37598,-0.0177378765852635,0.00494871671630828,-0.0274373613492277,-0.00803839182129929,0.000339156831126184
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYM,Ketimine reductase mu-crystallin,37541,-0.0261739751122985,0.00730367029261807,-0.0404891688858299,-0.0118587813387671,0.000340025622149944
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,-0.0271047125446255,0.00756836918721182,-0.0419387161515607,-0.0122707089376904,0.00034307020850849
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINI2,Serpin I2,37901,-0.018955057475822,0.00529574132501721,-0.0293347104728558,-0.00857540447878828,0.000345725890755496
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,-0.0344796607484844,0.00964582398995821,-0.0533854757688025,-0.0155738457281663,0.000352034433186446
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACYBP,Calcyclin-binding protein,37642,-0.0346547954298506,0.0096987794202109,-0.053664403093464,-0.0156451877662373,0.000354025924615372
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIFBP,KIF-binding protein,40305,-0.027428938513562,0.00772468589881791,-0.0425693228752451,-0.0122885541518789,0.000385151642578848
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,40042,-0.036765512579952,0.0103761720706815,-0.0571028098384878,-0.0164282153214162,0.000396362841056542
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,-0.0128919653943594,0.00364180645465872,-0.0200299060454905,-0.00575402474322833,0.000401514350787038
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,-0.0284582318100813,0.00804392904701531,-0.0442243327422314,-0.0126921308779313,0.000404573099823307
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,-0.014875182528269,0.00422261377962719,-0.0231515055363383,-0.00659885952019974,0.000428307034930007
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,-0.024879552902241,0.00706422466916841,-0.038725433253811,-0.0110336725506709,0.000429682955316132
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFCAB2,Dynein regulatory complex protein 8,37714,-0.0115870216598378,0.00329003162652831,-0.0180354836478333,-0.00513855967184231,0.000429974813552162
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,40044,-0.015264574628455,0.00433620044800531,-0.0237635275065454,-0.00676562175036463,0.000432345713417899
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA4,Kallistatin,37781,-0.00798877105741028,0.00227164020673902,-0.0124411858626188,-0.00353635625220179,0.000438331952141961
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,-0.0161332017243941,0.00459571252503708,-0.0251407982734668,-0.00712560517532146,0.0004487399793402
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LY75,Lymphocyte antigen 75,40341,-0.0127988281571763,0.00364768783786031,-0.0199482963193825,-0.00564935999497011,0.00045146127672222
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F12,Coagulation factor XII,38013,-0.0138675978818738,0.00395270075231666,-0.0216148913564145,-0.00612030440733314,0.000452295687500052
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CR2,Complement receptor type 2,40403,-0.0153183885617653,0.00437263914845002,-0.0238887612927274,-0.0067480158308033,0.00046090006705459
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,-0.0144855169147813,0.00413679301221601,-0.0225936312187247,-0.0063774026108379,0.000463915107647769
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLSTN2,Calsyntenin-2,40516,0.0127826316717574,0.0036630104817942,0.00560313112744074,0.019962132216074,0.000484946198965252
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,-0.0274133693301975,0.00787499265738907,-0.0428483549386801,-0.011978383721715,0.000500761694064671
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,-0.0149879025661417,0.0043126718922329,-0.0234407394749182,-0.0065350656573652,0.000511900101054475
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HLA_A,,37959,-0.0107478535233104,0.00309610414972667,-0.0168162176567747,-0.00467948938984612,0.000519347226439519
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRAF2,TNF receptor-associated factor 2,40341,-0.0231305859192853,0.00666795530305346,-0.0361997783132701,-0.0100613935253005,0.000523944942299093
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37562,-0.0227029328918325,0.0065629017684025,-0.0355662203579014,-0.00983964542576362,0.000543337881886681
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSDE1,Cold shock domain-containing protein E1,37562,-0.0381784212294592,0.0110503389425683,-0.059837085556893,-0.0165197569020254,0.000552126756070933
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,-0.00694178317860706,0.00201047607614471,-0.0108823162878507,-0.00300125006936342,0.000556525554876852
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37942,-0.0342886776950257,0.0099704494875325,-0.0538307586905894,-0.014746596699462,0.000585566552787336
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VEGFD,Vascular endothelial growth factor D,40483,0.0107276429084816,0.00312422766039375,0.0046041566941098,0.0168511291228533,0.000596920655146203
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBC1D23,TBC1 domain family member 23,40305,-0.0288412470317913,0.00840494690578943,-0.0453149429671385,-0.012367551096444,0.00060187086716898
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,0.0072123512789195,0.00210313806918206,0.00309020066332265,0.0113345018945163,0.000606880501607771
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOL1,Apolipoprotein L1,37987,0.0211343202627981,0.00616340981078219,0.009054037033665,0.0332146034919312,0.000607619177975562
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LIFR,Leukemia inhibitory factor receptor,40341,-0.00786754699159434,0.00229600824020439,-0.0123677231423949,-0.00336737084079374,0.000612691576121461
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXNA4,Plexin-A4,40341,-0.0264821202967999,0.00772867814768786,-0.0416303294662681,-0.0113339111273317,0.00061301842512291
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PODXL2,Podocalyxin-like protein 2,40411,-0.00874794819639444,0.00256087380587539,-0.0137672608559102,-0.00372863553687868,0.0006370628007005
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,-0.0263183425517465,0.00771720412294149,-0.0414440626327118,-0.0111926224707812,0.000650416838028973
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,-0.0232016098273118,0.00681976673872374,-0.0365683526352103,-0.00983486701941327,0.000670313394996236
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDI2,Protein DDI1 homolog 2,37671,-0.0251950629142647,0.0074100702439793,-0.0397188005924641,-0.0106713252360652,0.000675576102074852
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37879,-0.0226432930922741,0.00666316594007651,-0.0357030983348241,-0.00958348784972415,0.000680083614737756
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLC,Galectin-10,40333,-0.0209883538687374,0.00617801396433895,-0.0330972612388417,-0.00887944649863306,0.000682298518576627
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC37,Hsp90 co-chaperone Cdc37,40411,-0.0266504248946437,0.00784488998116171,-0.0420264092577207,-0.0112744405315668,0.00068252841725786
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,-0.0100692480432045,0.0029716172481958,-0.0158936178496683,-0.00424487823674077,0.000704889824582848
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,-0.0153701677532308,0.00454275463159068,-0.0242739668311485,-0.0064663686753131,0.000717863828228082
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,0.0129887013533138,0.00384065178929229,0.00546102384630094,0.0205163788603267,0.000721615766553635
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTNNA1,Catenin alpha-1,37541,0.0116471029160279,0.0034457740035003,0.00489338586916729,0.0184008199628885,0.000726678993481701
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLITRK6,SLIT and NTRK-like protein 6,40042,-0.0108386313335669,0.0032085544648941,-0.0171273980847593,-0.00454986458237444,0.000731825850322743
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHIT1,Chitotriosidase-1,40398,-0.0472193297668532,0.014021420041726,-0.0747013130486362,-0.0197373464850703,0.000759891993185701
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELAVL4,ELAV-like protein 4,37541,-0.0278193057949389,0.00826918172687655,-0.044026901979617,-0.0116117096102609,0.000769820508784533
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA7,Carbonic anhydrase 7,37714,0.0112033613097595,0.0033326164649342,0.00467143303848844,0.0177352895810305,0.000776742752612746
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECE1,Endothelin-converting enzyme 1,39961,0.0111227137971368,0.00330945742013992,0.00463617725366255,0.017609250340611,0.000778799944058507
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37714,-0.0241119160046396,0.00717983802755444,-0.0381843985386462,-0.0100394334706329,0.000786494923586635
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP5,Rho GTPase-activating protein 5,37482,-0.0246112020991661,0.00733090335320028,-0.0389797726714387,-0.0102426315268936,0.000789655776623825
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,-0.00869513152812575,0.00259127057523198,-0.0137740218555804,-0.00361624120067107,0.000793980894768779
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,-0.0261166990555841,0.00778651631610255,-0.0413782710351451,-0.0108551270760231,0.000798456162894171
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37671,-0.0375989432133922,0.0112121096724417,-0.0595746781713779,-0.0156232082554066,0.000800428833131424
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,-0.0158720715342542,0.00474418796023358,-0.025170679936312,-0.0065734631321964,0.000823393384730442
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRK5,G protein-coupled receptor kinase 5,40042,-0.0165017517682216,0.00494323419317493,-0.0261904907868445,-0.00681301274959878,0.000845052455839205
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALCB,Calcitonin gene-related peptide 2,37942,-0.0125960800049196,0.00377587024309688,-0.0199967856813895,-0.00519537432844969,0.000852407011601921
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSR,"Glutathione reductase, mitochondrial",37944,-0.00698312639991238,0.00209894184170467,-0.0110970524096535,-0.00286920039017123,0.000880289378642987
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRAP2,GRB2-related adapter protein 2,40359,-0.0395571581609881,0.0118985460753719,-0.0628783084687169,-0.0162360078532592,0.00088765596634693
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPON1,Spondin-1,40379,-0.0102532109075641,0.00309135641222221,-0.0163122694755196,-0.00419415233960855,0.000912796505921159
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD1C,T-cell surface glycoprotein CD1c,40411,0.00743047994045757,0.00224532438059057,0.00302964415450005,0.0118313157264151,0.000937325220748124
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PMS1,PMS1 protein homolog 1,37572,-0.0163096554280985,0.00493333452439519,-0.0259789910959131,-0.00664031976028392,0.000948885862606542
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASS1,Argininosuccinate synthase,37562,-0.0250141717697076,0.00758024038911818,-0.0398714429323792,-0.0101569006070359,0.000969711112769966
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL3,Fc receptor-like protein 3,40044,-0.0168171513736259,0.00512831464679855,-0.0268686480813511,-0.00676565466590075,0.00104302434453572
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPTN,Neuroplastin,39980,0.0260655866012644,0.0079529620877693,0.0104777809092365,0.0416533922932922,0.00104972257342591
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MESD,LRP chaperone MESD,40332,-0.0371606016054288,0.0113409684776985,-0.059388899821718,-0.0149323033891397,0.00105264725792583
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP7,Caspase-7,37942,-0.0259091850636915,0.00791129200039103,-0.041415317384458,-0.0104030527429251,0.0010594238304418
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNPO1,Transportin-1,37714,0.0110097584135141,0.00336534713633249,0.00441367802630243,0.0176058388007258,0.00107248999603051
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOS,Proto-oncogene c-Fos,37457,-0.0108891998871007,0.00333195101553028,-0.01741982387754,-0.00435857589666132,0.00108547209267704
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGSF21,Immunoglobulin superfamily member 21,37628,0.0120504764026847,0.00369749740978579,0.00480338147950458,0.0192975713258649,0.00112053598512615
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,-0.0297216202122735,0.00913235296060282,-0.0476210320150551,-0.011822208409492,0.00113855399839819
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD99L2,CD99 antigen-like protein 2,40332,-0.0072389233311478,0.00222895372374352,-0.0116076726296851,-0.00287017403261049,0.00116592531675267
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIF22,Kinesin-like protein KIF22,37562,-0.0374414072153651,0.0115424949015394,-0.0600646972223824,-0.0148181172083478,0.00118246814768166
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,-0.0100452270747625,0.00309784061306257,-0.0161169946763651,-0.00397345947315988,0.00118716337075894
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TST,Thiosulfate sulfurtransferase,39923,-0.0230165218962505,0.00710899173185705,-0.0369501456906903,-0.00908289810181068,0.00120766828550265
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TYMP,Thymidine phosphorylase,40257,-0.0202337042136443,0.00625969162337044,-0.0325026997954504,-0.00796470863183828,0.00123015181361056
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,-0.0313984983928027,0.00971842431244644,-0.0504466100451978,-0.0123503867404077,0.00123684775872001
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB33A,Ras-related protein Rab-33A,37562,-0.0203279515525434,0.00629189785156831,-0.0326600713416173,-0.00799583176346952,0.00123742783317383
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,0.0201983725910919,0.00625544512043432,0.00793770015504067,0.0324590450271432,0.00124561480789296
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39980,-0.0144385399832536,0.0044783729675492,-0.02321615099965,-0.00566092896685719,0.00126648430050014
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSH,Pro-cathepsin H,40013,-0.0217077942387131,0.00680260912726534,-0.0350409081281532,-0.00837468034927307,0.00142014485327475
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMOTL2,Angiomotin-like protein 2,37855,-0.0145028583920336,0.00454813762637312,-0.0234172081397249,-0.00558850864434223,0.00143219615506182
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39980,-0.0124484847659832,0.00390692273595991,-0.0201060533284646,-0.0047909162035018,0.00144408516068641
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,40042,-0.0187630786927493,0.00589057702762991,-0.0303086096669039,-0.00721754771859467,0.00144903670423171
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,-0.028379365456458,0.00891366397009264,-0.0458501468378396,-0.0109085840750765,0.00145684216143838
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,-0.0200568222463047,0.00630716291238454,-0.0324188615545784,-0.00769478293803096,0.00147610262505555
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGF,Pro-epidermal growth factor,40324,-0.0306648420672993,0.0096455865399117,-0.0495701916855263,-0.0117594924490724,0.00147987220637428
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PER3,Period circadian protein homolog 3,37598,-0.0354584537341887,0.0111571316949939,-0.0573264318563767,-0.0135904756120007,0.00148588086651612
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,-0.0130770605719249,0.00411689450118982,-0.0211461737942569,-0.00500794734959283,0.00149387281152857
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KEL,Kell blood group glycoprotein,39961,-0.0106167349700531,0.00334456972136343,-0.0171720916239254,-0.00406137831618073,0.00150481403206867
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KDR,Vascular endothelial growth factor receptor 2,40411,-0.00750242844786566,0.00236768222371041,-0.0121430856063381,-0.00286177128939325,0.00153421509907281
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFDC12,WAP four-disulfide core domain protein 12,40465,-0.0189648557150628,0.00599090493900711,-0.0307070293955167,-0.00722268203460885,0.00155049193311043
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,-0.0189458904992275,0.00600074867751212,-0.0307073579071513,-0.00718442309130379,0.00159567374685657
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JPT2,Jupiter microtubule associated homolog 2,37901,-0.0261619199153315,0.00829246179481297,-0.0424151450331649,-0.00990869479749809,0.0016090469269767
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXNB3,Plexin-B3,40310,-0.0137998339920799,0.00437711262239492,-0.0223789747319739,-0.00522069325218583,0.00162055332839243
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CGN,Cingulin,37572,-0.0125523468416383,0.00398495558883401,-0.020362859795753,-0.00474183388752368,0.00163674057373885
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPHS1,Nephrin,37598,0.010318724220988,0.00328058002284378,0.00388878737621416,0.0167486610657618,0.00166231695527645
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TF,Serotransferrin,38013,-0.00648923334051212,0.00206502108322686,-0.0105366746636368,-0.00244179201738748,0.00167898913628505
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,-0.0308698157702788,0.00982838927933738,-0.0501334587577801,-0.0116061727827775,0.0016881100979623
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37628,-0.0168933980433174,0.00538390645524133,-0.0274458546955904,-0.00634094139104439,0.00170620341947366
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH5,Cadherin-5,40536,0.00895039942072478,0.00285401271714696,0.00335653449511673,0.0145442643463328,0.00171533625574816
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENG,Endoglin,40536,0.00502080733267066,0.00160205722061215,0.00188077518027085,0.00816083948507046,0.00172765501345383
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RLN1,Prorelaxin H1,37959,-0.0244830779851054,0.00781577444460437,-0.03980199589653,-0.00916416007368086,0.00173682347759637
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYL3,Myosin light chain 3,37628,-0.0201769166441561,0.00646435598957295,-0.0328470543837191,-0.00750677890459311,0.00180470073941402
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPM1F,Protein phosphatase 1F,37990,-0.015411291433318,0.00493970264352717,-0.0250931086146312,-0.00572947425200475,0.00181303282779202
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPMT,Thiopurine S-methyltransferase,39980,-0.0216869532868571,0.00695701959858486,-0.0353227117000834,-0.00805119487363072,0.00182863555471435
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,-0.0317314194500692,0.0101802434913037,-0.0516846966930245,-0.0117781422071139,0.00183109279814182
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFRC,Transferrin receptor protein 1,40391,-0.0115852280902655,0.00372109054757096,-0.0188785655635046,-0.00429189061702642,0.00185275165745187
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OPHN1,Oligophrenin-1,37942,-0.0313486851760594,0.0100969951384173,-0.0511387956473573,-0.0115585747047616,0.00190831738977649
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,-0.0233593873108887,0.00752689392654661,-0.0381120994069201,-0.00860667521485734,0.00191680225931773
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,-0.020201856752341,0.00651235994750592,-0.0329660822494526,-0.00743763125522942,0.00192503988981317
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,-0.0126827956263377,0.00409109534836602,-0.0207013425091351,-0.00466424874354034,0.0019380142434552
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39961,-0.0212800947749427,0.0068684216364095,-0.0347422011823053,-0.00781798836758004,0.00195014335633577
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBP2,Retinol-binding protein 2,40305,0.0221057027557964,0.0071457402609461,0.00810005184434203,0.0361113536672508,0.00198121288533195
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOLH1,Glutamate carboxypeptidase 2,37598,-0.0314797675092908,0.0101930237035618,-0.051458093968272,-0.0115014410503095,0.00201681230063027
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COPB2,Coatomer subunit beta',37562,-0.0125981009636792,0.00408040907434009,-0.0205957027493858,-0.00460049917797265,0.00202296169812574
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPB1,Heat shock protein beta-1,40116,-0.0195952264313098,0.00635717753222581,-0.0320552943944724,-0.0071351584681472,0.00205710237515542
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMS,Spermine synthase,37541,-0.0186637702835468,0.00605815739575599,-0.0305377587792285,-0.00678978178786505,0.00206896556819481
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHNAK2,Protein AHNAK2,37628,-0.00831489875019159,0.00270686735913244,-0.0136203587740912,-0.00300943872629202,0.00213220890602805
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39980,-0.0267434652172321,0.00871387404526595,-0.0438226583459533,-0.00966427208851082,0.00215098489952105
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX5,Sorting nexin-5,37628,-0.00869218823897215,0.0028330304564783,-0.0142449279336696,-0.00313944854427468,0.00215819097140556
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CERT,Ceramide transfer protein,39961,-0.0176879221282929,0.00576794656026988,-0.0289930973864218,-0.00638274687016393,0.00216888915695657
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST5,Cystatin-D,40070,-0.0158468610576094,0.00516887554909594,-0.0259778571338374,-0.00571586498138134,0.00217441946511927
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FBLN2,Fibulin-2,37998,-0.0089399379185264,0.00291618410228975,-0.0146556587590143,-0.00322421707803848,0.0021764038358084
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAMDC2,MAM domain-containing protein 2,37990,-0.00984220345187712,0.00321070225476707,-0.0161351798712206,-0.00354922703253366,0.00217780624890508
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GMFG,Glia maturation factor gamma,37990,-0.0207396901751404,0.00677001652589817,-0.0340089225659008,-0.00747045778437993,0.00219221614273756
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37714,-0.0157714385704434,0.00515193393604213,-0.025869229085086,-0.0056736480558008,0.00220844266925004
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFHR5,Complement factor H-related protein 5,37785,-0.0121205068458691,0.00396171681810456,-0.0198854718093541,-0.00435554188238417,0.00222215372541877
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNMA1,Paraneoplastic antigen Ma1,37628,-0.0161367541285026,0.00528243390826038,-0.0264903245886929,-0.00578318366831226,0.00225664105317217
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMED8,Protein TMED8,37901,-0.0296493401397556,0.00970954632417854,-0.0486800509351455,-0.0106186293443657,0.00226534299300144
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC51B,Organic solute transporter subunit beta,37562,-0.0229400553026304,0.00752862228447585,-0.0376961549802031,-0.00818395562505775,0.00231562356737354
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,40422,-0.0298147079983286,0.00979353944143758,-0.0490100453035462,-0.0106193706931109,0.0023358329479342
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37714,-0.0123993470920389,0.00407604611228421,-0.0203883974721159,-0.00441029671196186,0.00235468371307515
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37942,-0.0094901159636712,0.0031323230365831,-0.0156294691153741,-0.00335076281196833,0.0024522992479569
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH1,Protocadherin-1,40475,-0.0061889936692128,0.00204362771698841,-0.0101945039945101,-0.00218348334391551,0.0024621514553647
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYTL1,Cytokine-like protein 1,37998,-0.00657598689030451,0.0021732720908552,-0.0108356001883807,-0.00231637359222831,0.00248403729188747
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,-0.0136861372843664,0.00452487614603051,-0.0225548945305862,-0.00481738003814659,0.00249394720560018
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCRN1,Secernin-1,40341,-0.0159348857212347,0.00526995859179602,-0.0262640045611549,-0.0056057668813145,0.0025008479048072
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYOC,Myocilin,40332,0.0129971402666041,0.00430238577862541,0.00456446414049826,0.0214298163927099,0.00252413355100174
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,0.024899121757391,0.00824553965196415,0.00873786403954127,0.0410603794752407,0.00253418520410656
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,-0.0154838322456997,0.00512895572988224,-0.0255365854762689,-0.00543107901513054,0.00254163757316814
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,-0.017445469284015,0.00579283234330603,-0.0287994206768948,-0.00609151789113515,0.00260402917819861
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRTN,Neurturin,40044,-0.0139611830931564,0.00464153137319007,-0.0230585845846089,-0.00486378160170384,0.00263494069405042
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPC5,Glypican-5,40228,0.0157835349551243,0.00524842267701002,0.00549662650818461,0.0260704434020639,0.00264002438377069
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRADD,Death domain-containing protein CRADD,40192,-0.0215653276538666,0.00717110867502687,-0.0356207006569192,-0.0075099546508139,0.00264037748926993
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,0.00813064720581301,0.00270979048257113,0.00281945785997361,0.0134418365516524,0.00270070251872269
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PALM,Paralemmin-1,37824,-0.00831810058319628,0.00277379502080873,-0.0137547388239814,-0.00288146234241118,0.00271529634428283
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL12,Stromal cell-derived factor 1,40044,-0.0114031891008683,0.00380680356674483,-0.0188645240916882,-0.00394185411004846,0.0027444731083099
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD69,Early activation antigen CD69,40288,-0.024600597995359,0.00824264092335814,-0.040756174205141,-0.00844502178557704,0.00284426591467014
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40536,-0.00435121091398519,0.00145851565448984,-0.00720990159678526,-0.00149252023118511,0.0028557272728019
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX2,Peroxiredoxin-2,37763,-0.017747244041568,0.00595035169640328,-0.0294099333665184,-0.00608455471661754,0.0028637230838487
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP2,Caspase-2,40341,-0.0188238460928318,0.00633171271542376,-0.0312340030150623,-0.00641368917060119,0.00295397827479743
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDHD2,Phospholipase DDHD2,37959,-0.018575633358296,0.00625437450755465,-0.0308342073931031,-0.00631705932348892,0.00298301454637646
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,-0.00577249791547342,0.00194616362269765,-0.00958697861596081,-0.00195801721498602,0.00302066735739597
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37562,-0.0270889275684405,0.00914329064424664,-0.0450097772311639,-0.00916807790571705,0.00305490221223652
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,-0.0322001396138495,0.0108719047534369,-0.0535090729305857,-0.0108912062971132,0.00306324417205388
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP53BP1,TP53-binding protein 1,37598,-0.0248990287105557,0.00841971827451446,-0.041401676528604,-0.00839638089250734,0.0031097027690606
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NINJ1,Ninjurin-1,39980,-0.0156531309004944,0.00530130664840496,-0.0260436919313681,-0.00526256986962072,0.00315486701529081
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH22,Cadherin-22,37714,0.008238789309688,0.00279640621932998,0.00275783311980123,0.0137197454995748,0.00322257307289026
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DBH,Dopamine beta-hydroxylase,37967,0.0294901280408988,0.0100106521762408,0.00986924977546687,0.0491110063063306,0.00322592031585715
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECM1,Extracellular matrix protein 1,37655,0.0103307457991374,0.00351104249733123,0.00344910250436823,0.0172123890939066,0.00326288845498168
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,-0.0130724407789578,0.00447255611661674,-0.0218386507675266,-0.004306230790389,0.00347388088080199
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMB1,Laminin subunit beta-1,37628,-0.00813821858638191,0.00278856504961017,-0.0136038060836178,-0.00267263108914599,0.00352399152669348
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST6,Cystatin-M,39992,-0.0130844274571839,0.0044932749695131,-0.0218912463974296,-0.00427760851693822,0.00359630648663991
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMTN,Smoothelin,37905,-0.0264978616738372,0.00910031655706714,-0.0443344821256888,-0.00866124122198564,0.0035999859907503
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,-0.0078171404741114,0.00269019843381177,-0.0130899294043825,-0.00254435154384032,0.00366929549891143
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PARD3,Partitioning defective 3 homolog,37714,-0.0204111794951321,0.00702687931185749,-0.0341838629463728,-0.0066384960438914,0.00368178385836418
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,-0.012597368624095,0.0043614098803545,-0.0211457319895899,-0.00404900525860021,0.00387873846580255
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUCA1,Tissue alpha-L-fucosidase,40437,-0.0220089619793761,0.0076253662654413,-0.036954679859641,-0.00706324409911111,0.00390343859207144
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FZD8,Frizzled-8,37541,-0.0122876646165195,0.00426455763719657,-0.0206461975854248,-0.00392913164761427,0.00396624608007057
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,-0.00793982475807393,0.00275907488075097,-0.0133476115243458,-0.00253203799180204,0.00401097070709847
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PROS1,Vitamin K-dependent protein S,38013,0.00682120072992278,0.00237465622958283,0.00216687451994043,0.0114755269399051,0.00407869347403852
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD200,OX-2 membrane glycoprotein,40341,0.006992968142342,0.00243883079911166,0.00221285977608314,0.0117730765086009,0.00414476509185085
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEPTIN3,Neuronal-specific septin-3,37959,-0.0200093516321586,0.00698177001389811,-0.0336936208593989,-0.00632508240491833,0.00416411838664278
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,0.0140390482361381,0.00492612659073286,0.00438384011830165,0.0236942563539745,0.0043798927495565
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD84,SLAM family member 5,40341,-0.008221296556569,0.00288636092193063,-0.013878563963553,-0.00256402914958496,0.00440063173395772
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,-0.019939547970247,0.00702139487083469,-0.033701481917083,-0.00617761402341103,0.0045206666338192
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,0.00774261743148547,0.00272841843382414,0.00239491730119016,0.0130903175617808,0.00454871658122646
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C9orf40,Uncharacterized protein C9orf40,37901,-0.0221112092021713,0.00780499403536569,-0.037408997511488,-0.00681342089285453,0.00461882494566738
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,-0.0293608597607272,0.0103688732604403,-0.0496838513511903,-0.00903786817026421,0.00463686533279508
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WAS,Wiskott-Aldrich syndrome protein,40044,-0.018078690336947,0.00638878769439972,-0.0306007142179705,-0.0055566664559236,0.00466434903391919
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB37,Ras-related protein Rab-37,40044,-0.0220976176022342,0.00780971801115145,-0.0374046649040911,-0.00679057030037741,0.00466799647993328
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTLA,B- and T-lymphocyte attenuator,37482,-0.0238541376719639,0.00843065387784072,-0.0403782192725318,-0.00733005607139614,0.0046698935725068
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPT,Dermatopontin,40536,-0.00703869315265772,0.00248802487589908,-0.0119152219094199,-0.00216216439589552,0.00467473241134214
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PROCR,Endothelial protein C receptor,37562,0.00988512706858407,0.00349413587040336,0.00303662076259348,0.0167336333745747,0.00467555339595893
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP3,Caspase-3,40536,-0.0233287066500684,0.00826596114329686,-0.0395299904909303,-0.00712742280920655,0.0047744727056243
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCAM,Basal cell adhesion molecule,40332,-0.00626716966014808,0.00222298335265237,-0.0106242170313467,-0.00191012228894945,0.00481939821070828
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SATB1,DNA-binding protein SATB1,37959,-0.0080319467253421,0.00285190547336525,-0.013621681453138,-0.0024422119975462,0.00486440593265323
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSBP1,Heat shock factor-binding protein 1,37628,-0.0254093761409918,0.00902945484480598,-0.0431071076368115,-0.00771164464517208,0.00489934639412626
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTC,Probetacellulin,39980,-0.0199109467934312,0.00708350316549998,-0.0337946129978112,-0.00602728058905122,0.00494665741598781
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP6,Platelet glycoprotein VI,40311,-0.0231692624374143,0.00824570351827757,-0.0393308413332384,-0.00700768354159028,0.00496239344373039
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX2,Sorting nexin-2,37900,-0.0207140814128898,0.00737350513556656,-0.0351661514786002,-0.00626201134717929,0.00497274254675893
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RHOC,Rho-related GTP-binding protein RhoC,40152,-0.0305830652688775,0.0108872368057208,-0.0519220494080902,-0.00924408112966471,0.00497454576333677
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX5,Syntaxin-5,37598,-0.0111353495040849,0.00396432748062318,-0.0189054313661064,-0.00336526764206351,0.0049786382592703
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD55,Complement decay-accelerating factor,39802,-0.00692804038574225,0.0024680635332965,-0.0117654449110034,-0.00209063586048112,0.00500565650580248
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,-0.0206687975475696,0.00736342813814114,-0.0351011166983263,-0.00623647839681299,0.00500859629111194
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA4C,Semaphorin-4C,40305,-0.00743184906352072,0.00266008754091485,-0.0126456206437138,-0.00221807748332761,0.00521493457538018
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NMI,N-myc-interactor,37857,-0.0189062941028815,0.00677284585859324,-0.0321810719857242,-0.00563151622003871,0.00525411082546087
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,0.00632145233714233,0.00227526234881809,0.00186193813345888,0.0107809665408258,0.00547007569687887
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBPMS,RNA-binding protein with multiple splicing,37598,-0.0169811929578873,0.00611831597609044,-0.0289730922710246,-0.00498929364475006,0.00552001429955919
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,QSOX1,Sulfhydryl oxidase 1,37761,-0.0117935311358379,0.0042509422558185,-0.0201253779572421,-0.00346168431443363,0.00553920521292398
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,-0.00790788858013848,0.00285048658509736,-0.0134948422869293,-0.00232093487334765,0.00553993729863713
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37714,-0.0176297452354186,0.00636015354839402,-0.0300956461902709,-0.00516384428056635,0.00558068993826977
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMC3,26S proteasome regulatory subunit 6A,37482,0.00793901667710704,0.00286448543676427,0.00232462522104907,0.013553408133165,0.00558721111555725
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,-0.00861850630735294,0.00311063568593543,-0.0147153522517864,-0.0025216603629195,0.00560196881833125
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERC2,ERC protein 2,37572,-0.0202032275475131,0.00729982945976593,-0.0345108932886543,-0.00589556180637187,0.0056544649291966
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWF,von Willebrand factor,40536,-0.0185321922108625,0.00671924545014294,-0.0317019132931427,-0.00536247112858236,0.00582082576139611
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCIN,Adseverin,37541,-0.0192237867958898,0.00697529812803282,-0.0328953711268341,-0.00555220246494543,0.00585974265881498
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,-0.0227554288169277,0.00825832979189432,-0.0389417552090406,-0.00656910242481486,0.00586911471896279
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDLIM5,PDZ and LIM domain protein 5,37959,-0.0308084742808535,0.0111860698162439,-0.0527331711206915,-0.00888377744101542,0.00589177157183625
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37598,-0.0178038922118942,0.00646619245221382,-0.0304776294182333,-0.00513015500555511,0.00590641749653155
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,-0.0358639204158941,0.0130269967613458,-0.0613968340681318,-0.0103310067636563,0.00591222534099927
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAD1,Glutamate decarboxylase 1,37482,0.00673414901866329,0.00245319111721918,0.0019258944289137,0.0115424036084129,0.00605833232673941
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,0.0236241836978307,0.00860825817328958,0.00675199767818311,0.0404963697174783,0.00606965511672649
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,-0.0186345129330542,0.00680003066689895,-0.0319625730401761,-0.00530645282593225,0.00614545646383929
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RALB,Ras-related protein Ral-B,37598,-0.00767101257803361,0.00280385016982726,-0.013166558910895,-0.00217546624517219,0.00622961845604777
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37942,-0.061655812746248,0.0225806870086206,-0.105913959283144,-0.0173976662093515,0.00633268507265868
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRGN,Neurogranin,37987,-0.0233890052148998,0.00857729970362701,-0.0402005126340088,-0.00657749779579091,0.00640245552932099
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFTPD,Pulmonary surfactant-associated protein D,40359,-0.0169650701369718,0.00623670088521507,-0.0291890038719934,-0.0047411364019503,0.00653134286898723
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37990,-0.0274667171142275,0.0101018095874288,-0.047266263905588,-0.00766717032286704,0.00655650787889295
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,-0.0159335305675,0.00586413366244969,-0.0274272325459014,-0.00443982858909862,0.00659372172248782
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDNRB,Endothelin receptor type B,37598,-0.0121426468290982,0.00448890079519618,-0.0209408923876827,-0.00334440127051367,0.0068384587571401
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXDC2,Plexin domain-containing protein 2,37942,0.00682689598902818,0.00252882813581311,0.00187039284283448,0.0117833991352219,0.00695035168928521
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAG3,BAG family molecular chaperone regulator 3,40203,-0.0100274657278364,0.00371864354012594,-0.0173160070664833,-0.0027389243891896,0.00701387753829587
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,40359,-0.00720735152722324,0.00267413563507488,-0.01244865737197,-0.00196604568247648,0.00704186473320866
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK8,Kallikrein-8,39801,-0.00896439019747985,0.00332675846203224,-0.015484836783063,-0.00244394361189666,0.00705430719152641
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SRPX,Sushi repeat-containing protein SRPX,37990,-0.00832175486203689,0.00308909371765135,-0.0143763785486335,-0.00226713117544024,0.00707052959136836
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,0.0294897422688201,0.010955265970831,0.00801742096599131,0.0509620635716489,0.00711355603910723
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39961,-0.0103436323981968,0.00384592706238641,-0.0178816494404742,-0.00280561535591946,0.00716350503758881
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL4,Interleukin-4,40044,-0.0226048621370509,0.00842492606718273,-0.0391177172287291,-0.00609200704537276,0.0073021605879466
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NXPH1,Neurexophilin-1,39961,-0.0094881390956624,0.00354011822769389,-0.0164267708219424,-0.00254950736938238,0.00736612514916414
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRELP,Prolargin,40357,-0.00583820659441591,0.00218164896690332,-0.0101142385695464,-0.00156217461928541,0.00745713555631352
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LCN15,Lipocalin-15,37959,-0.0161691566047614,0.00604259025480809,-0.0280126335041853,-0.00432567970533754,0.00746265345998589
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C2orf69,UPF0565 protein C2orf69,37572,-0.0152762984581128,0.00571523297525236,-0.0264781550896075,-0.00407444182661819,0.00752896210747012
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLKB1,Plasma kallikrein,37721,0.00637769373501722,0.00238611735409206,0.00170090372099678,0.0110544837490377,0.00753056069256331
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARTN,Artemin,40044,-0.011148027264015,0.00417496800205951,-0.0193309645480516,-0.00296508997997833,0.00758831858161046
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SULT1A1,Sulfotransferase 1A1,40471,0.0321265892768781,0.0120611706661583,0.00848669477120791,0.0557664837825483,0.00773780950895144
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICOSLG,ICOS ligand,40305,0.00478093689786938,0.00179520046675801,0.00126234398302368,0.00829952981271509,0.00774848507055513
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39980,-0.0191661856311868,0.00721789246574115,-0.0333132548640394,-0.00501911639833412,0.00793019793925274
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17RA,Interleukin-17 receptor A,40332,-0.010915306074997,0.0041174781345983,-0.0189855632188096,-0.0028450489311843,0.00803408862080181
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UROS,Uroporphyrinogen-III synthase,37572,-0.0176341163351323,0.00665621877434653,-0.0306803051328515,-0.00458792753741306,0.00807626665406493
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,-0.00559237719964005,0.00211903517119556,-0.00974568613518333,-0.00143906826409676,0.00832037450924948
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37901,-0.0108332715704267,0.0041195798194448,-0.0189076480165385,-0.0027588951243149,0.00855567630299284
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,-0.00669044948459604,0.0025640301803949,-0.0117159486381701,-0.00166495033102203,0.0090799006184884
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESM1,Endothelial cell-specific molecule 1,40357,0.00830176457840815,0.00318293938771297,0.00206320337849074,0.0145403257783256,0.00911029921974383
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39961,-0.034842924360206,0.0133665682531756,-0.0610413981364301,-0.00864445058398193,0.00915010617391092
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IKZF2,Zinc finger protein Helios,39980,-0.0229275899981216,0.00881959486471484,-0.0402139959329627,-0.00564118406328052,0.00934155156112062
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,-0.00701147472023455,0.00270095620825809,-0.0123053488884204,-0.0017176005520487,0.00944418413554594
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37598,0.0104900001515569,0.00404224753280009,0.0025671949872687,0.018412805315845,0.00946709299701199
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRRT3,Proline-rich transmembrane protein 3,37628,-0.00920810097736169,0.00355666898821323,-0.0161791721942596,-0.00223702976046376,0.00963699348589593
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37567,-0.0145630025259088,0.00562549273640092,-0.0255889682892546,-0.00353703676256302,0.00964309169211891
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRK1,Protein BRICK1,39961,-0.0107315647585374,0.00414621140101632,-0.0188581391045294,-0.00260499041254543,0.00965459263151565
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRR4,Proline-rich protein 4,37577,-0.0168882233374694,0.00653002516578377,-0.0296870726624056,-0.00408937401253321,0.00971355203999017
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37572,-0.0121306394118444,0.00469259935629934,-0.0213281341501911,-0.00293314467349766,0.00974696311892563
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,-0.0147788728285567,0.00573402259069575,-0.0260175571063203,-0.00354018855079299,0.00996544542108704
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP112,Centrosomal protein of 112 kDa,37562,-0.0115001066927598,0.00446566994049336,-0.0202528197761268,-0.00274739360939285,0.0100283357235132
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37671,-0.0200451466307283,0.00778682489965238,-0.0353073234340469,-0.0047829698274096,0.0100568757410693
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FADD,FAS-associated death domain protein,40359,-0.0184337980762088,0.00716457243176104,-0.0324763600424604,-0.00439123610995715,0.0100937305057407
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,-0.0227855565643835,0.0088629621338683,-0.0401569623467654,-0.00541415078200164,0.0101532683614369
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,-0.0227147195794855,0.00883751645465106,-0.0400362518306015,-0.00539318732836938,0.0101713041882215
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,-0.0185447858840083,0.00722539418644477,-0.03270655848944,-0.00438301327857656,0.0102790216701928
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBP1,Retinol-binding protein 1,37572,-0.0167900548699977,0.00654208794788962,-0.0296125472478614,-0.0039675624921341,0.0102850243538126
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL9A2,Collagen alpha-2(IX) chain,37714,-0.011278307505523,0.00439763607700212,-0.0198976742164472,-0.00265894079459889,0.0103395066418583
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,-0.00789968719772925,0.00309085884208654,-0.0139577705282189,-0.00184160386723964,0.0106049041415545
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDZD2,PDZ domain-containing protein 2,37562,-0.0147953250116739,0.00579832877039541,-0.0261600494016489,-0.00343060062169888,0.010732560631438
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37987,-0.0173771669966853,0.00683171886082969,-0.0307673359639115,-0.00398699802945909,0.0109826572035068
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GTPBP2,GTP-binding protein 2,37572,-0.019224562095211,0.00756231554151564,-0.0340467005565817,-0.00440242363384036,0.0110285951375397
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM26,Tripartite motif-containing protein 26,37482,-0.0132369262264252,0.00521720294935368,-0.0234626440071584,-0.00301120844569194,0.0111868552686174
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABO,Histo-blood group ABO system transferase,37987,0.03468236619369,0.013679112508462,0.00787130567710437,0.0614934267102756,0.0112422489572061
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37942,-0.00901338098199131,0.00355667313702618,-0.0159844603305626,-0.00204230163342,0.01128111060968
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,-0.00727565200505129,0.00287637896862135,-0.0129133547835491,-0.00163794922655346,0.0114337599085622
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAM,Signal transducing adapter molecule 1,37900,-0.00894518016509464,0.00354940908622501,-0.0159020219740957,-0.00198833835609362,0.0117406779828839
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEZ6,Seizure protein 6 homolog,37572,0.00747645123632795,0.00296704056459888,0.00166105172971415,0.0132918507429417,0.011752774363396
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOS2,"Nitric oxide synthase, inducible",37562,-0.00935203608669874,0.00371719717567771,-0.0166377425510271,-0.00206632962237043,0.0118852813917965
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37671,-0.0207849451289621,0.00826593377254802,-0.0369861753231562,-0.00458371493476796,0.0119308624418081
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DBN1,Drebrin,37598,-0.0122790580999955,0.00488855325874782,-0.0218606224871412,-0.00269749371284974,0.0120236689302821
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPSD1,Tryptase delta,37959,-0.00908907910498231,0.0036187830563777,-0.0161818938954826,-0.00199626431448202,0.0120287421114129
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TLR2,Toll-like receptor 2,37714,-0.00545684780351993,0.00218032568806721,-0.00973028615213167,-0.0011834094549082,0.0123345872969603
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA11,Annexin A11,40312,-0.0157830750329837,0.0063088235022459,-0.0281483690973857,-0.00341778096858174,0.01236824198765
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,0.0111964014278112,0.00447536796969332,0.00242468020721229,0.0199681226484101,0.0123686820207695
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFHD1,EF-hand domain-containing protein D1,37959,-0.00817382716579398,0.00328590551264263,-0.0146142019705735,-0.00173345236101441,0.0128749051841095
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA11,Serpin A11,40536,-0.00937255296250718,0.0037754537426571,-0.0167724422981151,-0.00197266362689927,0.013056635509886
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK1,Kallikrein-1,40209,0.0296661472555434,0.0119580266393712,0.0062284150423759,0.053103879468711,0.0131170713709314
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MANSC4,MANSC domain-containing protein 4,37562,-0.0154201214222165,0.00621616539315865,-0.0276038055928075,-0.00323643725162554,0.0131268130739895
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DKKL1,Dickkopf-like protein 1,40305,0.0204838230716836,0.00825999415482409,0.00429423452822837,0.0366734116151388,0.0131528393902176
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBC1D5,TBC1 domain family member 5,40341,-0.0181994388586968,0.0073417724731236,-0.0325893129060191,-0.00380956481137457,0.0131895301552542
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,0.0087295926558942,0.00352894853947838,0.00181285351851658,0.0156463317932718,0.0133821784844761
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,-0.0177724878112922,0.00719197827036034,-0.0318687652211984,-0.0036762104013859,0.0134784208030107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,-0.0206492605898867,0.00836092217368242,-0.0370366680503042,-0.00426185312946912,0.013533564223857
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,0.00984844175115313,0.00400533604728886,0.00199798309846695,0.0176989004038393,0.0139514990346967
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,0.010411281322348,0.00424172007164028,0.00209750998193303,0.0187250526627629,0.0141188171270585
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,-0.0098050268910701,0.00400043170820416,-0.0176458730391503,-0.00196418074298995,0.0142592040377345
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37900,-0.0100732775167304,0.0041134854010732,-0.0181357089028339,-0.00201084613062693,0.0143442888909952
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,-0.0169645988589426,0.00692944047965176,-0.0305463021990601,-0.0033828955188252,0.0143703876062216
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCN1,Transcobalamin-1,37766,-0.00767871614449454,0.00313930272678613,-0.0138317494889954,-0.00152568279999372,0.0144581857370877
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDK1,Cyclin-dependent kinase 1,37482,-0.00848291076749683,0.00347132680427666,-0.0152867113038791,-0.00167911023111459,0.0145503396287992
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,0.00648065682759324,0.00265214091139717,0.00128246064125479,0.0116788530139317,0.0145540737007208
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37562,0.00930057063481949,0.00381125097964367,0.00183051871471789,0.0167706225549211,0.0146884885827412
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MATN3,Matrilin-3,40203,-0.00715017737959721,0.00293280708876182,-0.0128984792735704,-0.00140187548562404,0.0147798411274358
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBX2,Chromobox protein homolog 2,37562,0.00948520934582559,0.00389132334131826,0.0018582155968418,0.0171122030948094,0.0148012712628546
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX1,Peroxiredoxin-1,39953,0.0203505650976651,0.00836828525191526,0.00394872600391114,0.036752404191419,0.0150324277246456
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNL1,Thioredoxin-like protein 1,37525,-0.0219996581307775,0.00905486662288182,-0.0397471967116259,-0.00425211954992918,0.0151290817446522
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX18,Sorting nexin-18,37901,-0.0104490577636138,0.00430717865066466,-0.0188911279189166,-0.0020069876083111,0.0152808742555603
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANPEP,Aminopeptidase N,40370,0.00644917343092124,0.00265961479595374,0.00123632843085191,0.0116620184309906,0.0153256637910801
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSG4,Desmoglein-4,40250,0.0115915339561967,0.00478261892459869,0.00221760086398322,0.0209654670484101,0.0153753262109735
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK7,Kallikrein-7,37352,0.00892023164405519,0.00368568866483365,0.00169628186098123,0.0161441814271292,0.0155242146830945
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYZL2,Lysozyme-like protein 2,37482,-0.0082122660105819,0.00339785138403977,-0.0148720547232998,-0.00155247729786395,0.0156669741255439
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAP1A,Ras-related protein Rap-1A,37598,-0.015942038620021,0.0066036103332109,-0.0288851148731143,-0.00299896236692758,0.01578598134767
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB39B,Ras-related protein Rab-39B,37562,-0.0203329174894819,0.00842416149033792,-0.0368442740105442,-0.00382156096841956,0.0158075522261556
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COPE,Coatomer subunit epsilon,39961,-0.0109554885372589,0.00454067852783906,-0.0198552184518234,-0.00205575862269433,0.0158445216053774
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLHL41,Kelch-like protein 41,37959,-0.0108383741616907,0.00449809261027617,-0.019654635677832,-0.0020221126455494,0.0159855430843055
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,-0.012900361166305,0.00535745614107729,-0.0234009752028165,-0.00239974712979353,0.0160572095418765
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AFP,Alpha-fetoprotein,40182,0.0156663265307215,0.00651931954253152,0.00288846022735975,0.0284441928340833,0.0162699532002882
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37562,-0.0229391938015402,0.00957083396686191,-0.0416980283765896,-0.0041803592264909,0.0165537179448659
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,-0.012947832279985,0.0054166696841132,-0.0235645048608468,-0.00233115969912312,0.0168455301889744
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGS8,Regulator of G-protein signaling 8,40044,-0.0148682582172041,0.0062342263138545,-0.0270873417923589,-0.00264917464204926,0.0170937646084303
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP170,Centrosomal protein of 170 kDa,37628,-0.0173530105222898,0.00730087005182785,-0.0316627158238724,-0.00304330522070721,0.0174757889188376
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,-0.0053131488209029,0.00223825079322253,-0.00970012037561906,-0.000926177266186738,0.0176202177743355
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37901,-0.0115547162422015,0.00490429704639304,-0.0211671384531319,-0.00194229403127113,0.0184852348313453
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,0.00571126053262786,0.00242767077013951,0.000953025823154422,0.0104694952421013,0.0186589797596552
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNU13,NHP2-like protein 1,37562,-0.0138118924774459,0.00589672627323784,-0.025369475972992,-0.00225430898189968,0.01918026605441
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFBR1,TGF-beta receptor type-1,37598,-0.00477756530525644,0.00203985989804754,-0.00877569070542963,-0.00077943990508326,0.0191901820882754
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,-0.0196697466187163,0.00842161327627421,-0.0361761086402138,-0.00316338459721885,0.0195255702072009
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATXN10,Ataxin-10,39961,-0.0158752892675594,0.00679871786998036,-0.0292007762927209,-0.00254980224239791,0.0195539336336876
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,-0.0118946157385283,0.00509798134205164,-0.0218866591689496,-0.00190257230810712,0.0196526233179635
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSCA,Prostate stem cell antigen,37901,-0.0574767812679812,0.0246378920561401,-0.105767049698016,-0.00918651283794671,0.0196701027982896
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLL4,Delta-like protein 4,37628,-0.0186024491376041,0.0079770192193368,-0.0342374068075042,-0.00296749146770397,0.019715413332071
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKG1,cGMP-dependent protein kinase 1,37671,-0.0276328815731695,0.0118517464384384,-0.0508623045925088,-0.00440345855383022,0.0197395811869357
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOSB,Protein fosB,39961,-0.00854248957712939,0.00367190915565758,-0.0157394315222182,-0.00134554763204054,0.0200077142896921
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RASA1,Ras GTPase-activating protein 1,39961,-0.0071081852252998,0.00306046000698649,-0.0131066868389933,-0.00110968361160627,0.0202142137383222
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37900,-0.011587549070764,0.00501039697626278,-0.021407927144239,-0.00176717099728895,0.0207541141388128
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,40305,-0.0116640116144512,0.00504975360378866,-0.0215615286778769,-0.00176649455102539,0.0209110165046804
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RILPL2,RILP-like protein 2,37990,-0.021201008526099,0.00918312959148336,-0.0391999425254063,-0.00320207452679158,0.0209757226806659
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK6,Kallikrein-6,40387,-0.00658935397496714,0.00285636358842412,-0.0121878266082784,-0.000990881341655873,0.0210729827135271
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,37482,0.00558020182725886,0.00242375640144767,0.000829639280421427,0.0103307643740963,0.0213342376643906
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,0.00681426191957063,0.00296386924106115,0.00100507820709077,0.0126234456320505,0.0215139776169004
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RP2,Protein XRP2,40305,-0.00889851640350309,0.00387649420254024,-0.016496445040482,-0.00130058776652422,0.0217171248247581
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,-0.0190711414744791,0.00830950376710355,-0.035357768858002,-0.00278451409095612,0.0217430734232194
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,-0.0126059297847918,0.00549685598408298,-0.0233797675135944,-0.00183209205598917,0.0218466910707362
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37562,-0.0120369218210902,0.00525177595111377,-0.0223304026852731,-0.00174344095690717,0.0219230501172914
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COMT,Catechol O-methyltransferase,39877,-0.0182648741422815,0.00798098964394837,-0.0339076138444203,-0.00262213444014267,0.0221191129370218
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHP1,Calcineurin B homologous protein 1,37541,-0.0158692779826408,0.00693586180150402,-0.0294635671135887,-0.00227498885169295,0.0221531704290997
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCND2,G1/S-specific cyclin-D2,37714,0.00795654832252958,0.00348005220752855,0.00113564599577362,0.0147774506492855,0.0222506420616245
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CORO1A,Coronin-1A,39990,-0.0192470087786242,0.00844125739270497,-0.0357918732683259,-0.00270214428892241,0.0226145567270259
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRL,Prolactin,40471,-0.0164020195514894,0.00719501115710758,-0.0305042414194202,-0.00229979768355851,0.0226422652750579
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC10A,C-type lectin domain family 10 member A,40228,0.00768718579702766,0.00338339708090297,0.00105572751845785,0.0143186440755975,0.0230979896135277
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,0.00961311665979422,0.00423637232826525,0.00130982689639434,0.0179164064231941,0.0232732944181901
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,-0.00970004686084745,0.00428487437281,-0.018098400631555,-0.00130169309013985,0.0236030238803321
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,0.00406555941980746,0.00180057000019119,0.000536442219432722,0.0075946766201822,0.0239659091335405
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,0.0257363754675308,0.0114048900387606,0.0033827909915601,0.0480899599435016,0.0240463726656322
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARB1,Scavenger receptor class B member 1,39961,-0.0125599520257671,0.0055697775732273,-0.0234767160692926,-0.00164318798224162,0.0241460458955147
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYGD,Gamma-crystallin D,37942,-0.0203806967880832,0.00907368142000646,-0.0381651123712958,-0.00259628120487052,0.0247115938894893
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37959,-0.0071875870931417,0.00320447225660731,-0.013468352716092,-0.000906821470191372,0.024913851237187
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,-0.0131719129371984,0.00587422711006962,-0.0246853980729348,-0.0016584278014619,0.0249571971652964
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CKB,Creatine kinase B-type,37998,0.0128224131323028,0.00571864683020708,0.00161386534509688,0.0240309609195086,0.0249638494553941
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,-0.0208192312197785,0.00928554137515264,-0.0390188923150776,-0.0026195701244793,0.0249681413980586
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,0.00552210565117878,0.00246544771306645,0.000689828133568551,0.010354383168789,0.0251206277850358
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL2L1,Bcl-2-like protein 1,37942,-0.0210933075932482,0.00942925930343864,-0.0395746558279879,-0.00261195935850845,0.0253022318340411
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,0.012206726362211,0.00546185211722297,0.00150149621245397,0.022911956511968,0.0254403981696399
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STXBP3,Syntaxin-binding protein 3,39980,-0.00926134690009959,0.00415516652970183,-0.0174054732983152,-0.001117220501884,0.0258364754640987
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,40332,-0.00679219853804654,0.00304973939854908,-0.0127696877592027,-0.000814709316890348,0.0259518393584601
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELL,L-selectin,38013,0.00488155377089225,0.00219498820071384,0.000579376897493123,0.00918373064429138,0.0261679139662619
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINC1,Antithrombin-III,37981,0.00308502221018752,0.00139422914008844,0.000352333095614171,0.00581771132476087,0.0269344046003757
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FBN2,Fibrillin-2,37572,-0.0127883505199234,0.00578559274707183,-0.0241281123041842,-0.00144858873566258,0.0270960880218496
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TTN,Titin,37562,-0.0137024911556083,0.00621089306523817,-0.0258758415634751,-0.00152914074774145,0.0273870637322856
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37942,0.00767207752282521,0.00347811215152975,0.000854977705826898,0.0144891773398235,0.027413640387221
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A13,Protein S100-A13,37598,-0.00726879101032017,0.00329535417254126,-0.013727685188501,-0.000809896832139299,0.0274173953571448
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THBS4,Thrombospondin-4,40355,-0.00936107143608302,0.00424401109573078,-0.0176793331837154,-0.00104280968845068,0.0274183343362455
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCLN,Nicalin,40044,-0.0110295459709649,0.00500908251331818,-0.0208473476970686,-0.00121174424486131,0.0276862965202564
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN2,Contactin-2,40489,0.00925073131534309,0.00420764903258946,0.00100373921146775,0.0174977234192184,0.0279240904086823
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,-0.0190531146962728,0.00869238687077918,-0.036090192963,-0.00201603642954565,0.028401791141177
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,0.00548439048356921,0.00250404667909767,0.00057645899253778,0.0103923219746006,0.02852338856762
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PMM2,Phosphomannomutase 2,37562,-0.0124640020220304,0.00570937846866263,-0.0236543838206092,-0.00127362022345166,0.0290479541458297
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYH7B,Myosin-7B,37482,0.00943474693297535,0.00433606748675547,0.000936054658934624,0.0179334392070161,0.0295824105951115
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,-0.00801993900406597,0.00370279395643612,-0.0152774151586808,-0.00076246284945118,0.0303355586586714
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPB41L5,Band 4.1-like protein 5,37572,-0.0130939081152032,0.00604838007892353,-0.0249487330698933,-0.00123908316051304,0.0304162271387635
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,-0.0097423566255424,0.00450292636767722,-0.0185680923061898,-0.000916620944895049,0.030515522101964
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,40128,0.0354740498906993,0.0164050859673103,0.00332008139477104,0.0676280183866275,0.0306038793160357
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYOM2,Myomesin-2,37562,-0.00957042674421004,0.00444270720096867,-0.0182781328581086,-0.000862720630311458,0.0312435928476556
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGB2A2,Mammaglobin-A,37562,0.00652985446094503,0.00303224147234367,0.000586661175151431,0.0124730477467386,0.0312995888687586
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTB,Lymphotoxin-beta,37900,-0.00721569705003172,0.00335317356842039,-0.0137879172441357,-0.000643476855927766,0.0314229101496051
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,-0.00856249210346802,0.00398632341030023,-0.0163756859876565,-0.00074929821927956,0.0317341666255671
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTD,Deoxycytidylate deaminase,37671,-0.0191844062641461,0.00894282880313214,-0.0367123507182851,-0.00165646181000709,0.0319527903974188
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDRG1,Protein NDRG1,39961,-0.0137998221809193,0.00645999069558346,-0.0264614039442629,-0.00113824041757568,0.032678850041273
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,-0.0114291059881572,0.00535786840853744,-0.0219305280688905,-0.000927683907423779,0.0329285307255613
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAA10,N-alpha-acetyltransferase 10,37562,-0.010338093316774,0.00484714490157423,-0.0198384973238594,-0.000837689309688467,0.0329579197095818
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,0.0120545999594338,0.00566923456827299,0.000942900205618703,0.0231662997132488,0.0334953542247717
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,-0.0139026241898752,0.00654224452117394,-0.0267254234513761,-0.0010798249283743,0.0336001926190549
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFNB2,Ephrin-B2,37572,-0.0116808549582253,0.0054986496560897,-0.0224582082841611,-0.000903501632289503,0.0336625969288955
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUSD1,Sushi domain-containing protein 1,40042,-0.00981584244656595,0.00462373966817863,-0.0188783721961961,-0.000753312696935829,0.0337760327059915
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,-0.0109956736475983,0.00519135819362634,-0.0211707357071059,-0.000820611588090641,0.0341847800903818
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSAPL1,Proactivator polypeptide-like 1,37901,0.0101274060467105,0.00479328593166148,0.000732565620654022,0.019522246472767,0.0346335582774845
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,-0.00847184354875933,0.00401318470602877,-0.0163376855725757,-0.000606001524942938,0.0347909501571816
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,-0.014555207830397,0.00690555173188965,-0.0280900892249007,-0.00102032643589328,0.0350711481413356
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC12A2,Solute carrier family 12 member 2,37562,0.00569502822133326,0.00270544294013887,0.000392360058661062,0.0109976963840055,0.0353080067219058
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,-0.0249082216142352,0.0119142589922215,-0.0482601692389894,-0.00155627398948101,0.0365781076499714
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,-0.0130116530642515,0.0062427228409485,-0.0252473898325105,-0.000775916295992414,0.0371529867522239
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,-0.0231884217492862,0.0111454116797224,-0.045033428641542,-0.00134341485703034,0.0374923683236951
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYPLA2,Acyl-protein thioesterase 2,37541,-0.0213557032172662,0.0102771680358284,-0.0414989525674898,-0.00121245386704264,0.037731059490344
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIF20B,Kinesin-like protein KIF20B,37541,-0.0153892005260539,0.00742257284999711,-0.0299374433120482,-0.000840957740059529,0.0381641325195231
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PODXL,Podocalyxin,40305,0.00295913064713963,0.00142743554600412,0.00016135697697155,0.00575690431730772,0.03818469578791
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP5,Platelet glycoprotein V,37671,-0.00703866287696453,0.00339970842397036,-0.0137020913879464,-0.000375234365982624,0.0384368435507934
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,0.0110773853764329,0.00536165692894811,0.000568537795694553,0.0215862329571712,0.0388411270348041
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OBP2B,Odorant-binding protein 2b,40184,-0.0128368325345332,0.00621447948405737,-0.0250172123232856,-0.000656452745780748,0.0388795042428289
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37714,-0.0115637408469804,0.00560851423510413,-0.0225564287477845,-0.000571052946176338,0.039244416847925
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPQ,Carboxypeptidase Q,37986,-0.00711072750675609,0.00345212333500034,-0.0138768892433568,-0.000344565770155418,0.0394355281638736
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STK4,Serine/threonine-protein kinase 4,40359,-0.0165858772526575,0.00806837170169431,-0.0323998857879783,-0.000771868717336636,0.0398310082489284
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCNE1,G1/S-specific cyclin-E1,37598,-0.0182266231127652,0.00887315259105823,-0.0356180021912393,-0.000835244034291055,0.0399826860590829
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,-0.00954110834171695,0.00464965409729653,-0.0186544303724182,-0.000427786311015744,0.0401860344727823
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEP,Leptin,40359,-0.0122955494444971,0.00599310071049417,-0.0240420268370657,-0.00054907205192853,0.0402232007898782
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPA,Apolipoprotein(a),37735,0.0341911479349234,0.0166980911037562,0.00146288937156126,0.0669194064982856,0.0406180322166498
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMA1,Laminin subunit alpha-1,37562,0.0107923245543112,0.00531193159564089,0.000380938626855065,0.0212037104817674,0.0422027665771555
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCP2,Non-specific lipid-transfer protein,39980,-0.0149050404244126,0.00734400948820588,-0.0292992990212961,-0.000510781827529047,0.0424192376793597
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DOCK9,Dedicator of cytokinesis protein 9,37541,-0.0230266177744276,0.0113513349515888,-0.0452752342795417,-0.000778001269313426,0.0425255430950186
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STEAP4,Metalloreductase STEAP4,37541,0.0144696081088798,0.00715724825357157,0.000441401531879545,0.0284978146858801,0.0432305602022814
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LMOD1,Leiomodin-1,37959,-0.00692715648225796,0.0034312734344862,-0.0136524524138509,-0.000201860550665011,0.0435246502911497
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLASP1,CLIP-associating protein 1,37482,-0.0136344214441117,0.00677036970591222,-0.0269043460676996,-0.000364496820523726,0.0440471591826704
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,-0.00702242396051757,0.00349404978265468,-0.0138707615345207,-0.000174086386514398,0.0444697902812953
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EVPL,Envoplakin,37714,0.00657210898079296,0.0032738428121721,0.000155377068935641,0.0129888408926503,0.0447209391707787
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPS10,40S ribosomal protein S10,37562,0.00802555271245671,0.0039991902626276,0.000187139797706605,0.0158639656272068,0.0447920509129444
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37900,-0.00777171109202919,0.00387672567351032,-0.0153700934121094,-0.000173328771948968,0.0450140570008141
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF5,Eukaryotic translation initiation factor 5,37562,-0.00861058867564289,0.00429596940832058,-0.0170306887159512,-0.000190488635334555,0.0450540479571405
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOP56,Nucleolar protein 56,37562,-0.0209600959692283,0.0104693982759765,-0.0414801165901421,-0.000440075348314434,0.0453015899538121
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL11,Interleukin-11,40044,-0.0119697861470263,0.00598848388918881,-0.0237072145698364,-0.000232357724216235,0.0456472442970428
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNNI3,"Troponin I, cardiac muscle",40042,-0.0159148335089484,0.00796504436758235,-0.0315263204694098,-0.000303346548487045,0.0457248147553404
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TREML1,Trem-like transcript 1 protein,37987,-0.00997791224983386,0.0049971406938061,-0.0197723080096938,-0.000183516489973905,0.0458751322303823
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTX3,Pentraxin-related protein PTX3,40341,-0.00919852075152235,0.0046070247267268,-0.0182282892159069,-0.000168752287137822,0.0458824934202956
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAT1,Diamine acetyltransferase 1,37562,0.00986637473620433,0.0049429156725344,0.000178260018036894,0.0195544894543718,0.04594763424126
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17F,Interleukin-17F,40044,-0.0148477308964844,0.00746049952196814,-0.029470309959542,-0.000225151833426881,0.0465886321911743
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATXN2,Ataxin-2,37541,-0.0217185775743439,0.0109260133646014,-0.0431335637689627,-0.000303591379725049,0.0468561509119933
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100G,Protein S100-G,37959,0.00836513485761171,0.00421236237340025,0.000108904605747223,0.0166213651094762,0.0470697682933253
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP164,Centrosomal protein of 164 kDa,40044,-0.0119071849241485,0.00599840062194333,-0.0236640501431575,-0.000150319705139618,0.0471552936695764
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,0.0115697803173804,0.00583438483666911,0.000134386037508974,0.0230051745972519,0.0473845599683037
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP4,Caspase-4,37714,-0.0320029729715814,0.0162072682221303,-0.0637692186869568,-0.000236727256206062,0.0483335615953428
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFRA2,GDNF family receptor alpha-2,40305,-0.00392666062684345,0.00199430438577468,-0.00783549722296182,-1.78240307250862e-05,0.0489776632041267
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGMA,Repulsive guidance molecule A,40471,0.0057046259617439,0.00290222752981559,1.62600033053522e-05,0.0113929919201824,0.0493617822458138
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC1A4,Neutral amino acid transporter A,37572,-0.00979722947503336,0.00498880509957425,-0.0195752874701989,-1.91714798678348e-05,0.0495693965839823
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,-0.010679105693993,0.00544360948001861,-0.0213485802748295,-9.63111315654096e-06,0.049807192634654
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACTN2,Alpha-actinin-2,37562,-0.0101357107936123,0.00516938890104705,-0.0202677130396645,-3.70854756007177e-06,0.0499331393631666
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,-0.0165686338815893,0.00845773876684821,-0.0331458018646118,8.53410143320313e-06,0.0501351802462189
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,-0.00886640584802139,0.00452937664904863,-0.0177439840801567,1.11723841139284e-05,0.0503054470924627
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACTN4,Alpha-actinin-4,40044,-0.00596348042262766,0.00304672627452977,-0.011935063920706,8.103075450701e-06,0.0503252754003185
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST1,Cystatin-SN,36179,-0.0192816809514238,0.00986182911065487,-0.0386108660083073,4.75041054597905e-05,0.0505851891687976
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F2,Prothrombin,38013,0.00272322068824914,0.0013930577717349,-7.17254435126562e-06,0.00545361392084955,0.0506211484132559
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOH,Beta-2-glycoprotein 1,40332,-0.00650644891353604,0.00332986769801245,-0.0130329896016405,2.00917745683702e-05,0.0507227442708105
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMA1,Proteasome subunit alpha type-1,39980,-0.00855968275863472,0.00438369328076019,-0.0171517215889247,3.23560716552554e-05,0.0508827005280237
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLNS1A,Methylosome subunit pICln,37572,-0.00621364971966957,0.00319053400736981,-0.0124670963741144,3.97969347752571e-05,0.0514929410461022
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,0.0127108927412535,0.00653558537886951,-9.88546013307567e-05,0.0255206400838377,0.0518078409027393
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,0.00615270769695654,0.00317200619698222,-6.4424449128621e-05,0.0123698398430417,0.0524388357062605
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYO6,Unconventional myosin-VI,37959,-0.00687928133239362,0.0035475196728735,-0.0138324198912257,7.38572264384453e-05,0.0525001492928868
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTTG1,Securin,37714,-0.00759566685842246,0.00392108738299153,-0.0152809981290859,8.96644122409355e-05,0.0527503249421008
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,-0.0135076097470169,0.00697502599563242,-0.0271786606984564,0.000163441204422654,0.0528159321324172
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGA6,Integrin alpha-6,40341,-0.00962854510561241,0.0049814702893974,-0.0193922268728313,0.000135136661606501,0.0532696993566739
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLSTN1,Calsyntenin-1,39961,0.00954092296931981,0.00493810553787815,-0.000137763884921368,0.019219609823561,0.0533651240508342
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XG,Glycoprotein Xg,40458,-0.00542436164773569,0.00281416732479759,-0.010940129604339,9.14063088675839e-05,0.0539326276590214
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,0.00626575403092745,0.00325255647744437,-0.000109256664863523,0.0126407647267184,0.0540749535532799
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,0.0324479694534255,0.0168868456997371,-0.000650248118059187,0.0655461870249102,0.0546874117885125
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,40424,-0.00378695046839975,0.00197559912530749,-0.00765912475400243,8.52238172029287e-05,0.0552733152850402
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB10,Ras-related protein Rab-10,37990,-0.00969180931475684,0.00506775018019081,-0.0196245996679308,0.000240981038417146,0.0558398204772115
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39980,-0.0108164642630939,0.00565675017601873,-0.0219036946080906,0.000270766081902841,0.055877392156834
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,-0.00672666008412509,0.00351909782940301,-0.013624091829755,0.000170771661504819,0.0559621509139028
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGS10,Regulator of G-protein signaling 10,37959,-0.0108231371291364,0.00566678298935066,-0.0219300317882637,0.000283757529990864,0.0561638784119035
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUSP29,Dual specificity phosphatase 29,37572,-0.0120669614766207,0.00632954501002751,-0.0244728696962747,0.000338946743033188,0.0566136639317806
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,-0.00783935150540131,0.00413854631606957,-0.0159509022848977,0.000272199274095041,0.0582166435478596
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OTOA,Otoancorin,37541,-0.00985933541092039,0.0052071562562395,-0.0200653616731498,0.000346690851309023,0.0583240305022922
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC13A1,Solute carrier family 13 member 1,37900,-0.0111128476413054,0.00587809881261102,-0.022633921314023,0.000408226031412226,0.0587057385417035
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OPTC,Opticin,40305,0.00799729388003664,0.00423295058167776,-0.000299289260051775,0.0162938770201251,0.0588704957790037
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37628,-0.0469279232950429,0.0248565328662862,-0.0956467277129639,0.00179088112287813,0.0590544424642041
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIRREL2,Kin of IRRE-like protein 2,39961,-0.0070999982646511,0.00377009526681303,-0.0144893849876046,0.000289388458302445,0.0596864013742014
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37572,-0.00693558411010144,0.00368304656664997,-0.0141543553807354,0.000283187160532499,0.0597074805953199
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTRC,Chymotrypsin-C,40360,0.0110984729954833,0.00589744964465359,-0.000460528308037719,0.0226574742990043,0.0598663953401286
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCLRE1C,Protein artemis,37482,0.00566847120566141,0.00301382236214261,-0.0002386206241381,0.0115755630354609,0.0600180658898339
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G4A,Cytosolic phospholipase A2,40422,-0.015365611124279,0.00816997346088182,-0.0313787591076074,0.000647536859049317,0.060025222268443
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,-0.00643533485170751,0.00342393975561403,-0.013146256772711,0.000275587069295999,0.0601965635395181
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BSND,Barttin,37482,0.0061090344975978,0.00325471806846339,-0.000270212916590457,0.012488281911786,0.0605434232287664
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,0.0103745083194345,0.00555758088057412,-0.000518350206490737,0.0212673668453598,0.0619577845856612
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,-0.0118975102472052,0.00638382064002565,-0.0244097987016555,0.00061477820724508,0.0623863584090788
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,-0.00933665715213232,0.0050318227803575,-0.019199029801633,0.000525715497368377,0.063543911946702
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,-0.018633672927506,0.0100491107800949,-0.038329930056492,0.00106258420147991,0.0637240314401976
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTNAP2,Contactin-associated protein-like 2,40341,-0.00696658070259579,0.00376513035479127,-0.0143462361979867,0.000413074792795101,0.0642904043842967
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPEP2,Dipeptidase 2,40305,-0.00497254957925402,0.00269405379797024,-0.0102528950232757,0.000307795864767654,0.0649471587938602
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEZ6L,Seizure 6-like protein,40411,0.00475140887896386,0.00257662579128178,-0.000298777671948428,0.00980159542987614,0.0651953910826969
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA4,Carbonic anhydrase 4,40536,-0.00404495127989765,0.00219525983629895,-0.00834766055904359,0.000257757999248291,0.0654081226507202
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,0.00939062232733183,0.0051172354672026,-0.000639159188385271,0.0194204038430489,0.0665139933358533
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFAP3,Microfibril-associated glycoprotein 3,40042,-0.00856500524032054,0.00468364773225648,-0.0177449547955432,0.000614944314902154,0.0674630608654238
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37598,-0.0151134067251905,0.00827682851519329,-0.0313359906149694,0.00110917716458831,0.0678744283333321
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STXBP1,Syntaxin-binding protein 1,37959,-0.0133431546648455,0.00731322538775623,-0.0276770764248477,0.000990767095156669,0.0680949828798897
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,40042,-0.0100614835272229,0.00552067750320618,-0.020882011433507,0.000759044379061243,0.0683969605399632
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,0.00903245132174525,0.00495649485318356,-0.000682278590494519,0.018747181233985,0.0684251707365686
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,0.00545419821461141,0.00300647792102886,-0.000438498510605152,0.011346894939828,0.0696777108005649
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF2RB,Cytokine receptor common subunit beta,37598,-0.00760832873346574,0.00419463082649533,-0.0158298051533966,0.000613147686465101,0.0697273708592786
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP9,Caspase-9,37598,-0.0107033285535608,0.00590418467655809,-0.0222755305196147,0.000868873412493065,0.0698796565727754
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,-0.0130348269939732,0.00719273545485949,-0.0271325884854978,0.00106293449755141,0.0699708418895558
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GJA8,Gap junction alpha-8 protein,37482,-0.0107014561622206,0.00591132935057295,-0.0222876616893435,0.000884749364902432,0.0702676714045772
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM5,Intercellular adhesion molecule 5,40359,-0.00749803894805618,0.00414395704986022,-0.0156201947657822,0.000624116869669858,0.0704091353208945
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP13,Collagenase 3,39961,0.00559736690456477,0.00309684062286694,-0.000472440716254438,0.011667174525384,0.0707124013103707
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39980,-0.00996452445995614,0.00552109062236287,-0.0207858620797874,0.000856813159875089,0.0711236451447376
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENSA,Alpha-endosulfine,37900,-0.00900398793646079,0.00499252299502371,-0.0187893330067073,0.000781357133785677,0.0713329548624313
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMEM132A,Transmembrane protein 132A,37628,0.0107076677688047,0.00594744400328943,-0.000949322477642636,0.0223646580152519,0.0718232922584456
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEPTIN7,Septin-7,37714,-0.00896084046516214,0.0049792306112452,-0.0187201324632027,0.000798451532878448,0.0719396535629592
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAPS,Calcyphosin,37942,-0.0161293264197241,0.00898397175913028,-0.0337379110676194,0.00147925822817125,0.0726211653627079
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,-0.0182815820286798,0.010199578744412,-0.0382727563677273,0.00170959231036768,0.0730936272237305
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLINT1,Clathrin interactor 1,37482,0.0077928629311359,0.004358927635912,-0.000750635235251621,0.0163363610975234,0.0738325446307063
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,40422,-0.00466895941714836,0.00261410513679961,-0.00979260548527561,0.000454686650978883,0.0741078415953103
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37628,-0.0123861924757564,0.00693536014870728,-0.0259794983672227,0.00120711341570988,0.0741306699788569
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX6,Peroxiredoxin-6,40489,0.0100157401094887,0.00560927581572349,-0.00097844048932934,0.0210099207083067,0.0741882177559006
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNAP25,Synaptosomal-associated protein 25,37541,0.0079124441475622,0.004434755765633,-0.000779677153078466,0.0166045654482029,0.0744160543971295
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL7,Interleukin-7,40341,-0.0107507701934501,0.0060371203260242,-0.0225835260324575,0.00108198564555735,0.0749678486520419
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX1B,Syntaxin-1B,37572,-0.00726110438617405,0.00407911805519027,-0.015256175774347,0.000733967001998881,0.0750880960091977
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37959,-0.00660747535904594,0.00371616174206987,-0.0138911523735029,0.000676201655411009,0.0754201685069179
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIAA1549,UPF0606 protein KIAA1549,37714,-0.0119451245697306,0.00672162233044343,-0.0251195043373997,0.00122925519793854,0.0755715325332902
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,-0.00505489215411208,0.00284495314930635,-0.0106310003267525,0.000521216018528361,0.0756219404116013
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL15A1,Collagen alpha-1(XV) chain,37998,-0.00434254158709122,0.00245005741076393,-0.00914465411218853,0.000459570938006088,0.0763466023422605
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37959,-0.0131637197755604,0.0074298305753323,-0.0277261877032117,0.0013987481520909,0.0764604525192953
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRND,Prion-like protein doppel,37942,-0.00900130286979231,0.00508319416345901,-0.018964363430172,0.000961757690587336,0.0766171114377625
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,40042,0.00561889492918386,0.00317322643101552,-0.000600628875606554,0.0118384187339743,0.0766268419987862
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,-0.0149437563282122,0.00844005808761449,-0.0314862701799365,0.00159875752351224,0.0766547692412665
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,-0.0142849949389916,0.00807160692129035,-0.0301053445047207,0.00153535462673748,0.0767859069871435
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,-0.0190854492392517,0.0107876313040599,-0.0402292065952091,0.00205830811670568,0.0768834998809868
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOB,Apolipoprotein B-100,37987,0.00372361030526288,0.002117317696805,-0.000426332380474909,0.00787355299100068,0.0786604102851822
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REST,RE1-silencing transcription factor,37482,0.00596429172486371,0.00340267712125789,-0.000704955432801753,0.0126335388825292,0.079655859160938
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEB,Nebulin,37562,-0.00603861030808225,0.00344607700175868,-0.0127929212315293,0.000715700615364756,0.0797431398560756
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LHB,Lutropin subunit beta,39980,-0.0139900534567823,0.0079877841730342,-0.0296461104359293,0.00166600352236475,0.0798914251125968
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,-0.0104191299612121,0.00598438131622679,-0.0221485173410166,0.00131025741859245,0.0816974097885938
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,-0.00443228088867539,0.00254771036772557,-0.0094257932094175,0.000561231432066729,0.0819294332260568
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD70,CD70 antigen,40341,-0.00676338720770091,0.0038997141458394,-0.0144068269335461,0.000880052518144311,0.0828791249021025
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37562,-0.0110554822069287,0.00638339439717646,-0.0235669352253945,0.00145597081153719,0.083312618511297
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TJP3,Tight junction protein ZO-3,37541,0.00721473515039035,0.00417549993190988,-0.000969244716153006,0.0153987150169337,0.0840345159696694
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMCN2,Hemicentin-2,37648,-0.00936224002232315,0.00542138810946082,-0.0199881607168663,0.00126368067222005,0.0842075388763135
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37959,-0.0204885575620843,0.0118725471052664,-0.0437587498884065,0.00278163476423778,0.0844227069437318
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,-0.0135514882941718,0.00785997452028368,-0.0289570383539278,0.00185406176558426,0.0847072801173896
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37544,0.00660076763359281,0.0038309967006995,-0.000907985899778201,0.0141095211669638,0.0849140116808267
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTNAP4,Contactin-associated protein-like 4,37572,-0.0165947125892001,0.0096417516115835,-0.0354925457479037,0.00230312056950356,0.0852507243242964
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN2B,Sodium channel subunit beta-2,37572,0.00484136285478826,0.00281613081102025,-0.000678253534811431,0.010360979244388,0.085609902085079
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNL2,Interferon lambda-2,37541,-0.0105472993319048,0.00615273629030719,-0.0226066624609069,0.00151206379709731,0.086507356718627
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DOK1,Docking protein 1,37942,-0.0220774900015448,0.0128821026973096,-0.0473264112882716,0.00317143128518206,0.0865864056434408
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL14,C-X-C motif chemokine 14,40044,-0.00987341091988596,0.00576167879208262,-0.0211663013523679,0.00141947951259599,0.0866157704521321
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TERF1,Telomeric repeat-binding factor 1,37598,0.00480616373003991,0.002814196253182,-0.000709660926196815,0.0103219883862766,0.0876918344886831
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCS,Copper chaperone for superoxide dismutase,40228,-0.00773129197929322,0.00452725410148491,-0.0166047100182036,0.0011421260596172,0.0877075901061058
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,0.00476453615209795,0.00279393449689617,-0.000711575461818548,0.0102406477660145,0.0881587692031548
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAPPA,Pappalysin-1,40044,-0.00749107029660141,0.00440950014041415,-0.0161336905718131,0.00115154997861032,0.0893677851284475
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL20,Interleukin-20,40044,-0.00811367208308899,0.00478462473706959,-0.0174915365677454,0.0012641924015674,0.0899474701473923
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37598,-0.00658771093502473,0.00388749847989018,-0.0142072079556095,0.00103178608556002,0.0901771602970836
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VCAN,Versican core protein,40471,0.00477674003335832,0.00282028143879251,-0.000751011586675002,0.0103044916533916,0.0903397664158027
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,-0.00902464375896972,0.00532876926542745,-0.0194690315192075,0.00141974400126809,0.0903709245598868
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF9,Fibroblast growth factor 9,37457,0.00651060631142385,0.0038533712543204,-0.00104200134704414,0.0140632139698918,0.0911309470676308
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYB5A,Cytochrome b5,37482,-0.0117612015775728,0.00696327886461251,-0.0254092281522133,0.00188682499706776,0.091237202949932
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BPIFB2,BPI fold-containing family B member 2,37951,-0.0108109221492054,0.00641560094934833,-0.0233855000099282,0.00176365571151729,0.0919926047758573
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBP6,Guanylate-binding protein 6,37562,0.00750826018935282,0.00449237754225848,-0.0012967997934738,0.0163133201721794,0.0946797288892378
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,37541,-0.0157753239766216,0.00944033979266454,-0.0342783899702441,0.00272774201700088,0.0947347844452085
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,40357,-0.045877298672159,0.0275181373498365,-0.0998128478778384,0.00805825053352049,0.0955011204950812
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEO1,Neogenin,37959,0.00335468285291333,0.00201998809609325,-0.000604493815429448,0.00731385952125611,0.0967881082544547
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,-0.0139363906444918,0.0083923028494162,-0.0303853042293475,0.00251252294036398,0.096814548823298
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,-0.0160600055203183,0.00967556132682118,-0.0350241057208878,0.00290409468025122,0.0969679081535116
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1A,Interleukin-1 alpha,40044,-0.00833999424466835,0.00505213237532599,-0.0182421737003073,0.00156218521097059,0.0988022236450785
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37572,0.0058836562322336,0.00357246767496828,-0.00111838041070424,0.0128856928751714,0.0995933888468238
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,-0.00554628982855626,0.00337514378867567,-0.0121615716543606,0.00106899199724806,0.100349327448066
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EXOSC10,Exosome component 10,37562,-0.00976844821884399,0.00594521777193199,-0.0214210750518307,0.00188417861414271,0.100391066036408
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,-0.00709510214024084,0.00432248615264504,-0.0155671749994251,0.00137697071894344,0.100730076429295
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37572,-0.0130129900014601,0.00794030757426893,-0.0285759928470272,0.00255001284410696,0.101268035898917
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSTN,Growth/differentiation factor 8,40042,0.00786187492876198,0.00480532257213728,-0.00155655731262709,0.0172803071701511,0.101843781493165
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,-0.010583136068035,0.00647412392344647,-0.02327241895799,0.00210614682192013,0.102139061284619
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOE,Apolipoprotein E,38013,-0.0116059500460035,0.00710154282580265,-0.0255249739845766,0.00231307389256975,0.10222208198486
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL2RB,Interleukin-2 receptor subunit beta,40044,-0.00594828747201762,0.00364145461210268,-0.0130855385117389,0.00118896356770363,0.102385723686592
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,-0.00786831457251987,0.00483055862801793,-0.017336209483435,0.00159958033839526,0.10336619269062
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,-0.0123935461015747,0.00761415593120856,-0.0273172917267435,0.00253019952359409,0.103609258392603
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NECTIN1,Nectin-1,37598,-0.00491534835405874,0.00302268701801102,-0.0108398149093603,0.00100911820124285,0.103941306321719
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,-0.00997402696931978,0.00615199466251253,-0.0220319365078443,0.00208388256920477,0.104983796721497
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK14,Kallikrein-14,40489,0.00697523402761018,0.00431202209961066,-0.00147632928762671,0.0154267973428471,0.105763140878247
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37628,-0.00939501354684764,0.00583624752316578,-0.0208340586922526,0.00204403159855729,0.107472130825982
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37562,-0.00613480249282263,0.00381444881893381,-0.0136111221779329,0.00134151719228764,0.107792166577031
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37901,-0.00836972958171171,0.005207796532919,-0.018577010786233,0.00183755162280954,0.108044125879029
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,-0.00738821593219863,0.00459762954180968,-0.0163995698341456,0.00162313796974834,0.108086722158446
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37714,0.0044072994640073,0.00275532635969365,-0.000993140200992242,0.00980773912900685,0.109720884136249
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,-0.0044513838852015,0.00278938567193102,-0.0099185798021863,0.0010158120317833,0.11055026454653
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINI1,Neuroserpin,37642,-0.00481748263297399,0.00302355707672069,-0.0107436545033465,0.00110868923739856,0.111113223532022
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK15,Kallikrein-15,37880,0.00772793530797531,0.00485080696609491,-0.00177964634557072,0.0172355169615213,0.111155991203898
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37598,-0.00883804280021602,0.00554900148752461,-0.0197140857157643,0.00203800011533221,0.111245558519271
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTF4,Neurotrophin-4,39980,-0.00611272695205731,0.00384257628116988,-0.0136441764631503,0.00141872255903566,0.111677492126612
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DIPK2B,Divergent protein kinase domain 2B,37671,0.00401979238350289,0.00253245014033039,-0.000943809891544667,0.00898339465855045,0.112465568640831
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,-0.0156065822679116,0.00984907982600955,-0.0349107787268903,0.00369761419106714,0.113087570172391
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,0.0072685162935171,0.00458769133926287,-0.00172335873143811,0.0162603913184723,0.11313784052106
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39530,-0.00425516896889287,0.00269037071688507,-0.0095282955739876,0.00101795763620186,0.113755211377852
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37562,-0.0178412071444976,0.0113077348360661,-0.0400043674231871,0.00432195313419185,0.114638472716552
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOP1,DNA topoisomerase 1,37901,0.015919571062401,0.0101183901980078,-0.00391247372569436,0.0357516158504963,0.115665852589416
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TEX33,Testis-expressed protein 33,37714,0.0058934933301913,0.00374638596457738,-0.00144942316038036,0.013236409820763,0.115716209083563
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARFIP1,Arfaptin-1,37959,-0.0102132176841119,0.00649717216418512,-0.0229476751259147,0.00252123975769093,0.115986002016975
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37987,-0.00520579450189079,0.00331544967564885,-0.0117040758661625,0.00129248686238096,0.116400704176987
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CADPS,Calcium-dependent secretion activator 1,37572,0.00668676227757195,0.00427720949174343,-0.00169656832624518,0.0150700928813891,0.11799513654816
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAD2,Glutamate decarboxylase 2,37598,0.00700922971180554,0.00448843859060203,-0.00178810992577444,0.0158065693493855,0.118401908753535
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HBQ1,Hemoglobin subunit theta-1,40489,0.00864632535594111,0.00554518245506464,-0.00222223225598558,0.0195148829678678,0.118956969780624
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,-0.00434360955706611,0.00279132460912646,-0.00981460579095398,0.00112738667682175,0.119705191876205
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GC,Vitamin D-binding protein,38013,-0.00383060648612776,0.00246179605465961,-0.0086557267532606,0.000994513781005079,0.119726422170627
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARG2,"Arginase-2, mitochondrial",37900,-0.0065240746966938,0.00420935039636729,-0.0147744014735737,0.00172625208018608,0.121188907634376
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPA33,Cell surface A33 antigen,40305,-0.0198063695743312,0.012795704467509,-0.0448859503306488,0.0052732111819864,0.121668243703566
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RANGAP1,Ran GTPase-activating protein 1,39980,-0.00722327319229485,0.00468957204037743,-0.0164148343914346,0.0019682880068449,0.123511497382823
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,-0.00710664084651432,0.00461923388684808,-0.0161603392647366,0.0019470575717079,0.123953212781624
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40522,-0.00796454786833162,0.00519092043014636,-0.0181387519114185,0.00220965617475525,0.124969931332831
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,-0.0148315804366083,0.00967419783760783,-0.0337930081983196,0.00412984732510307,0.125269416357081
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,-0.0121623027248036,0.00794705101405709,-0.0277385227123555,0.00341391726274832,0.125933890736138
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFRA3,GDNF family receptor alpha-3,40194,0.00409854398361982,0.00267954250802198,-0.00115335933210326,0.00935044729934291,0.126143648759231
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,-0.00966733900765388,0.0063306417723958,-0.0220753968815496,0.00274071886624188,0.126767537985859
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37942,-0.00408371400921363,0.00267596507596519,-0.00932860555810539,0.00116117753967814,0.127015505100508
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TET2,Methylcytosine dioxygenase TET2,37697,-0.0145802652101527,0.0095572718579399,-0.0333125180517149,0.00415198763140947,0.127141438960825
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNLZ,DNL-type zinc finger protein,37541,0.0137109702243312,0.00903932836819118,-0.00400611337732355,0.0314280538259859,0.12933806918634
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX3,Syntaxin-3,37942,-0.00555540079255623,0.00366333888427313,-0.0127355450057316,0.00162474342061911,0.129420031482793
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NLGN1,Neuroligin-1,37572,-0.00998162839689801,0.00661953071105809,-0.0229559085905719,0.00299265179677584,0.131602729650391
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PFDN2,Prefoldin subunit 2,39961,-0.00794956189397266,0.00527317418224986,-0.0182849832911824,0.00238585950323706,0.131690681519302
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPN1,Epsin-1,37714,-0.00631720892725797,0.00419581868709304,-0.0145410135539603,0.00190659569944438,0.132194664666163
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,0.00543710958560749,0.00361410725613682,-0.00164654063642068,0.0125207598076357,0.132499173815809
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,-0.0117100148720645,0.00779233931136759,-0.026982999922345,0.00356297017821595,0.132925209809279
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB6B,Ras-related protein Rab-6B,39961,-0.00688310196425161,0.00458320264751395,-0.0158661791533789,0.00209997522487573,0.133166408787594
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH3GL3,Endophilin-A3,37643,-0.0117937546610087,0.00786950558264743,-0.0272179856029977,0.00363047628098028,0.133984422041649
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MELTF,Melanotransferrin,37990,-0.00413099623194803,0.00276076602775828,-0.00954209764635426,0.0012801051824582,0.134592954444697
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSB,Lupus La protein,39961,-0.00848644504932053,0.00567563246601766,-0.0196106846827152,0.00263779458407409,0.134871596042745
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TUBB3,Tubulin beta-3 chain,37541,0.00394715350074356,0.00264181745877677,-0.00123080871845891,0.00912511571994602,0.135172201168241
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,-0.00518113875753517,0.00346796013381719,-0.0119783406198169,0.00161606310474653,0.135199191520132
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DGKZ,Diacylglycerol kinase zeta,40044,-0.00489258831970858,0.0032840234239038,-0.01132927423056,0.00154409759114287,0.136293035858216
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKCQ,Protein kinase C theta type,40044,-0.00619188203398886,0.00416083412744247,-0.0143471169237761,0.00196335285579838,0.136735572676481
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,0.0044775918530687,0.00300990523731619,-0.00142182241207102,0.0103770061182084,0.136875482506013
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,0.00713811062420343,0.00480109086112964,-0.00227202746361067,0.0165482487120175,0.137100161571132
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NELL2,Protein kinase C-binding protein NELL2,40422,0.00393702963589855,0.0026536760456215,-0.00126417541351959,0.00913823468531668,0.137931217346773
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,-0.0121067554500267,0.00816949459360796,-0.0281189648534983,0.00390545395344492,0.138378663424588
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FMR1,Synaptic functional regulator FMR1,39980,-0.00489558512294311,0.00330615075023519,-0.0113756405934041,0.00158447034751786,0.138693300563316
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLB,Beta-klotho,39961,0.0102074118594592,0.00690355879151538,-0.00332356337191097,0.0237383870908293,0.13927492813546
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37562,-0.00872887381434125,0.00595606769802566,-0.0204027665024716,0.00294501887378905,0.142796789109481
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,-0.00931594961275449,0.00636038358343188,-0.021782301436281,0.00315040221077199,0.14302752743886
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NENF,Neudesin,37900,-0.0149788403756284,0.0102497539928699,-0.0350683582016533,0.00511067745039661,0.143933082060857
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAG,S-arrestin,37541,0.00740750789941982,0.00507265586846992,-0.00253489760278122,0.0173499134016209,0.1442365967273
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BGLAP,Osteocalcin,37998,0.0124990936198726,0.00862200082773198,-0.00440002800248211,0.0293982152422273,0.147172496891251
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EP300,Histone acetyltransferase p300,37598,-0.00408565267864529,0.00282381320539016,-0.00962032656121001,0.00144902120391943,0.147960943197505
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,-0.00617239546519392,0.00428337615272135,-0.0145678127245278,0.00222302179413993,0.149604639369785
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH6,Cadherin-6,40359,-0.00512845685624026,0.00356180196214942,-0.0121095887020531,0.0018526749895726,0.149929814670827
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,0.00400157672331253,0.00278535717968814,-0.00145772334887622,0.00946087679550127,0.15084194683422
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THPO,Thrombopoietin,40042,0.00513278848396167,0.00358468503902765,-0.00189319419253253,0.0121587711604559,0.152202233300425
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QL2,Complement C1q-like protein 2,37598,0.00581417481160517,0.00406575588373095,-0.0021547067205075,0.0137830563437178,0.152730626804903
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRISP3,Cysteine-rich secretory protein 3,37875,-0.00366373864503299,0.00256346534480216,-0.00868813072084523,0.00136065343077925,0.152966220657325
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRING1,SREBP regulating gene protein,37482,-0.00780434214725784,0.00546658641126422,-0.0185188515133357,0.00291016721882003,0.153418166738914
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MST1,Hepatocyte growth factor-like protein,37787,-0.00833325839013662,0.00584360408129719,-0.0197867223894791,0.00312020560920588,0.15387797125747
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UNC5D,Netrin receptor UNC5D,37598,0.0036084932189995,0.00253249686039292,-0.00135520062737062,0.00857218706536963,0.154216876467483
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39980,-0.00636585202934619,0.00447109937190117,-0.0151292067982725,0.0023975027395801,0.154530896902848
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN4B,Sodium channel subunit beta-4,37628,-0.00562643959915616,0.00396456054789885,-0.0133969782730379,0.00214409907472558,0.155869130146077
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GUK1,Guanylate kinase,37562,0.00533631947349287,0.0038002291166438,-0.00211212959512898,0.0127847685421147,0.160280034016613
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPA4,Carboxypeptidase A4,37410,-0.00585268744077201,0.00416845130870301,-0.0140228520058299,0.00231747712428588,0.160329828566936
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PALM3,Paralemmin-3,37562,-0.00962843106533051,0.00686059170917544,-0.0230751908153144,0.00381832868465335,0.160509259460231
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUMF1,Formylglycine-generating enzyme,37598,-0.00891307577550615,0.00635636127021309,-0.0213715438651238,0.00354539231411151,0.160870408417355
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37562,0.00688899865993008,0.00494006470343277,-0.00279352815879814,0.0165715254786583,0.163185507799855
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESR1,Estrogen receptor,37598,-0.00767560190509623,0.00551554038533983,-0.0184860610603623,0.00313485725016984,0.164057442081937
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL4A1,Collagen alpha-1(IV) chain,40359,-0.00517015145753162,0.00371873249671517,-0.0124588671510933,0.00211856423603011,0.164457440280875
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSLP,Thymic stromal lymphopoietin,40042,-0.00795797536262651,0.00573022969648695,-0.0191892255677409,0.00327327484248792,0.16492231308516
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36973,-0.00663462922744109,0.00477922937132387,-0.0160019187952359,0.00273266034035369,0.165094288639738
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37714,-0.00496207311348487,0.00357530271394643,-0.0119696664328199,0.00204552020585013,0.16519843939533
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,-0.0186032858966352,0.0134324033427496,-0.0449307964484244,0.0077242246551541,0.166089671954192
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,0.00394563884210814,0.00284910343028746,-0.00163860388125528,0.00952988156547157,0.166115720880941
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,0.00966690019099952,0.00699799309904442,-0.00404916628312754,0.0233829666651266,0.167184876121072
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VGF,Neurosecretory protein VGF,37959,-0.00396745733254573,0.00288537461683585,-0.00962279158154399,0.00168787691645253,0.169147027615851
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRD1,Bromodomain-containing protein 1,37714,0.00403082632869228,0.00294008243889586,-0.00173173525154361,0.00979338790892817,0.170400985981801
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,-0.00941994069662205,0.00694495300020232,-0.0230320485770186,0.00419216718377449,0.175000250977398
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDA1,DET1- and DDB1-associated protein 1,37562,-0.00522514373873115,0.00385606071048347,-0.0127830227312788,0.00233273525381645,0.175425910500701
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,0.00484528155725082,0.00358074788858517,-0.00217298430437612,0.0118635474188778,0.176031711579929
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUGT1,Protein SGT1 homolog,39980,-0.010314867804218,0.00765066424227129,-0.0253101697190697,0.00468043411063374,0.177603548024713
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BIN2,Bridging integrator 2,40332,-0.0114648789634166,0.00850637056076926,-0.0281373652625244,0.00520760733569111,0.177742219943671
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PMVK,Phosphomevalonate kinase,39951,-0.0139659119855213,0.0103875692148989,-0.0343255476467231,0.00639372367568049,0.178811871424904
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALMS1,Alstrom syndrome protein 1,37714,0.00574705076482106,0.00427603001894349,-0.00263396807230817,0.0141280696019503,0.178966355352028
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDAC8,Histone deacetylase 8,37598,-0.00794084712896146,0.00592634489710553,-0.0195564831272883,0.00367478886936538,0.180293468494849
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,-0.00715366946431879,0.00534577268501217,-0.0176313839269426,0.00332404499830506,0.180856458615318
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,-0.00430704962318656,0.0032191481809413,-0.0106165800578315,0.00200248081145839,0.180936961151379
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNF75D,Zinc finger protein 75D,37714,-0.00753875653709976,0.00564461075747145,-0.0186021936217438,0.00352468054754428,0.181713723300834
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40536,0.00436175735042991,0.00327336707954841,-0.00205404212548498,0.0107775568263448,0.182715248400023
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFL4,Insulin growth factor-like family member 4,37598,-0.00988529556186017,0.00745768716384717,-0.0245023624030006,0.00473177127928028,0.18502257137632
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,-0.00515138351981499,0.00389518732863261,-0.0127859506839349,0.00248318364430491,0.18602492653613
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA4,Annexin A4,40279,-0.00888274089009087,0.00673726145706203,-0.0220877733459325,0.00432229156575071,0.18737220458234
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOX9,Transcription factor SOX-9,37572,-0.0033967860438018,0.00257710043234721,-0.00844790289120233,0.00165433080359872,0.187504880226829
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGR,Progesterone receptor,37598,-0.0128745769498935,0.00981052186525137,-0.0321031998057862,0.00635404590599917,0.189433968146264
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB2,Integrin beta-2,40221,0.00352527653022586,0.002695785239634,-0.00175846253945677,0.0088090155999085,0.190994377642788
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPP10,Inactive dipeptidyl peptidase 10,40341,0.00415720337916762,0.00319361192491993,-0.00210227599367545,0.0104166827520107,0.193029400446444
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF20,Fibroblast growth factor 20,37598,0.0055030862427576,0.00423585370690976,-0.00279918702278552,0.0138053595083007,0.19390901212593
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LXN,Latexin,40183,0.00806725481951572,0.00622735744945028,-0.00413836578140683,0.0202728754204383,0.195182685816706
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL6ST,Interleukin-6 receptor subunit beta,40359,0.00211869173872339,0.0016414463494783,-0.00109854310625407,0.00533592658370085,0.196810225518576
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPTX2,Neuronal pentraxin-2,37998,-0.0039713796596031,0.00308851607470343,-0.0100248711660218,0.00208211184681563,0.198516122985967
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPM1B,Protein phosphatase 1B,37598,-0.00771204971102909,0.00600843927921127,-0.0194885906982832,0.00406449127622499,0.19932688695765
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAG,Myelin-associated glycoprotein,37572,-0.00567989032829876,0.0044269516968343,-0.014356715654094,0.00299693499749646,0.199505931584149
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,-0.0143364700425491,0.0111794043070956,-0.0362481024844565,0.00757516239935831,0.199721011405217
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAPN3,Calpain-3,37900,-0.00450672612890214,0.00351556952812672,-0.0113972424040305,0.00238379014622622,0.1998880967421
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40489,-0.00389575663244248,0.00304475853076165,-0.00986348335273531,0.00207197008785036,0.200740926641399
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,0.00303086482619085,0.00237512400715421,-0.0016243782278314,0.00768610788021311,0.201943253618746
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBM25,RNA-binding protein 25,37482,0.00557908385885115,0.00439767080552979,-0.00304035091998724,0.0141985186376895,0.204590307209675
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPA2,Replication protein A 32 kDa subunit,37598,-0.00390916765936849,0.00308882356191698,-0.00996326184072576,0.00214492652198878,0.205684257251629
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRG3,Proteoglycan 3,37998,0.00598102007444039,0.00473781885571502,-0.00330510488276105,0.0152671450316418,0.206826807744289
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHPK,Sedoheptulokinase,37714,-0.00511627366778842,0.00406661753490286,-0.013086844036198,0.0028542967006212,0.208372217051165
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCUN1D1,DCN1-like protein 1,37541,-0.00888800938046831,0.0071051978859715,-0.0228141972369724,0.00503817847603583,0.210987296835657
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CREBZF,CREB/ATF bZIP transcription factor,37482,0.00313098400243582,0.00250363099367145,-0.00177613274516022,0.00803810075003186,0.21111120567477
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MORN4,MORN repeat-containing protein 4,37482,-0.00934814033281268,0.00748855833325043,-0.0240257146659835,0.00532943400035816,0.211935188735079
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH4,Cadherin-4,37541,-0.00586565471777558,0.0047059438980485,-0.0150893047579506,0.00335799532239949,0.212626925107596
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF12,Fibroblast growth factor 12,37598,0.00569086142986632,0.00456735431998536,-0.003261153037305,0.0146428758970376,0.212791587329308
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37572,0.00463452273483199,0.00372347997214008,-0.00266349801056257,0.0119325434802266,0.213273442165029
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDC4,Syndecan-4,40359,-0.00525933650005147,0.00424591474459949,-0.0135813293994665,0.00306265639936352,0.215481710894804
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37901,-0.0114029787054522,0.00925606208285943,-0.0295448603878567,0.00673890297695227,0.217990389402992
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTR,Methionine synthase,37562,-0.00761432919442902,0.00619319904342716,-0.0197529993195463,0.00452434093068822,0.218919109434635
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,0.00569882354824986,0.00465462723922663,-0.00342424584063433,0.0148218929371341,0.220847821333487
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PYDC1,Pyrin domain-containing protein 1,37628,-0.00493352752799048,0.00404042226684908,-0.0128527551710147,0.00298570011503371,0.222091756688152
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,-0.0108779521554674,0.00898260089247956,-0.0284838499047273,0.00672794559379256,0.225915726798686
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNW1,Interferon omega-1,37562,0.0042070919773102,0.00348299338149755,-0.002619575050425,0.0110337590050454,0.227109255815765
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL34,Interleukin-34,39934,-0.00404853597371499,0.00337026496076924,-0.0106542552968227,0.00255718334939273,0.229672018572579
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ROBO4,Roundabout homolog 4,37628,-0.00202364236313452,0.00169107781831719,-0.00533815488703622,0.00129087016076718,0.231461284985386
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPVL,Probable serine carboxypeptidase CPVL,40465,-0.00452166158632191,0.00380345082534859,-0.0119764252040051,0.00293310203136132,0.234523667488815
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RUVBL1,RuvB-like 1,39980,-0.0120167720622854,0.0101156506055573,-0.0318434472491776,0.00780990312460683,0.234875760887522
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP1B4,Protein ATP1B4,37482,0.00475824128279351,0.0040129859537609,-0.00310721118657786,0.0126236937521649,0.235758101034676
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRP2BP,LRP2-binding protein,37572,-0.00977270247722387,0.00825044262138559,-0.0259435700151396,0.0063981650606919,0.236234102681392
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GH1,Somatotropin,40330,-0.0194503497258926,0.0164348579225023,-0.0516626712539972,0.012761971802212,0.236636106403168
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPM1A,Protein phosphatase 1A,39980,0.00345619215562311,0.00292097502588559,-0.00226891889511266,0.00918130320635887,0.236735188483235
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,-0.00209971401467578,0.00177975666947981,-0.0055880370868562,0.00138860905750465,0.238107056530592
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCG3,Secretogranin-3,40379,0.00369948235760833,0.0031359161290996,-0.00244691325542689,0.00984587797064354,0.238131832987389
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM171B,Protein FAM171B,37900,-0.00308908522163716,0.00262145305446891,-0.00822713320839623,0.00204896276512191,0.238663357167041
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXK,Tyrosine-protein kinase TXK,37714,-0.00842476378574477,0.00719987086162706,-0.0225365106745338,0.00568698310304426,0.241970863875489
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37598,0.00557467465819786,0.0047829792312652,-0.00379996463508194,0.0149493139514777,0.243828303179547
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37942,0.00723397040920826,0.00621149309673275,-0.00494055606038794,0.0194084968788045,0.244197264850079
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,-0.0122506432468899,0.01053116990101,-0.0328917362528696,0.00839044975908976,0.244735974403703
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40536,-0.00244700297320732,0.00212238374093571,-0.00660687510544131,0.00171286915902668,0.248947918192897
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PKD1,Polycystin-1,37990,-0.00279989895576349,0.00244545813909872,-0.00759299690839698,0.00199319899687,0.252254911639376
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,-0.00416440261291004,0.00364716927225161,-0.0113128543865232,0.00298404916070312,0.253550112749662
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMP2,Metalloproteinase inhibitor 2,37990,-0.00269023145096653,0.00236041661195193,-0.00731664801039231,0.00193618510845926,0.254420059034827
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40536,0.00353348968085369,0.00310606171167151,-0.00255439127402246,0.00962137063572984,0.255299936450622
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CX3CL1,Fractalkine,40228,0.00363159375548606,0.0032064193376543,-0.00265298814631637,0.00991617565728849,0.257399060887483
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,-0.0100545272702953,0.00888609998072119,-0.0274712832325089,0.00736222869191822,0.257869833797305
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC4A1,Band 3 anion transport protein,37998,0.00491131943589781,0.00436944141234294,-0.00365278573229435,0.01347542460409,0.261026411147014
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLU,Clusterin,38013,0.00352292054596255,0.00313532618827874,-0.00262231878306379,0.00966815987498889,0.261193435945009
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNPY2,Protein canopy homolog 2,40042,-0.00644765395699492,0.00574670129396098,-0.0177111884931584,0.0048158805791686,0.261890440381266
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,0.00276620095616666,0.00246876968814167,-0.002072587632591,0.00760498954492433,0.262530270757182
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,0.00332480016932647,0.002968638518297,-0.00249373132653565,0.00914333166518859,0.262741247708015
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VIT,Vitrin,37990,-0.00388913208913545,0.00348435326929288,-0.0107184644969495,0.00294020031867859,0.264368999514832
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,-0.00733084627688708,0.00658980098296361,-0.0202468562034957,0.0055851636497216,0.26596343523824
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EVI2B,Protein EVI2B,37482,-0.00443659566480047,0.00399954443825362,-0.0122757027637776,0.00340251143417661,0.267331930243872
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A3,Protein S100-A3,37900,0.00480871055496125,0.00434882209026886,-0.00371498074196572,0.0133324018518882,0.268854470203371
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37562,-0.00400229962645658,0.0036272829917659,-0.0111117742903177,0.00310717503740459,0.269879066016585
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC2L,C-type lectin domain family 2 member L,37572,-0.00519694732504124,0.00471335677598439,-0.0144351266059706,0.00404123195588815,0.270221121594881
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37942,0.00477385141925914,0.00433797889314392,-0.00372858721130294,0.0132762900498212,0.271143437726553
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,40330,-0.00499963889445566,0.00456746685921372,-0.0139518739385146,0.00395259614960323,0.273699915282533
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDHR1,Cadherin-related family member 1,39961,-0.0045063193930471,0.00412954169657069,-0.0126002211183257,0.00358758233223145,0.275184423542477
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGLON5,IgLON family member 5,37482,0.00973339752887427,0.00894139599212372,-0.00779173861568823,0.0272585336734368,0.276360621833755
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6V1D,V-type proton ATPase subunit D,40305,-0.00268621754272333,0.002470984548014,-0.00752934725683076,0.0021569121713841,0.277007314611908
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POMC,Pro-opiomelanocortin,37628,0.00699654550468903,0.00644631096345328,-0.0056382239836794,0.0196313149930575,0.277783648050696
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BMP4,Bone morphogenetic protein 4,40203,-0.00462155038488788,0.00426114908956873,-0.0129734026004426,0.00373030183066683,0.278125013418567
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAA4,Serum amyloid A-4 protein,38013,0.00335511193995382,0.00309409958720579,-0.00270932325096953,0.00941954713087718,0.27822533271246
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CABP2,Calcium-binding protein 2,37572,-0.00672257927797167,0.00620191556909942,-0.0188783337934065,0.00543317523746318,0.278405965214127
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,0.00485586111728799,0.00449138389502761,-0.00394725131696613,0.0136589735515421,0.279649517236963
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DHODH,Dihydroorotate dehydrogenase,37562,-0.00494479198338704,0.00457504442371004,-0.0139118790538587,0.00402229508708464,0.279797803994962
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEG1,Protein LEG1 homolog,37231,0.00711840943440622,0.00660320734052458,-0.00582387695302195,0.0200606958218344,0.281043837283998
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMEM25,Transmembrane protein 25,37959,-0.00445161311242947,0.00414994611193693,-0.0125855074918259,0.00368228126696691,0.28342859084013
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL9A1,Collagen alpha-1(IX) chain,40341,0.00473324558101879,0.00442333212818867,-0.003936485390231,0.0134029765522686,0.284607050736716
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF6,Fibroblast growth factor 6,37598,0.00432676339384226,0.00407578205331281,-0.00366176943065085,0.0123152962183354,0.288446491551913
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYL6B,Myosin light chain 6B,37572,-0.00931468469687144,0.00878708824990591,-0.026537377666687,0.00790800827294414,0.289144897857689
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HCG22,Protein PBMUCL2,37562,0.00535236951332989,0.00505512081909773,-0.00455566729210166,0.0152604063187614,0.289709697211215
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC123,Cell division cycle protein 123 homolog,37482,-0.00641972601439479,0.00608505332873344,-0.0183464305387123,0.00550697850992274,0.29144528025054
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,-0.00252193359295255,0.00239753884331849,-0.0072211097258568,0.00217724253995169,0.292872151640318
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,0.00686391328549785,0.00654816785790078,-0.00597049571598768,0.0196983222869834,0.294556602989819
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,-0.00403645722346345,0.0038520396161619,-0.0115864548711408,0.00351354042421388,0.294715374783673
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPT,Microtubule-associated protein tau,39961,-0.00514922621940101,0.00499228935809374,-0.0149341133612647,0.00463566092246271,0.302352560408291
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLSPN,Claspin,39925,-0.00330230694596784,0.00320483982847992,-0.00958379300978847,0.0029791791178528,0.302832524725949
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,0.00430367329075742,0.00417676815600303,-0.00388279229500852,0.0124901388765234,0.302848990543128
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,0.00635152312571486,0.00619554974577074,-0.00579175437599579,0.0184948006274255,0.305299536066008
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRX,Cone-rod homeobox protein,40042,-0.0103619386484415,0.0101096018008526,-0.0301767581781125,0.00945288088122952,0.305397909525738
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,37541,-0.00389761114807799,0.00381805281559459,-0.0113809946666434,0.00358577237048739,0.307350344246861
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,37482,-0.00477175972035905,0.00468156198259142,-0.0139476212062382,0.00440410176552013,0.308095344647694
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TEX101,Testis-expressed protein 101,37572,0.00379158570494375,0.003730804173103,-0.00352079047433812,0.0111039618842256,0.309509190668798
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,37482,-0.00572509009452491,0.00563854091354342,-0.01677663028507,0.0053264500960202,0.309958075548407
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,-0.0113658724627517,0.0112199849512888,-0.0333570429672778,0.0106252980417744,0.311074364081318
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKD2,Serine/threonine-protein kinase D2,37562,-0.00451011240590266,0.0044845384566103,-0.0132998077808589,0.00427958296905352,0.314577168574371
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37692,-0.00531010230916015,0.00528700414647144,-0.0156726304362442,0.00505242581792387,0.315219210607744
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHD,SH2 domain-containing adapter protein D,37531,-0.00833210852337987,0.00830983685943672,-0.0246193887678758,0.0079551717211161,0.316033757003329
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,37541,0.00604813452657023,0.00604844144006133,-0.00580681069594999,0.0179030797490904,0.317353550200632
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK3,Prostate-specific antigen,37998,0.00540900976648424,0.00541175181949648,-0.00519802379972885,0.0160160433326973,0.31757362932475
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSTN,Osteocrin,37572,-0.00404727882264094,0.00408718215545396,-0.0120581558473307,0.00396359820204882,0.322076573939234
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,0.00283149793879141,0.00286326550561035,-0.00278050245220487,0.00844349832978769,0.32272792455636
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,-0.00248416008260603,0.0025141102950192,-0.00741181626084367,0.0024434960956316,0.323128314613939
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,37541,-0.004657952732721,0.0047340342825782,-0.0139366599265743,0.00462075446113228,0.325168702377949
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KCNIP4,Kv channel-interacting protein 4,39961,-0.00474547601241303,0.00482342723173692,-0.0141993933866174,0.00470844136179133,0.325210008662116
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL25,Interleukin-25,37429,-0.00324925036791073,0.00331505978528034,-0.00974676754706021,0.00324826681123874,0.327031169249763
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PFDN6,Prefoldin subunit 6,37572,-0.00615122440564765,0.0062809783578986,-0.0184619419871289,0.00615949317583359,0.327429200458632
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF7,Fibroblast growth factor 7,37482,-0.00752464545830774,0.00769204797157128,-0.0226010594825875,0.00755176856597197,0.32797531262568
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,-0.00393728178929852,0.00403785542586219,-0.0118514784239884,0.00397691484539136,0.329531933575724
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPM3,Tropomyosin alpha-3 chain,37562,-0.00390055608829758,0.00401499989749511,-0.011769955887388,0.00396884371079283,0.331319298616989
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDAN1,Codanin-1,37942,0.00213480980441247,0.00219882464345394,-0.00217488649675725,0.00644450610558219,0.33162206324812
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGBL2,Cytosolic carboxypeptidase 2,37541,0.00839863911227126,0.00865217611595995,-0.00855962607501025,0.0253569042995528,0.331717254781982
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRNN,Cornulin,39857,0.00603248599322169,0.00623245329481332,-0.00618312246461242,0.0182480944510558,0.333101940554477
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,-0.00241381755644049,0.00250362829383962,-0.00732092901236614,0.00249329389948517,0.334999094105181
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGM2,Phosphoglucomutase-2,37572,0.00547693554674029,0.00569722860245514,-0.00568963251407178,0.0166435036075524,0.336402328302802
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PROC,Vitamin K-dependent protein C,40372,0.00227051070492825,0.00237243317256582,-0.00237945831330075,0.00692047972315725,0.338562181232486
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,0.00796385270658276,0.00832449831447868,-0.00835216398979546,0.024279869402961,0.338745096793164
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLAU,Urokinase-type plasminogen activator,40332,0.00263706602911281,0.00275660618795281,-0.0027658820992747,0.00804001415750031,0.338766066957151
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39897,-0.0051451496742315,0.00538562607940841,-0.015700976789872,0.00541067744140898,0.339416452089841
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRDT,Bromodomain testis-specific protein,37562,-0.00333731454549827,0.00351651357471128,-0.0102296811519324,0.00355505206093584,0.342617400251317
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MGLL,Monoglyceride lipase,40396,-0.00766655149511251,0.00809987331590864,-0.0235423031942934,0.00820920020406842,0.343906619265694
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL21R,Interleukin-21 receptor,37598,0.0050152535652215,0.0053067700984274,-0.00538601582769621,0.0154165229581392,0.344642014941704
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERVV_1,,37562,0.00429802515946372,0.00457502234872041,-0.00466901864402829,0.0132650689629557,0.347514770149569
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPSG1,Tryptase gamma,37598,0.00242528440039582,0.00258606296033806,-0.00264339900186678,0.00749396780265842,0.348349611743549
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATRN,"Attractin, Isoform 2",38013,-0.00144835241960017,0.00154800589075035,-0.00448244396547085,0.00158573912627051,0.349483155484064
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYOM1,Myomesin-1,37541,-0.00415943455092739,0.00444635467724362,-0.0128742897183249,0.00455542061647011,0.349563031179719
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZPR1,Zinc finger protein ZPR1,37541,-0.0086385171861388,0.00923654739264692,-0.0267421500757268,0.00946511570344915,0.349674708888858
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,37482,0.00415989329344582,0.00445931908846131,-0.00458037211993834,0.01290015870683,0.350912681772703
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,0.00405376039361911,0.00434762781615453,-0.00446759012604377,0.012575110913282,0.351143140272453
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,0.00247708464002888,0.00266931126866542,-0.00275476544655534,0.00770893472661309,0.35343164520775
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CENPJ,Centromere protein J,37714,-0.00644842080312646,0.0069533543540678,-0.0200769953370993,0.00718015373084642,0.353744726398318
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUSP3,Dual specificity protein phosphatase 3,39961,-0.00736313634210988,0.0079645971082719,-0.0229737466743228,0.00824747399010305,0.355249170071516
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37572,-0.00683393609018568,0.00741524726431497,-0.021367820728243,0.00769994854787166,0.356751093467425
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,-0.00322107080683432,0.00349672476318501,-0.0100746513426769,0.0036325097290083,0.356979196928567
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,-0.00735169930390233,0.00798879956833196,-0.023009746457833,0.00830634785002831,0.357458638260431
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,0.00762244381363568,0.00833218871724669,-0.00870864607216783,0.0239535336994392,0.360300539548832
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPHA2,Glycoprotein hormone alpha-2,37901,-0.00424029927564844,0.00464348152000608,-0.0133415230548604,0.00486092450356348,0.361168234028274
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALY,Neuron-specific vesicular protein calcyon,37562,0.0032889443978219,0.00362099724434482,-0.00380821020109396,0.0103860989967378,0.363737517923168
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,0.00614816691006566,0.00677334843166986,-0.00712759601600727,0.0194239298361386,0.364050512436274
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC44A4,Choline transporter-like protein 4,37572,-0.00603632083587891,0.00665448410628074,-0.0190791096841892,0.00700646801243134,0.364367534236497
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSLNL,Mesothelin-like protein,37572,0.00323885665990571,0.00357082280640511,-0.00375995604064832,0.0102376693604597,0.364405629116688
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,0.00263754015778754,0.0029130222435183,-0.00307198343950833,0.0083470637550834,0.36525123529309
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSP90B1,Endoplasmin,39878,-0.00594949150670994,0.00659038824369946,-0.0188666524643609,0.006967669450941,0.366671197261213
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,-0.0103128573038961,0.0114837592227459,-0.032821025380478,0.0121953107726858,0.369178659928601
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZP4,Zona pellucida sperm-binding protein 4,37482,0.00277083782753598,0.00308876907442534,-0.00328314955833769,0.00882482521340965,0.369698872964915
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP15,Matrix metalloproteinase-15,37990,-0.00421188146634702,0.00471820689463653,-0.0134595669798346,0.00503580404714058,0.372040736942983
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37598,-0.00188339214789396,0.0021194202715383,-0.00603745588010902,0.00227067158432111,0.374215251005763
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,-0.00663895277553493,0.00751185728071194,-0.0213621930457303,0.00808428749466047,0.376821902955206
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37883,-0.00351315509226963,0.00398568018748218,-0.0113250882597347,0.00429877807519545,0.378093161161038
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPAN7,Tetraspanin-7,37541,0.00751318464531101,0.00870516393215979,-0.00954893666172217,0.0245753059523442,0.388113606769447
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCC,Netrin receptor DCC,37572,-0.0019133159100012,0.00221755127752124,-0.00625971641394283,0.00243308459394043,0.388260068658335
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,-0.00707359480374652,0.00825032302890661,-0.0232442279404035,0.00909703833291043,0.391252585176875
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,0.00292592156538514,0.00342479757488315,-0.00378668168138584,0.00963852481215611,0.392935474740052
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,37541,0.00574945415983419,0.00674296803694072,-0.00746676319256963,0.018965671512238,0.393863889176049
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SKIV2L,Helicase SKI2W,37562,-0.00326164957556494,0.00384106193306632,-0.0107901309643749,0.00426683181324505,0.39581162210874
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37562,0.00393290259551684,0.00463814628202327,-0.00515786411724877,0.0130236693082824,0.396482923975437
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL24,Interleukin-24,40044,-0.00392251076286827,0.00462674511577848,-0.0129909311897941,0.00514590966405755,0.396567643330053
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AIF1L,Allograft inflammatory factor 1-like,37628,-0.00464236611427005,0.0054858992681969,-0.015394728679936,0.00610999645139587,0.397436403777476
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,-0.00477163631593589,0.00567613501686857,-0.0158968609489983,0.00635358831712651,0.400560020740536
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,-0.00392146815858534,0.0047002855912572,-0.0131340279174495,0.00529109160027877,0.404124862796226
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,0.00529945891262108,0.00635931218123819,-0.00716479296260577,0.0177637107878479,0.40466909813561
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39980,-0.00358720923992144,0.00431345026294906,-0.0120415717553016,0.00486715327545872,0.405628700562821
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COMMD9,COMM domain-containing protein 9,37900,0.00308360786866862,0.00371551707644687,-0.00419880560116725,0.0103660213385045,0.406594801259655
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37562,0.00304435929667401,0.00369558131124956,-0.00419898007337513,0.0102876986667231,0.410077510269985
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCARE,Photoreceptor cilium actin regulator,37541,-0.00668424341801313,0.00818570038154032,-0.0227282161658322,0.0093597293298059,0.41418584972238
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,-0.0060049295319469,0.00736591183789825,-0.0204421167342275,0.00843225767033366,0.414953767866304
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UNG,Uracil-DNA glycosylase,37900,-0.00261401015543941,0.0032086306965129,-0.0089029263206047,0.00367490600972588,0.415269413392953
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,-0.00560965127483164,0.00693929413825215,-0.0192106677858059,0.00799136523614258,0.41888118986789
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1R,Complement C1r subcomponent,38013,-0.00152358429693391,0.00188560934266883,-0.00521937860856482,0.002172210014697,0.419101107607866
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF3,Fibroblast growth factor 3,37598,-0.00232331496006067,0.00288712166552372,-0.00798207342448716,0.00333544350436582,0.420997745048076
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RTKN2,Rhotekin-2,37562,0.0040116517506092,0.00498599662584654,-0.00576090163605002,0.0137842051372684,0.421074525549078
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,-0.00262495739227532,0.00327425845705932,-0.00904250396811159,0.00379258918356095,0.422741133225418
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37572,-0.00406835096804613,0.00510987944778254,-0.0140837146856999,0.00594701274960766,0.425945561979778
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FZD10,Frizzled-10,37572,-0.0045629706936372,0.00578531161624564,-0.0159021814614787,0.00677624007420426,0.430291976712725
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,-0.00145782631346289,0.00185451826944557,-0.00509268212157621,0.00217702949465042,0.43182595567906
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPCAM,Epithelial cell adhesion molecule,40358,0.00736018924851323,0.00937800615313013,-0.0110207028116218,0.0257410813086483,0.432561893165387
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB5,Serpin B5,40042,-0.00360292996714845,0.00459090391360214,-0.0126011016378086,0.00539524170351173,0.432584224398524
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENOPH1,Enolase-phosphatase E1,37900,0.00425946756845668,0.00542825408894258,-0.00637991044587078,0.0148988455827841,0.432652316875879
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA8,Carbonic anhydrase-related protein,37598,-0.00205921192542366,0.0026354910422214,-0.0072247743681776,0.00310635051733027,0.434617210753912
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NLGN2,Neuroligin-2,37541,-0.00357135458865746,0.00458959479091476,-0.0125669603788504,0.00542425120153547,0.436499611928531
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F13B,Coagulation factor XIII B chain,37934,0.0019007508414961,0.00244453659282775,-0.00289054088044629,0.00669204256343848,0.43684764963588
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,37482,0.00214910896609332,0.00276891300503819,-0.00327796052378154,0.00757617845596818,0.437670858109968
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSC1,Hamartin,37598,-0.00560438247332015,0.0072225916621282,-0.0197606621310914,0.00855189718445112,0.43779144813491
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINF2,Alpha-2-antiplasmin,37755,0.000990623870423076,0.00128603060154847,-0.00152999610861192,0.00351124384945807,0.441138172428382
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAGEA3,Melanoma-associated antigen 3,37714,-0.00616864028368333,0.00802234938172991,-0.021892445071874,0.00955516450450729,0.441947437120042
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MLLT1,Protein ENL,37482,0.00521059098341004,0.00680040414526877,-0.00811820114131676,0.0185393831081368,0.443560574576829
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37901,-0.00190701791773694,0.00250143843379745,-0.00680983724797994,0.00299580141250606,0.445853458824236
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB2B,Ras-related protein Rab-2B,37900,-0.00439628979651105,0.00580272220676448,-0.0157696253217694,0.00697704572874733,0.448688538316184
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,-0.00253134290049428,0.00337289608096109,-0.00914221921917802,0.00407953341818947,0.452969540386856
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37863,-0.00307283391050462,0.00409969045558289,-0.0111082272034471,0.00496255938243785,0.453552010973262
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYH4,Myosin-4,37562,0.00334826355360707,0.00450307901980986,-0.00547777132522027,0.0121742984324344,0.457162201088897
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,0.00672226624797483,0.0090565495297215,-0.0110285708302793,0.024473103326229,0.457946425902657
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCL2,Phosducin-like protein 2,37482,-0.00379861053327233,0.00511901254794283,-0.0138318751272403,0.00623465406069561,0.45806482279828
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB9,Serpin B9,40228,-0.00233066872109658,0.00314614381850412,-0.00849711060536466,0.00383577316317151,0.458824703762888
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,0.00487039334446417,0.00659598402297865,-0.00805773534057398,0.0177985220295023,0.460289672209394
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LMOD2,Leiomodin-2,37541,-0.00454631508515267,0.00617779305103167,-0.0166547894651747,0.0075621592948694,0.461797141177473
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DENND2B,DENN domain-containing protein 2B,37562,0.00363346455106877,0.0049670826821686,-0.00610201750598168,0.0133689466081192,0.464481523464229
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37714,-0.00311548935302713,0.00426623563816542,-0.0114773112038314,0.00524633249777709,0.465240145186309
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLI2,Zinc finger protein GLI2,37598,0.00232428983563819,0.00318920436666832,-0.00392655072303171,0.00857513039430809,0.466137436877132
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPBGL,Trophoblast glycoprotein-like,37572,0.00287591543875153,0.00396623500862025,-0.00489790517814416,0.0106497360556472,0.468403858364523
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSHB,Thyrotropin subunit beta,40359,-0.00568685379998987,0.00787614638990505,-0.0211241007242038,0.00975039312422403,0.470283538417777
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,40042,-0.00429498608946565,0.00597415729821213,-0.0160043343939614,0.00741436221503012,0.472196354363729
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,-0.00386639911202409,0.00537842929631421,-0.0144081205327999,0.00667532230875175,0.472230919432681
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMY2A,Pancreatic alpha-amylase,39695,-0.00318224296780186,0.00442679255202397,-0.0118587563697688,0.00549427043416512,0.472238360429604
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERCC1,DNA excision repair protein ERCC-1,37482,-0.00227517186771516,0.0031883893892308,-0.00852441507060753,0.00397407133517721,0.475499521142894
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37572,-0.00249543178331079,0.00349903982436368,-0.00935354983906361,0.00436268627244202,0.475749441312671
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,0.00244907124686094,0.00343450165274258,-0.00428255199251452,0.0091806944862364,0.475809458218139
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,-0.00584967445553878,0.0082288649637891,-0.0219782497845654,0.0102789008734879,0.4771758365893
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHH,Sonic hedgehog protein,37598,0.00292271765537275,0.0041170498322494,-0.00514670001583607,0.0109921353265816,0.477775130033183
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD109,CD109 antigen,40332,0.00222030193531787,0.00313682436892608,-0.00392787382777725,0.008368477698413,0.479068440509788
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,-0.00217476196295427,0.00307426768137581,-0.00820032661845085,0.00385080269254232,0.479325458232005
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37562,-0.00386121766215192,0.00548857665492369,-0.0146188279058024,0.00689639258149852,0.481756247854019
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IMPA1,Inositol monophosphatase 1,40228,-0.00398668398110209,0.00571262377085888,-0.0151834265719855,0.00721005860978131,0.485267115192726
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,37541,0.00470581680161199,0.00674784180358731,-0.00851995313341914,0.0179315867366431,0.485576762660776
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37572,0.0047812531801167,0.00688224951919879,-0.00870795587751293,0.0182704622377463,0.487241564387415
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,-0.00250957877263779,0.00361653386017064,-0.00959798513857224,0.00457882759329666,0.487745783860381
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37714,-0.00490923114477705,0.00708723250162314,-0.0188002068479584,0.00898174455840431,0.48851836486053
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPGN,Epigen,37900,-0.00323339883403515,0.00468538760287326,-0.0124167585356667,0.00594996086759645,0.490141487637538
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,-0.00317476431355394,0.00460288999713159,-0.0121964287079319,0.00584690008082398,0.490374428704289
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP290,Centrosomal protein of 290 kDa,37714,-0.00348633252979827,0.00505609996934028,-0.0133962884697052,0.00642362341010867,0.490501875478003
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRTAP,Cartilage-associated protein,37572,-0.00316655751984764,0.00459606264082553,-0.0121748402958657,0.00584172525617041,0.490853201393845
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,0.00270094969224473,0.00392196692479053,-0.00498610548034471,0.0103880048648342,0.491041764015003
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,-0.00236761509744049,0.00343810505264688,-0.00910630100062838,0.0043710708057474,0.491062281633442
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLK,STE20-like serine/threonine-protein kinase,37714,-0.00505973907529551,0.00737281918399348,-0.0195104646759227,0.00939098652533171,0.492555334998772
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC25A,M-phase inducer phosphatase 1,37482,-0.00266805521731043,0.00388811833123466,-0.0102887671465304,0.00495265671190951,0.492594599270243
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PVALB,Parvalbumin alpha,40417,0.00725018571046803,0.0105911067340264,-0.0135083834882238,0.0280087549091598,0.49363526658336
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD86,T-lymphocyte activation antigen CD86,37901,-0.00188530253058923,0.0027693757838663,-0.00731327906696718,0.00354267400578871,0.496029994377154
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,0.00429544261369753,0.00634034300088617,-0.00813162966803936,0.0167225148954344,0.498114707113274
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TEF,Thyrotroph embryonic factor,37562,-0.00275452823128605,0.0040750055532924,-0.0107415391157392,0.00523248265316706,0.499079916323126
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK12,Kallikrein-12,39980,-0.00910572569533401,0.0134822513003692,-0.0355309382440576,0.0173194868533896,0.499440524376464
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPAN15,Tetraspanin-15,37562,0.00325452850914588,0.00483170300017705,-0.00621560937120113,0.0127246663894929,0.500591562323679
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,0.00500605750704095,0.00744817251607971,-0.00959236062447528,0.0196044756385572,0.50151984163863
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,-0.00410663056408387,0.0061183763288672,-0.0160986481686636,0.00788538704049585,0.502107278305663
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ID4,DNA-binding protein inhibitor ID-4,37714,0.00289588976931997,0.00432074315079025,-0.00557276680622892,0.0113645463448689,0.502723134659682
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHC1,SHC-transforming protein 1,37482,-0.00739537383175786,0.0110858780525989,-0.0291236948148517,0.014332947151336,0.504720961364228
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,0.00226431322581329,0.00342560053029242,-0.00444986381355986,0.00897849026518644,0.508623426243184
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM171A2,Protein FAM171A2,37959,-0.0100710131168802,0.0152386718592087,-0.0399388099609292,0.0197967837271688,0.508697192064054
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRTG,Protogenin,40489,0.00155609156973257,0.00236240699268619,-0.00307422613593235,0.00618640927539749,0.510104935469595
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37598,-0.00183015209931406,0.00278759107305892,-0.00729383060250954,0.00363352640388143,0.511491218037323
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,0.00219869362981196,0.00335662862062515,-0.00438029846661333,0.00877768572623724,0.512457914763838
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37900,-0.00356234875924974,0.00544626047306761,-0.0142370192864623,0.00711232176796278,0.513064506246293
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANKRA2,Ankyrin repeat family A protein 2,37482,0.0034715162227055,0.00535837169329825,-0.00703089229615907,0.0139739247415701,0.517081904946371
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,METAP1,Methionine aminopeptidase 1,39961,-0.00184794742874509,0.00288636070876947,-0.00750521441793326,0.00380931956044307,0.522029677116046
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTF3,Neurotrophin-3,40341,0.00209844531723806,0.00327801799581753,-0.00432646995456429,0.00852336058904041,0.522079934029622
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,40203,0.00201082080813818,0.00315132489639635,-0.00416577598879867,0.00818741760507503,0.523426044134094
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUOX2,Dual oxidase 2,40042,0.00430216667983718,0.00682052873054362,-0.0090660696320283,0.0176704029917027,0.528201915625457
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCT,Secretin,37572,-0.00273816691674716,0.0043577627522803,-0.0112793819112165,0.00580304807772223,0.529790627507637
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KHDC3L,KH domain-containing protein 3,37482,0.00406642551300634,0.00647526673377729,-0.00862509728519715,0.0167579483112098,0.530019194567541
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37714,-0.005049945205941,0.00805535810236977,-0.0208384470865858,0.0107385566747038,0.53073222497406
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTPN,Myotrophin,40042,-0.00194836810897943,0.00311517858516739,-0.00805411813590752,0.00415738191794866,0.531689193262901
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA13,Carbonic anhydrase 13,40173,-0.00607437902354913,0.00972455226668808,-0.0251345014662578,0.0129857434191595,0.532214083478129
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,0.00210915069026825,0.00338681026651137,-0.00452899743209404,0.00874729881263053,0.533455095085103
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EXTL1,Exostosin-like 1,37562,0.00280637880324595,0.00451497120128097,-0.00604296475126475,0.0116557223577566,0.534234272729069
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRD3,Bromodomain-containing protein 3,37562,-0.00284396751787485,0.00457983931075189,-0.0118204525669486,0.00613251753119887,0.534626609175958
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDSN,Corneodesmosin,40456,-0.00250147494586276,0.0040538805979103,-0.0104470809177669,0.00544413102604142,0.53720598189513
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,40357,0.0015416624953294,0.00250116864271277,-0.00336062804438764,0.00644395303504644,0.537654638018539
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIRREL1,Kin of IRRE-like protein 1,37541,0.00359922716765093,0.00586633758596878,-0.00789879450084789,0.0150972488361497,0.539530634627607
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL13,Interleukin-13,40044,-0.00275306216791641,0.00449935859958824,-0.0115718050231094,0.00606568068727654,0.540626866703254
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37562,-0.00559333142134268,0.00919813491345856,-0.0236216758517215,0.0124350130090361,0.543135610037106
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37562,-0.00236571998712577,0.00389682896282726,-0.0100035047542672,0.00527206478001565,0.543802705969948
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FRMD4B,FERM domain-containing protein 4B,37562,-0.00401447536310125,0.00664994291117218,-0.0170483634689987,0.00901941274279622,0.546063075808394
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,37541,0.00189748773834793,0.00315730801837254,-0.00429083597766224,0.0080858114543581,0.547861865003752
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,-0.00221023403438093,0.00372088725727464,-0.00950317305863924,0.00508270498987737,0.552515922884142
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,-0.00231994759023638,0.0039079923946093,-0.00997961268367061,0.00533971750319784,0.552761850135835
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPESP1,Sperm equatorial segment protein 1,37990,-0.00154064265758555,0.00260965740247656,-0.0066555711664396,0.00357428585126851,0.554957810981499
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFR4,Fibroblast growth factor receptor 4,37671,-0.00296658790438996,0.00507277386618154,-0.0129092246821058,0.00697604887332585,0.558688241907159
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTNL10,Butyrophilin-like protein 10,37482,-0.00231723223821351,0.00397293653412406,-0.0101041878450967,0.00546972336866965,0.559732229920806
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CORO6,Coronin-6,37541,-0.00201796161779139,0.00346213631033646,-0.00880374878605084,0.00476782555046807,0.559993536997255
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MUCL3,Mucin-like protein 3,37482,-0.00249084378676424,0.00427831812739657,-0.0108763473164615,0.00589465974293304,0.560440948854966
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACE,Angiotensin-converting enzyme,37987,-0.00141027681258865,0.00242273936179712,-0.006158845961711,0.00333829233653371,0.560508956572548
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DIABLO,"Diablo homolog, mitochondrial",40314,0.00595802558062383,0.0102674214249084,-0.0141661204121966,0.0260821715734442,0.561731016402277
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,-0.00174519263294039,0.00301605595985167,-0.00765666231424966,0.00416627704836889,0.5628444927373
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB118,Beta-defensin 118,37541,0.00319475149201864,0.00553706257692702,-0.00765789115875832,0.0140473941427956,0.563965679701374
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,-0.00349085185551748,0.00605415354672295,-0.0153569928070945,0.0083752890960595,0.564216480712792
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENO1,Alpha-enolase,40299,-0.00428823271823322,0.00743826048635492,-0.0188672232714889,0.0102907578350224,0.564278594926989
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNC,Tenascin,40403,0.00255013547573828,0.00444699978329524,-0.00616598409952039,0.011266255050997,0.566347603519172
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCN,Decorin,40042,0.0012041570633642,0.00214358696930196,-0.00299727339646764,0.00540558752319603,0.574295365228371
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FN1,Fibronectin,38013,0.00138878036898698,0.00248068144533043,-0.00347335526386066,0.00625091600183462,0.575599015092915
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACHE,Acetylcholinesterase,37671,0.00169336104545926,0.00302831919588453,-0.00424214457847443,0.00762886666939294,0.576051617615271
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,0.00165488119111623,0.00296098878482467,-0.00414865682714012,0.00745841920937258,0.576241396138526
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,-0.00182690879396346,0.00327187021470866,-0.00823977441479243,0.00458595682686551,0.576602457182493
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,0.00917563588620481,0.0164379396745119,-0.0230427258758386,0.0413939976482482,0.57671802837282
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP9,Fatty acid-binding protein 9,40341,-0.00291795794073842,0.00524158713356563,-0.0131914687225271,0.0073555528410502,0.577744639983662
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOLR3,Folate receptor gamma,40355,-0.00960975014883025,0.0173139729790974,-0.0435451371878612,0.0243256368902007,0.578882905970669
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMY2B,Alpha-amylase 2B,39311,-0.00250912356152626,0.004534079386311,-0.0113959191586958,0.00637767203564329,0.580003296315401
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37900,0.00222991040112669,0.00404223501359774,-0.00569287022552488,0.0101526910277783,0.581195396767598
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PXDNL,Peroxidasin-like protein,37900,0.00305115764893512,0.00554782895744613,-0.00782258710765929,0.0139249024055295,0.582346839219722
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,-0.00222507666756188,0.00404972591521075,-0.010162539461375,0.00571238612625119,0.582712243730098
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,0.00445751929790278,0.00813553415569715,-0.0114881276472636,0.0204031662430692,0.583763449403645
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNF174,Zinc finger protein 174,37598,-0.00201277379226815,0.00367833019209428,-0.00922230096877294,0.00519675338423665,0.584252210261391
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNMA2,Paraneoplastic antigen Ma2,37541,-0.00222741229890536,0.00412801136183347,-0.010318314568099,0.00586348997028824,0.589492561099972
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,-0.00242119437758693,0.00449125297772143,-0.0112240502139209,0.00638166145874707,0.589833170710895
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAGLN3,Transgelin-3,37482,-0.00311078426468937,0.00579049187458419,-0.0144601483388744,0.00823857980949564,0.591122896669485
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENO2,Gamma-enolase,40471,-0.00330518023224574,0.0061659927533289,-0.0153905260287704,0.00878016556427891,0.591942666396149
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDKL5,Cyclin-dependent kinase-like 5,37541,-0.0027376981381523,0.0051556214512827,-0.0128427161826664,0.0073673199063618,0.595419301471624
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NME1,Nucleoside diphosphate kinase A,37598,0.00109291450977295,0.00207975833079933,-0.00298341181859374,0.00516924083813965,0.59924401294957
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MN1,Transcriptional activator MN1,37572,0.0029496711492688,0.00566663571418304,-0.00815693485052996,0.0140562771490676,0.602700885266592
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,-0.00217485853479787,0.00422814519706603,-0.0104620231210473,0.00611230605145156,0.606997431691314
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AFAP1,Actin filament-associated protein 1,37671,0.00412254896307654,0.00802742263591449,-0.0116111994033159,0.0198562973294689,0.607569472461347
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39961,0.00269050586608023,0.00525637370080654,-0.0076119865875006,0.0129929983196611,0.608759155609419
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,-0.00321338176767273,0.00637983538658314,-0.0157178591253757,0.00929109559003022,0.61449492158646
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL9,Interleukin-9,37714,0.00273094954426665,0.00545536023053063,-0.00796155650757338,0.0134234555961067,0.616661458369101
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37598,0.00295710915131469,0.00592124278225365,-0.00864852670190247,0.0145627450045319,0.617501158568186
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4C,C-type lectin domain family 4 member C,40341,-0.00213102882803199,0.00428228275004967,-0.0105243030181294,0.00626224536206537,0.618745738679937
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,0.00294648947472209,0.00592608443688705,-0.00866863602157652,0.0145616149710207,0.619051565357423
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,-0.00559399431003017,0.0112650053459194,-0.0276734047880322,0.0164854161679719,0.619491136191077
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FRZB,Secreted frizzled-related protein 3,40176,0.00122723562116528,0.00249944739106511,-0.00367168126532233,0.00612615250765289,0.623431332747244
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HBZ,Hemoglobin subunit zeta,37990,0.00483700963787306,0.00992895020481508,-0.0146237327635645,0.0242977520393106,0.626151248575207
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,-0.00131892883561863,0.00271209611091892,-0.00663463721301971,0.00399677954178244,0.626753031897496
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,0.00232654261909688,0.00480021506820458,-0.00708187891458409,0.0117349641527778,0.627915163239125
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HIP1,Huntingtin-interacting protein 1,37562,0.00154114881185906,0.00322139094731946,-0.00477277744488709,0.00785507506860521,0.632365695339097
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFP,Properdin,38013,0.000979178984148983,0.00206879511805991,-0.00307565944724845,0.00503401741554641,0.636000486270259
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMOD4,Tropomodulin-4,37482,-0.00187663591006908,0.00397383831753456,-0.00966535901243681,0.00591208719229866,0.636757921996884
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,-0.00482885694227512,0.0102570719802522,-0.0249327180235693,0.0152750041390191,0.637803617950759
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRD2,Bromodomain-containing protein 2,37541,-0.001542217541459,0.00328234568354994,-0.00797561508121688,0.00489117999829889,0.638468400808275
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37562,-0.00144954739141057,0.00310435171379649,-0.00753407675045169,0.00463498196763054,0.64055024258904
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PALLD,Palladin,37598,0.0018352333657922,0.0039337084013106,-0.00587483510077657,0.00954530183236096,0.640836563197236
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH23,Cadherin-23,37942,0.00116320470623786,0.00250288285294348,-0.00374244568553136,0.00606885509800709,0.642120888495581
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FH,"Fumarate hydratase, mitochondrial",37541,-0.0037706965863278,0.00813118865884732,-0.0197078263576686,0.0121664331850129,0.642847108239261
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RRP15,RRP15-like protein,37541,0.00393983430132825,0.00866245681415252,-0.0130385810544107,0.0209182496570672,0.649248302385099
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VIM,Vimentin,40042,-0.00497748818639513,0.011135248023338,-0.0268025743121376,0.0168475979393473,0.65487917384005
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,-0.00232281245456343,0.00520278022715349,-0.0125202616997843,0.00787463679065742,0.655275242178615
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUSD5,Sushi domain-containing protein 5,37604,0.0014349396959182,0.00324643496872782,-0.00492807284278833,0.00779795223462473,0.658493031964297
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN3B,Sodium channel subunit beta-3,37541,0.00192797738702066,0.00436221820586691,-0.00662197029647849,0.0104779250705198,0.658516921909255
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB7,Integrin beta-7,40489,0.00188436101010099,0.00427224770874205,-0.00648924449903342,0.0102579665192354,0.659168146272152
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB6,Integrin beta-6,40044,0.00124583726570256,0.00282778564817009,-0.00429662260471081,0.00678829713611592,0.659530498986214
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,-0.00111764657620289,0.00254595595425336,-0.00610772024653947,0.00387242709413368,0.660676552176158
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OMP,Olfactory marker protein,37541,0.00211080965375327,0.00481305750856638,-0.00732278306303684,0.0115444023705434,0.660988353955973
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,-0.0026433833507779,0.00604550755582624,-0.0144925781601973,0.00920581145864153,0.661939077133217
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INSL3,Insulin-like 3,37942,0.00246957336232066,0.00565148042066933,-0.00860732826219122,0.0135464749868325,0.662134201075402
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDAC9,Histone deacetylase 9,37541,0.0026320817403856,0.0060263202693724,-0.0091795059875843,0.0144436694683555,0.662289474240299
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBQLN3,Ubiquilin-3,37562,0.00185991893787823,0.00427094547490547,-0.00651113419293648,0.0102309720686929,0.663219930571834
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,-0.00176067804106117,0.00407350595282338,-0.00974474970859499,0.00622339362647264,0.665583758039716
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDHB15,Protocadherin beta-15,37900,-0.00164419184163638,0.00381400163248568,-0.00911963504130832,0.00583125135803556,0.666407195591005
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRR5,Proline-rich protein 5,37598,-0.00196790554442384,0.0045707861553053,-0.0109266464088222,0.00699083531997455,0.666810050002662
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTM4,Glutathione S-transferase Mu 4,37562,0.00291107564484203,0.00677991358378394,-0.0103775549793745,0.0161997062690585,0.667662739366308
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP350,Centrosome-associated protein 350,37482,0.00152227438451269,0.00355761128178307,-0.00545064372778212,0.0084951924968075,0.668736623372602
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NMRK2,Nicotinamide riboside kinase 2,37482,0.00175247246549123,0.00413825690360434,-0.00635851106557329,0.00986345599655574,0.671951472343731
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,0.00317430070718869,0.00753573256202014,-0.0115957351143708,0.0179443365287482,0.673591707012529
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37901,-0.00511499614455007,0.0122042904813658,-0.029035405488027,0.0188054131989268,0.675139085272186
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37714,-0.00216037301033345,0.00516138897022882,-0.0122766953919819,0.00795594937131504,0.675541384144483
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP152,Centrosomal protein of 152 kDa,37482,-0.00163353335283222,0.00394169990523226,-0.00935926516708746,0.00609219846142302,0.678570751147958
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37562,-0.00281821556104909,0.00680940104826241,-0.0161646416156434,0.0105282104935452,0.678975144852393
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD93,Complement component C1q receptor,39725,0.00120980939645447,0.00296585036894939,-0.00460325732668633,0.00702287611959527,0.683343148555964
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,-0.00221214405518077,0.00548596340083602,-0.0129646323208194,0.00854034421045783,0.686780384705872
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL2,Interleukin-2,40044,-0.00118118558640358,0.00293861117361444,-0.00694086348668788,0.00457849231388072,0.68772362249333
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSAP,Gamma-secretase-activating protein,39980,-0.00338026400237045,0.00841377521388799,-0.0198712634215909,0.01311073541685,0.687870944337872
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,0.00156279285796155,0.00392431193003144,-0.00612885852490007,0.00925444424082316,0.69046448231714
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A16,Protein S100-A16,39934,-0.00231784302970417,0.00584059581560231,-0.0137654108282847,0.00912972476887635,0.69148322139301
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,-0.00182315756145055,0.00463203520449992,-0.0109019465622704,0.00725563143936929,0.693884804562053
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NGF,Beta-nerve growth factor,40228,0.000450263300969271,0.00114443932182042,-0.00179283776979874,0.00269336437173729,0.694003013284543
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,37482,-0.00235238505232781,0.00602706581596546,-0.0141654340516201,0.00946066394696449,0.696318494885863
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRC1,Protein regulator of cytokinesis 1,37900,0.00172436152450209,0.00441815517192675,-0.00693522261247435,0.0103839456614785,0.696328341736386
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,0.00120270802293883,0.00309552891232803,-0.00486452864522412,0.00726994469110178,0.697628643404427
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DOC2B,Double C2-like domain-containing protein beta,37572,-0.00132898168682025,0.00342097112190246,-0.00803408508574906,0.00537612171210857,0.697666544320135
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RYR1,Ryanodine receptor 1,37562,-0.00124681554130742,0.00327049937587749,-0.0076569943180273,0.00516336323541245,0.703038072825899
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESPL1,Separin,37482,0.00207367165089163,0.00544112063150724,-0.00859092478686257,0.0127382680886458,0.703127000049899
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH12,Protocadherin-12,37959,-0.000915987648322729,0.00242545460503843,-0.00566987867419805,0.00383790337755259,0.705692041829272
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,-0.0015721760011673,0.00416868609292823,-0.00974280074330663,0.00659844874097202,0.706075922484582
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GH2,Growth hormone variant,39980,-0.00591571847300713,0.0158934391000065,-0.03706685910902,0.0252354221630057,0.709740573282289
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,-0.00198258869402381,0.0053301876806844,-0.0124297565481652,0.00846457916011761,0.709932473564375
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAGE2A,G antigen 2A,37482,-0.00218838707440996,0.00591171038242413,-0.0137753394239613,0.00939856527514134,0.711255638704755
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37998,-0.00205647638272872,0.00557084544531064,-0.0129753334555376,0.00886238069008015,0.712021854178009
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MASP1,Mannan-binding lectin serine protease 1,40192,-0.000819148648432039,0.00222805097400842,-0.00518612855748854,0.00354783126062446,0.713137260207782
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXDC1,Plexin domain-containing protein 1,39980,0.0011742013238298,0.00319577401258793,-0.00508951574084255,0.00743791838850215,0.713308420619528
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,0.00160078045213649,0.00436203447285407,-0.00694880711465749,0.0101503680189305,0.71363969092413
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37572,0.00134905427065651,0.00368464532417678,-0.00587285056472998,0.00857095910604301,0.714274972692311
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCNA,Proliferating cell nuclear antigen,37482,-0.00216517036482114,0.0059350820765955,-0.0137979312349483,0.00946759050530603,0.71526003176736
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYOM3,Myomesin-3,37671,0.00311259245362712,0.00854247684806383,-0.013630662168578,0.0198558470758322,0.715590170299163
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,-0.0018925328455422,0.00521201034484828,-0.0121080731214448,0.00832300743036042,0.716528611482163
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GKN1,Gastrokine-1,39602,-0.00095004851810509,0.00262683606226813,-0.00609864720015062,0.00419855016394044,0.717603487183538
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37714,-0.00227280448325757,0.00637756010176046,-0.0147728222827081,0.0102272133161929,0.721565241948203
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL31,Interleukin-31,37598,0.00195392203430679,0.00551489871216018,-0.00885527944152716,0.0127631235101407,0.723120644371394
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,-0.00192326410672089,0.00543010975181725,-0.0125662792202827,0.00871975100684092,0.723205855134893
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,0.00201502458709494,0.00573324600841879,-0.00922213758940588,0.0132521867635958,0.725246585631987
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL5,Interleukin-5,40044,0.00480645075178874,0.0136822287054298,-0.0220107175108537,0.0316236190144312,0.725374411878209
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,37541,-0.00167366338386211,0.00476553802195263,-0.0110141179068893,0.00766679113916504,0.725442950537992
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,-0.0016904684844128,0.00482887939591573,-0.0111550721004076,0.00777413513158203,0.726288264585875
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,-0.000961200243384743,0.00274930487984307,-0.00634983780787717,0.00442743732110768,0.726632701618798
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,0.0018942378774859,0.00543663963094666,-0.00876157579916955,0.0125500515541413,0.72752984994797
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPR101,Probable G-protein coupled receptor 101,37541,-0.00212552777211744,0.00613578854575678,-0.0141516733218007,0.00990061777756584,0.729036595684968
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,-0.00160601062101544,0.00468834089326869,-0.0107951587718221,0.00758313752979119,0.731939393263958
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G1B,Phospholipase A2,40514,-0.00134518780129312,0.00394109727282192,-0.00906973845602408,0.00637936285343785,0.73286477430091
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,37541,0.00137640016828293,0.00404268554903618,-0.00654726350782798,0.00930006384439385,0.733510492862452
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP73,Tumor protein p73,37572,0.00112043051824713,0.00332109437600258,-0.00538891445871793,0.00762977549521219,0.735845003235991
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MDM1,Nuclear protein MDM1,37572,-0.000991889676154851,0.00296637433807792,-0.00680598337878758,0.00482220402647788,0.738099846562489
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,-0.00107899210935551,0.00327258924246654,-0.00749326702458992,0.00533528280587891,0.741626527666618
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37572,-0.00209204445306973,0.00637763426741614,-0.0145922076172054,0.0104081187110659,0.742895508319962
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,0.00108796302337026,0.00335806473139071,-0.00549384385015554,0.00766976989689605,0.745954459972105
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ODAM,Odontogenic ameloblast-associated protein,39934,0.00161573158425083,0.0050324799617874,-0.00824792914085248,0.0114793923093541,0.748168718727902
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TLR4,Toll-like receptor 4,37598,0.000864342117225647,0.00269247214188434,-0.00441290328086766,0.00614158751531895,0.748199011980808
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ISM2,Isthmin-2,37998,-0.00135277791656934,0.00421830634757795,-0.00962065835782212,0.00691510252468344,0.748448610490794
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMIGO1,Amphoterin-induced protein 1,37572,-0.00149798929818045,0.00474397458618853,-0.01079617948711,0.00780020089074907,0.752184602356933
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPEP,Glutamyl aminopeptidase,37562,0.00138489209117417,0.00438946888643439,-0.00721846692623724,0.00998825110858558,0.752384538052135
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,0.000959790543313222,0.00304997764527721,-0.00501816564143011,0.00693774672805655,0.753003765056263
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB116,Beta-defensin 116,37541,-0.0023585078357521,0.00751693895768829,-0.0170917081928212,0.012374692521317,0.753709027031171
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,-0.00191908816105672,0.00616457630186067,-0.0140016577127036,0.0101634813905902,0.755569900673428
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HRG,Histidine-rich glycoprotein,37934,-0.000929188652957792,0.00298566057161035,-0.00678108337331408,0.0049227060673985,0.755640388718899
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,0.00101698324292512,0.00327699155541051,-0.00540592020567947,0.00743988669152971,0.756306988928788
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EHD3,EH domain-containing protein 3,37628,-0.00339581120931309,0.0110644303485942,-0.0250820946925577,0.0182904722739315,0.75891487737358
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SYT1,Synaptotagmin-1,37942,0.00113454981762159,0.00370437168347294,-0.00612601868198538,0.00839511831722855,0.759401359324169
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,-0.00105662653078517,0.00345038376879983,-0.00781937871763284,0.0057061256560625,0.759430932819069
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCUN1D2,DCN1-like protein 2,37482,0.00232876910247866,0.00767792257858134,-0.0127199591515408,0.0173774973564981,0.761660611637599
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRP2,Neuropilin-2,40332,0.000815615692360798,0.00272686445437757,-0.00452903863821923,0.00616027002294083,0.764864712954576
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA6C,Semaphorin-6C,37598,0.000751099254304932,0.00252136413468336,-0.00419077444967446,0.00569297295828432,0.765788773022722
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,-0.00141408834826025,0.00478646778650609,-0.0107955652098122,0.00796738851329169,0.767666588329037
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACRV1,Acrosomal protein SP-10,37598,0.000969688848695709,0.00333777622226023,-0.00557235254693435,0.00751173024432576,0.771423470425018
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUP50,Nuclear pore complex protein Nup50,37562,-0.000968437852823811,0.00336210382784271,-0.00755816135539553,0.0056212856497479,0.773316696755949
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,0.00165303105425347,0.00575485854262442,-0.00962649168929039,0.0129325537977973,0.773932398301602
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,-0.000718628675862708,0.00252355819654014,-0.00566480274108139,0.00422754538935597,0.775826348531456
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,0.00135768174456123,0.00479815268644444,-0.00804669752086987,0.0107620610099923,0.777212539907063
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYBB2,Beta-crystallin B2,37942,-0.00183088898774225,0.00651006467338301,-0.0145906157475729,0.0109288377720885,0.778530828727838
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,0.00130783564462218,0.00465651597632027,-0.00781893566896556,0.0104346069582099,0.778821131878411
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNM1,Dynamin-1,37901,0.00300612634768286,0.0107377740785348,-0.0180399108462454,0.0240521635416112,0.779513991255869
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRXN3,Neurexin-3,37572,-0.000924334615187664,0.00330899113318607,-0.00740995723623237,0.00556128800585704,0.779988075757238
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,-0.00185189648245221,0.00665768229791555,-0.0149009537863667,0.0111971608214623,0.780894432493572
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMMR,Hyaluronan mediated motility receptor,37460,0.00127166795559683,0.00462282295768204,-0.00778906504145997,0.0103324009526536,0.783255520094069
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,-0.0017731646566188,0.00650428544854907,-0.014521564135775,0.0109752348225374,0.78515281673679
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PMCH,Pro-MCH,37562,-0.00219066881008885,0.00804170972689516,-0.0179524198748034,0.0135710822546257,0.785308525510545
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,0.00141010435126248,0.00523223313880002,-0.00884507260078556,0.0116652813033105,0.78754661402204
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PITHD1,PITH domain-containing protein 1,37457,0.0020367036296342,0.00779292063790296,-0.0132374208206556,0.017310828079924,0.793824393139231
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37598,-0.000912527659387646,0.0034974406874981,-0.00776751140688392,0.00594245608810863,0.7941637046126
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,0.00201312038905226,0.0078239017746926,-0.0133217270893452,0.0173479678674498,0.796948178916015
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPLX2,Complexin-2,37482,-0.000748264837430464,0.00294153857263177,-0.00651368043978874,0.00501715076492781,0.799206998101265
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRN1,Neuritin,37959,-0.000869509645624499,0.0034705592072951,-0.00767180569192289,0.0059327864006739,0.802174534650183
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C4BPB,C4b-binding protein beta chain,40411,-0.000952871204912143,0.00387037789545679,-0.00853881188000746,0.00663306947018317,0.805533748369229
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,-0.000945176736652109,0.00386413511053475,-0.00851888155330021,0.00662852807999599,0.806768130683094
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,40403,-0.000763268148036895,0.00312733012666851,-0.00689283519630718,0.00536629890023339,0.807184529041822
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TG,Thyroglobulin,37900,0.00268054931692805,0.011118408466366,-0.0191115312771493,0.0244726299110054,0.809488186749719
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,0.000565749017635161,0.00236307616817226,-0.00406588027198247,0.00519737830725279,0.810789673891472
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,0.00116662294792253,0.00487772913988241,-0.008393726166247,0.010726972062092,0.810974915032513
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DKK3,Dickkopf-related protein 3,40536,0.000654100362413057,0.00276794158426854,-0.00477106514275329,0.0060792658675794,0.81319287006627
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PFDN4,Prefoldin subunit 4,37482,0.00121681070617824,0.00515878869334509,-0.00889441513277815,0.0113280365451346,0.813536169566764
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,0.000491846359391939,0.00215117861969001,-0.00372446373520048,0.00470815645398436,0.819151321333671
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDIA2,Protein disulfide-isomerase A2,37482,0.000880557154650459,0.00394744170598157,-0.00685642858907341,0.00861754289837433,0.823484260440577
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBLN1,Cerebellin-1,37541,-0.00204285297514925,0.00932657416109763,-0.0203229383309006,0.0162372323806021,0.8266256305742
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,40305,-0.000409127519285414,0.00198581715823126,-0.00430132914941868,0.00348307411084785,0.836774209835628
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37942,0.00075529767375234,0.00377680389515111,-0.00664723796074383,0.00815783330824851,0.841496663151486
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,-0.001087864677126,0.00547440440379746,-0.011817697308569,0.00964196795431702,0.842486145922423
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTF,Ciliary neurotrophic factor,37541,0.000632735139053496,0.00321840355472523,-0.00567533582820795,0.00694080610631494,0.84414435236969
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,0.000772612928529015,0.00398612945900405,-0.00704020081111893,0.00858542666817696,0.846315633436158
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF5,Fibroblast growth factor 5,40044,0.000584929635797958,0.0030243073142108,-0.00534271270005522,0.00651257197165114,0.846640828853053
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MZT1,Mitotic-spindle organizing protein 1,39980,-0.000951301661831544,0.00495747564706782,-0.0106679539300845,0.00876535060642139,0.847829037501196
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,37541,-0.00140491699003584,0.00768829571797747,-0.0164739765972717,0.0136641426172,0.855009162691195
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD82,CD82 antigen,37714,0.000702955211620503,0.00397352241069018,-0.00708514871333224,0.00849105913657325,0.85958191129656
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNF830,Zinc finger protein 830,37900,0.0013495074177995,0.00764999950763382,-0.0136444916171628,0.0163435064527618,0.859977482825945
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,-0.00103920373750496,0.00598707905335769,-0.012773878682086,0.0106954712070761,0.862202590646021
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLMH,Bleomycin hydrolase,40536,-0.000523979470266443,0.00303475272561984,-0.00647209481248132,0.00542413587194844,0.862921101638073
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NXPE4,NXPE family member 4,37562,0.000584725903888961,0.00344215576147165,-0.00616189938859546,0.00733135119637339,0.865113418257551
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,-0.00103268255449123,0.00609089181898168,-0.0129708305196953,0.0109054654107129,0.865370314638081
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASQ2,Calsequestrin-2,37562,-0.000801982121542565,0.00474608712686938,-0.0101043128902065,0.00850034864712141,0.865816915709053
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPC1,Glypican-1,40489,-0.000461524696241367,0.00275491562385872,-0.00586115931900447,0.00493810992652173,0.866956961243104
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRR1B,Cornifin-B,37714,-0.00134887216762602,0.00808703229844949,-0.017199455472587,0.014501711137335,0.867534322488456
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APPL2,DCC-interacting protein 13-beta,37671,-0.00174242290039975,0.0105679128716806,-0.0224555321288937,0.0189706863280942,0.869042041190347
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPP1,Osteopontin,40497,-0.000727139538691011,0.00447719010835919,-0.00950243215107502,0.008048153073693,0.870985201175522
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPB2,Carboxypeptidase B2,37981,0.000342548285400754,0.00211542769375706,-0.00380368999436308,0.00448878656516459,0.871364483531458
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEBP1,Heme-binding protein 1,40042,0.000829255419639693,0.00512566228673612,-0.00921704266236311,0.0108755535016425,0.87147723972038
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,37541,-0.00114618160571288,0.00718077168145729,-0.0152204941013692,0.0129281308899434,0.873184331014924
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMBN,Ameloblastin,40044,0.000436726039371843,0.00278393318096687,-0.00501978299532322,0.00589323507406691,0.875346378855949
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPR158,Probable G-protein coupled receptor 158,37959,-0.000541294609825031,0.00349453043821813,-0.00739057426873256,0.0063079850490825,0.876904307892503
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,0.000485787045797775,0.00315617022447393,-0.00570030659417113,0.00667188068576668,0.877677775419527
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPT1,Translationally-controlled tumor protein,40044,-0.000951256823775002,0.00623853019094133,-0.01317877599802,0.01127626235047,0.878809610979765
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,-0.000572312612303514,0.00385018181960468,-0.00811866897872868,0.00697404375412166,0.881835558617782
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBM19,Probable RNA-binding protein 19,37562,0.000669164961694408,0.00452948662440075,-0.00820862882213105,0.00954695874551987,0.882553961914368
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLGAP5,Disks large-associated protein 5,37959,0.000749456008704396,0.00509246427252175,-0.00923177396543823,0.010730685982847,0.883000339312284
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,0.000647102272769112,0.00444978144902719,-0.00807446936732418,0.0093686739128624,0.884378433453595
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOX2,Transcription factor SOX-2,37937,0.000313210620863945,0.0022093532907436,-0.00401712182899351,0.0046435430707214,0.887267157998677
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLMP,CXADR-like membrane protein,40489,-0.000263656325074982,0.00191374403540498,-0.00401459463446875,0.00348728198431878,0.890424003132732
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37562,-0.000502841040500844,0.00368523794494711,-0.00772590741259718,0.00672022533159549,0.891469719845515
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,-0.000782763996693723,0.00575434795631782,-0.0120612859910766,0.0104957579976892,0.891799647336315
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARF2,Scavenger receptor class F member 2,40471,-0.000374208578673074,0.00278857677884385,-0.00583981906520701,0.00509140190786086,0.893251336369982
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BEX3,Protein BEX3,37482,0.000565581635497025,0.00453396909316799,-0.00832099778711224,0.00945216105810629,0.900728811208667
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FRMD7,FERM domain-containing protein 7,37572,0.000388521095808313,0.00316079742008986,-0.00580664184756781,0.00658368403918444,0.902173363722764
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,H2AP,Huntingtin-interacting protein M,37482,-0.000598036086853835,0.00494639566104575,-0.0102929715825035,0.00909689940879584,0.903769407948486
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37572,0.000335678527708722,0.00280039632805612,-0.00515309827528127,0.00582445533069871,0.90458937375391
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTP1,Glutathione S-transferase P,39871,0.000785226433795881,0.00656160052969309,-0.0120755106044026,0.0136459634719943,0.904746161571171
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37598,-0.000548813139340807,0.00463592066367075,-0.00963521764013547,0.00853759136145386,0.905766184388784
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL24,C-C motif chemokine 24,40396,-0.000916831550126526,0.00778601001509486,-0.0161774111797124,0.0143437480794594,0.906264293180488
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,-0.000598638333349836,0.00517088125768068,-0.010733565598404,0.00953628893170429,0.907835769708472
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF16,Fibroblast growth factor 16,37598,-0.000523523992073469,0.00465237803666298,-0.00964218494393292,0.00859513695978598,0.91040628419939
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCHE,Cholinesterase,37748,-0.000299050568626479,0.00267983727518349,-0.00555153162798612,0.00495343049073316,0.911147958629405
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DIPK1C,Divergent protein kinase domain 1C,37572,0.000450658654166308,0.00407650026746358,-0.00753928187006231,0.00844059917839493,0.911974588040933
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MUC2,Mucin-2,37998,0.000909932448845967,0.00857713975624364,-0.0159012614733916,0.0177211263710835,0.9155140246331
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,-0.000497784546782094,0.0049256527750066,-0.010152063985795,0.00915649489223083,0.919504686078025
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,0.000467839928951959,0.0046999697530432,-0.00874410078701271,0.00967978064491663,0.920710220143696
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LACRT,Extracellular glycoprotein lacritin,37863,-0.000491823165825231,0.00503624763473316,-0.0103628685299022,0.00937922219825176,0.92220638391845
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,0.000630323994380142,0.00651163884066281,-0.012132488133319,0.0133931361220793,0.922886797349698
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL36A,Interleukin-36 alpha,37598,-0.00053970525952158,0.00560184786597884,-0.0115193270768401,0.0104399165577969,0.923248717763606
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAP1,Antigen peptide transporter 1,37714,-0.000560713135381522,0.00585079657073235,-0.0120282744140169,0.0109068481432539,0.923652789560262
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTO1,Protein LTO1 homolog,40044,-0.000360732734226193,0.00386053419028491,-0.00792737974718462,0.00720591427873223,0.925554305255978
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,-0.000409425305910095,0.0047977541553517,-0.00981302345039942,0.00899417283857923,0.931994871350584
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMC3,Structural maintenance of chromosomes protein 3,37482,0.000449304609011424,0.00529809494856388,-0.00993496149017378,0.0108335707081966,0.932417771298703
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,0.000525706345865354,0.00624655248876696,-0.0117175365321179,0.0127689492238486,0.932930941474873
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL3,Interleukin-3,37482,-0.000452268638757997,0.00571478489482435,-0.0116532470326137,0.0107487097550977,0.936922404914991
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MORF4L1,Mortality factor 4-like protein 1,37714,0.000300676089887417,0.00387829192305156,-0.00730077607929365,0.00790212825906848,0.938204712994214
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFAP2A,Transcription factor AP-2-alpha,37541,-0.000445262383970905,0.00576325928381974,-0.0117412505802576,0.0108507258123158,0.9384188621316
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,37541,-0.000396176899544485,0.0053878418157061,-0.0109563468583284,0.0101639930592395,0.941384182645974
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RELB,Transcription factor RelB,37598,0.000356811431590401,0.00488487220231567,-0.00921753808494831,0.00993116094812911,0.941772080707334
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HRAS,GTPase Hras,37697,-0.000675610159418269,0.00934186135384832,-0.018985658412961,0.0176344380941244,0.942347765961931
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPTXR,Neuronal pentraxin receptor,40359,0.000227587889171134,0.00318953983669005,-0.00602391019074136,0.00647908596908363,0.943116550746683
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCP11,T-complex protein 11 homolog,37714,0.000407621783306435,0.00576761548574835,-0.0108969045687603,0.0117121481353732,0.943658096662518
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,-0.000654434031640398,0.00942627360653679,-0.0191299303004525,0.0178210622371717,0.94465093799727
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLIC5,Chloride intracellular channel protein 5,37572,0.000212563737300346,0.00306339649930901,-0.00579169340134532,0.00621682087594601,0.944681635051382
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMPRSS11B,Transmembrane protease serine 11B,37541,0.000502097514692578,0.00746652376073879,-0.0141322890563555,0.0151364840857406,0.946386502376622
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HK2,Hexokinase-2,40042,-0.000167565811589521,0.0026026592654356,-0.0052687779718433,0.00493364634866426,0.94866645851803
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,0.00023999713301423,0.00388599081365931,-0.00737654486175802,0.00785653912778648,0.950755215935261
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YY1,Transcriptional repressor protein YY1,37598,-0.000160364893864814,0.00266054589524763,-0.00537503484855016,0.00505430506082053,0.951937382389443
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBR1,T-box brain protein 1,37572,0.000250366686505461,0.00463343749440169,-0.00883117080252184,0.00933190417553277,0.956908292315283
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL4A4,Collagen alpha-4(IV) chain,37688,0.000245689521507595,0.00498211023612114,-0.00951924654128983,0.010010625584305,0.960669528891253
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,0.000322859836375145,0.00667935920299917,-0.0127686842015032,0.0134144038742535,0.961448445266231
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA11,Carbonic anhydrase-related protein 11,39980,0.000145191155936664,0.00311582012057277,-0.00596181628038596,0.00625219859225929,0.962834181832499
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37714,0.000298637759743755,0.00644943294143905,-0.0123422508054768,0.0129395263249643,0.963068250848263
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37572,-0.000152852007505642,0.00342417817383559,-0.00686424122822339,0.00655853721321211,0.964395707997089
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLP1R,Glucagon-like peptide 1 receptor,37541,0.000159019915010361,0.00364785853674831,-0.00699078281701633,0.00730882264703705,0.965229754874179
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FIS1,Mitochondrial fission 1 protein,40354,0.000289886498499524,0.00724403780465159,-0.0139084275986176,0.0144882005956166,0.968079873227575
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,0.000104007424101139,0.00274103545874415,-0.0052684220750374,0.00547643692323968,0.96973235910628
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",37482,0.000298827808851881,0.00859959158436976,-0.0165563716965129,0.0171540273142166,0.972280364707048
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHA10,Ephrin type-A receptor 10,39961,0.000185130359635284,0.00614101974969433,-0.0118512683497656,0.0122215290690362,0.975950589842595
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGAX,Integrin alpha-X,37714,-0.000142861809203721,0.00524153079339004,-0.0104162621642482,0.0101305385458408,0.978256166877505
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANK2,Ankyrin-2,37562,0.000176400959484096,0.00702707807386516,-0.0135966720652916,0.0139494739842598,0.979973164535118
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,-7.96035138386744e-05,0.00323183443708621,-0.00641399901052765,0.0062547919828503,0.980349616053365
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPNMB,Transmembrane glycoprotein NMB,39957,6.07048889745842e-05,0.00265123677543083,-0.00513571919086985,0.00525712896881902,0.981732872322568
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KDM3A,Lysine-specific demethylase 3A,37598,-0.000193766070151552,0.00877594985345062,-0.0173946277829148,0.0170070956426117,0.982385102786203
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MORF4L2,Mortality factor 4-like protein 2,37482,6.46441411083129e-05,0.00345589011990212,-0.00670890049389983,0.00683818877611646,0.98507632972177
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSG3,Desmoglein-3,40419,-5.65505693547011e-05,0.00314339387368838,-0.00621760256178393,0.00610450142307452,0.985646823895339
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAS6,Growth arrest-specific protein 6,40429,-4.23695833682121e-05,0.00241461800359967,-0.00477502087042357,0.00469028170368715,0.986000364211044
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA6,Corticosteroid-binding globulin,38013,-2.86472524314648e-05,0.00169312411229239,-0.00334717051252454,0.00328987600766161,0.986500878296574
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPHS2,Podocin,37598,0.00016018994306967,0.00993973132307787,-0.019321683450163,0.0196420633363023,0.98714199461831
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UPK3A,Uroplakin-3a,37541,6.45966789164955e-05,0.00475755793785114,-0.00926021687927173,0.00938941023710472,0.989167105188448
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37942,-3.58044172992783e-05,0.00293684871509944,-0.00579202789889418,0.00572041906429562,0.990273058839192
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,6.52477599815082e-05,0.00550322575608303,-0.0107210747219412,0.0108515702419042,0.990540463258312
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,5.91744592628006e-05,0.00585501727150888,-0.0114166593928946,0.0115350083114202,0.991936371224255
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,3.63256633909754e-05,0.00499568208149638,-0.00975521121634194,0.00982786254312389,0.994198414273083
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,-2.5073036088368e-05,0.00467393812690571,-0.00918599176482356,0.00913584569264682,0.995719889863206
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAND5,DAN domain family member 5,37598,1.09050229656911e-05,0.0051587920475699,-0.0101003273902713,0.0101221374362027,0.998313407977504
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYTH3,Cytohesin-3,37482,-5.5067348524855e-06,0.00700250572041491,-0.0137304179468657,0.0137194044771607,0.999372559746162
